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ABSTRACT 
 
MEGHAN ELIZABETH FELTCHER: Identification of Targeting Elements and  
Substrates of the Mycobacterial SecA2 Protein Export System 
(Under the direction of Miriam Braunstein) 
 
 
Tuberculosis disease is a major global health crisis, as nearly one-third of the 
world’s population is infected with Mycobacterium tuberculosis, resulting in 1.4 million 
deaths annually. The essential general Sec export pathway is the most widely conserved 
system for exporting proteins in bacteria. Central to Sec export is the SecA ATPase, 
which powers translocation of unfolded preproteins containing Sec signal peptides 
through the SecYEG membrane channel. Mycobacteria have two non-redundant SecA 
homologs: SecA1 and SecA2. While the essential SecA1 handles housekeeping export, 
the nonessential SecA2 exports a subset of proteins and is required for M. tuberculosis 
virulence. SecA2 is thought to function in concert with the SecA1/SecYEG machinery, 
but this relationship is poorly understood. Using two SecA2 substrates of the model 
organism M. smegmatis, we demonstrated that there does not appear to be SecA2-specific 
signal peptides, and instead it is the mature portion of the preprotein that dictates SecA2-
dependent export. We also demonstrated that export of a SecA2 substrate is influenced by 
presence of both SecA2 and a functional twin-arginine translocation (Tat) pathway. 
Because the Tat system only accommodates proteins that fold in the cytoplasm, this result 
suggests that mycobacterial SecA2 substrates might be amenable to cytoplasmic folding. 
Furthermore, there may be a preprotein pool shared between the mycobacterial SecA2
iv 
 
and Tat export systems, suggesting that some mycobacterial Sec signal peptides might be 
compatible for export by the Tat pathway. We also performed a proteomic analysis of the 
M. tuberculosis secA2 mutant cell wall, which led to the identification of several 
candidate SecA2-dependent exported effectors that could explain the attenuation of the 
secA2 mutant. Additionally, our proteomic analysis revealed that export of several 
predicted Tat substrates is reduced in the M. tuberculosis secA2 mutant. We propose 
that SecA2 functions in export by adapting proteins with cytoplasmic folding tendencies, 
a property shared with Tat substrates, for export via SecYEG. Thus, our work has led to a 
model for mycobacterial SecA2 export where SecA2 would serve an integral role in 
connecting Sec- and Tat-mediated export. 
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CHAPTER 1 
INTRODUCTION
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Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), is a serious 
global health threat accounting for nearly two million deaths every year (169). There is 
no effective mycobacterial vaccine available and increased prevalence of drug-resistant 
M. tuberculosis strains seriously undermine current therapies (148). M. tuberculosis is 
spread through aerosols released from infected individuals and inhaled bacilli are 
engulfed by alveolar macrophages inside the lung. Instead of being killed, M. 
tuberculosis survives within the phagosomal compartment of the macrophage, blocks 
phagosome maturation, and replicates intracellularly (129). Another significant feature of 
M. tuberculosis pathogenesis is the ability of the bacteria to persist long-term in a latent 
state in the host and later reactivate to cause disease, particularly in individuals who 
become immune-compromised.  
The ability of M. tuberculosis to reside in a latent state has contributed to an 
ongoing HIV-TB co-epidemic, where TB is the leading killer of those infected with HIV 
(169). The ability of M. tuberculosis to survive and replicate within macrophages is  
________________________ 
1
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essential for M. tuberculosis pathogenesis, but our understanding of this process is 
incomplete. A better understanding of M. tuberculosis biology will facilitate the 
discovery of novel mycobacterial targets for new TB treatment strategies.The research 
described in this thesis is directed at elucidating the mechanisms of the SecA2-dependent 
protein export pathway that contributes to the success of M. tuberculosis as an 
intracellular pathogen. 
Bacterial protein export 
Over 20% of bacterial proteins have functions outside the cytoplasm and are 
exported to their proper locations by protein export systems (137). All bacteria, including 
mycobacteria, have systems for exporting these specific proteins out of the cytoplasm and 
into the cell envelope or extracellular environment, where they have roles in cell wall 
synthesis, nutrient acquisition, and other vital physiological processes (23, 30, 99). For 
bacterial pathogens like M. tuberculosis, some exported proteins are virulence factors that 
are required for modulation of the host environment to promote bacterial survival and 
growth.  
Most exported proteins are translocated across the bacterial cytoplasmic 
membrane by the conserved general secretion (Sec) pathway or twin-arginine 
translocation (Tat) pathway (35, 97). The Sec pathway is present and essential for 
viability in all bacteria, while Tat systems are not universal but found in many Gram 
positive and Gram negative species (34). Mycobacteria possess functional Sec and Tat 
pathways, which are both essential for in vitro growth of M. tuberculosis (16, 131, 135). 
In addition to the conserved Sec and Tat systems, M. tuberculosis also has specialized 
protein export systems that are dedicated to exporting specific subsets of proteins. These 
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systems include five ESX pathways (ESX-1 through ESX-5) and the SecA2 export 
pathway (1, 48). Both ESX-1 and the SecA2 system are essential for M. tuberculosis 
virulence, presumably because they export effectors that modulate the host immune 
response or promote bacterial growth in the intracellular environment. The research 
described in this thesis is aimed at elucidating the mechanisms of SecA2-dependent 
export and how SecA2-dependent exported effectors promote intracellular M. 
tuberculosis growth. 
 
The general Sec export pathway 
Although best studied in Escherichia coli, all bacteria have a general secretion 
(Sec) pathway, which performs the bulk of protein export [for extensive reviews of Sec 
export, see references (97, 114)]. The Sec pathway translocates unfolded proteins through  
a heterotrimeric protein complex composed of the SecY, SecE, and SecG proteins (19). 
SecY forms the channel through which the unfolded proteins pass the cytoplasmic 
membrane (159). SecE is thought to stabilize an open SecY conformation necessary for 
translocation while SecG increases export efficiency (37, 63, 101, 102, 153, 155).  
The SecYEG channel is used in two types of Sec export: post-translational and 
co-translational. In post-translational Sec export, proteins translocate completely across 
the cytoplasmic membrane through SecYEG with energy provided by the cytoplasmic 
SecA motor protein. In co-translational export, SecYEG works with the signal 
recognition particle (SRP) to insert integral membrane proteins into the cytoplasmic 
membrane (174) or, in some cases, translocate proteins across the cytoplasmic membrane 
(142). For integral membrane proteins, SRP recognizes transmembrane domains as they 
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emerge from the ribosome during translation and targets them as ribosome-mRNA-
nascent protein complexes to FtsY for delivery to SecYEG (158). A lateral gate in SecY 
is thought to then open and allow passage of transmembrane domains into the membrane 
(41). 
In post-translational Sec export, the proteins destined for translocation across the 
cytoplasmic membrane are synthesized as preproteins that are distinguished from the 
larger pool of cytoplasmic proteins by the presence of N-terminal Sec signal peptides. 
Sec signal peptides have a positively charged N-terminus, hydrophobic core, and polar C-
terminus containing a signal peptidase cleavage site (164). In addition to the signal 
peptide, another requirement for Sec export is that the mature portion of the preprotein 
remains unfolded for competent passage through SecY. Some proteins are recognized and 
kept unfolded by cytoplasmic chaperones, such as SecB (6, 51), although other 
preproteins may be unfolded as they are translocated (3, 104). 
 A central component of the post-translational Sec pathway is the cytosolic SecA 
ATPase motor protein (77), which has a vital role in targeting and powering preprotein 
transport through SecYEG (19, 40). Since the discovery of SecA in 1981, Sec export has 
been the focus of extensive study (108). A combination of genetic, structural and 
biochemical studies including in vitro reconstitution have led to a relatively sophisticated 
understanding of the Sec pathway and SecA function in particular (Figure 1.1). SecA 
binds preproteins along a cleft that includes the SecA preprotein-crosslinking (PPXD) 
domain, and targets them to the SecYEG complex in the membrane through interactions 
with SecY and membrane phospholipids (4, 18, 53, 74, 93, 96, 113, 160). After delivery 
to SecYEG, the signal peptide of the preprotein inserts into SecY to stabilize an open 
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SecY channel conformation (58, 67, 82, 147). SecA then undergoes cycles of 
conformational changes coupled to ATP-binding and hydrolysis to drive preproteins 
through the SecY channel (40, 57, 161). Several models have been proposed to explain 
how SecA powers preprotein insertion through SecY (77). Nonetheless, most of these 
models propose that portions of SecA, including the IRA-1 (intramolecular regulator of 
ATP hydrolysis 1) two-helix finger, insert into SecY to promote forward preprotein 
motion through the channel (42, 168). During or shortly after translocation through the 
SecYEG channel, the signal peptide is removed. This cleavage event takes place on the 
periplasmic side of the membrane by one of two possible peptidases: the Type I signal 
peptidase (LepB) or the lipoprotein Type II signal peptidase (LspA) (110).  After signal 
peptide cleavage, the protein folds into a mature conformation. 
SecA, SecY, and SecE all have essential roles in Sec export and are consequently 
essential for cell viability (95, 107). The SecG component of SecYEG is not essential but 
increases translocation efficiency, possibly by stabilizing the SecY/E complex or 
assisting the conformational changes of SecA (100-102). Other non-essential membrane-
bound proteins that increase Sec export efficiency are SecD, SecF and YajC (38, 100, 
117). 
 
The Sec pathway of mycobacteria 
Mycobacteria have homologs of all the Sec export factors reviewed above except 
the SecB chaperone (Figure 1.1). However, detailed studies have focused on only a few 
components of the mycobacterial Sec pathway. The M. tuberculosis Type I signal 
peptidase LepB is essential for in vitro growth, which is expected given the essential role 
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of the general Sec pathway (109). The M. tuberculosis Type II signal peptidase (LspA) 
removes signal peptides from lipoproteins (133), but this lipoprotein processing is not 
required for in vitro growth. However, an lspA mutant of M. tuberculosis is attenuated in 
both macrophages and mice, illustrating the importance of functional lipoproteins to M. 
tuberculosis virulence (120, 133). The other components of the mycobacterial Sec 
pathway to receive attention are the SecA proteins. Mycobacteria are unusual in having 
two homologs of SecA: SecA1 and SecA2. SecA1 is the “housekeeping” SecA protein of 
mycobacteria responsible for exporting the majority of proteins while SecA2 is an 
accessory SecA, which is discussed in detail below.  As is the case for housekeeping 
SecA proteins of other bacteria, SecA1 of mycobacteria is essential. The secA1 gene 
cannot be deleted from M. tuberculosis or the nonpathogenic M. smegmatis unless an 
exogenous copy of secA1 is provided (16, 61, 135).  The contribution of SecA1 to protein 
export in mycobacteria can be examined by conditional silencing of secA1 in M. 
smegmatis (61). Under the control of a tetracycline repressor, SecA1 depletion leads to 
growth inhibition and decreased Sec export as evidenced by reduced export of the cell 
wall porin, MspA (61, 125). 
 
SecA2 Systems 
For years, it was thought that all bacterial species had a single SecA protein (39). 
However, we now know that a number of bacteria possess two SecA homologs: SecA1 
and SecA2. The first example of a second SecA was revealed by the Mycobacterium 
tuberculosis genome sequencing project (16, 29). It is now recognized that two SecA 
proteins exist in all mycobacteria and a diverse, but small, set of Gram positive bacteria 
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including Listeria, Staphylococcus, and some Streptococcus species (48, 124). In bacteria 
with two SecAs, the two proteins are not interchangeable and each SecA has unique 
functions (10, 16). SecA1 is the name given to the SecA with higher sequence similarity 
to the well-studied SecA proteins of Escherichia coli and Bacillus subtilis. SecA1 is 
essential and is responsible for canonical Sec export, as described above (16, 24, 43, 61, 
125). Unlike SecA1, SecA2 is responsible for exporting a smaller set of proteins and 
often dispensable. Notably, proteins exported by SecA2 are linked to virulence in many 
bacterial pathogens including M. tuberculosis (17, 76, 150), Streptococcus gordonii 
(175), Streptococcus parasanguinis (172), Staphylococcus aureus (146), and Listeria 
monocytogenes (80).  
Currently, there are two types of SecA2 systems known to exist. Some bacteria 
with a SecA2 also have an accessory SecY2 protein. As a consequence, these SecA2–
SecY2 systems appear to function largely independent of the canonical Sec machinery to 
export a set of proteins that are highly glycosylated and incompatible with the canonical 
SecA1/SecYEG (12, 26). There are also SecA2-only systems, so named because they 
lack a SecY2 or an obvious accessory membrane channel. SecA2-only systems likely 
function as part of the canonical Sec pathway, utilizing SecYEG (43, 125)
 
. Furthermore, 
the repertoire of proteins exported by SecA2-only systems is more diverse than that of 
SecA2–SecY2 systems. 
 While several published crystal structures for SecA (SecA1) proteins exist (134), 
including those of M. tuberculosis (141), B. subtilis (69) and E. coli (112), there is no 
structure available for any SecA2 protein. However, sequence alignments and structural 
modeling predict that most domains, including PPXD and IRA-1 mentioned above, are 
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conserved between SecA (SecA1) and SecA2 (Figure 1.2). In addition, all SecA2 
proteins have two nucleotide-binding domains (NBD1 and NBD2) which together 
constitute the DEAD (Asp-Glu-Ala-Asp)-like motor domain. The motor domain contains 
two ATP-binding Walker boxes and is responsible for ATP hydrolysis, suggesting that 
SecA2 proteins are functional ATPases (69, 73, 143). In fact, SecA2 from S. gordonii and 
M. tuberculosis have demonstrated endogenous ATPase activity in vitro (10, 68). 
Furthermore, SecA2 ATPase activity is shown to be required for accessory SecA2 protein 
export in mycobacteria and C. difficile (43, 68, 125).  
Even though SecA2 proteins of SecA2–SecY2 and SecA2-only systems likely 
function differently, it is interesting that all SecA2 proteins are smaller than their SecA1 
counterparts due to a carboxyl-terminal domain (CTD) truncation, although the boundary 
of this truncation varies (Figure 1.2). In E. coli, portions of the SecA CTD binds 
phospholipids, SecB, and Zn+ (18, 45-47, 162, 180). One area of the CTD missing in all 
SecA2 proteins is the C-terminal linker (CTL), which lies within the preprotein-binding 
cleft and in E. coli, has been shown to influence substrate binding (53). In addition to the 
CTD truncation, the helical wing domain (HWD) is absent in the mycobacterial SecA2 
and truncated in other SecA2 proteins. However, even in the canonical SecA1, the 
function of the HWD is not clear. The significance of the CTD and HWD truncations in 
SecA2 proteins awaits further studies. 
 
SecA2–SecY2 systems  
Bacteria with SecA2–SecY2 systems share a conserved secA2–secY2 genomic 
locus, composed of a suite of similarly arranged homologous genes (Figure 1.3a). In 
9 
 
addition to genes encoding SecA2 and SecY2, each locus contains a gene that encodes a 
large serine-rich glycosylated protein that is exported by the SecA2–SecY2 system, as 
well as glycosylation factors that modify this substrate, and additional export machinery 
with unknown functions. The SecA2–SecY2 systems that are found in a subset of Gram 
positive species include pathogenic Streptococcus gordonii (9), Streptococcus agalactiae 
(91), Streptococcus parasanguinis (27), Streptococcus pneumoniae (105), and 
Staphylococcus aureus (145), although it should be noted that not all streptococcal 
species possess SecA2–SecY2 systems (124).  
The current model of SecA2–SecY2 export suggests that these specialized 
systems exist to export the large serine-rich protein encoded in the secA2–secY2 locus. 
The serine-rich substrates have cleavable N-terminal signal peptides that are unusually 
long and mature domains that are heavily glycosylated (124). Examples of 
experimentally confirmed SecA2–SecY2-exported substrates include GspB of S. gordonii 
(9), Fap1 of S. parasanguinis (27), Srr1 of S. agalactiae (91), and SraP of S. aureus 
(145). These substrates have roles related to bacterial adhesion to host tissues and/or 
biofilm formation (9, 91, 132, 146, 171, 172). Consequently many of these exported 
glycoproteins, and presumably their respective SecA2–SecY2 systems, are required for 
virulence (91, 105, 146, 175). In S. parasanguinis, the FimA adhesin is a second protein 
whose export is reported to depend on SecA2 (27). However, FimA is not a serine-rich 
glycoprotein and the fimA gene is not at the S. parasanguinis secA2–secY2 locus. It is 
currently unknown whether FimA is a true SecA2–SecY2 substrate.  
SecA2 is not essential for growth in bacteria with SecA2–SecY2 systems; 
however, SecA2 is absolutely required for export of their respective serine-rich 
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substrates, suggesting a lack of functional redundancy with canonical SecA1. Mutations 
in secA2 abolish export of the serine-rich glycosylated substrates of S. gordonii (9), S. 
parasanguinis (27), S. agalactiae (91), and S. aureus (145). Another notable Gram 
positive pathogen with a putative SecA2–SecY2 pathway is Bacillus anthracis. However, 
the B. anthracis secA2 is phylogenetically more distant from those of Streptococcus and 
Staphylococcus (124), which is also reflected by the dissimilar organization of the B. 
anthracis secA2 locus (Figure 1.3a). B. anthracis SecA2 is required for optimal export of 
two glycosylated proteins, Sap and EA1, but it appears that SecY2 is not required for this 
export (98). Furthermore, the Bacillus SecA2–SecY2 system lacks the additional export 
machinery found in the other SecA2–SecY2 systems, which suggests this system may 
function differently than those of streptococcal and staphylococcal species. 
Below, we discuss other genes in the secA2–secY2 loci that have also been 
analyzed for roles in glycosylation and/or export.  
Glycosylation factors of SecA2–SecY2 systems 
In export-defective SecA2–SecY2 mutants, the serine-rich substrate retained in 
the cytoplasm is glycosylated, indicating that the protein is modified by cytoplasmic 
glycosylation factors prior to export (7, 27). There are two core glycosyltransferases 
conserved in all SecA2–SecY2 systems, GtfA and GtfB (Gtf1 and Gtf2) (Figure 1.3a).  
Some SecA2–SecY2 systems include additional glycosylation factors that further modify 
the substrate prior to export, including Gly and Nss of S. gordonii (151), Nss (Gtf3) and 
GalT1-2 of S. parasanguinis (173, 182), and the GtfC-GtfH proteins of S. agalactiae 
(91).  
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Export machinery of SecA2–SecY2 systems 
In S. gordonii (9) and S. aureus (145), secY2 mutations result in a loss of substrate 
export that is equivalent to the export defect exhibited by secA2 mutations, demonstrating 
that SecY2 is essential for accessory SecA2–SecY2 export in these systems. However, in 
S. parasanguinis (170), deletion of secY2 has only a modest effect on Fap1 export and the 
residual exported Fap1 species is incorrectly glycosylated (170). This result suggests that 
in the absence of SecY2 and full glycosylation, Fap1 export defaults to the canonical 
SecA1/SecYEG pathway. This result also suggests that in the S. parasanguinis SecA2–
SecY2 system, export and glycosylation of Fap1 are coupled (as discussed further 
below).   
There are additional proteins encoded by SecA2–SecY2 loci that are referred to as 
accessory secretion proteins (Asps) in S. gordonii or glycosylation accessory proteins 
(Gaps) in S. parasanguinis. All SecA2–SecY2 systems include the Asp1, Asp2, and Asp3 
proteins (Gap1-3). While Asp1 and Asp3 are primarily cytosolic proteins, Asp2 may be 
membrane localized (140, 178). Some organisms, including S. gordonii, have the 
additional Asp4 and Asp5 (Figure 1.3). Asp4 and Asp5 are both required for GspB export 
in S. gordonii (152) and are predicted integral membrane proteins with sequence 
homology to B. subtilis SecE (17% identity) and SecG (15% identity), respectively. This 
sequence homology is intriguing, albeit limited, and suggests that Asp4 and Asp5 may be 
accessory components of a SecY2 membrane channel. With regard to the role(s) of Asps 
1-3, findings in different bacterial systems are not in complete agreement. In both S. 
aureus and S. gordonii, Asps 1-3 are clearly required for export of the respective serine-
rich glycoproteins, SraP and GspB (145, 151). By contrast, deletion of either gap1 or 
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gap3 in S. parasanguinis (the asp1 and asp3 homologs) has only a modest effect on 
export of Fap1, and the residual exported Fap1 protein has altered glycosylation (83, 
115). On the basis of this result, the Asp1 and Asp3 homologs of S. parasanguinis were 
named Gap1 and Gap3 to reflect a proposed function in glycosylation. However, a secY2 
deletion in S. parasanguinis results in a phenotype similar to that of the gap1 and gap3 
mutants – export of an aberrantly glycosylated Fap1 (83, 115, 170). It seems highly 
unlikely that SecY2 would have a direct role in protein glycosylation. Additionally, the S. 
gordonii and S. aureus studies of Asp1-3 in SecA2–SecY2 export are compelling. It is 
possible that the discrepancy in S. parasanguinis results is because Fap1 glycosylation 
and export are highly coupled processes. In this case, export defects of gap1, gap3 and 
secY2 mutants (83, 115, 170) would indirectly affect Fap1 glycosylation to such an extent 
that the resulting altered Fap1 species is then compatible for export by the canonical 
SecA1/SecYEG system. However, at this time, a more direct role for Gaps in 
glycosylation cannot be ruled out. In fact, it was recently demonstrated that in addition to 
a role in GspB export, S. gordonii Asp2 is required for N-acetylglucosamine deposition 
on GspB (139). While currently there is no clear understanding of the function of any of 
the Asp proteins, a network of interactions between Asp1, Asp2, Asp3 and SecA2 has 
been mapped in S. gordonii (140) and S. parasanguinis (83, 181, 183). Asp3 may be a 
central scaffolding protein in this network as it interacts with multiple members of the 
SecA2–SecY2 system in S. gordonii including Asp1, Asp2, SecA2, and itself (140). 
Interestingly, the S. gordonii Asp2 and Asp3 proteins also bind the GspB substrate prior 
to its glycosylation, which suggests a possible function for these proteins in delivering the 
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substrate to an export/glycosylation complex (179). In S. parasanguinis, interactions 
between Gap1 (Asp1), Gap3 (Asp3), and SecA2 have also been identified (83, 181, 183). 
Targeting proteins to the SecA2–SecY2 pathway 
The serine-rich glycoproteins exported by SecA2–SecY2 systems have features 
that not only prevent their routing to the canonical SecA1/SecYEG pathway but promote 
their targeting to the SecA2–SecY2 pathway (Figure 1.4). The characteristic 
glycosylation of these exported substrates is one such element (7, 27, 91). In addition to 
being important for protein stability (12, 91), glycosylation of these proteins blocks their 
export by the canonical Sec pathway in both S. gordonii and S. parasanguinis (12, 26). 
For example, in the absence of secA2, the canonical SecA1/SecYEG pathway can export 
a stable, truncated GspB variant that is non-glycosylated. However, a glycosylated GspB 
protein cannot utilize the canonical Sec pathway and instead requires SecA2–SecY2  for 
export (12).  
As mentioned above, SecA2–SecY2 serine-rich proteins are glycosylated in the 
cytoplasm prior to export. This is in contrast to many other glycosylated Sec substrates in 
bacteria (103, 163), as well as the analogous eukaryotic Sec pathway where glycosylation 
occurs only after proteins are translocated from the cytosol into the endoplasmic 
reticulum lumen (138). However, there is evidence that some bacterial proteins in 
addition to SecA2–SecY2 substrates share the unusual property of being glycosylated 
prior to Sec export (25, 28, 59), such as the HMW1 adhesin of Haemophilus influenza 
(59). But, there is likely a limit to the modifications that the SecA1/SecYEG system can 
handle, as the level and/or type of glycosylation of SecA2–SecY2 substrates appear 
incompatible with canonical Sec export. It will be interesting in the future to determine 
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the degree and structure of glycosylation modifications that are incompatible with the 
SecA1/SecYEG.  
In addition to glycosylation, there are other features of SecA2–SecY2 substrates 
that dictate export by the accessory SecA2 pathway. The distinctive long signal peptides 
of GspB, Fap1, and presumably other SecA2–SecY2 substrates, are absolutely required 
for export. Furthermore, three glycine residues in the hydrophobic core of the GspB 
signal peptide promote SecA2–SecY2 -dependent export (8). However, these same 
glycine residues also act along with glycosylation to block export by the canonical SecA1 
(8). The mechanisms by which these glycine residues act in preprotein targeting are 
currently unknown. Interestingly, these glycine residues are conserved in the signal 
peptides of most SecA2–SecY2 substrates. 
Finally, there is also a region of approximately 20 amino acids at the start of the 
mature domain of GspB that is required for targeting this protein to the SecA2–SecY2  
system (11). This accessory Sec transport (AST) domain can interact with SecA2 (but not 
SecA1), which suggests that in S. gordonii the AST is required for GspB docking to the 
accessory SecA2 system (13). It was initially hypothesized that the AST domain may 
interact directly with SecY2 to stabilize an open channel conformation. But it is possible 
that stabilization of the SecY2 channel is promoted by a high affinity interaction 
occurring between SecA2 and SecY2. This SecA2-SecY2 interaction only occurs when 
the preprotein binds to SecA2 via the AST domain in the mature domain of the substrate 
(11, 13). Currently, it is not known if the AST domain is a conserved feature of all 
SecA2–SecY2 substrates. However, the first 34 amino acids of the Fap1 mature domain 
are also required for SecA2-dependent export (26).  
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Model for SecA2–SecY2 export 
The current model of SecA2–SecY2 export is as follows (Figure 1.5). The 
distinctive glycosylation of the serine-rich proteins of SecA2–SecY2 systems is 
incompatible with export via the canonical SecA1/SecYEG pathway and demands a 
specialized export system. In a signal peptide-dependent manner, the SecA2–SecY2 
preproteins are targeted to the SecA2–SecY2 machinery (8, 12, 26). Features of the 
mature domain, such as the AST (11, 13), may also be involved in targeting. In addition, 
Asp2 and Asp3 could contribute to translocase-targeting by binding the unmodified 
substrate (179).  
Analogous to canonical Sec export, SecA2 likely uses cycles of ATP hydrolysis 
to drive glycosylated preproteins through the SecY2 channel. In some bacteria, Asp4 and 
Asp5 may function like SecE and SecG, whereas SecA2–SecY2 systems lacking Asp4 
and Asp5 could utilize the canonical SecE or SecG for export. In fact, there is some 
genetic evidence that SecY2 and SecG may function together in S. aureus (144). Also 
akin to canonical Sec export, experiments using a slow-folding model protein suggest 
that SecA2–SecY2  preproteins must remain unfolded for passage through the SecY2 
channel (11). 
 
SecA2-only systems 
Compared to the SecA2–SecY2 systems, considerably less is known regarding the 
mechanisms of export by SecA2-only systems. SecA2-only systems are characterized by 
the presence of a non-redundant SecA homolog that is functionally distinct from the 
canonical SecA1 (SecA2) but lack a SecY2 homolog or obvious accessory membrane 
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channel (10, 16). The emerging model is that the SecA2 proteins of these systems work 
with the canonical SecA1/SecYEG translocase. Unlike secA2–secY2 loci, there is no 
conservation of gene content or organization at the secA2 genomic region for SecA2-only 
systems (Figure 1.3). In addition, there is a greater variety in the types of proteins 
exported by SecA2-only systems when compared to the category of glycosylated serine-
rich proteins exported by SecA2–SecY2 systems of Streptococcus and Staphylococcus. 
SecA2-only systems exist in all mycobacteria, including the human pathogen M. 
tuberculosis (16), as well as some Gram positive bacteria such as L. monocytogenes (81), 
Corynebacterium glutamicum (24), and Clostridium difficile (43).  
In mycobacteria (16, 17, 130) and Listeria (20, 62, 81, 85, 90), SecA2 is not 
essential for growth in liquid media but secA2 mutants are defective in the export of 
specific proteins. However, secA2 mutants of both M. tuberculosis and L. monocytogenes 
are attenuated for growth in infection models, indicating the importance of the respective 
SecA2 systems for exporting virulence factors (17, 76, 80). Additionally, secA2 mutants 
of both M. tuberculosis and L. monocytogenes elicit aberrant immune responses during 
infection, which has led to the use of these mutants in vaccination studies (65, 66, 76, 
119). By contrast, SecA2 is essential for growth of Corynebacterium glutamicum (24), 
and Clostridium difficile (43).  
SecA2-only exported substrates 
 Proteins exported by SecA2-only systems have been identified in the model 
organism M. smegmatis (a nonpathogenic mycobacterial species), M. tuberculosis, L. 
monocytogenes, and C. difficile. Some of these proteins have predicted N-terminal Sec 
signal peptides and some do not. In M. smegmatis there are two lipoproteins (Ms1704 and 
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Ms1712) with predicted N-terminal Sec signal peptides that are exported to the cell wall 
in a SecA2-dependent manner (54, 125). Ms1704 and Ms1712 are homologous solute-
binding proteins, specifically predicted to bind sugars as part of two ABC-type 
transporters (54). However, it is important to note that not all mycobacterial lipoproteins 
require SecA2 for export (54).  
In M. tuberculosis and L. monocytogenes, several proteins are reduced in exported 
fractions of secA2 mutant bacteria analyzed by 2D-PAGE, 3 and 17 respectively (17, 80). 
Of these proteins, only a few have been studied further and confirmed to be SecA2-
dependent. In M. tuberculosis, one of these proteins is superoxide dismutase SodA, which 
notably lacks a predicted cleavable Sec signal peptide.  
In L. monocytogenes the p60 autolysin, which is a cell wall amidase that cleaves 
peptidoglycan, is a confirmed SecA2 substrate (80). The gene for p60 is positioned 
adjacent to secA2 in the genome (Figure 1.3); although, other SecA2-dependent proteins 
of Listeria are encoded elsewhere. An additional peptidoglycan-hydrolyzing autolysin 
NamA (MurA) of Listeria is also SecA2-dependent (80, 85, 90). However, unlike p60, 
NamA lacks a typical Sec signal peptide. MnSod superoxide dismutase is another protein 
lacking a predicted Sec signal peptide that is exported in a SecA2-dependent manner in L. 
monocytogenes (2). This particular finding parallels the SecA2-dependence of SodA 
export in M. tuberculosis and suggests that other similarities may exist between the 
mycobacteria and Listeria SecA2-only systems. Also among the list of SecA2-dependent 
proteins identified in L. monocytogenes are five predicted lipoproteins with Sec signal 
sequences, three of which are predicted solute-binding proteins (80, 122). One of these 
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solute-binding proteins is predicted to bind a sugar, similar to the Ms1704 and Ms1712 
substrates of M. smegmatis (54, 80). 
In C. difficile the S-layer protein SlpA, which constitutes a proteinaceous lattice 
structure surrounding the Clostridium cell, has been identified as being exported in a 
SecA2-dependent fashion (44) (22). SlpA is a member of a larger family of 29 clostridial 
cell wall proteins (Cwp) that are implicated in host-pathogen interactions (21, 44, 71, 
166). CwpV is another protein shown to require SecA2 for export (43), suggesting that 
additional members of this Cwp family may be SecA2-dependent as well. In C. difficile, 
the secA2 gene is adjacent to slpA and the larger secA2 genomic region includes genes 
encoding 12 Cwps (Figure 1.3) (43). However, the gene encoding CwpV is notably 
located elsewhere in the genome (43). In C. difficile, both of the demonstrated SecA2-
dependent proteins (SlpA and CwpV) contain predicted N-terminal Sec signal peptides 
(44).  
Export machinery of SecA2-only systems  
SecA2-only systems lack an obvious alternative membrane channel and accessory 
export factors. An attractive idea is that SecA2 works with the canonical SecA1/SecYEG 
machinery either through cooperation with SecA1 or by sharing SecYEG. In support of 
this model, depletion of the essential SecA1 protein in M. smegmatis abolishes export of 
the SecA2 substrate Ms1712 (125). The simplest interpretation of this experiment is that 
mycobacterial SecA2 export requires the canonical SecA1. However, it remains possible 
that SecA1 depletion in this experiment has an indirect effect on SecA2 export. 
In mycobacteria and C. difficile, studies using ATPase-defective dominant 
negative SecA2 proteins are also consistent with a model where SecA2 works with the 
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canonical Sec machinery (43, 125). Dominant negative proteins often exert their effect by 
forming nonfunctional complexes with their normal binding partners. In mycobacteria, 
over-expression of the dominant negative SecA2 inhibits growth (125). This result 
implies an interaction between SecA2 and proteins important to an essential process, with 
the essential SecA1/SecYEG machinery being a leading candidate. In C. difficile, 
expression of the corresponding dominant negative SecA2 also inhibits growth and over 
shorter time frames is shown to impact protein export (43). Importantly, over-expression 
of a dominant negative SecA1 in C. difficile reduces export of SecA2 substrates, possibly 
by blocking accessibility of the SecA2 substrates to the SecYEG channel (43).  However, 
unlike in mycobacteria, depletion of SecA1 in C. difficile does not influence export of 
SecA2 substrates (43) suggesting that in Clostridium SecA2 works with SecYEG but not 
SecA1.   
There has not been a similar investigation for a relationship between SecA2 and 
SecA1/SecYEG in Listeria, but recently it was shown that secretion of the SecA2-
dependent proteins p60 and NamA depends on the DivIVA protein (62). The DivIVA 
protein is involved in localizing proteins to the cell poles and septa of bacteria (15). 
Interestingly, GFP fusions to DivIVA, SecA2, p60, and NamA all localize to the septum 
in Listeria (62). Thus, it is possible that the SecA2-only system is specifically localized 
and DivIVA is required to either establish that localization pattern or deliver the SecA2-
dependent proteins to the SecA2 machinery.     
Targeting proteins to the SecA2-only pathway 
 The features defining exported substrates of SecA2-only systems have not yet 
received significant attention. One goal of this thesis research was to determine the 
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SecA2-targeting factors of export in the mycobacterial SecA2-only system. The two M. 
smegmatis lipoproteins that require SecA2 for export contain typical N-terminal Sec 
signal peptides. While these signal peptides are required for export (54), they are not 
specific for targeting these proteins to SecA2 (49). Therefore, there appears to be one or 
more features of the mature domains that determine SecA2-dependent export in 
mycobacteria. The mature domain of these SecA2-dependent substrates could possess 
post-translational modifications, as seen with the SecA2–SecY2 substrates, although 
there is currently no evidence for this possibility.   
Another unresolved issue is whether preproteins without recognizable Sec signal 
peptides, like the Sod proteins of M. tuberculosis and L. monocytogenes, are true SecA2 
substrates or if the export of these proteins is indirectly affected by SecA2. For example, 
SecA2 could export a currently unknown protein with a signal peptide that is itself 
required for export of proteins like Sod. Still, it is also plausible that proteins without 
signal peptides are recognized by SecA2 and exported directly through the SecYEG 
channel. In support of this model, SodA of Rhizobium leguminosarum is exported in a 
SecA-dependent manner despite lacking a recognizable signal peptide (75). However, at 
this time an indirect role for the Sec system in exporting SodA of R. leguminosarum 
cannot be ruled out (17, 43).  
 
Model for SecA2-only Export 
For SecA2-only systems, genetic studies support a model where SecA2 utilizes 
SecYEG to assist in Sec export of a certain class of preproteins (43, 125) (Figure 1.6). 
These SecA2 substrates must have features, which are not well understood at this time, 
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that make them incompatible for Sec export without the assistance of SecA2. SecA2 of 
both mycobacteria and Clostridium primarily localize to the cytoplasm, while much of 
SecA1 is found at the membrane in these bacteria (43, 125). Thus, SecA2 could possibly 
function in the cytoplasm to recognize and target for export a specific subset of proteins 
that are otherwise overlooked or incompatible with the canonical SecA1. Alternatively, 
SecA2 could serve as an alternate motor protein that is necessary for translocation of 
certain proteins through SecYEG. In either case, SecA2 ATPase activity is required for 
export.  
 
Contribution of SecA2 export to M. tuberculosis pathogenesis 
As previously mentioned, the SecA2 system is important to virulence. The secA2 
mutant of M. tuberculosis is attenuated for growth during the acute phase of mouse 
infection when it is thought that M. tuberculosis is actively proliferating in macrophages 
(17). Consistent with this mouse phenotype, the secA2 mutant is also unable to grow in 
bone-marrow derived murine macrophages (17, 150). Because SodA is an antioxidant, 
the identification of SodA as a SecA2-dependent protein suggested that the role of the 
SecA2 system might be to protect M. tuberculosis against reactive oxygen intermediates 
(ROI) produced by macrophages. However, the M. tuberculosis secA2 mutant is 
attenuated for growth in macrophages even if they are derived from phox
-/-
 mice, which 
are unable to elicit an oxidative burst (76).  While these results with phox
-/- 
macrophages 
do not rule out a role for the SecA2 system in resisting oxidative stress, it does reveal 
another role for SecA2 export beyond detoxification of ROI. This result also implies that 
proteins other than SodA are exported by the SecA2 system of M. tuberculosis.  
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In further support of this possibility, it has been shown that SecA2 is required to 
block phagosome maturation, which is a vital step in allowing M. tuberculosis to grow 
inside host macrophages during infection (150). The secA2 mutant more readily localizes 
to acidified phagosomal compartments than wild type M. tuberculosis, and chemical 
inhibitors of phagosome acidification rescue growth of the secA2 mutant (150). These 
results suggest that SecA2 is required for exporting one or more protein effectors that 
block phagosome acidification. As very little is currently known about proteins involved 
in M. tuberculosis phagosomal maturation arrest, elucidation of SecA2-dependent 
exported proteins that contribute to this process would be extremely informative. 
The SecA2-dependent export pathway of M. tuberculosis also has affects on host 
immune responses. Macrophages infected with the M. tuberculosis secA2 mutant 
produce higher levels of pro-inflammatory cytokines and exhibit more apoptosis than 
wild type infected macrophages (66, 76). The secA2 mutant of M. tuberculosis also 
elicits better protective immunity in mice and guinea pigs to M. tuberculosis challenge 
than vaccination with the M. bovis Bacille Calmette-Guérin (BCG) vaccine (66). The 
identification of SecA2-dependent exported proteins that contribute to these processes 
would also be valuable.  
 
The Tat Export Pathway 
 Like the general Sec pathway, the twin-arginine translocation (Tat) pathway 
exports proteins with N-terminal signal peptides beyond the cytoplasmic membrane [for 
an extensive review of Tat export, see references (97) and (111)]. The Tat pathway is 
found in many Gram positive and Gram negative bacteria but, unlike the Sec pathway, is 
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not present in all bacteria (34). Also, the Tat system differs from the Sec system because 
it only exports proteins that are pre-folded in the cytoplasm. Substrates requiring export 
by the Tat system include those that must acquire metal co-factor insertion prior to 
translocation out of the cytoplasm (156), as well as hetero-oligomeric protein complexes 
that form before export (136). It has also been proposed that Tat export systems are 
important for handling export of proteins that are difficult to keep unfolded in the 
cytoplasm prior to export. This rationale might explain why halophilic archaea, which 
live in high salt environments that interfere with periplasmic protein folding, rely 
extensively on the Tat system for protein export of proteins folded in the cytoplasm (14, 
127). 
The N-terminal signal peptides of Tat preproteins are similar to Sec signal 
peptides (79).  However, a distinguishing feature of Tat signal peptides is the presence of 
a pair of arginine residues that are contained within the Tat motif, R-R-X-Φ-Φ, where Φ 
is a hydrophobic residue.  The twin-arginine pair is nearly invariant and replacement of 
both arginines with lysine residues abolishes Tat-dependent export (149). 
The Tat export machinery consists of two core components: the TatA and TatC 
integral membrane proteins (126). Most Gram positive bacteria possess this minimal Tat 
translocase, while Gram negative and some Gram positive species (including 
mycobacteria and other actinomycete species) possess an additional protein, TatB (111). 
TatB is similar to TatA in amino acid sequence but functionally distinct. The mechanisms 
of Tat export are less understood than those of Sec export, but there is a growing 
understanding of the process (Figure 1.7) (111).  
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The current model is that a Tat signal peptide first targets a folded preprotein to 
the TatBC complex in the cytoplasmic membrane (52, 78, 87, 123, 154). With energy 
supplied by the proton motive force, TatA is then recruited to the TatBC complex and 
forms a homo-oligomeric translocase channel (94, 176). There is evidence that the size of 
the TatA pore can vary, which may explain how the pore can handle folded proteins of 
different shapes and sizes (56, 167). The preprotein is then translocated across the 
cytoplasmic membrane through the TatA channel and the signal peptide is removed by a 
Type I signal peptidase (84).  Type II signal peptidases may also act on Tat precursors 
since some Tat signal peptides contain lipobox motifs.  For example, in Haloferax 
volcanii a lipoprotein is exported by the Tat pathway (55). There is also a category of Tat 
substrates that become integrally-embedded in the membrane (64).  
A folded conformation prior to export is not only a characteristic of Tat 
substrates, but is actually a requirement for Tat export.  Proteins are only exported by the 
Tat system when conditions are favorable for cytoplasmic folding (33). Therefore, in 
addition to the Tat signal peptide there are features of the mature domain of Tat 
substrates that promote folding and thereby dictate Tat export (157). Some Tat 
preproteins require substrate-specific chaperones to facilitate substrate folding prior to 
export, such as the HyaE and HybE chaperones which assemble hydrogenase components 
in E. coli (36, 70). Because not all Tat substrates require assistance of substrate-specific 
chaperones, general cytoplasmic chaperones may facilitate Tat export of other substrates. 
The DnaK general chaperone has been shown to interact with Tat substrates and is 
required for export of the multi-copper oxidase, CueO Tat substrate (60, 116). 
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The Tat pathway is present and linked to virulence in a number of bacterial 
pathogens (31). In Pseudomonas aeruginosa, the Tat pathway exports multiple virulence 
factors, and a mutant defective in Tat export is attenuated in the rat model of infection 
(106). Two of the Tat-dependent virulence factors in P. aeruginosa are secreted 
phospholipase C enzymes (106).  In Legionella pneumophila, Tat export is required for 
replication in the amoeba host as well as in macrophages (32, 128). Furthermore, the L. 
pneumophila phospholipase C enzyme also requires the Tat pathway for export (128). 
 
The Mycobacterial Tat Pathway 
 The Tat pathway is functional in both M. tuberculosis and M. smegmatis. Both 
species contain genes encoding TatA, TatB, and TatC. Tat export is essential for growth 
of M. tuberculosis, at least under standard laboratory conditions, as shown by the 
inability to delete tatA, tatB, or tatC unless exogenous copies of the tat genes are 
provided (131).  However, deletion mutants of tatA, tatB, and tatC can be made in M. 
smegmatis. These mutants have growth defects in vitro; nonetheless, M. smegmatis tat 
mutants can be utilized to study Tat export in mycobacteria (88, 118). 
Another phenotype of M. smegmatis tat mutants is increased sensitivity to β-
lactam antibiotics (88, 118). Because β-lactamases need to be exported to the cell wall in 
order to degrade β-lactams, the hypersensitivity of these tat mutants can be attributed to 
reduced export of the β-lactamase, BlaS. M. smegmatis BlaS has a predicted Tat signal 
peptide and BlaS is not exported by a tat mutant (88, 118). By expressing the M. 
tuberculosis β-lactamase (BlaC) in wild type M. smegmatis and tat mutants, the Tat 
dependence of BlaC is also established (88).  Furthermore, when the RR dipeptide of the 
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BlaC signal peptide is changed to KK, BlaC export in M. smegmatis is abolished, 
indicating that the twin-arginine motif is required for Tat export in mycobacteria as 
expected (88).  
 In silico analysis of the M. tuberculosis genome using several Tat prediction 
programs predicts a total of 108 proteins with Tat signal peptides (86, 89). Some of these 
predicted Tat substrates have demonstrated or suggested roles in M. tuberculosis 
pathogenesis or essential physiologic processes. However, relying exclusively on Tat 
prediction programs to identify Tat substrates is risky. The current Tat prediction 
programs are built on Tat consensus sequences defined in bacteria other than 
mycobacteria. There is also little overlap in the predictions of the currently available Tat 
prediction programs (89).  Furthermore, there is an increasing list of unusual Tat exported 
proteins that lack a cleavable signal peptide with a twin arginine motif, and are missed by 
the current programs (50).   
To overcome some of the bias of Tat prediction programs, a genetic reporter 
approach can be used to indentify Tat exported proteins of M. tuberculosis (89). This 
approach utilizes a ‘BlaC reporter lacking its endogenous Tat signal peptide and a β-
lactam-sensitive blaC or blaS mutant mycobacteria background. When the signal peptide 
from a Tat substrate is fused to ‘BlaC, the resulting BlaC fusion protein can be exported 
and confer β-lactam resistance, reporting on Tat export. Importantly, the ‘BlaC reporter 
only works when exported by the Tat pathway and not by the Sec pathway (88). Using 
the ‘BlaC reporter, eighteen M. tuberculosis proteins are shown to have functional Tat 
signal peptides (5, 86, 89). The list of proteins with proven Tat signal peptides includes 
two Phospholipase C proteins, PlcA and PlcB. Phospholipase C is necessary for the full 
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virulence of M. tuberculosis in mice, providing strong support for the Tat pathway 
contributing to M. tuberculosis pathogenesis (121). Another protein identified as having a 
functional Tat signal peptide is Rv2525c, which is suggested to have a role in infection 
by the demonstration of increased virulence of a M. tuberculosis rv2525c mutant in 
macrophages and mice (89, 131). 
 
Summary 
Our understanding of the mechanisms of canonical Sec export has reached an 
impressive level of detail (35), but by comparison our understanding of SecA2 export is 
limited (48). In addition to mechanistic unknowns, our understanding of how the SecA2 
export pathway contributes to M. tuberculosis remains incomplete, as we do not fully 
appreciate the repertoire of proteins exported by SecA2 in this pathogen. In the following 
chapters, we describe experiments to determine what features define mycobacterial 
SecA2 substrates. We also examine a potential relationship between preproteins export 
by the SecA2 and Tat export systems in mycobacteria. Finally, we identify new SecA2-
dependent exported proteins of M. tuberculosis. 
In Chapter 2, we describe experiments utilizing two M. smegmatis SecA2 
substrates, Ms1704 and Ms1712, to determine what features of these preproteins target 
them to SecA2 for export. Interestingly, we find that that the mature domains dictate 
SecA2-dependent export. But unlike the substrates of SecA2–SecY2 systems, there does 
not appear to be a SecA2-targeting AST domain or post-translational modification that 
influences preprotein routing to SecA2. Furthermore, mycobacterial SecA2 substrates 
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may share folding characteristics of Tat substrates, as the mature domain a SecA2 
preprotein is compatible for export by the Tat pathway.  
In Chapter 3, we describe a semi-quantitative comparative mass spectrometry 
study aimed at defining the SecA2-dependent exported proteome of M. tuberculosis. We 
identified several proteins underrepresented in the cell wall of the M. tuberculosis secA2 
mutant, as expected for proteins that require SecA2 for their export. Interestingly, we 
observed that the majority of predicted solute-binding proteins of M. tuberculosis (the 
same family of proteins represented by the two known SecA2 substrates of M. 
smegmatis) are dependent on SecA2. We also identified several predicted Tat substrates 
under-represented in the M. tuberculosis secA2 mutant. Because the Tat pathway only 
exports proteins that are folded, this supports a model where SecA2 assists in export of a 
subset of proteins with cytoplasmic folding tendencies. Further, it suggests that the 
SecA2 and Tat systems of mycobacteria may share a common pool of preprotein 
substrates. Our proteomic analysis also resulted in several candidate SecA2-dependent 
exported effectors that could help explain the requirement of SecA2 for M. tuberculosis 
virulence. 
In Chapter 4, we demonstrate that export of Ms1704 is not only dependent on 
SecA2 but additionally influenced by the Tat pathway of M. smegmatis. Or data suggest 
portions of the cytoplasmic pool of Ms1704 preprotein can be exported by 
SecA2/SecYEG while another portion can be exported independently by the Tat system. 
These observations suggest that there is a preprotein pool between the mycobacterial 
SecA2 and Tat export systems. Furthermore, the data presented in Chapter 4 reinforce a 
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model where the defining feature of mycobacterial SecA2 substrates is cytoplasmic 
folding, a property shared with preproteins of the Tat export system.  
Taken together, our results reinforce the fundamental differences observed 
between SecA2–SecY2 and SecA2-only systems. Unlike SecA2–SecY2 systems, which 
appear dedicated to exporting unfolded glycosylated proteins, our data suggest that the 
mycobacterial SecA2-only system is adapted to handle preproteins with unique folding 
characteristics.  Possible roles for the mycobacterial SecA2 in exporting proteins with a 
tendency to fold prior to export include keeping preproteins unfolded prior to or during 
export. Alternatively, SecA2 could provide the energy required to translocate such 
challenging substrates through the SecYEG channel.  Our results are significant because 
they suggest that in addition to Tat export, SecA2-dependent export is another strategy 
bacteria use to solve the problem of exporting folding proteins across the cytoplasmic 
membrane. 
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Figure 1.1 General Sec export 
Post-translational Sec export is powered by the essential SecA ATPase. SecA can be 
divided into two main structural domains: a motor domain that drives ATP hydrolysis 
and a specificity domain that interacts with the preprotein destined for export. Step 1: 
Preproteins synthesized with N-terminal Sec signal peptides (grey) are bound by 
cytoplasmic SecA along a cleft between the two domains. Cytoplasmic chaperones, such 
as SecB, aid in keeping some preproteins unfolded prior to export and can directly deliver 
these preproteins to SecA. Step 2: SecA delivers the preprotein to a membrane-spanning 
complex composed of SecY, SecE, and SecG. Here, the signal peptide inserts into SecY 
to help keep an open channel conformation. Step 3: SecA goes through rounds of 
conformational changes coupled to ATP hydrolysis to promote forward movement of the 
unfolded preprotein through the SecY channel. During these cycles, it is proposed that 
SecA inserts into the SecY channel, specifically by the IRA-1 two-helix finger (two 
helices). Step 4: During or shortly after translocation the signal peptide is removed by 
periplasmic signal peptidases (SP) and the protein then adopts its mature, folded 
conformation. The SecD, SecF, and YajC transmembrane proteins contribute to the 
efficiency of Sec export but are not shown. After translocation, the exported protein can 
remain associated with the cell envelope or be fully secreted into the extracellular 
environment.  
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Figure 1.2 Domain organization of SecA2 proteins 
Sequence alignments and structural modeling suggest that most functional domains are 
conserved between SecA1 and SecA2 proteins. The crystal structure of the M. 
tuberculosis SecA1 protein depicted here represents a typical SecA1 protein with the 
corresponding colored domains outlined below (141). *The C-terminal domain (CTD) 
was not resolved in the M. tuberculosis crystal structure but is shown in the domain 
graphic. For comparison to SecA1, the predicted domain organization of M. tuberculosis 
SecA2 and Streptococcus gordonii SecA2 are included. SecA1 can be divided into two 
main structural domains, which are both composed of several subdomains (77, 134). The 
DEAD (Asp-Glu-Ala-Asp)-like motor domain is responsible for the ATP hydrolysis (69, 
73, 143) and consists of two nucleotide-binding folds: NBD1 and NBD2. NBD1 contains 
the two ATP-binding Walker boxes (92, 177). The helical scaffold domain (HSD) 
connects the motor domain with the rest of the specificity domain, to allow coupling of 
preprotein-binding with ATP hydrolysis (72, 165). Interactions between SecA1 and the 
preprotein map along a hydrophobic cleft formed by NBD1, the preprotein crosslinking 
domain (PPXD) (53, 96, 113), and portions of the HSD linker. Within the HSD region is 
a two-helix finger known as IRA-1, which is thought to assist inserting of the preprotein 
into the SecY channel during translocation. Conservation of the motor domain between 
SecA1 and SecA2 proteins confirms the observation that SecA2 proteins are ATPases 
(10, 68). There are differences between SecA1 and SecA2 in the specificity domain that 
could affect substrate specificity and/or function. All SecA2 proteins are smaller than 
their SecA1 counterparts due to a truncation of the CTD and helical wing domain 
(HWD). Although not depicted in the M. tuberculosis SecA1 structure, the CTD was 
resolved in an E. coli SecA structure (53) and the C-terminal linker (CTL) within the 
CTD lies along the hydrophobic preprotein-binding cleft. 
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Figure 1.3 Organization of secA2 genomic loci 
a. SecA2–SecY2 systems are found in a diverse set of Streptococcus and Staphylococcus 
spp. (including Streptococcus gordonii, Streptococcus parasanguinis, Streptococcus 
agalactiae and Staphylococcus aureus), in which they function in the biogenesis of 
surface glycoproteins (the genes encoding which are shown in blue). All of these loci 
contain the core secA2 and secY2 genes (shown in red). Some Bacillus spp., including 
Bacillus anthracis, have putative SecA2–SecY2 systems, although the exported 
substrates of these systems are unknown, and secA2 and secY2 are separated. Genes 
encoding putative export machinery components are shown in yellow, and those 
encoding the glycosylation machinery are shown in green. b. Examples of SecA2-only 
systems are found in Mycobacterium tuberculosis, Listeria monocytogenes and 
Clostridium difficile. The secA2 loci of SecA2-only systems are not conserved and export 
a diverse set of substrates. In some cases, the genes encoding the exported substrates 
(blue) are found at the secA2 locus. However, this is not always the case, and substrate-
encoding genes that are located elsewhere in the genome are not depicted. In addition to 
slpA (encoding the protein that constitutes the S-layer (surface layer) of bacteria and is a 
SecA2-only substrate), the C. difficile secA2 locus contains genes encoding 11 cell wall 
proteins (Cwps) that are putative SecA2 substrates, of which three are shown in light 
blue. asp, accessory Sec system protein gene; gap, glycosylation-associated protein gene; 
sraP, serine-rich adhesin for platelets. 
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Figure 1.4 SecA2/SecY2-targeting features 
SecA2–SecY2 preproteins have features both for targeting to the SecA2–SecY2 
machinery for glycosylation and/or export, and for blocking export by the canonical Sec 
pathway (involving SecA1–SecYEG). Most of these targeting features have been defined 
using the Streptococcus gordonii protein GspB, shown here. The mature portion of GspB 
can be divided into several domains. Two serine-rich-repeat domains (SRR1 and SRR2) 
are glycosylated in the cytoplasm before export, and this post-translational modification 
blocks GspB export by SecA1–SecYEG. GspB, like all SecA2–SecY2 preproteins, has an 
unusually long amino-terminal signal peptide that is required for export. The signal 
peptide has the same tripartite structure as Sec signal peptides, including a positively 
charged N terminus, a hydrophobic core and a cleavage domain. In the hydrophobic core 
of the signal peptide are three glycine residues that are required for GspB export though 
SecA2–SecY2, but these same glycines also inhibit export by SecA1–SecYEG through 
unknown mechanisms. The accessory Sec transport (AST) domain is adjacent to the 
signal peptide and is required for export by SecA2–SecY2. Also depicted in the mature 
portion are the basic region and the carboxy-terminal cell wall-anchoring (CWA) domain. 
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Figure 1.5 Model of SecA2–SecY2 Export 
The biogenesis of surface glycoproteins by SecA2–SecY2 systems involves both 
glycosylation factors (green) and export machinery (red) that are distinct from the 
canonical Sec machinery. Serine-rich proteins are synthesized with N-terminal signal 
peptides. The accessory Sec system proteins (Asps) promote SecA2–SecY2-mediated 
export by unknown mechanisms, but could target preproteins to the translocase and/or 
serve as a scaffold for the export complex. Asp4 and Asp5 are putative accessory 
components of the SecY2 channel, but they are not present in all SecA2–SecY2 systems. 
SecA2–SecY2-mediated export and glycosylation are likely to be coupled processes. As 
glycosyl groups (orange hexagons) are added to the preprotein by cytoplasmic 
glycosylation factors, including the core GtfA and GtfB glycosyltransferases, SecA2 
energizes transport of the unfolded preprotein through a channel formed by SecY2. 
SecA2–SecY2 substrates also contain a carboxy-terminal cell wall-anchoring domain, 
which targets the exported protein to the cell wall after SecA2–SecY2-mediated export 
through the membrane. 
 
 
 
 
 
35 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Model of SecA2-only Export 
SecA2-only systems lack a SecY2 channel; therefore, SecA2 probably uses the canonical 
SecYEG channel for export. SecA2 could target a certain subset of preproteins to the Sec 
translocase that are otherwise overlooked or incompatible with SecA1. The proteins that 
require SecA2-only systems for transport include proteins with N-terminal Sec signal 
peptides (pictured here) and also proteins lacking signal peptides. SecA2 might deliver 
some preproteins to SecYEG and/or associate with SecYEG as needed to export 
substrates. The ATPase activity of SecA2 probably drives the export of preproteins 
through the SecYEG channel, possibly in conjunction with SecA1. 
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Figure 1.7 The Twin-arginine translocation (Tat) Pathway 
The conserved Tat pathway exports folded preproteins containing N-terminal signal 
peptides with a twin-arginine (RR) motif. Tat preproteins are recognized by the TatBC 
complex in the membrane and then translocated across a homo-oligomeric TatA channel. 
As with Sec export, the signal peptide is removed by a membrane-bound signal peptidase 
(SP). 
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CHAPTER 2 
Protein Export by the Mycobacterial SecA2 System is Determined by the  
Preprotein Mature Domain
1,2
 
 
 At the core of the bacterial general secretion (Sec) pathway is the SecA ATPase, 
which powers translocation of unfolded preproteins containing Sec signal sequences 
through the SecYEG membrane channel. Mycobacteria have two non-redundant SecA 
homologs: SecA1 and SecA2. While the essential SecA1 handles “housekeeping” export, 
the nonessential SecA2 exports a subset of proteins and is required for Mycobacterium 
tuberculosis virulence. Currently, it is not understood how SecA2 contributes to Sec 
export in mycobacteria. In this study we focused on identifying the features of two SecA2 
substrates that target them to SecA2 for export, the Ms1704 and Ms1712 lipoproteins of 
the model organism M. smegmatis. We found that the mature domains of Ms1704 and 
Ms1712, not the N-terminal signal sequences, confer SecA2-dependent export. We also 
demonstrated that the lipid modification and the extreme N-terminus of the mature 
protein do not impart the requirement for SecA2 in export. Because the Tat system only 
exports folded proteins, this result implies that SecA2 substrates can fold in the 
________________________ 
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cytoplasm and suggests a putative role of SecA2 in enabling export of such proteins. 
Thus, the mycobacterial SecA2 system may represent another way that bacteria solve the 
problem of exporting proteins that can fold in the cytoplasm. 
 
Introduction 
Protein export pathways exist in all bacteria and fulfill the vital role of 
transporting proteins synthesized in the cytoplasm to the bacterial cell envelope or 
extracellular environment. Many of the proteins exported by these pathways function in 
essential physiological processes or have important roles in bacterial pathogenesis. 
There are two conserved protein export pathways found across bacteria: the 
general secretion (Sec) and the twin-arginine translocation (Tat) pathways (49, 58). The 
Sec pathway carries out the bulk of protein export, which makes Sec export an essential 
process in all bacteria. The core components of the Sec pathway are a cytoplasmic SecA 
ATPase and a membrane complex composed of SecY, SecE, and SecG proteins (19). 
Proteins bound for export by the Sec pathway are synthesized as preproteins with 
N-terminal signal sequences that are composed of a positively charged N-terminus, a 
hydrophobic core, and a polar C-terminus containing a cleavage site (76). The signal 
sequence promotes binding of the preprotein to a cleft of SecA formed by multiple 
domains, including the preprotein-binding domain and C-terminal domain (3, 32, 40, 54, 
59). SecA then targets the preprotein to SecYEG at the membrane, where the signal 
sequence inserts into a channel formed by SecY (36, 47, 69). SecA also contains two 
nucleotide-binding domains with ATPase activity. SecA powers translocation of the 
preprotein across the membrane through the SecY channel using cycles of 
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conformational changes coupled to ATP-binding and hydrolysis (26, 48). Preproteins 
must be in an unfolded conformation to be competent for Sec export. Cytosolic 
chaperones and the process of translocation itself can help keep preproteins in an 
unfolded and translocation competent state (2, 29, 56). After export, the signal sequence 
is cleaved from the preprotein by signal peptidases to yield the mature protein (57). 
Proteins exported by the Tat pathway are also synthesized as preproteins 
containing cleavable N-terminal signal sequences (45). Tat signal sequences, however, 
are distinguished from Sec signal sequences by the presence of a twin-arginine motif that 
includes a nearly invariant pair of arginine residues (12). Tat exported proteins are 
targeted to a different membrane channel comprised of the TatA, TatB, and TatC proteins 
(67). A major distinction between the Sec and Tat pathways is that, while the Sec 
pathway exports proteins in an unfolded state, the Tat pathway only exports folded 
preproteins (25, 61).   
Mycobacteria, including the human pathogen Mycobacterium tuberculosis, and 
some Gram positive species also have a SecA2 protein export system (17, 28). SecA2 
systems are defined by the presence of a second, non-redundant, homolog of the SecA 
ATPase. In these bacteria, SecA1 is the essential SecA protein responsible for canonical 
Sec export, while SecA2 is involved in exporting a subset of proteins (17, 28). In many 
bacterial pathogens containing SecA2 systems, such as M. tuberculosis, SecA2 is not 
essential but required for virulence (8, 18, 22, 46, 53, 68) 
Some SecA2 systems are known as SecA2-SecY2 systems because they contain 
an extra SecY, which is presumed to function as a specialized channel (28). SecA2-
SecY2 systems appear dedicated to exporting proteins that are glycosylated in the 
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cytoplasm prior to export, such as the GspB protein of Streptococcus gordonii (8, 22, 53, 
68). Other SecA2 systems, such as those found in mycobacteria, are known as SecA2-
only systems because they lack an extra SecY or any obvious alternative membrane 
channel. In mycobacteria, SecA2 likely works with machinery from the general Sec 
pathway including SecA1 and SecYEG (64).  
A past study in M. smegmatis identified two proteins that require SecA2 for 
export to the cell wall: Ms1704 and Ms1712 (33). Both of these proteins are predicted 
ABC-type sugar-binding components of putative ABC transporters (73). Ms1704 and 
Ms1712 possess N-terminal Sec signal sequences that contain a lipobox motif 
(L[A/S][G/A]C), common to exported bacterial lipoproteins (15, 39). Currently, it is not 
known what feature(s) make a preprotein dependent on SecA2 for export in SecA2-only 
systems. In this study, we used M. smegmatis Ms1704 and Ms1712 to address this 
fundamental question about SecA2 export in mycobacteria. We tested the role of the 
signal sequence and mature domain in determining SecA2-dependency by swapping the 
signal sequences of Ms1704 and Ms1712 with those of preproteins exported by the 
canonical Sec pathway, independent of SecA2. These studies showed that the mature 
domain of Ms1704 and Ms1712, not the signal sequence, contains the information that 
makes these proteins SecA2-dependent. We also showed that the lipid modification and 
extreme N-terminus of the mature domain is not sufficient to impart the requirement for 
SecA2 in export. Remarkably, however, when the mature domain of Ms1704 was fused 
to a Tat signal sequence, the protein was no longer exported in a SecA2-dependent 
manner; instead, Ms1704 was then exported by the Tat pathway. Because the Tat 
pathway is uniquely built to export folded preproteins, this suggests that SecA2 substrates 
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may be prone to folding in the cytoplasm and the role of SecA2 may be to facilitate 
export of such proteins. Our results also reinforce the differences that exist between the 
SecA2-SecY2 systems of other bacteria and the SecA2-dependent export system of 
mycobacteria.    
 
Materials and Methods 
Bacterial strains and growth conditions: Escherichia coli DH5α was used for all DNA 
cloning and was grown at 37º C in Luria-Bertani medium (Fisher) supplemented with 40 
µg/ml kanamycin or 150 µg/mL hygromycin when appropriate. M. smegmatis mc
2
155 
(wild type) (70) or NR116 (∆secA2) (64) were grown at 30º C in Mueller-Hinton medium 
(BD Diagnostic Systems) with 0.1% (v/v) Tween 80 and supplemented with 20 µg/mL 
kanamycin when appropriate. Because the M. smegmatis strains PM759 (31) and LL115 
are leucine auxotrophs, they were always grown in Luria-Bertani medium (Fisher) 
supplemented with 80 µg/mL L-Lysine. 
Construction of M. smegmatis ∆blaS ∆secA2 mutant: Strain LL115 (ept-1 ΔlysA4 
rpsL6 ΔblaS1 ΔsecA2), the M. smegmatis ∆blaS ∆secA2 mutant, was constructed by two-
step allelic exchange, as described previously (64), using the ∆blaS mutant PM759 strain 
and the ∆secA2 suicide plasmid pNR6. Successful deletion of secA2 was confirmed by 
Southern blot analysis (data not shown). 
Plasmid construction and M. smegmatis electroporation: All plasmids and 
oligonucleotides used in this study are listed in Tables 2.1 and 2.2, respectively. All 
cloned plasmid inserts were confirmed error-free by DNA sequencing (Eton Biosciences, 
NC). Plasmids were electroporated into M. smegmatis as previously described (16). 
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Construction of Ms1704 and PhoA signal sequence chimera expression vectors 
To create ssPhoA-Ms1704-HA, the signal sequence of Ms1704-HA was first removed by 
inverse PCR of pHSG58 using primers pHSG51-SSswap-1 and pHSG58-SSswap-2 to 
yield plasmid pMF122. The signal sequence of M. smegmatis PhoA was amplified from 
pML440 using primers PhoAss-1 and PhoAss-2. The PCR product was cut with BamHI 
and NdeI and ligated with similarly cut pMF122 to produce the ssPhoA-Ms1704-HA 
expression plasmid, pMF124. To create ssMs1704-PhoA, the signal sequence of Ms1704 
was PCR amplified from pHSG58 using primers 1708ss-19kDa-1 and 1704ss-PhoA-2, 
while the mature domain of PhoA was amplified from M. smegmatis mc
2
155 genomic 
DNA using primers 1708ss-PhoA-3OL and 1708ss-PhoA-4OL. The two PCR products 
were fused using splice overlap extension PCR with primers 1708ss-19kD-1 and 1708ss-
PhoA-4OL. The resultant amplicon was cloned into pCR2.1 to yield pMF125. The 
ssMs1704-PhoA piece was excised by digestion with NotI and EcoR1, and ligated into 
similarly cut pMV261 to produce pMF126. 
Construction of Ms1712 and PhoA signal sequence chimera expression vectors 
To create ssPhoA-1712-HA, the signal sequence of Ms1712-HA was first removed by 
inverse PCR of pHSG51 using primers 19kDss-1708-1 and 19kDss-1708-2 to generate 
pHSG61. The signal sequence of M. smegmatis PhoA was amplified from pML440 using 
primers PhoAss-1 and PhoAss-2, cut with BamHI and NdeI, and ligated with similarly 
cut pHSG61 to produce the ssPhoA-Ms1712-HA expression plasmid, pHSG68. To create 
ssMs1712-PhoA, the signal sequence of Ms1712 was PCR amplified from pHSG51 using 
primers 1708ss-19kD-1 and 1708ss-PhoA-3OL, while the mature domain of PhoA was 
amplified from M. smegmatis mc
2
155 genomic DNA using primers 1708ss-PhoA-3OL 
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and 1708ss-PhoA-4OL. The two PCR products were fused using splice overlap extension 
PCR with primers 1708ss-19kD-1 and 1708ss-PhoA-4OL. The resultant amplicon was 
cloned into pCR2.1 to yield pHSG70. The ssMs1712-PhoA piece was excised by 
digestion with NotI and EcoR1, and ligated into similarly cut pMV261 to produce 
pMF128. 
Construction of Ms1712 and 19kD signal sequence chimera expression vectors 
To create ss19kD-Ms1712-HA, the signal sequence of 19kD was amplified from M. 
tuberculosis H37Rv genomic DNA with primers 19kDass-1 and 19kDass-2 and cloned 
into pCR2.1 to yield pMB244. The 19kD signal sequence was amplified from pMB244 
using primers 19kDss-1 and 19kDss-2, cut with BamHI and NdeI, and ligated with 
similarly cut pHSG61 to generate pMF115. To create ssMs1712-19kD, the signal 
sequence of Ms1712 was PCR amplified from pHSG51 using primers 1708ss-19kD-1 
and 1708ss-19kD-2, while the mature domain of 19kD was amplified from M. 
tuberculosis H37Rv genomic DNA using primers 1708ss-19kD-3 and 1708ss-19kD-4. 
The two PCR products were fused using splice overlap extension PCR with primers 
1708ss-19kD-1 and 1708ss-19kD-4. The PCR product was cloned into pCR2.1 to yield 
pHSG64. The ssMs1712-19kD piece was excised by digestion with NotI and EcoR1, and 
ligated into similarly cut pMV261 to produce pHSG66. 
Construction of Non-lipidated Ms1704CA and Ms1712CA expression vectors 
The invariant cysteine in the lipobox motifs of both Ms1704 and Ms1712 carried on 
pHSG58 and pHSG85 respectively, was changed to alanine using the Quikchange site-
directed mutagenesis kit (Stratagene).  
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Construction of the Ms1704 and Antigen 85B signal sequence chimera expression 
vector 
To create ssAg85B-Ms1704-HA, the signal sequence of M. tuberculosis Antigen85B was 
excised as a BamHI-NdeI fragment from pMM7-2. This fragment was ligated with 
similarly cut pMF122 containing the Ms1704 mature region to generate pMF127. The 
region of pMF127 containing the hsp60 promoter and ssAg85B-1704-HA fusion was 
excised as a NotI-EcoRV fragment and ligated with similarly cut pMV306 to generate the 
integrating expression vector, pMF136. 
Construction of the ssPhoA-N-Ms1704-HA expression vector 
The sequence regions flanking either side of the Ms1704 sequence to be deleted were 
amplified using primers 19kDHA-F and phoA1704F1SOE-R, and phoA1704F1SOE-F 
and msmeg1704R primers respectively. The two PCR products were fused using splice 
overlap extension PCR with primers 19kDHA-F and msmeg1704R. The PCR product 
was digested with NotI and EcoRV, and ligated into similarly cut pMF124 to produce 
pMF246. 
Construction of Ms6020-HA expression vector 
To generate an Ms6020-HA expression vector, ms6020 was amplified from M. 
smegmatis genomic DNA using primers Msmeg6020-F and Msmeg6020-R and cloned 
into pCR2.1 to generate pMF169. The fragment containing ms6020 was excised as a 
SmaI-HindIII fragment and ligated with MscI/HindIII-cut pJSC77, a pMV261.kan 
derivative containing the HA epitope. The resultant plasmid, pMF170, expresses 
Ms6020-HA. 
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Construction of Ms1704-‘BlaTEM1 expression vector 
To generate an expression plasmid containing full-length Ms1704 fused to the N-
terminus of ’BlaTEM1 (lacking its native signal sequence), the C-terminal HA-tag was 
first removed from Ms1704-HA by amplifying msmeg1704 from pHSG58 using primers 
hsp60 SD plus smeg secA2 5’ and 1704R-BamHI. This piece containing msmeg1704 was 
cut with XmnI and BamHI, then ligated into MscI/BamHI-cut pMV261 to generate 
pMF168. A fragment containing‘BlaTEM1 was excised from pJM114 with BamHI, and 
ligated into BamHI-cut pMF168 to generate pMF171, containing Ms1704-‘BlaTEM1. 
Construction of ssPlcB-Ms1704-HA and ssPlcB-19kD chimera expression vectors 
To generate an ssPlcB-Ms1704-HA chimera, the signal sequence from M. tuberculosis 
plcB was removed from pMB222 using BamHI and NheI and ligated into similarly cut 
pMF122 to generate the episomal pMF131. A NotI-EcoRV fragment containing the 
hsp60 promoter and the ssplcB-Ms1704-HA fusion was then subcloned into similarly cut 
pMV306 to generate the integrating expression vector, pMF135. To create ssPlcB-19kD, 
the mature domain of 19kD was amplified without the native signal sequence from 
pHSG67 using primers 19kDmature-F and Msmeg1712R-2, and then cloned into pCR2.1 
to generate pMF161. A BamHI fragment containing ∆ss19kD was excised from pMF161 
and ligated with similarly cut pMB222 to generate pMF167. 
Subcellular fractionation: Subcellular fractions of M. smegmatis cells were generated as 
previously described (33, 65). Briefly, whole cell lysates of M. smegmatis were generated 
by passing cells through a French pressure cell at 20,000 psi. Unlysed cells were removed 
by centrifugation at 3,000 x g to generate clarified whole cell lysates (WCL). Protein 
concentrations of clarified lysates were determined by BCA assay using a BSA standard 
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(Pierce) and equalized between strains for every experiment. One milliliter of each 
equalized lysate was centrifuged at 27,000 x g for 30 minutes to pellet cell wall material 
(CW), then 100,000 x g for 2 hours to separate membrane (M) and soluble (SOL) 
fractions. For all experiments, protein derived from the same amount of starting cells for 
each fraction was analyzed by immunoblotting. 
Culture filtrate protein preparation: M. smegmatis was grown in Mueller Hinton 
media with Tween 80 omitted. Identical M. smegmatis cultures grown with Tween 80 
were used to monitor bacterial growth to an OD600 of 0.4-0.7 upon harvesting. Cells from 
the cultures where Tween 80 was omitted were separated from culture supernatants by 
centrifugation at 3,000 x g and lysed by passage through the French press to prepare 
WCL. Two hundred milliliters of culture supernatants were filtered through a 0.2 µM 
filter to remove cell material and concentrated using a 10kD membrane (Amicon) in a 
stirred cell concentrator (Amicon) at 4º C to a volume of approximately 10 mL. The 
concentrated volume was kept equivalent between strains for each experiment. Protein 
from 1 mL of concentrated culture supernatant was precipitated overnight at 4º C with 
10% trichloroethanoic acid. Protein pellets were washed with acetone, re-suspended in 25 
µL 1X SDS-PAGE buffer, and then boiled. Whole cell lysates from the cell pellets were 
analyzed for protein concentration by BCA assay and equal amounts of protein from each 
strain loaded on a 1D-PAGE gel. Protein obtained from equal culture supernatant 
volumes between strains were also loaded on a 1D-PAGE gel. 
Immunoblotting: Subcellular fraction material was combined with SDS-PAGE buffer, 
separated by 1D-PAGE, and transferred to a nitrocellulose membrane (Whatman). The 
following antibodies were used for immunoblots: anti-HA (Covance) used at 1:10,000, 
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anti-PhoA (Research Diagnostics International) used at 1:20,000, anti-19kD (provided by 
Douglas Young, MRC National Institute for Medical Research) used at 1:20,000, anti-
BlaTEM1 (QED Biosciences) used at 1:5,000, anti-MspA (provided by Michael 
Niederweis, University of Alabama at Birmingham) used at 1:20,000. For cytoplasmic 
and cell lysis controls, either the GroEL1 or GroEL2 chaperone was detected using anti-
HIS (Abgent) at 1:10,000, or anti-GroEL2 (HAT5, IT-64, obtained from the World 
Health Organization collection) at 1:20,000. The anti-HIS antibody recognizes a string of 
endogenous histidines in GroEL1 (62). Proteins were detected using either anti-rabbit or 
anti-mouse secondary antibodies conjugated to either horseradish peroxidase (BioRad) or 
alkaline phosphatase (GE Healthcare). Signal was detected using Western Lightning 
Chemiluminescent detection reagent (Perkin-Elmer) or ECF reagent (GE Healthcare), as 
appropriate.  
 
Immunoprecipitation of ssMsPhoA-Ms1704-HA for glycoprotein staining 
Wild type M. smegmatis cells expressing either ssPhoA-Ms1704-HA or MsPhoA-HA 
were re-suspended in 200 µL of denaturing lysis buffer (50mM Tris-Cl pH 8.0, 1 mM 
EDTA. 1 mM DTT, 1% SDS, 1X protease inhibitor cocktail (PIC) [2 µg/mL each of 
aprotinin, E-64, leupeptin, and pepstatin A, and 100 µg/mL Pefabloc SC], and 1 mM 
phenylmethanesµLfonylfluoride, PMSF). Whole cell lysates were generated by vortexing 
cells with glass beads and boiling. Next, 100 µL of the lysates supernatant was incubated 
overnight with 650 µL immunoprecipitation buffer (50 mM Tris-Cl pH 8.0, 150 mM 
NaCl, 2% Triton X-100, 0.1 mM EDTA, 1X PIC, 1 mM PMSF) containing 25 µL of anti-
HA beads (Sigma).  
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Periodic Acid Schiff Staining for Glycosylation 
Two SDS-PAGE gels were run with 25 µL of immunoprecipitated ssPhoA-Ms1704-HA 
or PhoA-HA, along with 600 µg Mpt32 protein (BEI Resources), 30 µg PhoS1 protein 
(BEI Resources), 7.5 ng trypsin (Pierce), and 7.5 ng horse radish peroxidase (Pierce). 
One gel was Coomassie stained to visualize all proteins, while the other was stained with 
the periodic acid Schiff stain (Pierce) to visualize glycoproteins only. 
 
Results 
The mature domain of Ms1704 imparts the requirement for SecA2 in export 
We set out to determine if preproteins exported by the mycobacterial SecA2 
system have signal sequences that specifically target them to SecA2 for export or if their 
distinguishing feature resides in the mature domain. To address this question, we created 
a series of chimeric fusion proteins in which the signal sequence of a SecA2-dependent 
protein (Ms1704 or Ms1712) was swapped with the Sec signal sequence of a protein 
exported by the canonical Sec pathway, independent of SecA2 (Figure 2.1). Export of the 
chimeras was assessed in the following manner. M. smegmatis cells expressing each 
chimera were lysed to generate whole cell lysates (WCL) that were then subjected to 
differential ultracentrifugation to separate cell wall (CW), membrane (M), and cytosol-
containing soluble (SOL) fractions. These subcellular fractions were then analyzed for 
localization of the fusion protein by immunoblot analysis with antibodies that recognize 
the mature domain or, in the case of Ms1704 and Ms1712, recognize a C-terminal HA 
epitope tag fused to the mature domain. To assess the requirement for SecA2 in protein 
export we specifically compared export to the cell wall between wild type and ∆secA2 
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mutant cells, although all the fractions are shown on the immunoblots. Immunoblotting 
for a cytoplasmic GroEL chaperone and the cell wall MspA porin was used as controls 
for subcellular fraction integrity. 
As previously reported, when expressed in wild type M. smegmatis the C-
terminally HA-tagged Ms1704 protein containing its native signal sequence was exported 
to the cell wall (CW) (33). However, Ms1704-HA export was severely compromised 
when expressed in the ∆secA2 mutant, indicating that SecA2 is required for export of this 
protein. In comparison, export of the MspA control protein was unchanged by deletion of 
secA2, as was also shown previously (Figure 2.2A). Our first set of chimeras employed 
an M. smegmatis alkaline phosphatase (MsPhoA), which is exported in a SecA2-
independent manner (33). In addition, MsPhoA is a proven lipoprotein with a Sec signal 
sequence that contains a lipobox motif, as is also the case for Ms1704 and Ms1712 (42). 
When the signal sequence of Ms1704 was replaced with the signal sequence of MsPhoA, 
the ssMsPhoA-Ms1704-HA chimera was exported to the cell wall in wild type M. 
smegmatis but was not exported to the cell wall of the ∆secA2 mutant (Figure 2.2A). 
These results indicated that the MsPhoA signal sequence can support export of the 
Ms1704 mature domain, but this export requires SecA2. In the converse fusion, when the 
Ms1704 signal sequence was fused to the mature domain of MsPhoA, the ssMs1704-
MsPhoA fusion protein was efficiently exported to the cell wall in both wild type and 
∆secA2 mutant M. smegmatis. Thus, export of the mature domain of MsPhoA remained 
SecA2-independent, despite containing a signal sequence from a SecA2 substrate. This 
set of chimeras suggested there is something distinct about the mature domain of Ms1704 
that dictates SecA2-dependency. 
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The mature domain of Ms1712 also imparts the requirement for SecA2 in export 
To see if the above results extend to the other known M. smegmatis SecA2 
substrate, we constructed similar chimeras with Ms1712. As previously demonstrated, 
Ms1712-HA containing its native signal sequence is only exported to the cell wall when 
SecA2 is present (33). Consistent with results using Ms1704, the Sec signal sequence 
from MsPhoA supported export of the Ms1712 mature domain to the cell wall in wild 
type M. smegmatis, but this export was reduced in the ∆secA2 mutant (Figure 2.2B). 
Further, the converse fusion with the signal sequence of Ms1712 fused to the mature 
domain of MsPhoA (ssMs1712-MsPhoA) was exported equally in both wild type and the 
∆secA2 mutant.    
The M. tuberculosis 19kD lipoprotein is another protein previously shown to be 
exported by M. smegmatis in a manner independent of SecA2 (33, 80). Therefore, we 
also created chimeras between Ms1712 and the 19kD lipoprotein. In line with the results 
from the MsPhoA fusions, the Sec signal sequence of 19kD supported export of the 
Ms1712 mature domain to the cell wall in wild type M. smegmatis but not in the ∆secA2 
mutant. Furthermore, the signal sequence of Ms1712 could export the mature domain of 
the 19kD lipoprotein in both wild type and cells lacking SecA2, indicating that 
ssMs1712-19kD export occurred independently of SecA2 (Figure 2.2B). 
The results from these signal sequence swap experiments showed that whenever a 
chimera contained a mature domain from a SecA2-dependent protein the fusion protein 
was exported to the cell wall only in the presence of SecA2. In contrast, all chimeras 
containing the signal sequence of Ms1704 or Ms1712 fused to a mature domain of a 
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SecA2-independent protein were exported equally well by wild-type and the ∆secA2 
mutant strains. These results indicated that the mature domain of SecA2 substrates 
contains feature(s) that necessitate a role for SecA2 in export and that SecA2 substrates 
do not contain SecA2 specific signal sequences. 
SecA2-dependent export is independent of lipid modification of substrates 
  Because both Ms1704 and Ms1712 are lipoproteins we considered the possibility 
that they have a unique lipid modification that imparts the need for SecA2 in export. To 
test the influence of lipid modification on SecA2-dependent export, we used site-directed 
mutagenesis to replace the codon for the invariant cysteine in the lipoboxes of Ms1704 
and Ms1712 to one encoding an alanine. This cysteine is the site of diacylglycerol 
attachment, which is the first step in lipid modification (15). An alanine substitution for 
this cysteine (CA) will prevent lipid attachment but should not prevent export because it 
converts the lipoprotein signal sequences of Ms1704 and Ms1712 to standard Sec signal 
sequences (60). 
When the non-lipidated Ms1704CA-HA and Ms1712CA-HA proteins were 
expressed in wild type M. smegmatis, we could detect the proteins in whole cell lysates, 
but were initially surprised to find that neither protein localized to the cell wall fraction 
(data not shown). For at least some mycobacterial lipoproteins, the lipid moiety is shown 
to be required for anchoring to the cell wall and without lipid modification the proteins 
are fully secreted (74). Indeed, both Ms1704CA-HA and Ms1712CA-HA proteins were 
secreted into the media, as detected in culture filtrates (CF) from the wild type strain. 
Immunoblotting of culture filtrates with anti-GroEL antibodies confirmed that the 
presence of Ms1704CA-HA and Ms1712CA-HA in the media was not due to cell lysis. 
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When culture filtrates from wild type or ∆secA2 mutant expressing Ms1704CA-HA or 
Ms1712CA-HA were compared, we found less protein secreted in the culture filtrates 
obtained from the ∆secA2 mutant (Figure 2.3A). There was also evidence of Ms1712CA-
HA accumulation in the whole cell lysate of the ∆secA2 mutant, which included a higher 
molecular weight band that likely represents precursor protein containing the uncleaved 
signal sequence. This higher molecular weight form is consistent with a form of Ms1712 
that accumulated in the presence of globomycin, an inhibitor of the lipoprotein signal 
peptidase, seen in a previous study (33). These observations are indicative of an export 
defect in the ∆secA2 mutant and they showed that secretion of non-lipidated Ms1704CA-
HA and Ms1712CA-HA proteins is dependent on the presence of SecA2.  
As another way of testing the importance of the lipid modification to SecA2 
export, we replaced the Ms1704 signal sequence with the signal sequence of M. 
tuberculosis Antigen 85B, a well known secreted protein of M. tuberculosis with a 
standard Sec signal sequence (i.e. no lipobox) (78). This chimera did not include the 
invariant cysteine of the Ms1704 lipobox and was therefore non-lipidated. As with the 
CA mutant proteins, the ssAg85B-Ms1704-HA chimera expressed by wild type M. 
smegmatis did not localize to the cell wall but was instead secreted into the culture 
filtrate. In addition, secretion of the ssAg85B-Ms1704-HA protein was impaired in the 
∆secA2 mutant, which demonstrated a requirement for SecA2 in the export of this non-
lipidated chimera (Figure 2.3B). Taken together, these results show that SecA2-
dependent export of the Ms1704 and Ms1712 mature domains is not a consequence of 
lipid modification. 
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The Ms1704 mature domain is not heavily glycosylated 
We next considered the possibility that the mature domains of mycobacterial 
SecA2 substrates such as Ms1704 contain a post-translational modification, other than 
lipidation, which influences targeting to SecA2. Substrates of SecA2–SecY2 systems are 
heavily glycosylated prior to export and this modification blocks export by the canonical 
SecA1/SecYEG in species such as Streptococcus gordonii and Streptococcus 
parasanguinis (6, 22, 53). Because of the precedent that glycosylation can influence 
targeting to SecA2; we tested the mature domain of Ms1704 for evidence of sugar 
modification. The ssPhoA-Ms1704-HA chimera, containing the Ms1704 mature domain, 
was chosen for analysis of possible glycosylation because of the high level of expression 
that was achieved with this construct.  
The ssPhoA-Ms1704-HA protein was expressed in wild type M. smegmatis and 
immunoprecipitated using anti-HA beads. We then resolved the protein by 1D SDS-
PAGE and stained with either Coomassie or periodic acid–Schiff (PAS) stain. The PAS 
stain is a generic stain for protein-bound carbohydrates and is often used to detect 
glycoproteins on polyacrylamide gels (50). While ssPhoA-Ms1704-HA was readily 
visible by Coomassie staining, the PAS stain failed to detect a corresponding band 
(Figure 2.4). However, the PAS stain did react with multiple proteins known to be 
glycosylated including horseradish peroxidase (HRP), and the M. tuberculosis PhoS1 and 
Mpt32 proteins (35). We were also unable to detect PAS staining of trypsin and 
immunoprecipitated MsPhoA-HA, indicating that our PAS staining was specific for 
glycoproteins. 
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These results demonstrate that the mature domain of Ms1704 is not heavily 
glycosylated. While we cannot completely rule out the possibility that the Ms1704 
mature domain is modified post-translationally, our PAS staining suggests that 
mycobacterial SecA2 substrates are not necessarily glycosylated heavily like the serine-
rich glycoproteins of SecA2–SecY2 systems. 
Export of the Msmeg6020 ABC-type sugar-binding lipoprotein is independent of SecA2 
 Ms1704 and Ms1712 share 40% amino acid similarity in their mature domains 
and both are predicted to be ABC-type sugar-binding proteins. Given the signal sequence 
chimera results described above, it is interesting to point out that this similarity is limited 
to the mature domain and does not include the signal sequences of these two proteins. We 
questioned whether similar structure or function of the mature domain is the reason both 
these proteins share a SecA2 requirement for export.  
To address this possibility, we tested the role of SecA2 in the export of Ms6020, 
which is one of the other 19 predicted ABC-type sugar-binding proteins of M. smegmatis 
(73). Ms6020 is also a predicted lipoprotein with a lipoprotein type Sec signal sequence 
(39, 73). The amino acid sequence of the Ms6020 mature domain is 48% similar to the 
Ms1704 mature domain and 41% similar to the Ms1712 mature domain. By expressing a 
C-terminal HA-tagged Ms6020 protein in wild type M. smegmatis we showed that the 
protein was indeed exported to the cell wall. However, Ms6020-HA was exported to the 
cell wall equally well in the ∆secA2 mutant of M. smegmatis (Figure 2.5). This result 
indicated that the requirement for SecA2 does not extend to all exported ABC-type sugar-
binding proteins of mycobacteria. 
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The extreme N-terminus of the Ms1704 mature domain is not required for SecA2-
dependent export 
 Because our chimera analysis demonstrated that the mature domain of SecA2 
substrates imparts the requirement for SecA2, we reasoned the mature domain may 
contain sequences required for SecA2 targeting. To address this possibility, we 
constructed versions of Ms1704 with deletions at the N- or C-terminus of the mature 
domain. To focus in on the contribution of the mature domain, we made the deletions in 
the ssPhoA-Ms1704 chimera, which we showed above is SecA2-dependent (Figure 
2.2A). Unfortunately, all but one of these derivatives failed to produce enough protein for 
subsequent analysis, probably because the deletions yielded instable proteins. The only 
construct that could be analyzed had 9 amino acids at the most extreme N-terminus of the 
Ms1704 mature domain deleted (Figure 2.6A). Export of ssPhoA-N-Ms1704-HA to the 
cell wall was monitored in both wild type M. smegmatis and the secA2 mutant (Figure 
2.6B). The ssPhoA-N-Ms1704-HA protein was localized to the cell wall of the wild 
type strain, but export was severely reduced in the secA2 mutant. This result indicated 
that the most extreme N-terminus is not required for export by the SecA2-dependent 
pathway of mycobacteria. This result is interesting in light of the fact that the exported 
GspB protein of  the S. gordonii SecA2-SecY2 system has a short amino acid sequence 
named AST (for accessory sec transport) located in the extreme N-terminus of its mature 
domain. This AST domain is required for SecA2-SecY2 targeting/export of GspB (9, 11).  
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Addition of a ‘BlaTEM1 reporter to the C-terminus of full length Ms1704 eliminates 
the requirement for SecA2 in export 
As another way to identify sequences in the mature domain that target the protein 
to the SecA2-dependent export system, we tested if SecA2-dependency could be 
transferred to a fused heterologous protein. For this reason, we constructed a fusion 
protein in which the C-terminus of full length Ms1704 was fused to the truncated β-
lactamase reporter (‘BlaTEM1) that lacks its native signal sequence. β-lactam antibiotics 
target the bacterial cell wall, therefore the ‘BlaTEM1 reporter must be exported in order 
to protect against these drugs. We previously showed that ‘BlaTEM1 can report on export 
when fused to Sec exported proteins that are expressed in a β-lactamase mutant (ΔblaS) 
of M. smegmatis (51). Expression of the Ms1704-‘BlaTEM1 fusion protein in either a M. 
smegmatis ΔblaS mutant or in a ΔblaS ΔsecA2 double mutant resulted in β-lactam 
resistance (data not shown). This result indicated that Ms1704 was able to support export 
of the ‘BlaTEM1 reporter and this export occurred in a SecA2-independent manner. To 
more directly evaluate Ms1704-‘BlaTEM1 export we also localized the fusion protein to 
subcellular fractions by immunoblotting with anti-BlaTEM1 antibodies (Figure 2.7). This 
analysis showed that the Ms1704-‘BlaTEM1 fusion was exported to the cell wall in both 
wild type and ΔsecA2 mutant M. smegmatis. 
While this approach also failed to reveal any evidence of SecA2 targeting signals 
in Ms1704, these results are significant. Unlike all the chimeras described earlier, here 
the presence of the mature domain of Ms1704 did not impart a requirement for SecA2 in 
export. This result indicated that fusion to ‘BlaTEM1 influences the feature(s) of the 
Ms1704 mature domain that necessitate SecA2 export. One plausible explanation is that 
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fusion to ‘BlaTEM1 altered the structure of Ms1704, enabling it to now be exported in 
the absence of SecA2.   
 
Ms1704 can be exported by the twin-arginine translocation (Tat) pathway, independent 
of SecA2 
 The SecA2-independent export of the Ms1704-‘BlaTEM1 fusion suggested that a 
structural feature of Ms1704 may influence the need for SecA2. Because the canonical 
Sec pathway exports proteins that are maintained in an unfolded state, we hypothesized 
that SecA2 substrates may be prone to more rapid folding in the cytoplasm compared to 
strictly SecA1-dependent preproteins. To this end, we tested the ability of a SecA2 
substrate to fold in the cytoplasm by engineering a signal sequence chimera, where the 
Tat signal sequence of M. tuberculosis phospholipase C (PlcB) was fused to the mature 
domain of Ms1704 (52). This strategy uses export by the twin-arginine translocation 
(Tat) system as a reporter for cytoplasmic folding because the Tat pathway requires 
preproteins to fold prior to export (25, 63). The Tat pathway has been utilized previously 
as an in vivo assay for cytoplasmic folding (30). 
As seen with the non-lipidated mutants and ssAg85B-Ms1704-HA chimera 
discussed above, the ssPlcB-Ms1704-HA chimera did not localize to the cell wall fraction 
when expressed in wild type M. smegmatis but was instead secreted into the culture 
filtrate (Figure 2.8). This was not surprising given the lack of a lipobox in the PlcB signal 
sequence. Remarkably, when ssPlcB-Ms1704-HA secretion was compared between wild 
type and ΔsecA2 mutant the fusion was exported equally well by the two strains. To 
confirm that this export was occurring through the Tat pathway, we engineered an 
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ssPlcB-Ms1704-HA chimera where the twin-arginine residues of the PlcB signal 
sequence were substituted with lysine residues. Such twin arginine substitutions have 
previously been shown to eliminate Tat export of numerous proteins (1, 20, 71). Further, 
we previously showed that changing the arginine residues in the PlcB signal sequence 
abolishes export of M. tuberculosis PlcB (52). The resultant protein, ssPlcB(KK)-
Ms1704-HA, was not secreted into the culture supernatants of either wild type or ∆secA2 
mutant cells (Figure 2.8B). This loss of secretion demonstrated that the Tat pathway is 
responsible for the SecA2-independent export of ssPlcB-Ms1704-HA.   
Because the Sec pathway exports proteins in an unfolded state, we expected that 
this Tat-dependent export of the mature domain of Ms1704 was unusual. For this reason, 
we similarly tested the ability of the PlcB signal sequence to direct export of the Sec 
signal sequence containing 19kD lipoprotein using an ssPlcB-19kD fusion protein. When 
the 19kD protein with its native Sec signal sequence was expressed in M. smegmatis, the 
protein was detected in cell wall, membrane, and culture filtrate fractions of wild type M. 
smegmatis (Figure 2.8C-D).  In contrast, although the ssPlcB-19kD fusion protein was 
detected in whole cell lysates and the soluble fraction of wild type M. smegmatis, this 
chimera was not exported to the cell wall, membrane, or culture filtrate (Figure 2.8C-D).  
Further, multiple migrating species of ssPlcB-19kD were observed in the whole cell 
lysate and cytosolic containing soluble fractions. The larger of these species is likely 
unprocessed precursor and the smaller product a result of degradation of non-exported 
protein retained in the cytosol. The difference in compatibility for Tat export between the 
mature domains of Ms1704 and 19kD argues for a difference in the tendency of these 
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representative SecA2-dependent and SecA2-independent substrates to fold in the 
cytoplasm prior to export.  
 
Discussion 
SecA2 systems are emerging as important pathways for the export of virulence 
factors in a set of Gram positive pathogens and mycobacteria (28). Yet, many 
mechanistic questions concerning SecA2 export remain, especially in organisms 
containing SecA2-only systems like mycobacteria. In mycobacteria, both SecA1 and 
SecA2 proteins are proven ATPases with significant homology to the well-studied 
Escherichia coli SecA (37, 64). However, SecA1 and SecA2 cannot substitute for one 
another, indicating that each has distinct functions in mycobacterial protein export, and 
the role of the SecA2 protein is not immediately obvious (17).   
In this study, we investigated why certain preproteins require SecA2 for export, 
despite containing Sec signal sequences that would be expected to be compatible with the 
canonical SecA1. There is precedent for the amino acid composition of N-terminal signal 
sequences influencing the export pathway of a given protein: the post-translational SecA 
pathway, the co-translational SRP-mediated pathway, or the Tat pathway (13, 24, 55). 
However, our data from the signal sequence swap experiments showed that the signal 
sequences of two exported M. smegmatis SecA2 substrates are not uniquely capable of 
directing preproteins to SecA2 for export. Instead, the mature domains of preproteins 
impart SecA2-dependency. This result, however, is not entirely unexpected because, in 
addition to the signal sequence, it is shown that the E. coli SecA interacts with the mature 
domains of preproteins at multiple steps during translocation (5, 36, 59, 75).  
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We further showed that the mature domain of a SecA2-dependent preprotein is 
compatible with export by the Tat pathway. This latter finding is intriguing and consistent 
with the possibility that a key difference between mature domains of SecA2-dependent 
preproteins and the larger collection of preproteins exported by the canonical 
SecA1/SecYEG pathway is a tendency to fold in the cytoplasm prior to export.  
 
Comparison to SecA2-SecY2 exported proteins 
 While this is the first study exploring the features that define proteins exported by 
a SecA2-only system, we can compare our results to those published on the glycosylated 
preproteins exported by SecA2-SecY2 systems. In comparison to the most thoroughly 
studied SecA2-SecY2 substrate, the S. gordonii GspB protein, there are clear differences 
in the features that determine export by the two classes of SecA2 systems.  
With GspB, the signal sequence prevents export by the canonical Sec pathway by 
way of three glycine residues (7). With the M. smegmatis Ms1704 and Ms1712 proteins, 
the signal sequences are required for export, as truncated derivatives of these proteins 
lacking the signal sequences are not exported (33). However, unlike the case with the 
signal sequence of GspB, our chimera analysis demonstrated that signal sequences of 
Ms1704 and Ms1712 do not contain features that prohibit export by the canonical Sec 
pathway independent of SecA2.  
There are also features in the mature domain of S. gordonii GspB that function in 
preventing export by the canonical Sec pathway. The distinctive glycosylation of the 
GspB mature domain, which occurs prior to export, also blocks export by the canonical 
Sec machinery (10). A similar finding is reported for the Fap1 preprotein of the 
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Streptococcus parasanguinis SecA2-SecY2 system (21). We explored the possibility that 
the mature domains of mycobacterial SecA2 substrates are glycosylated. However, 
periodic-acid Schiff staining failed to detect glycosylation of the mature domain of 
Ms1704 (Fig. S1). Although this analysis cannot completely rule out glycosylation of 
Ms1704 as a factor in preventing export by the canonical Sec pathway, it makes this 
possibility seem unlikely. We also asked whether a specific lipid modification of the 
mature domain could be a defining feature of M. smegmatis SecA2 substrates, but our 
data from testing non-lipidated variants of Ms1704 and Ms1712 argues against this 
possibility.  
Finally, approximately 20 amino acids at the N-terminus of the GspB mature 
domain (the AST domain) are required for targeting this preprotein to the SecA2-SecY2 
system of S. gordonii (9). The AST domain is predicted to adopt an alpha-helical 
conformation and mutations predicted to disrupt this secondary structure reduce GspB 
export. There are no predicted alpha-helices within the first 20 amino acids of either the 
Ms1704 or Ms1712 mature domains. Further, we showed that deletion of the extreme N-
terminus of the Ms1704 mature domain did not affect SecA2-export. Thus, there does not 
appear to be an AST-like targeting element in the extreme N-terminus of substrates of the 
mycobacterial SecA2-only system.  
 
Model for the role of the mature domain in SecA2-dependent export in mycobacteria 
How might the mature domain dictate the need for SecA2-dependent export in 
mycobacteria?  With the mycobacterial SecA2-only system proteins are most likely 
exported via the canonical SecYEG channel. In support of this model, depletion of the 
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essential M. smegmatis SecA1 protein eliminates export of Ms1704, which indicates that 
both SecA1 and SecA2 are required for export of this SecA2 substrate (64). However, 
SecA1 and SecA2 are non-redundant homologs, indicating that SecA2 fulfills a unique 
role in promoting export in mycobacteria (17). Below we discuss three non-exclusive 
possibilities for how and why the preprotein mature domain may dictate a requirement 
for SecA2 in their export by mycobacteria (Figure 2.9). 
First, the mature domain could possess a post-translational modification that 
inhibits canonical export by the SecA1/SecYEG pathway and, thereby, necessitates 
SecA2 function.  However, as described above, there is no evidence currently to support 
this possibility. 
Second, the mature domains of SecA2 substrates may have specific targeting 
signals for SecA2 recognition. While we did not detect such a sequence at the extreme N-
terminus of the Ms1704 mature domain, we cannot rule out the possibility that SecA2 
targeting signals exist elsewhere. Unfortunately, our efforts to test other regions of 
Ms1704 by deletion analysis or with chimeric proteins, in which we swapped regions of 
the SecA2-dependent Ms1704 and SecA2-independent Ms6020 proteins, were 
unsuccessful due to protein instability problems (data not shown).  However, if a SecA2-
binding sequence exists, it does not appear sufficient for SecA2-dependent export as 
demonstrated by the inability of full length Ms1704 to promote SecA2-dependent export 
of the fused ‘BlaTEM1 protein. In fact, addition of ‘BlaTEM1 to the C-terminus of the 
Ms1704 mature domain overrode the requirement of SecA2 for export. This latter result 
indicates that the fusion of the ‘BlaTEM1 reporter to Ms1704 influenced a property of the 
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Ms1704 mature domain to enable export by the canonical Sec pathway in the absence of 
SecA2.  
The third possibility is that a defining feature of the mature domain of SecA2 
substrates is a propensity to fold in the cytoplasm, which would be problematic for 
canonical Sec export. Studies on Sec export in E. coli show that fast-folding preproteins, 
such as dihydrofolate reductase and β-galactosidase, are incompatible with export though 
the SecYEG channel (4, 38). Also, slower-folding variants of preproteins result in better 
translocation efficiency through SecYEG (61). In thinking then about the fusion of 
‘BlaTEM1 to the C-terminus of full length Ms1704, it may have abolished the 
requirement for SecA2 by slowing down folding of the resultant fusion protein.  
In further support of this third possibility we found that the mature domain of 
Ms1704 was exported by the Tat system when it was fused to a Tat signal sequence. The 
Tat system only exports folded proteins, and will even reject Tat substrates engineered to 
remain unfolded (25, 30). The Tat compatibility of the Ms1704 mature domain indicates 
that it can fold in the cytoplasm. Tat export has been used before as a reporter for 
cytoplasmic folding (25, 30, 63). A limitation of this approach is that it only indicates that 
some, but not necessarily all, of the Ms1704 preprotein pool exists in a Tat-competent, 
folded state. Some preproteins exhibit a range of cytoplasmic conformations that allow 
export by both the Sec and Tat pathways (51). However, when we tested the SecA2-
independent 19kD lipoprotein it did not share the compatibility with Tat export. 
Interestingly, ssPlcB-Ms1704 was exported by the Tat pathway in the presence of SecA2, 
which suggests that any interactions between SecA2 and the preprotein do not interfere 
with Tat export.  
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Our results are consistent with a model where cytoplasmic folding of Ms1704 
inhibits export by the canonical SecA1/SecYEG in the absence of SecA2 (Fig. 8). There 
is evidence in E. coli that SecA has some chaperone function and the canonical Sec 
translocase can assist in unfolding some preproteins through the action of translocation 
itself (2, 27). Thus, it is possible that the mycobacterial SecA2 fulfills a chaperone-like 
role by keeping preproteins unfolded prior to or during export. Alternatively, SecA2 
could provide the energy required to translocate such challenging substrates through 
SecY. It is possible that SecA2 cooperates with SecA1 to carry out such functions. This 
cooperation could be at the level of delivering the preprotein to SecA1 or in working with 
SecA1 to translocate the protein across the SecY channel. The possibility of SecA1 and 
SecA2 working together is supported by evidence that the canonical E. coli SecA can 
function as a dimer (66). 
In E. coli and other Gram-negative bacteria, the SecB chaperone promotes Sec 
export of preproteins that fold quickly in the cytoplasm (44, 77). It should be noted that 
mycobacteria possess a “SecB-like” homolog, but current data suggests this protein has a 
chaperone role unrelated to general Sec export (14). Interestingly, the E. coli ABC-type 
maltose-binding protein (MBP) requires the SecB chaperone in order to remain unfolded 
for Sec export, while export of the related ribose-binding protein (RBP) is SecB-
independent (23, 43). These data demonstrate that proteins with similar functions can 
have different folding kinetics in the cytoplasm and therefore different requirements for 
cytoplasmic chaperones. These differences could also explain the distinction in SecA2-
dependence of Ms6020 versus the Ms1704 and Ms1712 proteins.  
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In M. tuberculosis, one of the few known SecA2-dependent exported proteins, the 
superoxide dismutase SodA, lacks an obvious Sec signal sequence (18). While it remains 
possible that the role of SecA2 in the export of M. tuberculosis SodA is indirect, it is 
interesting to discover in this study that the mature domain, not the signal sequence, 
harbors the feature(s) that identify M. smegmatis proteins as SecA2 substrates. Thus, it is 
possible that SecA2 of M. tuberculosis facilitates the export of proteins like SodA in a 
similar manner to the way M. smegmatis SecA2 functions with its substrates. With these 
ideas in mind, it is worthwhile to note that in Rhizobium leguminosarum export of an 
SodA protein that lacks a typical Sec signal sequence was recently reported to occur in a 
SecA-dependent manner (41).   
The data presented in this study provides a better foundation for understanding 
SecA2-dependent protein export. In this study we clearly identify the preprotein mature 
domain as the distinguishing feature of SecA2 substrates in mycobacteria. By showing 
that the mature domain of a M. smegmatis SecA2 substrate is compatible with the Tat 
export pathway, this study indicates that preproteins exported by this SecA2-only system 
are capable of folding in the cytoplasm. Thus, acquisition of a second SecA homolog in 
bacteria with SecA2-only systems may represent another solution to the problem of 
exporting proteins that pre-fold in the cytoplasm prior to translocation across the 
cytoplasmic membrane. In addition, our results further reinforce the distinction between 
the two classes of SecA2 export systems: the SecA2-SecY2 and SecA2-only pathways. 
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Table 2.1 Plasmids used in this study 
 
Plasmid Genotype Description Source 
pCR2.1 bla aph ColE1 TA cloning vector Invitrogen 
pMV261 aph oriM Phsp60 ColE1 
Episomal mycobacterial shuttle 
vector  
(72) 
pMV306 aph int attP ColE1 
Integrating mycobacterial shuttle 
vector 
(72) 
pJSC77 aph oriM Phsp60-HA ColE1 HA tag cloned into pMV261.kan (34) 
pHSG58 aph Phsp60-Ms1704-HA oriM ColE1 
Ms1704-HA expression vector, 
episomal 
(33) 
pHSG85 aph Pms1712-Ms1712-HA oriM ColE1  
Ms1712-HA expression vector, 
episomal 
(33) 
pMF122 aph Phsp60-∆ssMs1704-HA oriM ColE1 
∆ssMs1704-HA for signal 
sequence chimera cloning 
This work 
pML440 PAL5000 origin hyg, Pimyc-phoA ColE1 
M. smegmatis PhoA expression 
plasmid 
(79) 
pMF124 
aph Phsp60-ssPhoA-Ms1704-HA oriM 
ColE1  
ssPhoA-Ms1704-HA expression 
vector, episomal 
This work 
pMF125 bla aph ColE1 ssMs1704-PhoA in pCR2.1 This work 
pMF126 
aph Phsp60-ssMs1704-PhoA oriM 
ColE1 
ssMs1704-PhoA expression 
vector, episomal 
This work 
pHSG51 aph Phsp60-Ms1712-HA oriM ColE1 
Ms1712-HA expression vector, 
episomal 
(33) 
pHSG61 aph Phsp60-∆ssMs1712-HA oriM ColE1 
∆ssMs1712-HA for signal 
sequence chimera cloning 
This work 
pHSG68 
aph Phsp60-ssPhoA-Ms1712-HA oriM 
ColE1 
ssPhoA-Ms1712-HA expression 
vector, episomal 
This work 
pHSG70 bla aph ColE1 ssMs1712-PhoA in pCR2.1 This work 
pMF128 
aph Phsp60-ssMs1712-PhoA oriM 
ColE1 
ssMs1712-PhoA expression 
vector, episomal 
This work 
pMB244 bla aph ColE1 ss19kD in pCR2.1 This work 
pHSG64 bla aph ColE1 ssMs1712-19kD in pCR2.1 This work 
pHSG66 
aph Phsp60-ssMsmeg1712-’19kD- oriM 
ColE1 
ssMs1712-19kD expression 
vector, episomal 
This work 
pMF115 
aph Phsp60-ss19kD-Ms1712-HA oriM 
ColE1 
ss19kD-Ms1712-HA expression 
vector, episomal 
This work 
pMF123 aph Phsp60-Ms1704CA-HA oriM ColE1 
Non-lipidated Ms1704CA-HA 
expression vector, episomal 
This work 
pMF105 
aph Pmsmeg1712-Ms1712CA-HA oriM 
ColE1 
Non-lipidated Ms1712CA-HA 
expression vector, episomal 
This work 
pMM7-2 aph Phsp60-ssAg85B oriM ColE1 
M. tuberculosis Ag85B signal 
sequence in pMV261 
{Zeoli, 
2001 
 #660} 
pMB222 aph Phsp60-ssPlcB oriM ColE1 
M. tuberculosis PlcB signal 
sequence in pMV261 
(52) 
pMF127 
aph Phsp60-ssAg85B-Ms1704-HA oriM 
ColE1 
ssAg85B-Ms1704-HA 
expression vector, episomal  
This work 
pMF136 
aph Phsp60-ssAg85B-Ms1704-HA int 
attP ColE1 
ssAg85B-Ms1704-HA 
expression vector, integrating 
This work 
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pMF169 bla aph ColE1 Ms6020 in pCR2.1 This work 
pMF170 aph Phsp60-Ms6020-HA oriM ColE1  
Ms6020-HA expression vector, 
episomal 
This work 
pJM114 cat oriV ori2 
E. coli ′blaTEM-1 cloned into 
pCC1 
(51) 
pMF168 aph Phsp60-Ms1704 oriM ColE1 
Ms1704  (no HA tag) expression 
vector, episomal 
This work 
pMF171 
aph Phsp60-Ms1704-‘BlaTEM1 oriM 
ColE1 
Ms1704-‘BlaTEM1 expression 
vector, episomal 
This work 
pMF131 
aph Phsp60-ssPlcB-Ms1704-HA oriM 
ColE1 
ssPlcB-Ms1704-HA expression 
vector, episomal 
This work 
pMF135 
aph Phsp60-ssPlcB-Ms1704-HA int attP 
ColE1 
ssPlcB-Ms1704-HA expression 
vector, integrating 
This work 
pMF165 
aph Phsp60-ssPlcB(KK)-Ms1704-HA int 
attP ColE1 
ssPlcB(KK)-Ms1704-HA 
expression vector, integrating, 
PlcB signal sequence with RR to 
KK change 
This work 
pHSG67 aph Phsp60-19kD oriM ColE1 
19kD expression vector, 
episomal 
This work 
pMF161 bla aph ColE1 ∆ss19kD in pCR2.1 This work 
pMF167 aph Phsp60-ssPlcB-19kD oriM ColE1 
ssPlcB-19kD expression vector, 
episomal 
This work 
pMF246 
aph Phsp60-ssPhoA-N-Ms1704-HA 
oriM ColE1 
ssPhoA-N-Ms1704-HA  
expression vector, episomal 
This work 
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Table 2.2 Oligonucleotides used in this study 
 
Primer Name Sequence (5’-3’) 
pHSG51-SSswap-1 ATCCATATGGAAGTGATTCCTCCGGATCG 
pHSG58-SSswap-2 ATCAGGATCCTCCGCCGAAGGTGGCGGCGGTGG 
PhoAss-1 CCATATGCCTGTCAGTACCTATC 
PhoAss-2 GGATCCGGTGTCGCTGCTGCAGGCCG 
19kDss-1708-1 CATATGGAAGTGATTCCTCCGGATCG 
19kDss-1708-2 AGGATCCAGCGGCAAGGCACCGGGGT 
1704ss-PhoA-2 GTGTCACCGCTGGACTCCGTTTCGGCGGACCGT 
1708ss-PhoA-3OL ACGGAGTCCAGCGGTGAC 
1708ss-PhoA-4OL GAATTCTCAGTGCGCGGGTTCCTC 
19kDass-1 GCATATGAAGCGTGGACTGACGGTCGC 
19kDass-2 TGGATCCGCTTGAACATCCGGAAAGAC 
19kDss-1 GCATATGAAGCGTGGACTGACGGTCGC 
19kDss-2 TGGATCCGCTTGAACATCCGGAAAGAC 
1708ss-19kD-1 GTGGTCGATACCAAGCCATTTCC 
1708ss-19kD-2 
GTCTCACCGCTTCCTGTAGTTGCCTTGCCGCTGCCGC
AG 
1708ss-19kD-3 ACTACAGGAAGCGGTGAGAC 
1708ss-19kD-4 GAATTCTTAGGAACAGGTCACCTCGA 
Msmeg6020-F TCCCGGGTGAAGCGCACCAGCACCCTG 
Msmeg6020-R TAAGCTTCTCCTGCCGCGGAGCACA 
hsp60 SD plus smeg secA2 5’ AGGATCCATCCGGAGGAATCACTT 
1704R-BamHI TGGATCCCTTGACCTGGGTCTCGGTGTAG 
Msmeg1712R GGATCCACGTCGACATCGATAAGC 
19kDmature-F TCGGATCCAACAAGTCGACTACAGGAAGCGGTGAGAC 
19kDHA-F CGCGGCCGCGGTACCAG 
phoA1704F1SOE-R TCACCGTCGCTGCTGCAGGCCGTGAG 
phoA1704F1SOE-F  CTGCAGCAGCGACGGTGACGCCAAGG 
msmeg1704R  AGGATCCACTACGTCGACGATATCAG 
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Figure 2.1 Schematic of signal sequence chimeras 
The signal sequence regions of chimeras generated between M. smegmatis SecA2 
substrates and SecA2-independent lipoproteins are shown. Amino acid sequences from 
either SecA2 substrate (Ms1704 or Ms1712) are highlighted in grey, while sequences 
from SecA2-independent proteins (MsPhoA or 19kD) are boxed in white. The predicted 
lipobox in each signal sequence is highlighted in bold and the predicted cleavage site 
adjacent to the invariant cysteine (site of lipid modification) at the +1 position of the 
mature domain is noted with an arrow. Amino acids introduced from cloning are 
unboxed. 
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Figure 2.2 The mature domains of Ms1704 and Ms1712 require SecA2 for export to 
the cell wall.  
(A) Equalized whole cell lysates (WCL) generated from wild type and ΔsecA2 M. 
smegmatis cells expressing either Ms1704-HA, ssMsPhoA-Ms1704-HA, or ssMs1704-
PhoA were subjected to ultracentrifugation to generate subcellular fractions. Fractions 
were separated by SDS-PAGE, and proteins detected with either anti-HA or anti-PhoA 
antibodies. The total amount of cell wall (CW), membrane (M), and soluble (SOL) 
fractions shown is equivalent to the amount of WCL loaded. Native MspA and GroEL 
were detected as cell wall and cytoplasmic controls respectively. (B) Wild type or 
ΔsecA2 M. smegmatis cells expressing either Ms1712-HA, ssPhoA-Ms1712-HA, 
ssMs1712-PhoA, ss19kD-Ms1712-HA, or ssMs1712-19kD were fractionated and 
material was separated by SDS-PAGE. Immunoblotting was performed as described in 
(A) with the addition of the anti-19kD antibody when appropriate. The experiment shown 
is representative of three independent experiments. 
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Figure 2.3 SecA2-dependent export occurs regardless of lipidation.  
(A) Culture filtrate (CF) proteins from M. smegmatis cells expressing either Ms1704CA-
HA or Ms1712CA-HA proteins were analyzed by SDS-PAGE and immunoblot using an 
anti-HA antibody. Whole cell lysate (WCL) and CF material loaded was obtained from 
an equal number of wild type (WT) or ΔsecA2 M. smegmatis cells for each experiment. 
Native GroEL protein was detected as a loading and cell lysis control. Accumulation of 
presumptive precursor Ms1712CA-HA, containing an uncleaved signal sequence, in the 
WCL of the ΔsecA2 mutant is noted with an arrow. (B) Immunoblot of WCL and CF 
proteins from wild type and ΔsecA2 M. smegmatis cells expressing the nonlipidated 
ssAg85B-Ms1704-HA chimera. The experiments shown are representative of three 
independent experiments. 
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Figure 2.4 Periodic acid-Schiff staining fails to detect glycosylation of the Ms1704 
mature domain 
(A) Immunoprecipiated ssPhoA-Ms1704-HA or MsPhoA-HA, HRP, trypsin, PhoS1, and 
Mpt32 proteins were separated on a SDS-PAGE gel and coomassie stained. Asterisks 
denote the mouse IgG heavy and light chains from the anti-HA beads used for 
immunoprecipitation. (B) An identical SDS-PAGE gel was stained with the Periodic 
Acid Schiff Stain (PAS) (Pierce) to detect glycoproteins. The only reactive proteins 
include the positive controls: HRP, PhoS1, and Mpt32. The ssPhoA-Ms1704-HA failed 
to react with the PAS stain indicating that there is no evidence for glycosylation of the 
Ms1704 mature domain based on this system. 
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Figure 2.5 Ms6020-HA is exported to the cell wall independent of SecA2  
Equalized whole cell lysates (WCL) generated from wild type and ΔsecA2 M. smegmatis 
cells expressing HA-tagged Ms6020 were subjected to ultracentrifugation to subcellular 
fractions. Ms6020-HA was detected with an anti-HA antibody while native MspA and 
GroEL were detected as cell wall and cytoplasmic controls respectively. The total amount 
of cell wall (CW), membrane (M), and soluble (SOL) material shown is equivalent to the 
amount of WCL loaded. Shown here is a representative of three independent 
experiments. 
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Figure 2.6 The extreme N-terminus of the Ms1704 mature domain is not required 
for SecA2-mediated export 
(A) The first 9 amino acids (italics) were removed from the Ms1704 mature domain, 
adjacent to the signal peptide cleavage site (arrow), to assess the contribution of this 
region to SecA2-mediated export. This extreme N-terminus truncation was created in the 
ssMsPhoA-Ms1704-HA signal sequence chimera, where sequence derived from MsPhoA 
is boxed in white and sequence from Ms1704 is boxed in grey. (B) Equalized whole cell 
lysates (WCL) generated from wild type and ΔsecA2 M. smegmatis cells expressing this 
ssPhoA-ΔN-Ms1704-HA protein were subjected to ultracentrifugation to generate 
subcellular fractions. Fractions were separated by SDS-PAGE, and proteins detected an 
anti-HA antibody. The total amount of cell wall (CW), membrane (M), and soluble 
(SOL) fractions shown is equivalent to the amount of WCL loaded. Native MspA and 
GroEL were detected as cell wall and cytoplasmic controls respectively. Shown here is a 
representative of three independent experiments. 
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Figure 2.7 An Ms1704-‘BlaTEM1 fusion is exported to the cell wall independently of 
SecA2 
(A) The structure of the Ms1704-‘BlaTEM1 fusion protein is shown. The signal peptide 
and entire Ms1704 mature domain constitute the N-terminus of this fusion and are 
depicted in thegrey rectangle. The E. coli ‘BlaTEM1 (lacking its native signal sequence) 
was fused to the C-terminus of Ms1704. Amino acids introduced from cloning are 
unboxed. (B) Equalized whole cell lysates (WCL) generated from wild type and ΔsecA2 
M. smegmatis cells expressing Ms1704-‘BlaTEM1 were subjected to ultracentrifugation 
to generate subcellular fractions. The Ms1704-‘BlaTEM1 fusion was detected with an 
anti-BlaTEM1 antibody while native MspA and GroEL were detected as cell wall and 
cytoplasmic controls respectively. The total amount of cell wall (CW), membrane (M), 
and soluble (SOL) fractions shown is equivalent to the amount of WCL loaded. Shown is 
a representative of two independent experiments. 
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Figure 2.8 Ms1704 is compatible with export by the twin-arginine translocation 
(Tat) pathway 
(A) Concentrated culture filtrate (CF) proteins from M. smegmatis cells expressing 
ssPlcBMs1704-HA were analyzed by SDS-PAGE and immunoblot using an anti-HA 
antibody. Whole cell lysate (WCL) and CF material loaded was obtained from an equal 
number of wild type and ΔsecA2 M. smegmatis cells for each experiment. Native GroEL 
was detected as a loading and cell lysis control. (B) In the signal sequence of the 
ssPlcB(KK)-Ms1704-HA chimera, the twin arginine residues were changed to lysines to 
abolish targeting to the Tat machinery. Secretion of this chimera was analyzed as 
described in (A). (C) Export of 19kD containing its native Sec signal sequence and the 
ssPlcB-19kD chimera were analyzed by SDS-PAGE and immunoblot using an anti-19kD 
antibody. Equalized whole cell lysates (WCL) generated from wild type M. smegmatis 
cells expressing each protein were subjected to ultracentrifugation to generate cell wall 
(CW), membrane (M), and soluble (SOL) fractions. (D) WCL and culture filtrate (CF) 
proteins from wild type M. smegmatis cells expressing either protein were also analyzed 
by immunoblot. Wild type 19kD is readily detected in both CW and CF fractions while 
the ssPlcB-19kD chimera is not exported. The ssPlcB-19kD also exhibits three forms in 
the WCL and SOL fraction (denoted by arrows), likely representing precursor protein 
containing an uncleaved signal sequence and cytoplasmic degradation products. All 
immunoblots are representative of at least two independent experiments 
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Figure 2.9 Models for mycobacterial SecA2 export  
(A) The feature(s) that make a preprotein dependent on SecA2 for export are not 
contained in the N-terminal signal sequence. Instead, the mature domain of select 
proteins, such as Ms1704 and Ms1712, impart the requirement for SecA2.  Lipidation of 
the mature domain is not a factor. (B) SecA2 is required for the export of certain proteins, 
likely through the canonical SecYEG channel. One possibility is that glycosylation or 
another post-translational modification in the mature domain (depicted as attached 
circles) prevents export by the canonical Sec pathway and/or direct preproteins to SecA2 
for export (1). A second possibility is that the mature domain contains an amino acid 
sequence that directs the preprotein to SecA2 and/or away from SecA1 (depicted as a 
thick black oval) (2). A third possibility is that the defining feature of SecA2 substrates is 
a tendency to fold in the cytoplasm (3).  Our data is consistent with this last possibility, 
where SecA2 would then function in maintaining an unfolded preprotein conformation 
prior to or during export.  The signal sequence of preproteins is depicted by the oval with 
diagonal lines. 
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CHAPTER 3 
Identification of Mycobacterium tuberculosis Proteins that Depend on  
SecA2 for Cell Wall Localization
1
 
 
Mycobacterium tuberculosis is an intracellular pathogen that is able to survive in 
host macrophages by blocking phagosome maturation. This immune evasion strategy is a 
complex process involving multiple exported bacterial protein effectors. One protein 
export pathway that contributes to interrupting maturation of the M. tuberculosis 
phagosome is the SecA2 system. Mycobacteria have two non-redundant SecA homologs. 
While the essential SecA1 handles “housekeeping” protein export, the nonessential 
SecA2 exports a subset of proteins and is required for M. tuberculosis virulence. 
Identification of SecA2-dependent exported proteins will help elucidate the role of SecA2 
in M. tuberculosis virulence, which is not currently understood. Here, we used a label- 
free mass spectrometry method called spectral counting to identify M. tuberculosis 
proteins that require SecA2 for export to the cell wall. We identified a total of 1,920 cell 
wall-associated M. tuberculosis proteins. Proteins underrepresented in the secA2 cell 
wall included the majority of predicted solute-binding proteins and multiple proteins 
belonging to two transporter complexes with roles in M. tuberculosis virulence: 
________________________ 
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Mce1 and Mce4. Several predicted substrates of the twin-arginine translocation (Tat) 
pathway were also reduced in the cell wall of the secA2 mutant. Because the Tat 
pathway only exports folded preproteins, this suggests that the mycobacterial SecA2 and 
Tat systems might assist in export of a common pool of preprotein substrates that fold in 
the cytoplasm. Additionally, several proteins were more abundant in the secA2 mutant, 
suggesting that they were up-regulated in the mutant strain. Our semi-quantitation 
analyses generated a list of potential SecA2 substrates, some of which are candidates for 
M. tuberculosis virulence factors.  
 
Introduction 
Mycobacterium tuberculosis, the etiological agent of tuberculosis, is one of the 
most prevalent infectious agents worldwide, infecting an estimated 1/3 of the global 
population (130). Emergence of drug-resistant strains of M. tuberculosis combined with 
co-infection with HIV has resulted in the highest mortality rate of any infectious bacteria, 
with over 1 million tuberculosis-related deaths reported annually (130). One of the keys 
to the success of M. tuberculosis as a pathogen is its ability to survive and grow inside 
host cells as an intracellular pathogen (93). 
Upon inhalation into the lung, M. tuberculosis bacilli are engulfed by resident 
alveolar macrophages. These macrophages normally sequester bacteria inside 
phagosomal compartments that undergo a process of maturation and acidification, 
eventually leading to the destruction of the invading bacterial cell (23). Many 
intracellular pathogens, such as Legionella pneuomophila, Salmonella typhimurium, and 
M. tuberculosis, have evolved mechanisms to circumvent this innate host defense 
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pathway. Often, such bacterial pathogens export protein effectors into the macrophage 
environment to promote their intracellular survival and growth (43).  
M. tuberculosis survives in macrophages by interrupting phagosomal maturation 
using a multi-factorial process involving both bacterial surface lipids and exported 
protein effectors (93). While several M. tuberculosis exported effectors have been linked 
to phagosomal maturation arrest, our understanding of this complex process is 
incomplete, as the list of bacterial effectors and corresponding host targets continues to 
grow. One strategy to better understand how M. tuberculosis survives and grows in the 
host is to study protein export pathways that are required for intracellular growth in 
macrophages. In M. tuberculosis, the specialized SecA2 protein export pathway is 
required for growth in macrophages and, more specifically, for phagosome maturation 
arrest (120). However, the SecA2-dependent exported proteins required for interrupting 
phagosomal maturation are unknown. 
Mycobacteria contain two conserved protein export systems for transporting 
proteins from the cytosol to the cell wall and/or the extracellular environment: the 
universal general secretion (Sec) pathway and the twin-arginine translocation (Tat) 
pathway (67). In M. tuberculosis, both Sec and Tat export are essential for in vitro growth 
and also contribute to survival in the host (96, 105, 106). The Sec pathway handles the 
majority of protein export while the Tat pathway is responsible for exporting a more 
limited set of proteins. The core of the general Sec export pathway is the protein-
conducting SecYEG membrane channel and a cytoplasmic ATPase called SecA (13). 
SecA recognizes proteins synthesized with N-terminal signal peptides and powers their 
translocation through SecYEG. Mycobacteria, including M. tuberculosis, are among a 
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select group of bacteria that have two non-redundant SecA protein homologs known as 
SecA1 and SecA2 (24, 99). While SecA1 is essential and required for powering 
housekeeping export as part of the canonical Sec pathway, SecA2 is dispensable for in 
vitro growth but necessary for exporting a subset of proteins (24).  
In M. tuberculosis, SecA2 is required for growth in macrophages and mice, 
suggesting that at least some SecA2-dependent exported proteins are virulence factors (7, 
63). Deletion of secA2 is linked to multiple phenotypes during macrophage infection with 
M. tuberculosis including increased host cell apoptosis, increased induction of pro-
inflammatory cytokines, and an inability to block phagosome maturation (44, 63, 120). 
Understanding how SecA2 influences these macrophage responses requires a complete 
understanding of the proteins exported by the SecA2 system.  
In a previous study, comparative 2-dimensional gel electrophoresis (2D-GE) 
analysis of proteins secreted into the culture media by wild type M. tuberculosis or the 
secA2 mutant was used to identify SecA2-dependent proteins (7). Only a small number 
of proteins were found to be secreted less into culture media by the secA2 mutant. One 
protein was later confirmed to require SecA2 for export: the Fe-superoxide dismutase, 
SodA (7, 44). Interestingly, SodA lacks a recognizable signal peptide for export. 
Subsequent studies showed that inadequate SodA secretion is not sufficient to explain the 
growth defect of the secA2 mutant in macrophages (63, 120). Therefore, there must be 
additional SecA2-dependent exported proteins important for intracellular growth of M. 
tuberculosis awaiting identification.  
In the non-pathogenic Mycobacterium smegmatis model species, two cell wall 
proteins were identified as dependent on SecA2 for export: Ms1704 and Ms1712 (34). 
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These proteins are predicted solute-binding lipoprotein (SBP) components of two ABC 
transporters with putative roles in sugar uptake, and both these proteins contain typical N-
terminal Sec signal peptides for export (84, 90). The SecA2 systems of M. tuberculosis 
and M. smegmatis are functionally conserved, suggesting that in M. tuberculosis there 
will also be cell wall proteins that require SecA2 and are synthesized with N-terminal 
signal peptides (100).  
Past efforts to identify mycobacterial SecA2 substrates in the cell wall were 
subject to the technical limitations of 2D gel comparisons, in particular, the difficulties 
associated with separating hydrophobic cell wall proteins by 2D-GE (7, 8, 34). Large-
scale “shot-gun” proteomic analyses offer an attractive alternative to 2D-GE for 
comparing large complex protein samples, and spectral counting is one increasingly 
popular label-free method for determining relative protein abundance in such studies. 
Spectral counting quantitation is based on the observation that the total number of MS 
spectra assigned to a particular protein correlates with the abundance of that protein (69). 
Spectral counting has previously been used to identify exported proteins in Pseudomonas, 
Porphyromonas, Shigella, and Salmonella (46, 59, 62, 85).  
Here we compared the proteome of the wild type M. tuberculosis cell wall to that 
of a secA2 mutant using shot-gun proteomics and spectral counting. Our analysis led to 
the identification of 1,920 M. tuberculosis cell wall-associated proteins. Proteins exported 
to the cell wall by the SecA2-dependent pathway should be underrepresented in the cell 
wall of the secA2 mutant versus wild type strain. We identified 124 proteins that met 
our criteria for being significantly reduced or absent in the secA2 mutant cell wall.  
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Among the proteins underrepresented in the M. tuberculosis secA2 mutant were 
multiple lipoproteins, including the majority of predicted solute-binding proteins, which 
is significant in revealing similarity with the M. smegmatis SecA2 system. The broad 
impact of secA2 deletion on export of SBPs in M. tuberculosis also suggests a possible 
role for SecA2 export in nutrient acquisition inside the host.  Additionally, multiple 
proteins belonging to two transporter complexes with roles in M. tuberculosis virulence, 
Mce1 and Mce4, were underrepresented in the secA2 mutant cell wall. Finally, several 
predicted Tat substrates were less abundant in the secA2 mutant, most of which have 
putative SBP functions. Our list of cell wall-associated proteins affected by secA2 helps 
provide insight into the mechanisms of mycobacterial SecA2 export and the contribution 
of this protein export system to M. tuberculosis virulence.  
 
Materials and Methods 
M. tuberculosis growth conditions for cell wall analysis: For analysis of the cell wall 
proteome, M. tuberculosis H37Rv (wild type) and mc
2
3112 (secA2) were first grown at 
37° C in liquid Middlebrook 7H9 medium (Difco) supplemented with 0.05% Tyloxapol 
(Sigma), 0.5% glycerol, and 1X ADS [0.5% bovine serum albumin, 0.2% glucose, 0.85% 
NaCl]. After cultures reached an OD600 of 2 or 3, cells were harvested by centrifugation 
and washed two times with modified 7AGT medium. The washed cells were used to 
inoculate three independent 100 mL cultures at an OD600 of 0.08 using the modified 
7AGT medium, resulting in three replicates for each M. tuberculosis strain. This 
modified medium consisted of 7H9 supplemented with 0.1% Tyloxapol, 0.1% glycerol, 
0.5% bovine serum albumin, and 1 mM proprionic acid (Sigma). The media was buffered 
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using 100 mM 2-(4-morpholino)-ethane sulfonic acid (MES) and the pH adjusted to 6.5 
(92). Cultures were grown at 37° C to an OD600 of approximately 1, and then harvested 
by centrifugation. Cell pellets were washed with 1X phosphate-buffered saline (PBS) 
then sterilized by gamma-irradiation for 27 hours in a JL Shephard Mark I 137Cs 
irradiator (Dept. of Radiobiology, University of North Carolina at Chapel Hill) for 
removal from BSL-3 containment. 
Preparation of subcellular fractions: Cell wall fractions were isolated by centrifugation 
as previously described (38). Briefly, cells suspended in 1X PBS containing a cocktail of 
protease inhibitors were lysed by four passages through a french press cell. Unlysed cells 
were removed by centrifugation at 3,000 x g to generate clarified whole cell lysates 
(WCLs). Protein concentrations were determined by BCA assay (Pierce) using a BSA 
standard and equalized among both strains and all replicates. Equalized WCLs were spun 
at 27,000 x g for 30 minutes to obtain the cell wall fraction. The supernatant was then 
spun at 100,000 x g for 2 hours to isolate the cytoplasmic membrane fraction from the 
remaining soluble fraction. Cell wall and membrane fractions were washed once and 
suspended in PBS. Prior to proteomic analysis, protein concentrations of the cell wall 
fractions were determined by BCA assay and equalized among all replicates of both 
strains.  
In-gel trypsin digestion of cell wall proteins: Cell wall proteins from the three 
biological replicates of M. tuberculosis H37Rv and mc
2
3112 were separated on a precast 
12% SDS-PAGE gel. For each sample, 34 mg of protein was loaded in an individual lane 
for separation. Protein bands were visualized by Coomassie Blue R-250 staining (Bio-
Rad, Hercules, CA) and the lane for each biological sample was cut into 32 equivalent 
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gel slices, approximately 2 mm thick. Trypsin digestion of the excised gel slices was 
performed as previously described  with modifications (17). Briefly, each gel slice was 
cut into smaller pieces and placed in a single well of a 96-well U-bottom polypropylene 
plate containing HPLC-grade water. After de-staining with multiple acetonitrile (ACN) 
washes, slices were incubated in 25 mM ammonium bicarbonate (ABC) containing 20 
µg/mL of sequencing-grade trypsin overnight at 37° C. The ABC supernatants from 
overnight trypsin incubation were then transferred to a new 96-well plate. Tryptic 
peptides were extracted from the gel slices by two washes using 50% ACN then 100% 
ACN. The ACN washes containing the tryptic peptides were added to the overnight ABC 
supernatant in the fresh plate. Digested peptides were store at -80° C until lyophilization.  
Mass spectrometry analysis: Samples were desalted using PepClean C18 spin columns 
(Pierce, Rockford, IL) according to manufacturer’s directions, and re-suspended in an 
aqueous solution of 0.1% formic acid. All samples were analyzed by reversed phase LC-
MS/MS using a 2D-nanoLC ultra system (Eksigent Inc, Dublin, CA) coupled to an LTQ-
Orbitrap XL system with ETD (Thermo Scientific, San Jose, CA).  The Eksigent system 
was configured to trap and elute peptides in 1D mode of operation via a sandwiched 
injection of ~ 250 fmol of sample. The trapping was performed on a 3 cm long 100 m 
i.d. C18 column while elution was performed on a 15 cm long 75 m i.d., 5 m, 300Å 
particle; ProteoPep II integraFrit C18 column (New Objective Inc, Woburn, MA). 
Analytical separation of all the tryptic peptides was achieved with a linear gradient of 2-
40% buffer B over either 120 min at a 200 nL/min flow rate, where buffer A is aqueous 
solution of 0.1% formic acid and buffer B is a solution of acetonitrile in 0.1% formic 
acid. Mass spectrometric data acquisition was performed in a data dependent manner on a 
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hybrid LTQ-Orbitrap mass spectrometer. A full scan mass analysis on an Orbitrap 
(externally calibrated to a mass accuracy of < 1 ppm, and a user defined resolution of 60 
000) was followed by intensity dependent MS/MS of the top 10 most abundant peptide 
ions in the collision cell of the mass spectrometer. High energy collision activated 
dissociation (HCD)-MS/MS spectra were obtained for peptide ions that were subjected to 
10 m.s. ion activation at a normalized collision energy of 35 eV. The MS/MS acquisition 
of a precursor m/z was repeated for a 30 s. duration and subsequently excluded for 60 s. 
Monoisotopic precursor ion selection and charge state screening was enabled for 
triggering data dependent MS/MS scans.  
Peptide identification and assignment of proteins: Mass spectra were processed, and 
peptide identification was performed using Mascot ver. 2.3 (Matrix Science Inc.) 
implemented on Proteome Discoverer ver. 1.3 (Thermo-Fisher Scientific). All searches 
were performed against a NCBI M. tuberculosis H37Rv data base with methionine 
oxidation as a variable modification. Peptides were confidently identified using a target-
decoy approach with a false discover rate (FDR) of 0.01. A precursor ion mass tolerance 
of 200 p.p.m. and a product ion mass tolerance 0.5 Da were used during the search to 
increase search space and reduce false positive identifications with a maximum of two 
missed trypsin cleavages. All spectra were post-search filtered and peptides having a 
mass accuracy of 6 p.p.m or less were reported for all the identified proteins.  
Peptide validation and label-free spectral count quantitation: Label-free quantitation 
was based on spectral counting was performed on the Mascot DAT files searched against 
a forward M. tuberculosis database as-well-as a decoy M. tuberculosis database using 
ProteoIQ: ver 2.3.02 (NuSep Inc., Athens, GA). The decoy database search was used to 
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independently asses FDR (error rate) of the identified spectra in ProteoIQ. All Mascot 
protein identifications were subjected to probability-based confidence measurements 
using an independent implementation of the statistical models commonly known as 
Peptide and Protein Prophet deployed in ProteoIQ (53, 82). All protein hits were filtered 
with a protein probability of 0.5 and Mascot identity having a significant score cut-off 
that was greater than 26. Label-free quantification was performed on the pooled DAT 
files of three replicate runs for both wild type and secA2 sample groups. Protein ratios 
between wild type and secA2 mutants were obtained using average spectral count for 
each identified protein. Average spectral counts were normalized by total spectral counts 
as part of ProteoIQ software. Protein quantification values were reported with F-test 
statistics with a p value cut-off of 0.05. We have also used a 2-fold change in log2 
(H37Rv/secA2) ratio as cut-off for changes in protein abundance. Q values were 
obtained using the QVALUE software developed by Alan Dabney and John Storey (118). 
Immunoblotting: Equalized whole cell lysates (WCLs) derived from replicates of wild-
type or secA2 mutant M. tuberculosis strains were separated on a 12% SDS-PAGE gel, 
then transferred to a nitrocellulose membrane (Whatman). Native proteins were detected 
using the following antibodies: anti-SecA1 at 1:50,000 (39), anti-SecA2 at 1:25,000 (39), 
or anti-19kD (provided by Douglas Young) at 1:20,000. For immunoblotting of 
subcellular fractions, native proteins were detected using either anti-MtrA at 1:2000 (29), 
anti-SigA at 1:15,000 (81), anti-HbHA at 1:1000 (NIH Biodefense and Emerging 
Infections Research Resources Repository, NIAID, NIH), anti-19kD at 1:20,000 
(provided by Douglas Young), or anti-PhoS1 at 1:1,000 (BEI Resources). Anti-mouse 
and anti-rabbit secondary antibodies conjugated to horse radish peroxidase (BioRad) 
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were used as appropriate at a concentration of 1:20,000 and detected using Western 
Lightning Chemiluminescent detection reagent (Perkin-Elmer). For quantitation of the 
PhoS1 immunoblot, secondary antibody conjugated to alkaline phosphatase (GE 
Healthcare) was used and detected using or ECF reagent (GE Healthcare). Fluorescence 
was quantified using ImageJ (NIH). 
 
Results 
Our appreciation of the proteins exported by the SecA2 system of M. tuberculosis 
remains incomplete. Previous efforts to identify SecA2-dependent proteins were subject 
to limitations of 2D-GE analysis. Quantitative “shotgun” proteomics enables a more 
comprehensive assessment of complex protein samples than 2D-GE. Consequently, to 
identify additional examples of proteins exported in a SecA2-dependent fashion, we used 
shotgun proteomics combined with label-free spectral counting to measure the relative 
abundance of proteins in cell wall fractions of wild-type versus a secA2 deletion mutant 
of M. tuberculosis.  
 
Growth of wild type and secA2 mutant M. tuberculosis for cell wall proteome analysis 
It is well known that bacteria alter gene expression in response to environmental 
triggers associated with infection. These transcriptional responses can influence 
expression of genes encoding proteins destined for export. For example, temperature and 
aerobic conditions influence expression of some SecA2-dependent proteins in Listeria (9, 
98). The protein export systems themselves can also be regulated by host conditions.  As 
an example, the Sp-II protein secretion system is activated when Salmonella typhimurium 
is located inside the macrophage (15).  
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M. tuberculosis also undergoes transcriptional adaptations upon macrophage 
infection (30, 101, 109). Therefore, to increase the possibility that we detect SecA2-
dependent substrates important to virulence we modified standard laboratory growth 
media to be more reflective of the phagosomal environment encountered by M. 
tuberculosis. Although M. tuberculosis arrests the normal process of phagosome 
maturation, the bacterium is exposed to mildly acidic conditions (27, 101). Therefore, we 
adjusted conventional mycobacterial 7H9 media to a slightly acidic pH of 6.5 to mimic 
the phagosomal pH M. tuberculosis experiences during infection (119). Among the many 
M. tuberculosis genes induced inside a macrophage are those involved in fatty acid 
metabolism (109) and it is now clear that M. tuberculosis preferentially uses fatty acids 
for carbon and energy sources during infection (72, 76). For this reason, we also provided 
the fatty acid propionate as a carbon source (49). Finally, to avoid possible growth 
problems associated with degradation products of Tween detergent we instead utilized 
the non-hydrolyzable Tyloxapol as the dispersing agent in liquid cultures (127). 
Triplicate cultures of M. tuberculosis H37Rv (wild type) and mc
2
3112 (secA2) were 
grown in this modified media then cells harvested during log phase at an OD600 of 
approximately 1.0 for preparation of cell wall fractions. 
 
Preparation of M. tuberculosis cell wall proteins for MS analysis 
Whole cell lysates were generated from triplicate cultures of wild type or secA2 
mutant, assayed for protein concentration, and equalized among samples prior to 
subcellular fractionation. The equalized whole cell lysates (WCLs) were further analyzed 
by immunoblotting to ensure equivalent total protein levels between all strains and 
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replicates (Figure 3.1A). All lysates had equivalent levels of the cytoplasmic SecA1 
protein and the exported 19kD lipoprotein, indicating that total proteins levels were 
equivalent between strains. As expected, the SecA2 protein was only detected in wild 
type H37Rv samples and not in samples from the secA2 deletion mutant. 
These equalized whole cell lysates (WCL) were then subjected to differential 
ultracentrifugation to generate cell wall (CW), cytoplasmic membrane (M), and 
cytosolic-containing soluble (SOL) fractions. The WCL samples and corresponding 
subcellular fractions were analyzed for fraction integrity by immunoblotting using 
antibodies to known M. tuberculosis cytoplasmic or cell wall associated proteins. Two 
cytoplasmic proteins, the housekeeping sigma factor SigA and response regulator MtrA 
were only detected in the soluble fraction as expected (Figure 3.1B). Two known cell 
wall proteins, the 19 kD lipoprotein and the heparin-binding haemagglutinin adhesin 
(HBHA) were only detected in the cell wall fraction as expected. Notably, both of the cell 
wall proteins were detected at similar levels in the two M. tuberculosis strains. The cell 
wall proteins from each biological replicate were also separated by SDS-PAGE and 
Coomassie stained for protein visualization (Figure 3.2). Protein bands exhibited 
equivalent intensity between each strain. Together, the immunoblotting and Coomassie 
stained gels showed that we had prepared quality cell wall fractions with relatively equal 
amounts of protein from both wild type M. tuberculosis and the secA2 mutant samples. 
 
M. tuberculosis cell wall protein LC-MS analysis 
 Initial efforts to identify SecA2-dependent cell wall proteins in M. tuberculosis 
used 2D-GE and were unsuccessful (Gibbons, H.S. unpublished).  However, the high 
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insolubility of cell wall proteins can be a significant technical challenge for 2D-GE.  As 
an alternate strategy, here we combined SDS-solubilization and 1D SDS-PAGE 
separation of cell wall proteins with LC-MS/MS label-free quantitative mass 
spectrometry to comprehensively identify and compare the cell wall proteomes of wild 
type and the secA2 mutant. Following SDS-PAGE of each of the replicate samples, cell 
wall proteins were excised for the entire lane in 32 slices and subjected to trypsin 
digestion. Tryptic peptides were then analyzed by LC-MS/MS to generate a complete 
proteomic profile for each sample.  
In total, we identified 1,920 cell wall-associated proteins between the fractions of 
wild type M. tuberculosis and the secA2 mutant, representing diverse functional 
categories (Figure 3.3A and Appendix). The largest group of proteins identified (50%) 
are predicted to be involved in cell wall processes or intermediary metabolism, while the 
next most abundant group represents conserved hypotheticals (23%) (11, 16). The large 
representation of these three broad functional protein classes is consistent with what has 
previously been reported for the M. tuberculosis cell wall proteome identified by MS 
analysis (73).  
Of the 1,920 proteins identified, 27% are predicted to contain a signal for export 
out of the cytoplasm (Figure 3.3B). These include 370 proteins predicted by the 
TMHMM algorithm to contain one or more transmembrane domains for insertion in the 
cytoplasmic membrane (116). Additionally, 134 proteins are predicted by SignalP to 
contain an N-terminal Sec signal peptide, which would target them for export out of the 
cytoplasm by the general Sec pathway (90). Another 33 proteins are predicted by the 
TatP program to contain Tat signal peptides for export by the Tat pathway (3). On the 
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basis of a lipobox motif in the N-terminus, we identified 74 potential lipoproteins, which 
represent 72% of the total number of lipoproteins predicted in the H37Rv genome (6, 51, 
121). Although all these lipoproteins contain potential lipoboxes, some of these 
lipoproteins have predicted Sec or Tat signal peptides, while others have potential signal 
peptides not recognized by the SignalP or TatP prediction programs (121). In Gram 
positive bacteria, lipoproteins are anchored to the inner membrane via their lipid moiety, 
while in Gram negative bacteria lipoproteins can be anchored in either the inner or outer 
membrane (47). In mycobacteria it is unclear where lipoproteins localize, either the inner 
membrane or the outer mycolate-based cell wall layer of the cell envelope, which is the 
fraction analyzed here (47, 121). Indeed, there are mycobacterial lipoproteins shown to 
have a peripheral localization (either secreted or associated with in the cell wall), which 
makes the high number of lipoproteins identified in the cell wall here not unexpected (34, 
64, 65, 83, 131).  
It may be surprising that 73% of the proteins identified in the cell wall fraction do 
not contain a predicted transmembrane or signal peptide for export However, past 
proteomic studies of both the mycobacterial cytoplasmic membrane and cell wall 
fractions have also identified an abundance of proteins lacking predicted export signals 
and may not be exported (41, 70, 73). Although care is taken to wash the cell wall 
fraction, the sensitivity of mass spectrometry inevitably detects some level of cytoplasmic 
contaminants, particularly the most abundant cytoplasmic proteins. Additionally, it is 
difficult to separate the cytoplasmic membrane and cell wall fractions. Therefore, some 
non-exported cytoplasmic proteins may peripherally associate with membrane-bound 
protein complexes or membrane lipids, contributing to co-fractionation with the cell wall 
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material. Finally, it is also possible that some exported proteins simply lack a predictable 
signal peptide for export. 
 
Label-free quantitation and comparison of M. tuberculosis and secA2 cell wall 
proteomes 
 We next wanted to determine which proteins were differentially localized 
between the cell wall proteomes of wild type M. tuberculosis and the secA2 mutant, 
with the primary goal of identifying SecA2-dependent cell wall proteins. We employed a 
label-free semi-quantitative mass spectrometry method called spectral counting to obtain 
relative protein amounts between strains. Using the ProteoIQ program (ver. 2.3.02, 
NuSep), we compared the total number of MS/MS spectra associated with each identified 
protein between wild type M. tuberculosis and the secA2 mutant. Although care was 
taken to begin with equivalent amounts of total protein for each strain and biological 
replicate, we first performed a normalization step across the entire experiment (86). The 
ProteoIQ program first normalized the spectral count for each protein within a replicate 
by the total spectral counts obtained for all proteins from that particular replicate. Then, 
the spectral count for that protein is normalized by the maximum number of total spectral 
counts obtained for wild type versus the secA2 mutant. 
The normalized spectral counts were then compared between the two M. 
tuberculosis strains using the ProteoIQ software to produce a log2 (secA2/WT) ratio for 
each protein, where ratios of +1 represent a 2-fold change. In total, we obtained relative 
abundance ratios for 1,780 proteins, most of which (89%) were relatively unchanged 
between the strains with log2 (secA2/WT) ratios between + 1. This is expected as past 
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2D-GE comparisons of M. tuberculosis or M. smegmatis secA2 mutant fractions revealed 
few differences when compared to the respective wild type strains (7, 34). 
 Statistical significance for changes in protein abundance was determined with the 
ProteoIQ program. ProteoIQ assigns a standard p value for each log2 (secA2/WT) ratio 
based on ANOVA testing, which takes into account the reproducibility of the relative 
abundance of each protein across all groups. The volcano plot in Figure 3.4 displays the 
log2 (secA2/WT) ratios and p values assigned to each of the 1,780 proteins subjected to 
semi-quantitative analysis. 
Because our analysis resulted in 1,780 pairwise comparisons, we wanted to 
determine the number of false-positive hits we could expect with a standard p < 0.05 cut-
off for significance. This is achieved by calculating a corrected p value, called the q 
value, which is becoming a common way to determine the number of false positives that 
can be expected when imposing p value cut-offs to large proteomic data sets (118).  
The q value is an extension of a “false discovery rate” and can be described as the rate at 
which significantly different proteins are actually null, or in other words, the number of 
false-positives that can be expected given a particular p value significance cut-off. For 
our data set, a p value of 0.05 corresponds to a FDR of 10%. In addition to a p < 0.05, we 
also required that proteins exhibit a > 2-fold change in abundance in the secA2 mutant 
in order to be considered a significant change. Using these criteria, we observed 69 
proteins underrepresented in the secA2 mutant and 131 that were more abundant in the 
secA2 mutant by at least 2-fold (Tables 3.1).  
 We also searched the MS/MS data for proteins that were only identified in either 
the wild-type or the secA2 mutant strains. For a protein to be considered strain specific, 
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we required that it be detected by at least 2 unique peptides in only one of the strains. 
This resulted in 85 proteins that were unique to the secA2 mutant and 55 that were 
unique to the wild type strain (i.e. not detected in the secA2 mutant) (Tables 3.2 and 
3.3). As expected, peptides corresponding to SecA2 (a total of 26 peptides) were 
identified in the wild type replicates while no SecA2 peptides were detected in the secA2 
mutant samples. It should be noted that some of these “strain-specific” proteins could 
represent proteins reduced in abundance, but present at a level below our detection in one 
strain. 
 
Proteins with differential abundance between wild type M. tuberculosis and secA2 
Of the total 1,920 proteins identified, there were 124 proteins that were either 
reduced in the secA2 mutant cell wall by at least 2-fold with a p value of <0.05, or were 
uniquely identified in the wild type strain (Figure 3.5A). Conversely, there were 216 
proteins either up in the secA2 mutant by 2-fold (p < 0.05) or unique to the secA2 
mutant. Relative protein abundance changes we considered significant ranged from down 
in the secA2 mutant by 6-fold to increased in the secA2 mutant by 16-fold. However, 
most of the differences in relative protein abundance were not particular large, with an 
average change of + 3 fold. 
Of the 124 proteins classified as down or absent in the secA2 mutant, 32% (40 
proteins) contained a signal for export, including 17% (21 proteins) with putative 
transmembrane domains and 15% (19 proteins) with predicted N-terminal signal peptides 
(Figure 3.6A). Of the proteins with potential signal peptides, 3% (5 proteins) contained a 
predicted Tat signal peptide and 12% (14 proteins) had predicted Sec signal peptides (3, 
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90, 102, 121). Both signal peptide categories included putative lipoproteins (7 Sec and 3 
Tat).   
In contrast to the 32% of proteins with export signals down in the secA2 mutant, 
only 13% of the proteins more abundant or unique to the secA2 mutant had predicted 
signals for export (Figure 3.6B). These included 5% with possible transmembrane 
domains and 8% with predicted signal peptides. Moreover, only three putative 
lipoproteins were more abundant in the secA2 mutant, all of which had predicted Sec 
signal peptides.  
Some functional protein classes included multiple examples of both proteins with 
increased abundance in the secA2 mutant and proteins with decreased abundance in the 
mutant, including intermediary metabolism and respiration, conserved hypotheticals, and 
cell wall processes (Figure 3.5B). However, there were also functional classes showing 
disparate representation of proteins increased or decreased in abundance, which is 
discussed further below.   
 
Proteins underrepresented the secA2 cell wall 
The 124 proteins reduced in relative abundance or absent in the secA2 mutant 
represent candidate substrates for export to the cell wall by the SecA2 system. Among the 
functional categories represented by the proteins reduced in the secA2 mutant (Figure 
3.5B) were a specific group of lipoproteins: the periplasmic solute-binding proteins 
(SBPs). M. tuberculosis is predicted to have 18 SBPs that have putative functions in 
binding peptides, sugars, iron, anions, and other substrates for uptake into the bacterial 
cell via ABC-type membrane transporter complexes (6). Five SBPs were significantly 
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reduced in the secA2 mutant cell wall, including those predicted to bind sulfate, 
glutamine, iron, and peptides (Table 3.1).  
Because multiple SBPs were reduced in the secA2 mutant, and the two known 
SecA2 substrates of M. smegmatis are SBPs, we went back and looked for all predicted 
SBPs we identified to see how their cell wall presence was affected by deletion of secA2. 
Of the 18 predicted M. tuberculosis SBPs, we identified 15 in our proteomic study and 13 
of these SBPs followed a trend of being reduced in the secA2 mutant (Table 3.4). While 
5 SBPs were significantly reduced (p <0.05), an additional 8 SBP were present at reduced 
levels in the secA2 mutant cell wall although their reduced abundance did not achieve 
statistical significance. Another interesting observation is that of the 5 SBPs significantly 
down in the mutant, 3 of these SBPs contain predicted Tat signal peptides. Moreover, of 
the 5 SBPs with predicted Tat signal peptides in M. tuberculosis we identified 4 of these 
proteins in our proteomic analysis and all 4 were reduced in the mutant, although only 3 
had p < 0.05. 
Another functional category of proteins that were significantly reduced in the 
secA2 mutant were members of mce transporter systems: Mce1 and Mce4 (Figure 3.4 
and Figure 3.5B). The M. tuberculosis H37Rv genome contains four homologous mce 
loci, each containing two genes encoding putative membrane-spanning proteins (yrbE), 
and six genes encoding proteins with possible N-terminal transmembrane domains or 
signal peptides (mce) including one predicted lipoprotein (Figure 3.7). Mce1 and Mce4 
also contain additional ORFs referred to as mce-associated proteins (mas). 
Of the 10 ORFs comprising Mce4 we found 7 to be significantly reduced in 
abundance in the secA2 mutant by 2-fold (p < 0.05). We also detected reduction of an 
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additional Mce4-associated protein (Mas4B) in the secA2 mutant. Mas4B showed a log2 
(secA2/WT) ratio of -0.6 with a p value of 0.007. Among the 12 Mce1 members, eight 
proteins were reduced in the secA2 mutant (p < 0.05). However, only 3 met our 2-fold 
change cut-off. Interestingly, the predicted Mce-associated ATPase Mkl was also reduced 
in the secA2 mutant cell wall by about 1.8-fold (p = 0.02). Mkl does not contain a signal 
peptide and is predicted to provide energy required for substrate import by all the M. 
tuberculosis Mce transporters (12, 50). 
 
Proteins with increased abundance in the secA2 cell wall 
For the 216 proteins increased in relative abundance or uniquely identified in the 
secA2 mutant, many have putative functions in intermediary metabolism, cell wall 
processes, or are conserved hypotheticals of unknown function (Figure 3.5B). There were 
also a large number of proteins in the categories of information pathways and gene 
regulation.  Most notably, numerous proteins encoded by the DosR dormancy regulon 
were found to be more abundant in the secA2 mutant samples. These findings suggest 
that deletion of secA2 could result in regulatory responses at the transcriptional level 
(including the DosR regulon). Increased transcription in the secA2 mutant would also 
help explain why most of the proteins increased in the mutant do not contain export 
signals (Figure 3.6). 
The DosR response regulator is part of a two-component response system that is 
induced upon exposure to hypoxia (a dormancy-associated condition), nitric oxide, or 
redox stress (61, 112, 128) and activates expression of at least 49 genes. Our proteomic 
analysis showed that 14 DosR-regulated proteins were more abundant in the secA2 
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mutant (>2-fold, p < 0.05) and 7 DosR-regulated proteins were uniquely identified in the 
secA2 mutant. Among these DosR-regulated proteins present in higher levels in the 
secA2 mutant samples, was the DosR response regulator itself. We subsequently looked 
for other DosR-regulated proteins in the dataset and found that there were an additional 4 
DosR-regulated proteins that followed the trend of being increased in the secA2 mutant, 
although they failed to meet our 2-fold,  p < 0.05 cut-off (Table 3.5). Only 1 of the 49 
DosR-regulated proteins was underrepresented in the mutant (Figure 3.5B). Because 
genes in the DosR regulon are co-regulated at the transcriptional level, it seems likely 
that the higher levels of DosR-regulated proteins in the secA2 mutant are a reflection of 
transcriptional effects.  
 
Immunoblot confirmation of label-free mass spectrometry quantification 
 We next wanted to confirm some of our label-free quantitation results through 
immunoblot analysis on the cell wall samples used for our proteomic comparison. This 
effort was hindered by the lack of available antibodies for proteins showing statistically 
significant results in our study. We were, however, able to obtain antibodies to PhoS1 
which had an almost 3-fold reduced level in the secA2 mutant versus wild type strain.  
PhoS1 is one of the solute-binding lipoproteins identified in our study. The PhoS1 protein 
had a log2 (secA2/WT) ratio of -1.37 with a p value of 0.08. Immunoblotting using an 
anti-PhoS1 antibody revealed that there was less PhoS1 protein in the cell wall of the 
secA2 mutant compared to the cell wall of wild type M. tuberculosis (Figure 3.8A). 
Quantitation of the PhoS1 signal in the cell wall fractions showed there was a consistent 
reduction in PhoS1 levels among the secA2 replicates of about 1.8 fold, although this 
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difference was not statistically significant (Figure 3.8B). Nonetheless, this result was 
consistent with the proteomic ratio we obtained with spectral counting, which also just 
failed to pass a significance of p < 0.05.  
 
Discussion 
The SecA2 protein export system is required for M. tuberculosis growth inside 
host macrophages and mice, but our understanding of the exported substrates of the 
SecA2 system and their role in virulence remains limited. Thus far, efforts to identify 
mycobacterial SecA2 substrates have relied on 2D-GE comparisons of extra-cytoplasmic 
fractions, but a surprisingly small number of proteins have been identified as 
underrepresented in secA2 deletion mutants (7, 34). Here, we employed a proteomic 
approach that avoids the use of 2D-GE to generate a more comprehensive list of M. 
tuberculosis proteins that depend on SecA2 for localization to the cell wall. 
An advantage to shotgun proteomics combined with approaches like spectral 
counting is that these techniques can report on small differences in protein levels within 
large complex protein samples. Because past efforts to identify SecA2-dependent wall 
proteins using 2D-GE were unsuccessful in M. tuberculosis and resulted in only two 
protein differences in M. smegmatis, we anticipated that many SecA2-dependent export 
defects would be subtle (Gibbons, H.S. unpublished) (34). Indeed, the average difference 
in protein abundance we observed was only 3-fold. Many of our “strain-specific” protein 
identifications likely also represent small differences in abundance for proteins just below 
our level of detection in one strain. One reason for such subtlety in global protein 
differences can be attributed to the sensitivity of mass spectrometry. It is possible some 
proteins that are retained in the cytoplasm because of export defects associated with 
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secA2 deletion could still be identified to some degree in the secA2 mutant as 
cytoplasmic contaminates. Many of the protein differences likely reflect partial export 
defects in the secA2 mutant, as we confirmed this to be the case for at least the PhoS1 
protein by immunoblotting. This highlights another advantage of using such a sensitive 
method as spectral counting, in that it can report on incomplete export defects that are not 
apparent from immunoblotting comparisons. 
Importantly, although our proteomic analysis of the secA2 mutant revealed 
subtle changes in protein abundance, these changes encompassed some specific families 
of proteins. Specifically, we detected a reduction in solute-binding lipoproteins and Mce 
transporter proteins in the secA2 mutant. Thus, our proteomic analysis allowed us to 
make some predictions concerning the role of SecA2-mediated export in M. tuberculosis 
virulence and also the mechanism of export by SecA2 in mycobacteria.  
 
Contribution of SecA2 export to M. tuberculosis virulence 
As previously mentioned, comparative 2D-GE analysis of wild type M. 
tuberculosis and the secA2 mutant was used in a previous study to identify SecA2-
dependent proteins secreted into the culture media. But, just a few protein differences 
were observed and only the superoxide dismutase SodA was later confirmed to be 
SecA2-dependent for export (7, 44). Macrophages infected with the M. tuberculosis 
secA2 mutant exhibit higher levels of apoptosis, and this pro-apoptotic phenotype was 
linked to the decrease in SodA secretion (44). It was therefore reasoned that increased 
apoptosis due to defective SodA secretion could explain why the secA2 mutant fails to 
grow in macrophages. But restoration of SodA secretion failed to rescue the M. 
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tuberculosis secA2 growth defect in macrophages (120). It is also possible that SodA 
secretion is required for detoxifying reactive oxygen species produced by the 
macrophage, which limits bacterial growth. However, restoration of SodA secretion 
failed to rescue the M. tuberculosis secA2 growth defect in macrophages (120).  Further 
the M. tuberculosis secA2 mutant remains attenuated for growth in macrophages even if 
they are derived from phox
-/-
 mice, which are unable to elicit an oxidative burst (63). 
These results suggest there are contributions of SecA2 export to M. tuberculosis 
intracellular growth that are not due to defects in SodA secretion. Therefore, there must 
be additional SecA2-dependent exported proteins that contribute to virulence.  
Our proteomic analysis resulted in the identification of several exported proteins 
underrepresented in the secA2 mutant that have known or predicted roles in M. 
tuberculosis virulence. Most of these export defects were incomplete. Thus, it is possible 
that a defect in export of a single protein may not completely explain the growth 
attenuation of the secA2 mutant. But collectively, many of these proteins could 
contribute to the ability of M. tuberculosis to block phagosome maturation and proliferate 
in macrophages. Below we discuss proteins underrepresented in the secA2 mutant with 
predicted roles in blocking phagosomal maturation, promoting growth in macrophages 
and mice, and acquiring nutrients during infection. 
Normally, M. tuberculosis blocks phagosome acidification and maturation inside  
macrophages (93). The M. tuberculosis secA2 mutant is unable to block the process of 
phagosome acidification and maturation, suggesting that SecA2-dependent exported 
effectors might be important for targeting host pathways that are critical to these 
processes (120). Several M. tuberculosis secreted proteins are implicated in inhibiting 
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phagosome maturation including PtpA, SapM, Ndk, LpdC, and PknG (93).Our proteomic 
study identified two of these proteins: Ndk and PknG. However, Ndk was more abundant 
in the secA2 cell wall by over 2-fold (log2 ratio = 1.8303, p = 0.049) and PknG was 
unchanged in abundance between the wild type and secA2 mutant cell wall. However, 
because even SodA was identified as unchanged in abundance in the secA2 mutant cell 
wall by spectral counting, it remains possible that the export defect of SodA and possibly 
other known secreted effectors are only apparent when looking at proteins fully secreted 
into the culture medium. Therefore, in the future it will be important to also look at the 
culture filtrate fraction when looking for SecA2-dependent exported effectors.  
LipO (rv1426c) is a predicted esterase, which contains a putative Sec signal 
peptide for export, that was significantly reduced in the secA2 mutant by about 2-fold. 
Interestingly, a transposon screen performed in macrophages for M. tuberculosis mutants 
unable to block phagosome-lysosome fusion, identified LipO as a putative effecter of 
phagosomal maturation arrest (91). While lipO inactivation did not translate to strong 
growth attenuation during macrophage infection in past studies, LipO might be one 
contributing factor to SecA2-dependent intracellular M. tuberculosis growth (91).   
Another possible contribution of SecA2 export to M. tuberculosis virulence is for 
the proper assembly of the Mce1 and Mce4 transporters. Mce1 is thought to function as a 
lipid transporter and numerous independent studies have linked Mce1 with M. 
tuberculosis virulence (21, 31). However, mce1 deficient M. tuberculosis strains have 
produced phenotypes ranging from attenuation to hyper-virulence, so the exact 
contribution to Mce1 function during infection is unclear (1, 12, 35, 50, 97, 108, 114, 
117). Mce4 is necessary for M. tuberculosis growth in mice, a requirement that is linked 
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to its function in cholesterol import (88, 110). While the composition and mode of 
activity of Mce transporters is still unknown, it is thought that for each Mce complex the 
two YrbE proteins form a cytoplasmic membrane-spanning channel, analogous to the 
permease components of ABC-type transporters (12). The Mce proteins themselves share 
a conserved domain found in the periplasmic component of a toluene efflux pump of 
Pseudomonas, suggesting that they could form a channel spanning the space between the 
cytoplasmic membrane and mycobacterial outer membrane (55, 60). The Mce proteins 
have hydrophobic stretches at their N-termini that represent putative Sec signal peptides 
and each mce locus encodes for one Mce protein with a predicted lipobox motif (77, 90). 
Some Mce proteins are not predicted by SignalP to contain Sec signal peptides; instead 
their N-termini could contain a transmembrane domain (90, 116). It’s been suggested that 
Mce proteins are similar to the periplasmic solute-binding proteins of ABC transporters, 
which suggests a possible function in binding the cognate lipid molecule (12). The 
proposed similarity between Mce proteins to SBPs is especially notably given the large 
number of SBPs we identified in this study that were reduced in the secA2 mutant. But, 
currently there is no evidence that Mce and SBP share similar functions. Our study 
showed a decrease in abundance of every Mce component and at least one YrbE 
permease of both Mce1 and Mce4 in the secA2 mutant. This is intriguing because it 
suggests that perhaps SecA2 has a role in exporting many components of these 
transporters. An equally plausible explanation is that SecA2 assists in the export of a 
single protein in the complex resulting in instability of the entire complex in the cell wall 
when export of that protein is impaired in the absence of secA2. If SecA2 were to export 
only one of the Mce proteins, the lipoprotein Mce would be the leading candidate due to 
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its similarity to SecA2-dependent SBP lipoproteins. A final possibility is that 
transcription of the mce operon could be reduced in the secA2 mutant.  This last 
possibility could be tested by RT-PCR analysis of mce loci in wild-type versus secA2 
mutant strains.  
Interestingly, a transposon screen performed in an M. tuberculosis mce1 mutant 
background identified a positive genetic interaction between the mce1 locus and secA2 
(50). In this study, a transposon insertion in secA2 in wild type M. tuberculosis reduced 
bacterial growth during a mouse infection, which is expected given the established in 
vivo requirement for SecA2 (7). However, a mutation in mce1 suppressed the growth 
attenuation of the secA2 mutant in mice and vice versa (50). The functional significance 
of this genetic interaction is unclear at this time. Nonetheless, combined with results from 
our proteomic analysis of the secA2 cell wall, it is important to better elucidate the 
relationship between SecA2 and Mce transporters. It is unlikely that Mce1-mediated 
transport is a process directly required for blocking phagosomal maturation because an 
M. tuberculosis mce1A mutant retains the ability to block this process (120). But the 
reduction of lipid import into the secA2 mutant could produce defects in the 
mycobacterial cell wall that change the way M. tuberculosis interacts with the host, or 
have implications in nutrient import.  
Another interesting finding is that one of the four putative phospholipase C 
proteins of M. tuberculosis, PlcA (rv2351c), was underrepresented in the secA2 mutant 
by over 4-fold. As phospholipase activity is required for M. tuberculosis growth during 
mouse infection, PlcA is another potential SecA2-dependent virulence factor warranting 
further study (96).  
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Finally, a striking observation from our study was the decrease in abundance of 
multiple solute-binding lipoproteins (SBPs) in the secA2 mutant cell wall. Because 
SBPs function as the periplasmic substrate-binding components of ABC-type importers, 
the reduction in a variety of SBPs in the secA2 mutant could have a severe impact on the 
ability of M. tuberculosis to import vital nutrients during infection (Table 3.4). The SBPs 
that exhibited the most significant reduction in the secA2 mutant are predicted to have 
roles in uptake of sulfate (SubI), peptides (DppA and OppA), iron (FecB2), and 
glutamine (GlnH). FecB2 is one of two M. tuberculosis SBPs with homology to FecB of 
Escherichia coli suggesting  that M. tuberculosis may be able to uptake and utilize ferric 
dicitrate as an iron source (2). However, M. tuberculosis has other systems devoted to 
iron acquisition so it is unclear what exactly the role of the FecB2 protein is, particularly 
during infection. Inactivation of subI completely prevents sulfate uptake, demonstrating 
that this ABC transporter is the sole locus encoding inorganic sulfur transport in M. 
tuberculosis (129). While a subI transposon mutant of Mycobacterium bovis did not show 
growth attenuation during mouse infection, it remains possible that this sulfur transporter 
is important during M. tuberculosis infection (74). DppA and OppA are both 
demonstrated peptide-binding SBPs (28, 37). The Dpp ABC transporter (rv3663c-
rv3666c) may serve a vital function during M. tuberculosis infection as dpp mutants are 
attenuated for growth in mice (28, 107, 117). Bacterial peptide transporters can have 
nutrient acquisition functions, but are also used for peptide-mediated signaling that 
influences protein expression (79). The specific peptide substrate imported by the M. 
tuberculosis Dpp transporter in vivo is unknown, but it has been suggested that this 
particular transporter might serve a signaling function. A dpp deficient M. tuberculosis 
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strain has altered expression of several genes encoding surface-exposed PE-family 
proteins and proteins involved in synthesis of virulence-associated surface lipids 
(28). However, we did not detect differences in the abundance of PE proteins thought to 
be influenced by the Dpp transporter (28, 31). Further, a defect in the synthesis of 
virulence-associated lipids in the secA2 mutant resulting from an effect on Dpp could 
certainly contribute to growth attenuation in macrophages, but this possibility has yet to 
be explored. There has yet to be a link to pathogenesis made for the M. tuberculosis Opp 
transporter (rv1280c-rv1283c). However, the homologous peptide transporter of M. bovis 
is implicated in binding and importing a toxic peptide produced by host macrophages, 
which subsequently reduces host cell apoptosis (19, 37). However, the significance of 
this is unclear because the increase in apoptosis observed did not correlate to growth 
attenuation (19). GlnH is a predicted glutamine-binding SBP and whole genome 
mutagenesis studies suggest it is essential for in vitro growth (107). A M. tuberculosis 
mutant deficient in glutamine synthase is auxotrophic for L-glutamine, and attenuated for 
growth in macrophages and guinea pigs (124). These results suggest that in the host 
phagosome, M. tuberculosis has limited access to glutamine, which has an essential role 
in bacterial nitrogen metabolism. It is possible that glutamine import via GlnH may 
contribute to maintaining intracellular glutamine levels in M. tuberculosis during 
infection. 
It is unlikely that any one of the SBPs discussed will fully explain the inability of 
the secA2 mutant to grow inside macrophages, since their presumed function would not 
involve blocking phagosome maturation.  However, a combination of subtle export 
defects in multiple cell wall components with roles in nutrient acquisition or signaling 
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could result in a fitness disadvantage and decreased virulence for the secA2 mutant 
during infection.  
 
Insights into SecA2 Export Mechanisms 
 Our proteomic comparison showed that many, but not all, predicted lipoproteins 
were underrepresented in the M. tuberculosis secA2 mutant cell wall (Figures 3.4 and 
3.6). Of the 102 predicted M. tuberculosis lipoproteins, 52% followed a trend of being 
reduced in the secA2 mutant, of which 10 lipoproteins were significantly reduced by at 
least 2-fold (Figure 3.4) (121). The only known SecA2 substrates in M. smegmatis are 
two lipoproteins yet, SecA2 is not required for export of all lipoproteins in this species, 
this level of association observed between SecA2 and M. tuberculosis lipoproteins was 
not entirely unexpected (25, 34, 123). Like all bacterial lipoproteins, the putative 
lipoproteins affected by deletion of secA2 in M. tuberculosis have putative N-terminal 
signal peptides with lipobox motifs. In Chapter 2, we demonstrated that SecA2 exported 
proteins of mycobacteria do not have SecA2-specific signal peptides.  Instead, the mature 
domain of the preprotein is what necessitates SecA2 for export. The question then 
remains, what are the features of particular M. tuberculosis lipoproteins that make them 
SecA2-dependent for export? 
The two SecA2 substrates of M. smegmatis, Ms1704 and Ms1712 are examples of 
putative sugar-binding proteins, which are part of the larger solute-binding protein (SBP) 
family (34, 122). SBPs are the periplasmic components of ABC-type transporters, and are 
responsible for binding their cognate substrate for import past the cytoplasmic membrane 
via the ABC permease membrane-channel. Given the precedent set in M. smegmatis with 
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Ms1704 and Ms1712, we were particularly interested in seeing how deletion of secA2 
would influence export of the 17 predicted SBPs in M. tuberculosis (6, 121). We 
identified 15 of these putative SBPs in our proteomic study of the M. tuberculosis cell 
wall, 13 of which were underrepresented in the secA2 mutant, albeit some do not pass 
our significance tests (Figure 3.4 and Table 3.4). These results clearly show that, while 
not all mycobacterial SBPs may require SecA2 for export, SBPs are a particular subset of 
mycobacterial lipoproteins whose export is influenced by SecA2. Because the M. 
smegmatis Ms1704 and Ms1712 proteins are also SBPs requiring SecA2 for export, these 
results argue for there being a particular property of SBP proteins that imparts some 
requirement for SecA2 in their export. 
 
Export of putative Tat substrates are reduced in the M. tuberculosis secA2 mutant 
We know the determining factor for SecA2-dependent export in mycobacteria is 
the mature domain of the preprotein (Chapter 2). This is somewhat analogous to 
preproteins of the twin-arginine translocation (Tat) pathway, as the mature domain of Tat 
substrates must be folded to be compatible for Tat export. More specifically, we 
hypothesize that the mature domains of mycobacterial SecA2 substrates also exhibit 
some degree of cytoplasmic folding, which necessitates SecA2 for their export. 
Surprisingly, 4 of the 13 SBP underrepresented in the M. tuberculosis secA2 mutant 
have predicted Tat signal peptides, 3 of which are significantly reduced in the mutant cell 
wall with p < 0.05 (Figure 3.6 and Table 3.4). One of these SBPs, Rv2041c, has a signal 
peptide that was previously proven to be compatible with Tat export (75). It is interesting 
to note that bacterial SBPs are often predicted Tat substrates, suggesting that structures 
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shared among SBPs results in similar cytoplasmic folding properties of those preproteins 
(115). This idea is supported by our data showing that a M. smegmatis SecA2 substrate, 
the Ms1704 SBP, can be exported by the Tat pathway (25). 
There are two possible explanations for the reduction of certain putative Tat 
substrates in the M. tuberculosis secA2 cell wall. The first possibility is that deletion of 
secA2 has an indirect affect on Tat export, perhaps by influencing the levels of Tat 
machinery components. This possibility seems unlikely, because one would predict that 
an indirect affect of secA2 deletion on Tat export would affect all Tat substrates, and this 
was not the case. Of the 33 proteins with predicted Tat signal peptides that were 
identified in this study, only 5 were significantly reduced in the secA2 mutant by at least 
2-fold (3 of which are SBPs), while 3 were significantly more abundant in the mutant 
(Figure 3.4).  
Therefore, a more plausible explanation is that there is a common set of 
preproteins whose export is influenced by both the SecA2 and Tat export pathways, and 
this shared preprotein pool includes the SBPs with predicted Tat signal peptides. The fact 
that export of these SBPs with Tat signal peptides was reduced, but not eliminated in the 
secA2 mutant, is consistent with the idea that these proteins can be exported by two 
independent systems (either SecA2/Sec or Tat). In support of this possibility, there are 
reports of preproteins in other bacteria that can utilize either the canonical Sec or Tat 
pathways for export (56, 94, 125).  
A model where export of a particular SBP preprotein is shared (some being 
exported by Tat while another fraction is exported by SecA2/SecYEG) requires that the 
signal peptides of some SecA2 SBPs be compatible with both the Sec and Tat machinery. 
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Four of the SBPs reduced in the M. tuberculosis secA2 mutant have predicted Tat signal 
peptides with “RR” motifs. However, there are examples of Tat signal peptides with 
“RR” residues that are functional with the Sec machinery (56, 57). Therefore, it is 
plausible that a portion of the SBPs with predicted Tat signal peptides are targeting to the 
canonical Sec machinery where SecA2 assists in their export. Other SBPs that were 
reduced in the secA2 mutant cell wall are not predicted to contain Tat signal peptides. 
Because there are naturally occurring variations to the twin-arginine motif that are still 
capable of targeting preproteins to Tat (45, 48), these other SBPs could also have signal 
peptides that are functional with both Sec and Tat machinery. An example of a functional 
Tat motif variant is “KR,” which is found in the Tat signal peptide of the B. subtilis TtrB 
protein (45). Notably, “KR” is similar to the naturally occurring “RK” in the signal 
peptide of the M. smegmatis SecA2 substrate, Ms1704. Additionally, the DppA SBP that 
was reduced in the M. tuberculosis secA2 mutant has a “RQ” in its signal peptide. There 
is an example of a similar “RQ” signature within a signal peptide that is functional with 
the mycobacterial Tat pathway (75). 
The partial export defects of many SBPs in the secA2 mutant, including SBPs 
with Tat signal peptides, is consistent with a model where the SecA2 and Tat pathways 
can export a common class of preprotein. This model reaffirms our hypothesis that the 
mature domains of preproteins impart SecA2-dependency for export, and further supports 
the idea that SecA2 is required for exporting preproteins that fold in the cytoplasm. If a 
protein has a signal peptide compatible for either Sec- or Tat-targeting, than it falls in a 
category of preprotein that potentially could be exported in an unfolded conformation 
through SecYEG with assistance from SecA2, or exported independently of the Sec 
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system as a folded preprotein through the TatABC membrane machinery. Our proteomic 
analysis also indicated that deletion of secA2 resulted in increased abundance of the TatB 
component of the Tat machinery, as this protein could only be detected in the secA2 cell 
wall. The integral membrane protein TatB interacts with preproteins containing Tat signal 
peptides after their initial docking with the TatC protein at the membrane (87). It is 
thought that TatB might help mediate interaction between the preprotein-bound TatC and 
TatA. Homomultimers of TatA eventually form the membrane-spanning pore for 
translocation of the substrate across the membrane (80, 133). At this time it is unclear if 
the increase in TatB protein in our secA2 mutant reflects a difference in tatB gene 
expression or TatB protein stability. However, if Tat and SecA2 share a common pool of 
preproteins it would make sense that increased levels of TatB might help compensate for 
absence of SecA2. 
 
The influence of secA2 deletion on other protein export machinery 
 Currently it is not known what membrane channel SecA2 utilizes in order to 
promote protein export, but current data suggests the mycobacterial SecA2 works with 
components of the canonical Sec export system including SecYEG (22, 100). We wanted 
to know whether deletion of secA2 would influence the expression or stability of other 
components of the Sec pathway. This was particularly important given our observation 
that secA2 deletion resulted in increased TatB levels. Our spectral counting analysis 
showed that levels of SecY, SecE, SecD, and SecA1 were unchanged in the secA2 
mutant cell wall compared to wild type.  
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Interestingly, the M. tuberculosis signal recognition particle (SRP) was absent in 
the secA2 mutant cell wall. SRP is required for a separate branch of Sec export known 
as co-translational export, where it works with SecYEG to insert integral membrane 
proteins into the cytoplasmic membrane as they emerge from the ribosome during 
translation (132). Because co-translational export is an essential process, there must be 
SRP present in the secA2 mutant that was below the level of detection with MS. It will 
be important to validate the changes in SRP abundance associated with the secA2 
mutant. For now, we can speculate on why deletion of secA2 reduced the level of SRP 
detected in our study. There are two possible reasons why the presence of SecA2 could 
impact SRP levels. First, deletion of secA2 could indirectly affect the level of membrane-
associated SRP because of the shared usage of SecYEG by both SecA2 and SRP. The 
other possibility is that SecA2 has a direct function related to co-translational export. Co-
translational export is thought to occur independently of SecA, but it has also been 
suggested that there might be some overlap in the function of SecA proteins and SRP 
(113). While we detected 21 proteins with putative transmembrane domains that were 
significantly reduced in the secA2 cell wall, we also detected 11 that were significantly 
increased. Because there doesn’t appear to be a global reduction in integral membrane 
protein insertion upon deletion of secA2, we favor the more indirect explanation for the 
effect of secA2 deletion on the reduction of SRP. Nonetheless, this result warrants further 
investigation for a possible relationship between SRP and SecA2.  
Because we hypothesize that SecA2 fulfills a role in mycobacterial export that is 
related to preproteins that fold in the cytoplasm, we also specifically examined proteins 
with known or putative chaperone roles related to protein export. The cytoplasmic 
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chaperones GroEL1 and DnaK can both increase Sec export efficiency in E. coli, but 
neither showed changes in protein level in the secA2 mutant (26). However, we did 
detect relative differences in amounts of two proteins with putative functions in protein 
folding: PpiB and trigger factor (Tf).  
PpiB is a predicted peptidyl-prolyl cis–trans isomerase that was decreased by over 
2-fold in the secA2 mutant (p = 0.04). Peptidyl-prolyl cis–trans isomerases, also known 
as cyclophilins, catalyze the cis–trans isomerization of peptide bonds and can also 
accelerate protein folding (58). An example of a Ppi protein with functions related to 
protein export is the Escherichia coli SurA protein, which assists protein folding in the 
periplasm following export by the Sec pathway (103). The M. tuberculosis PpiB is 
predicted to be essential and contains a putative transmembrane domain, but a role for 
this PpiB related to protein export has not yet been established (42). The functional 
significance of PpiB reduction in the secA2 mutant is not clear at this time, but it 
suggests possible changes in the levels of mis-folded proteins in the absence of SecA2. A 
homologous Ppi protein of Listeria monocytogenes (32% identical and 48% similar to M. 
tuberculosis PpiB at the amino acid level) was recently shown to be reduced in 
abundance in the supernatant of a secA2 mutant (98). Because L. monocytogenes also has 
a SecA2-only protein export system, this similar link between SecA2 and PpiB is 
intriguing.   
Trigger factor (Tf) is a chaperone that binds ribosomes and interacts with nascent 
polypeptides as they emerge from the ribosome (126). In our proteomic study, Tf was 
increased 2-fold in the secA2 mutant (p = 0.004). As a chaperone, Tf also has peptidyl-
prolyl cis–trans isomerase activity and assists in folding of cytoplasmic proteins. In E. 
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coli, Tf is not essential, however when Tf is deleted in combination with other 
cytoplasmic chaperones it results in massive protein aggregation (20). If our model is 
correct, where SecA2 assists in export of proteins with tendencies to fold in the 
cytoplasm, then deletion of secA2 in M. tuberculosis could result in increased levels of 
mis-folded cytoplasmic preproteins. An increase in Tf expression or localization to the 
membrane in the secA2 mutant could reflect a response to this cytoplasmic stress. 
 
Proteins increased in the M. tuberculosis secA2 mutant reflect possible 
transcriptional changes  
While the ultimate goal of this study was to identify proteins underrepresented in 
the secA2 cell wall, we also identified a large list of proteins that were more abundant in 
the secA2 cell wall. Only 13% of the proteins more abundant in the secA2 mutant have 
predicted signal peptides or transmembrane domains, while 32% of proteins 
underrepresented in the secA2 mutant have these putative export signals. Therefore, 
many of the proteins increased in the secA2 mutant cell wall are likely a reflection of 
regulatory effects that lead to increased expression of cytoplasmic (non-exported) 
proteins. It is not surprising to detect non-exported proteins in the cell wall as past mass 
spectrometry studies of the mycobacterial cell wall also result in identification of 
cytoplasmic proteins (41, 73). These results highlight an advantage of using shotgun 
proteomic studies for studying protein export pathways, which is that they can report both 
on protein localization as well as expression differences. 
Interestingly, among those proteins over-represented in the secA2 cell wall were 
almost half of the proteins that correspond to genes under control of the DosR response 
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regulator (25 out of the 49 genes of the Dos regulon) (89, 112). Of these 25 proteins, 14 
were statistically significant in their increased abundance and 7 were unique to the 
secA2 mutant. The DosR system was first identified as a regulon that was induced under 
hypoxic conditions, a state that is associated with M. tuberculosis dormancy (5, 68). 
Since then, the stresses that induce the DosR response have expanded to include exposure 
to ethanol, as well as nitric oxide and redox stresses (54, 61, 112, 128). In fact, the DosR 
regulon can even be induced in M. tuberculosis as quickly as 10 minutes after being 
removed from aeration, such as the conditions experienced during the centrifugation steps 
upon harvesting cells for proteomic analysis (54). The DosR response system is thought 
to be important for M. tuberculosis survival in the host as it is induced in macrophages, 
mice, guinea pigs, and possibly during human infection (18, 109, 111, 128). In addition, 
it has been shown that DosR is required for rapid M. tuberculosis growth recovery 
following anaerobic or nitric oxide-induced non-respiring states in vitro (66). Our 
proteomic analysis suggests that the secA2 mutant is more sensitive to induction of the 
DosR regulon. However, exactly why the DosR regulon appears to be activated in the 
secA2 mutant is unclear at this time. At this time, we cannot definitively say if the 
increased levels of Dos regulated proteins observed reflect transcriptional changes in the 
secA2 mutant. This possibility requires RT-PCR to measure transcript levels between 
wild type and the secA2 mutant. Given the importance of DosR in M. tuberculosis 
survival in infection models, this possibility certainly merits further testing. 
In addition to the DosR response regulator, we also detected changes in the 
abundance of some alternative sigma factors in the secA2 mutant. M. tuberculosis has 
12 alternative sigma factors for inducing transcriptional changes in response to different 
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environmental conditions (71, 104). Three alternative sigma factors showed differences 
in abundance between wild type M. tuberculosis and the secA2 mutant, suggesting that 
there may be additional transcriptional alterations in the secA2 mutant. The SigF and 
SigI proteins were not detected in the secA2 cell wall fraction, while SigD was uniquely 
identified in the secA2 mutant. It is unclear if these changes in protein abundance reflect 
altered activity of these sigma factors. But the absence of SigF and SigI in the secA2 
mutant could reflect localization away from the cytoplasmic membrane (and 
consequently the cell wall) to the cytoplasm in order to activate gene transcription. On 
the other hand, the higher levels of SigD in the secA2 mutant could increase 
transcription of SigD-regulated genes. While we detected changes in the levels of some 
proteins expressed from genes within both the SigF and SigD regulons, most of the 
proteins within these regulatory networks were unchanged or not identified. For 
corresponding genes under SigF control, nine proteins were more abundant in the secA2 
mutant while three proteins were underrepresented in the mutant (33, 40). Our analysis 
showed 6 genes under SigD regulation had corresponding proteins more abundant in the 
secA2 mutant and two proteins that were less abundant in the mutant (10, 95). At this 
time, the regulon of SigI has not been defined (78). There is evidence that both SigF and 
SigD are activiated during host infection (4, 14, 33, 36, 52, 109). In the future, it will be 
important to test for activation of these sigma response networks in the secA2 mutant, 
which could influence survival in the host. 
In addition to genes regulated by DosR and the alternative sigma factors 
described, there were also many proteins with predicted roles in intermediary metabolism 
and respiration that were more abundant in the secA2 mutant. Given the large effect of 
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secA2 deletion on solute-binding proteins, these increased protein abundances could 
reflect adaptations the secA2 mutant to changes in nutrient acquisition.  
   
Conclusions 
 Using a large-scale shotgun proteomic approach combined with semi-quantitative 
spectral counting, we generated a list of putative SecA2-dependent exported proteins with 
possible roles in M. tuberculosis virulence. The most interesting virulence candidates are 
components of two Mce lipid importer complexes and an array of solute-binding 
proteins, which could have possible roles in nutrient acquisition in the host. Going 
forward, it will be important to validate the SecA2-dependence of exported proteins, 
particularly those with possible roles in M. tuberculosis virulence. It will also be 
important to establish if the reduction of specific proteins in the secA2 mutant reflects 
differences at the level of export as opposed to transcription. Finally, the SecA2-
dependent export defects observed will need to be confirmed by complementation to 
ensure they are due to inactivation of secA2. Many of the changes in protein abundance 
detected in the secA2 mutant cell wall were subtle, which may present difficulties 
confirming their SecA2-dependency by immunoblotting. A mass spectrometry technique 
called selective reaction monitoring (SRM) is becoming a widely used method for 
confirming hits obtained from large-scale proteomic studies because it is a MS detection 
method targeted to specific proteins, which improves sensitivity and dynamic range (32). 
Because our proteomic strategy resulted in many more candidate SecA2-dependent 
proteins than identified previously by 2D-GE analyses of mycobacterial secA2 mutants, 
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future studies should include spectral counting analysis of culture supernatants to find 
SecA2-dependent secreted proteins.  
 Results from our proteomic analysis of the secA2 mutant also strengthen our 
model whereby SecA2 assists in export of preproteins that have a tendency to fold in the 
cytoplasm. This model is supported by the observation that multiple predicted Tat 
substrates were under-represented in the secA2 mutant. Thus, the mycobacterial SecA2 
and Tat systems might assist in export of a common pool of preprotein substrates that 
tend to fold in the cytoplasm. Deletion of secA2 also resulted in protein level differences 
in one component of the Tat pathway (TatB) and two proteins with putative chaperone 
activities (PpiB and Tf), which could indicate that deletion of secA2 in M. tuberculosis 
increased cytoplasmic levels of preproteins with tendencies to fold. Prior to this M. 
tuberculosis study, the data from which our model of SecA2 export was built was 
generated in M. smegmatis. Thus, the results presented here are also significant in 
supporting the model developed in M. smegmatis. Taken together, our results from 
Chapters 2 and 3 suggest that SecA2 may be an alternate solution to solving the problem 
of getting folded preproteins past the cytoplasmic membrane. In Chapter 4 we return to 
our model organism, M. smegmatis, to specifically test the influence of the Tat export 
system on export of SecA2 substrates. 
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Figure 3.1 Control immunoblots of M. tuberculosis lysates and cell wall fractions  
(A) Equalized whole cell lysates (WCL) were generated from triplicate cultures of M. 
tuberculosis H37Rv (wild type) and mc
2
3112 (secA2) and analyzed by immunoblotting 
using anti-SecA1, anti-SecA2, or anti-19kD antibodies. (B) The same equalized WCLs 
were then subjected to ultracentrifugation to generate subcellular fractions. The total 
amount of cell wall (CW), membrane (M), and soluble (SOL) fractions shown is 
equivalent to the amount of WCL loaded. Fractions were separated by SDS-PAGE then 
transferred to a nitrocellulose membrane for immunoblotting using antibodies against 
native proteins. The MtrA and SigA proteins were detected as representative cytoplasmic 
controls, while two cell wall-associated proteins, 19 kDa and HbHA, were detected using 
anti-HbHA and anti-19kDa antibodies.  
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Figure 3.2 SDS-PAGE of M. tuberculosis cell wall fractions for proteomic analysis 
Cell wall fractions generated from triplicate cultures of M. tuberculosis H37Rv (wild 
type) and mc
2
3112 (secA2) were separated on a 12% SDS-PAGE gel and Coomassie 
stained for protein visualization. For each of the six samples, protein bands were excised 
from the entire lane for trypsin digestion. Tryptic peptides were then analyzed by LC-
MS/MS for spectral counting comparison between wild type and secA2. 
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Figure 3.3 Functional categories and export signals of cell wall proteins identified 
(A) A total of 1,920 proteins were identified by mass spectrometry analysis of cell wall 
protein fractions of M. tuberculosis H37Rv (wild type) and mc
2
3112 (secA2), 
representing multiple functional categories. (B) Amino acid sequences of all proteins 
identified were analyzed for the presence of N-terminal signal peptides or transmembrane 
domains. A total of 379 (19%) of proteins identified in the M. tuberculosis cell wall 
contain probable transmembrane domains predicted by the TMHMM 2.0 (116). 
Additionally, 167 proteins (8%) are predicted to contain signal peptides for export 
through the conserved Sec and Tat export machinery. These include 134 proteins with 
putative Sec signal peptides as determined by SignalP and 33 with predicted Tat signal 
peptides as determined by the TatP and/or TatFind programs (3, 90, 102). Of the 167 
proteins with putative export signals, 74 represent predicted lipoproteins as they contain 
putative lipobox motifs (51). 
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Figure 3.4 Label-free quantitation of M. tuberculosis wild type and secA2 cell wall 
proteins 
To identify changes in protein abundance between the cell wall fractions of wild type M. 
tuberculosis (H37Rv) and the secA2 mutant, we employed a label-free quantification 
analysis (LFQ) based on spectral counting. The total number of MS/MS spectra assigned 
to a particular protein were compared between the two bacterial strains using the 
ProteoIQ program. We obtained relative abundance ratios for 1,780 proteins (grey 
diamonds), shown here plotted by secA2/WT ratio (log2 scale) and p value (-log scale). 
Of these shared proteins, 200 were statistically different (p < 0.05, ANOVA) in 
abundance between strains by 2-fold or more, with a corresponding false discovery rate 
(FDR) of 10% for this p value cut-off. Of these proteins, 69 were less abundant in the 
secA2 cell wall and 130 were more abundant in the mutant cell wall. The majority of 
lipoproteins (orange squares) are underrepresented in the mutant, particularly solute-
binding lipoproteins (green diamonds). Additionally, all four solute-binding proteins with 
putative Tat signal peptides identified (black triangles) were less abundant in the secA2 
mutant protein. The PhoS1 lipoprotein (pink asterisk) was underrepresented in the 
secA2 mutant (p = 0.08) and analyzed by immunoblot to confirm our LFQ findings. 
Also labeled here are proteins underrepresented in the secA2 cell wall that correspond to 
Mce1/Mce4 transporters (red circles). 
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Figure 3.5 Functional categories of proteins with different relative abundances 
between wild type M. tuberculosis and the secA2 cell wall  
(A) Of the 1,920 proteins identified in the cell wall fractions of wild type M. tuberculosis 
(H37Rv) and the secA2 mutant by mass spectrometry analysis, 83% were unchanged 
between these strains as determined by semi-quantitative spectral counting analysis. This 
label-free quantitation also revealed that 3% of proteins were underrepresented in the 
secA2 mutant cell wall, while 7% were more abundant in the mutant cell wall. An 
additional set of proteins were only identified in 1 strain: 3% were absent in the secA2 
mutant cell wall and 4% were only unique to the cell wall of the mutant. (B) Proteins 
with different abundances between the M. tuberculosis and the secA2 mutant cell wall 
fractions represent multiple functional categories (6, 11, 12, 16, 121). The total number of 
M. tuberculosis H37Rv predicted proteins within each category is in parentheses. An 
asterisk denotes functional categories for which no proteins were identified as increased 
in abundance or unique to the secA2 mutant. 
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Figure 3.6 Export signals of proteins with differential abundance  
(A) Our proteomic analysis of the M. tuberculosis cell wall resulted in the identification 
of 124 proteins either less abundant or absent in the secA2 mutant cell wall. 32% of 
these protein contained predicted export signals. (B) We also identified 216 proteins that 
were more abundant or unique to the secA2 mutant cell wall. Of this group, only 13% 
are predicted to contain signals for export.  
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Figure 3.7 Components of two transporters are reduced in the M. tuberculosis 
secA2 mutant cell wall. 
The M. tuberculosis H37Rv genome contains four mce loci encoding putative 
transporters. Each mce locus contains two yrbE ORFs with predicted membrane-spanning 
domains, six mce ORFs with possible signal peptides, and one mce regulatory ORF. 
Some mce loci have additional ORFs for “mce-associated proteins” (mas). Mkl is 
encoded at a different chromosomal locus than the four mce loci and is a predicted 
ATPase possibly powering Mce transport. Spectral counting comparison of the wild type 
M. tuberculosis cell wall to that of the secA2 mutant showed eight proteins of Mce1 and 
Mce4 underrepresented in the mutant cell wall (orange) Proteins with fold changes of -2 
or more are denoted with asterisks.  
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Figure 3.8 Immunoblot conformation of relative PhoS1 protein abundance between 
the M. tuberculosis wild type and secA2 mutant cell wall 
(A) The same M. tuberculosis wild type and secA2 mutant cell wall fractions (CW) used 
for spectral counting were also analyzed by immunoblot using an anti-PhoS1 antibody. 
Our label-free quantitation produced a log2 (secA2/WT) ratio for PhoS1 of -1.36 (p = 
0.081). Also included are the whole cell lysates (WCL) from which the corresponding 
cell wall fraction was derived, as well as cytoplasmic membrane (M) and soluble 
fractions (SOL). Shown here is a representative blot from all three replicates analyzed. 
(B) The mean intensity obtained from the cell wall fraction immunoblotting was 
determined using ImageJ and reported with +/- the standard error. A paired t-test showed 
no statistical difference between PhoS1 in the cell wall of wild type and secA2 mutant 
M. tuberculosis. 
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Table 3.1 Proteins with 2-fold or greater abundance differences between the M. 
tuberculosis H37Rv and secA2 cell wall fractions. Proteins with label-free 
quantification ratios showing at least a 2-fold difference (log2 + 1) with a t-test 
significance of p < 0.05 are shown below. Proteins less abundant in the secA2 mutant 
are highlighted in pink while proteins that were more abundant in the secA2 mutant are 
highlighted in blue. Proteins with higher average spectral counts (Avg SpC) were most 
abundant in the M. tuberculosis cell wall. 
Locus 
Gene  
Name 
Description/Function 
log2 
A2/
WT 
p 
Avg 
SpC 
Sec
a
 Tat
b
 TM
c
 Lipo
d
 
Rv2688c  
antibiotic ABC transporter ATP-
binding  
-2.63 0.001 4.8 - - X - 
Rv0778 cyp126 cytochrome P450 126  -1.80 0.001 11.6 - - - - 
Rv1462  hypothetical protein  -1.80 0.001 2.3 - - - - 
Rv3083  monooxygenase  -1.48 0.001 12.1 - - - - 
Rv1922  lipoprotein  -1.44 0.001 3.9 X - - X 
Rv3499c mce4A MCE4-associated -1.06 0.001 19.8 X - X - 
Rv1280c oppA 
ABC transporter oligopeptide-
binding protein 
-1.05 0.001 22.5 - X X X 
Rv2599  hypothetical protein  -2.33 0.002 3.2 X - - - 
Rv0728c serA2 
D-3-phosphoglycerate 
dehydrogenase  
-2.00 0.002 5.2 - - - - 
Rv3572  hypothetical protein  -1.66 0.002 2.1 X - - - 
Rv0001 dnaA 
chromosomal replication 
initiation protein  
-1.48 0.002 47.4 - - - - 
Rv3497c mce4C MCE4-associated -1.48 0.002 43.5 - - X - 
Rv3495c lprN MCE4-associated lipoprotein -1.43 0.002 28.3 X - - X 
Rv3501c yrbE4A MCE4-associated -1.38 0.003 11.5 - - X - 
Rv0227c  hypothetical protein  -1.23 0.003 66.9 - - X - 
Rv3062 ligB ATP-dependent DNA ligase  -1.09 0.003 4.7 - - - - 
Rv0845  two component sensor kinase  -1.85 0.004 6.2 - - X - 
Rv1320c  adenylate cyclase  -1.51 0.004 3.9 - - X - 
Rv1754c  hypothetical protein  -2.02 0.005 2.7 - - X - 
Rv2932 ppsB 
phenolpthiocerol synthesis type-I 
polyketide synthase 
-2.00 0.006 2.6 - - - - 
Rv1844c gnd1 
6-phosphogluconate 
dehydrogenase  
-1.87 0.006 10.9 - - - - 
Rv3498c mce4B MCE4-associated -1.24 0.006 23.0 - - X - 
Rv2328 PE23 PE family protein  -1.16 0.006 3.9 - - - - 
Rv1380 pyrB 
aspartate carbamoyltransferase 
catalytic subunit  
-1.15 0.006 15.6 - - - - 
Rv1426c lipO esterase -1.11 0.006 2.5 X - X - 
Rv1641 infC translation initiation factor  -1.99 0.007 1.8 - - - - 
Rv2351c plcA 
membrane-associated 
phospholipase C  
-2.14 0.008 3.2 - X - - 
Rv2721c  hypothetical protein  -1.24 0.009 106.7 X - - - 
Rv0174 mce1F MCE1-associated -1.18 0.009 155.4 - - X - 
Rv2516c  hypothetical protein  -1.07 0.009 11.6 - - - - 
Rv1391 dfp 
phosphopantothenoylcysteine 
decarboxylase/ 
phosphopantothenate synthase 
-1.50 0.011 5.5 - - - - 
Rv0379 secE2 protein transport protein  -1.21 0.011 69.5 - - - - 
Rv0500A  hypothetical protein  -1.09 0.012 1.2 - - - - 
Rv2447c folC 
folylpolyglutamate synthase 
protein 
-1.09 0.012 1.2 - - X - 
Rv2975c  hypothetical protein  -1.09 0.012 1.2 - - - - 
Rv3704c gshA 
glutamate--cysteine ligase  
(gamma-glutamylcysteine 
synthetase) 
-1.09 0.012 1.2 - - - - 
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Rv3764c  two component sensor kinase  -1.09 0.012 1.2 - - X - 
Rv0265c fecB2 iron-transport SBP lipoprotein  -1.04 0.014 13.0 - X - X 
Rv0377  
LysR family transcriptional 
regulator  
-1.40 0.015 9.7 - - - - 
Rv2240c  hypothetical protein  -1.00 0.015 6.8 - - - - 
Rv3918c parA chromosome partitioning protein -1.19 0.016 12.4 - - - - 
Rv0156 pntAb 
NAD(P) transhydrogenase 
subunit alpha  
-2.03 0.017 8.8 - - - - 
Rv3059 cyp136 cytochrome P450 136  -1.43 0.018 26.0 - - - - 
Rv0168 yrbE1B MCE1-associated -1.18 0.018 4.4 - - X - 
Rv0169 mce1A MCE1-associated -1.10 0.018 80.5 - - X - 
Rv2467 pepN aminopeptidase N  -1.09 0.018 4.2 - - - - 
Rv0548c menB naphthoate synthase  -1.03 0.018 3.6 - - - - 
Rv3194c  hypothetical protein  -1.01 0.018 28.0 X - X - 
Rv0419 lpqM lipoprotein peptidase -2.10 0.019 11.5 X - X X 
Rv2799  hypothetical protein  -1.23 0.019 14.1 - - - - 
Rv3496c mce4D MCE4-associated -1.96 0.023 19.3 - - X - 
Rv0339c  transcriptional regulator -2.18 0.024 8.1 - - X - 
Rv3494c mce4F MCE4-associated -1.69 0.026 16.5 - - X - 
Rv2413c  hypothetical protein  -1.28 0.027 15.1 - - - - 
Rv1188  proline dehydrogenase  -1.14 0.027 3.2 - - - - 
Rv1596 nadC 
nicotinate-nucleotide 
pyrophosphorylase  
-1.56 0.028 12.1 - - - - 
Rv2700  secreted alanine rich protein  -1.31 0.032 10.6 - - - - 
Rv2784c lppU lipoprotein -1.03 0.033 4.3 X - - X 
Rv2822c  hypothetical protein  -1.06 0.034 9.2 - - - - 
Rv3609c folE GTP cyclohydrolase I  -1.74 0.036 4.8 - - - - 
Rv2692 ceoC 
TRK system potassium uptake 
protein 
-1.72 0.039 1.3 - - - - 
Rv2582 ppiB 
peptidyl-prolyl cis-trans 
isomerase B  
-1.50 0.041 26.1 - - - - 
Rv1259  hypothetical protein  -1.04 0.044 0.9 - - - - 
Rv3666c dppA 
periplasmic dipeptide-binding 
lipoprotein 
-1.77 0.045 5.7 X - X X 
Rv3077  hydrolase  -1.67 0.045 9.5 - - - - 
Rv1232c  hypothetical protein  -1.45 0.047 8.1 - - - - 
Rv2400c subI sulfate-binding lipoprotein  -2.25 0.048 2.6 - - - X 
Rv0533c fabH 
3-oxoacyl-(acyl carrier protein) 
synthase III  
-1.99 0.048 6.3 - - - - 
Rv0411c glnH glutamine-binding lipoprotein  -1.66 0.05 6.5 X X - X 
Rv0715 rplX 50S ribosomal protein L24  1.41 0.049 7.1 - - - - 
Rv2445c ndk nucleoside diphosphate kinase  1.83 0.049 4.1 - - - - 
Rv1589 bioB biotin synthase  1.36 0.047 3.2 - - - - 
Rv2018  hypothetical protein  1.45 0.046 0.9 - - - - 
Rv2683  hypothetical protein  1.98 0.044 3.2 - - - - 
Rv0701 rplC 50S ribosomal protein L3  1.07 0.042 10.7 - - - - 
Rv2531c  amino acid decarboxylase  1.13 0.042 10.5 - - - - 
Rv1904  hypothetical protein  1.38 0.041 5.1 - - - - 
Rv2626c  hypothetical protein  1.67 0.04 1.9 - - X - 
Rv2928 tesA thioesterase TESA  1.12 0.039 3.8 - - - - 
Rv2915c  hypothetical protein  1.45 0.039 1.4 - - - - 
Rv2766c fabG 
3-ketoacyl-(acyl-carrier-protein) 
reductase  
1.53 0.039 4.6 - - - - 
Rv0516c  hypothetical protein  1.97 0.037 6.3 - - - - 
Rv0802c  hypothetical protein  1.86 0.036 1.0 - - - - 
Rv2031c hspX heat shock protein 2.42 0.036 36.2 - - - - 
Rv3602c panC pantoate--beta-alanine ligase  1.78 0.034 2.4 - - - - 
Rv3161c  dioxygenase  1.80 0.034 4.1 - - - - 
Rv3130c tgs1 triacylglycerol synthase  1.21 0.033 19.9 - - - - 
Rv1957  hypothetical protein  1.25 0.033 3.5 - - - - 
Rv2495c pdhC 
branched-chain alpha-keto acid 
dehydrogenase subunit E2  
1.82 0.033 2.4 - - - - 
Rv1546  hypothetical protein  1.23 0.032 3.6 - - - - 
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Rv3134c  hypothetical protein  1.86 0.032 7.5 - - - - 
Rv3865  hypothetical protein  1.16 0.031 4.1 - - - - 
Rv3147 nuoC NADH dehydrogenase subunit C  1.28 0.031 15.3 - - - - 
Rv1278  hypothetical protein  1.09 0.03 14.6 - - - - 
Rv2777c  hypothetical protein  1.73 0.03 2.2 - - - - 
Rv2995c leuB 
3-isopropylmalate 
dehydrogenase  
1.94 0.029 2.9 - - - - 
Rv1290c  hypothetical protein  1.05 0.028 1.1 - X X - 
Rv0328  
TetR/AcrR family transcriptional 
regulator  
1.14 0.028 3.2 - - - - 
Rv1767  hypothetical protein  1.36 0.027 1.7 - - - - 
Rv0861c ercC3 DNA helicase   1.08 0.026 10.9 - - - - 
Rv0880  
MarR family transcriptional 
regulator  
1.01 0.025 1.1 - - - - 
Rv1593c  hypothetical protein  1.01 0.025 3.3 - - - - 
Rv1674c  transcriptional regulator 1.01 0.025 1.1 - - - - 
Rv2464c  DNA glycosylase  1.01 0.025 1.1 - - - - 
Rv1630 rpsA 30S ribosomal protein S1  1.37 0.025 18.1 - - - - 
Rv1501  hypothetical protein  1.84 0.025 1.9 - - - - 
Rv1274 lprB lipoprotein 1.19 0.024 6.4 X - - X 
Rv2118c  RNA methyltransferase  1.35 0.024 5.2 - - - - 
Rv3099c  hypothetical protein  2.74 0.024 1.6 - - - - 
Rv0189c ilvD dihydroxy-acid dehydratase  1.75 0.023 7.8 - - X - 
Rv0282  hypothetical protein  1.24 0.022 4.6 - - - - 
Rv2071c cobM 
precorrin-4 C11-
methyltransferase 
1.30 0.022 2.4 - - - - 
Rv0079  hypothetical protein  2.11 0.022 12.3 - - - - 
Rv3224  short chain dehydrogenase  2.16 0.022 4.4 - - - - 
Rv1019  
TetR family transcriptional 
regulator  
2.04 0.021 2.9 - - - - 
Rv0434  hypothetical protein  1.02 0.02 5.4 - - - - 
Rv0708 rplP 50S ribosomal protein L16  1.13 0.02 12.7 - - - - 
Rv0060  hypothetical protein  1.11 0.019 1.1 - - - - 
Rv0110  integral membrane protein  1.11 0.019 1.1 - - - - 
Rv0691c  transcriptional regulator 1.11 0.019 1.1 - - - - 
Rv1401  hypothetical protein  1.11 0.019 1.1 - - X - 
Rv2693c  
integral membrane alanine and 
leucine rich protein  
1.11 0.019 1.1 - - - - 
Rv3188  hypothetical protein  1.11 0.019 1.1 - - - - 
Rv2625c  hypothetical protein  3.20 0.019 9.8 - - - - 
Rv2444c rne ribonuclease E  1.24 0.018 6.1 - - X - 
Rv1738  hypothetical protein  1.70 0.018 6.2 - - - - 
Rv2823c  hypothetical protein  2.55 0.018 1.3 - - - - 
Rv3804c fbpA 
secreted antigen (Mycolyl 
transferase 85A) 
1.14 0.017 50.0 - X X - 
Rv0078  transcriptional regulator 1.15 0.017 8.6 - - - - 
Rv3249c  
TetR family transcriptional 
regulator  
2.32 0.016 6.1 - - - - 
Rv3819  hypothetical protein  1.26 0.015 17.3 - - - - 
Rv3617 ephA epoxide hydrolase 2.49 0.015 2.4 - - - - 
Rv0187  O-methyltransferase  1.30 0.014 1.3 - - - - 
Rv2534c efp elongation factor P  2.26 0.014 2.6 - - - - 
Rv1338 murI glutamate racemase  1.58 0.013 5.0 - - - - 
Rv2030c  hypothetical protein  2.67 0.013 12.4 - - - - 
Rv2883c pyrH uridylate kinase  1.64 0.012 3.0 - - - - 
Rv3868  hypothetical protein  2.02 0.012 8.9 - - - - 
Rv2940c mas 
multifunctional mycocerosic acid 
synthase membrane-associated 
MAS  
1.08 0.011 70.4 - - - - 
Rv1383 carA 
carbamoyl phosphate synthase 
small subunit  
1.18 0.011 4.0 - - - - 
Rv0317c glpQ2 
glycerophosphoryl diester 
phosphodiesterase  
1.20 0.011 29.9 - - - - 
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Rv2251  flavoprotein  1.59 0.011 2.1 - - - X 
Rv3271c  integral membrane protein  1.63 0.01 5.7 - - X - 
Rv2911 dacB2 
D-alanyl-D-alanine 
carboxypeptidase  
1.65 0.01 6.6 X - - - 
Rv3766  hypothetical protein  1.23 0.009 1.9 - - - - 
Rv2017  transcriptional regulator 1.39 0.009 5.5 - - - - 
Rv3799c accD4 
propionyl-CoA carboxylase beta 
chain  
1.22 0.008 6.6 - - - - 
Rv3297 nei endonuclease VIII  1.30 0.008 1.9 - - - - 
Rv3051c nrdE 
ribonucleotide-diphosphate 
reductase subunit alpha  
1.43 0.008 19.4 - - - - 
Rv3401  hypothetical protein  1.65 0.008 15.2 - - - - 
Rv3813c  hypothetical protein  1.94 0.008 4.2 - - - - 
Rv2026c  hypothetical protein  1.38 0.007 12.8 - - - - 
Rv2748c ftsK 
cell division transmembrane 
protein 
3.08 0.007 7.5 - - - - 
Rv2919c glnB nitrogen regulatory protein P-II 1.12 0.006 5.6 - - - - 
Rv1284  hypothetical protein  1.49 0.006 1.0 - - - - 
Rv3715c recR recombination protein 1.80 0.006 6.2 - - - - 
Rv3592 TB11.2 hypothetical protein  1.83 0.006 2.5 - - - - 
Rv0695  hypothetical protein  1.88 0.006 2.3 - - - - 
Rv2604c PdxT  
glutamine amidotransferase 
subunit  
1.03 0.005 3.3 - - - - 
Rv3236c  
integral membrane transport 
protein  
1.22 0.005 3.6 - - X - 
Rv1837c glcB malate synthase G  1.94 0.005 7.0 - - - - 
Rv2070c cobK cobalt-precorrin-6x reductase  2.33 0.005 2.2 - - - - 
Rv0425c ctpH 
metal cation transporting P-type 
ATPase  
2.38 0.005 9.3 X - - - 
Rv0409 ackA acetate kinase  1.06 0.004 1.3 - - - - 
Rv1422  hypothetical protein  1.06 0.004 1.3 - - - - 
Rv2397c cysA1 
sulfate-transport ATP-binding 
protein ABC transporter 
1.06 0.004 3.8 - - - - 
Rv2462c tig trigger factor  1.06 0.004 1.3 - - - - 
Rv2736c recX recombination regulator 1.06 0.004 1.3 - - - - 
Rv3036c TB22.2 hypothetical protein  1.06 0.004 1.3 X - - - 
Rv3600c  pantothenate kinase  1.06 0.004 1.3 - - - - 
Rv0102  integral membrane protein  1.07 0.004 1.3 - - - - 
Rv2676c  hypothetical protein  1.13 0.004 5.7 - - - - 
Rv0999  hypothetical protein  1.22 0.004 14.9 - - - - 
Rv2286c  hypothetical protein  1.91 0.004 1.2 - - - - 
Rv0860 fadB fatty oxidation protein 3.09 0.004 17.6 - - - - 
Rv3909  hypothetical protein  1.03 0.003 52.5 X - - - 
Rv1463  
ABC transporter ATP-binding 
protein  
1.98 0.003 2.6 - - - - 
Rv3880c  hypothetical protein  1.11 0.002 11.3 - - - - 
Rv2989  transcriptional regulator 1.33 0.002 9.5 - - - - 
Rv3052c nrdI 
ribonucleotide reductase 
stimulatory protein  
1.33 0.002 18.2 - - - - 
Rv0080  hypothetical protein  1.42 0.002 7.4 - - - - 
Rv0034  hypothetical protein  1.80 0.002 1.7 - - - - 
Rv2337c  hypothetical protein  1.11 0.001 5.1 - - - - 
Rv1167c  transcriptional regulator 1.15 0.001 8.6 - - - - 
Rv0972c fadE12 acyl-CoA dehydrogenase  1.50 0.001 2.1 - - - - 
Rv0910  hypothetical protein  1.64 0.001 3.3 - - - - 
Rv3133c 
devR/d
osR 
two component transcriptional 
regulatory protein 
1.69 0.001 4.6 - - - - 
Rv2002 fabG3 
20-beta-hydroxysteroid 
dehydrogenase  
1.97 0.001 8.0 - - - - 
Rv3676 crp 
CRP/FNR family transcriptional 
regulator  
2.24 0.001 15.3 - - - - 
Rv2927c  hypothetical protein  2.80 0.001 4.4 - - - - 
Rv0570 nrdZ ribonucleoside-diphosphate 3.12 0.001 6.6 - - - - 
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reductase large subunit 
Rv2627c  hypothetical protein  4.04 0.001 12.0 - - - - 
Rv1996  hypothetical protein  1.17 0 10.4 - - - - 
Rv2971  oxidoreductase  1.27 0 3.7 - - - - 
Rv1908c katG 
catalase-peroxidase-
peroxynitritase T 
1.30 0 8.6 - - - - 
Rv1133c metE 
5-
methyltetrahydropteroyltrigluta
mate--homocysteine S-
methyltransferase  
1.30 0 51.3 - - - - 
Rv1489  hypothetical protein  1.93 0 10.3 - - X - 
Rv0540  hypothetical protein  2.35 0 2.4 - - - - 
Rv3295  
TetR family transcriptional 
regulator  
2.57 0 3.8 - - - - 
a – An “X” indicates the presence of an N-terminal signal peptide predicted using SignalP v. 4.0 (90) 
b – An “X” indicates the presence of an N-terminal Tat signal peptides as predicted using TatP and TatFind 
c –  An “X” indicates one or more putative transmembrane domains predicted using using TMHMM  v. 2.0 (116)  
d – An “X” indicates a potential lipoprotein containing a putative lipobox-type signal peptide as predicted by the LipoP v. 1.0 
program (51) or using a lipoprotein pattern search against the M. tuberculosis H37Rv genome (121) 
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Table 3.2 Proteins identified only in the M. tuberculosis H37Rv (wild type) cell wall 
by at least 2 peptides. 
Locus 
Gene 
Name 
Description/Function 
Total 
Peptides 
Sec
a
 Tat
b
 TM
c
 Lipo
d
 
Rv1821 secA2 preprotein translocase subunit SecA2 26 - - - - 
Rv2121c hisG ATP phosphoribosyltransferase  5 - - - - 
Rv2264c  hypothetical protein  5 - - - - 
Rv1995  hypothetical protein 4 - - - - 
Rv2092c helY ATP-dependent DNA helicase 4 - - - - 
Rv0764c cyp51 cytochrome P450 sterol 14-alpha demethylase  3 - - - - 
Rv1189 sigI RNA polymerase sigma factor 3 - - - - 
Rv1878 glnA3 glutamine synthetase  3 - - - - 
Rv2064 cobG cobalamin biosynthesis protein CobG  3 - - - - 
Rv2714  hypothetical protein 3 - - - - 
Rv2791c  transposase  3 - - - - 
Rv2916c ffh signal recognition particle protein  3 - - - - 
Rv3032  transferase  3 - - - - 
Rv3397c phyA phytoene synthase  3 - - - - 
Rv3518c cyp142 cytochrome P450 monooxygenase 142  3 - - - - 
Rv3860  hypothetical protein 3 - - - - 
Rv0082  oxidoreductase  2 - - - - 
Rv0154c fadE2 acyl-CoA dehydrogenase FADE2  2 - - - - 
Rv0212c nadR transcriptional regulatory protein NadR  2 - - - - 
Rv0483 lprQ lipoprotein 2 - - - X 
Rv0486  mannosyltransferase  2 - - - - 
Rv0510 hemC porphobilinogen deaminase  2 - - - - 
Rv0680c  transmembrane protein  2 X - X - 
Rv0819  hypothetical protein 2 - - - - 
Rv1011 ispE 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase  2 - - - - 
Rv1302 rfe UDP-GlcNAc transferase 2 - - X - 
Rv1330c  nicotinate phosphoribosyltransferase  2 - - - - 
Rv1420 uvrC excinuclease ABC subunit C  2 - - - - 
Rv1522c mmpL12 transmembrane transport protein 2 - - X - 
Rv1551 plsB1 glycerol-3-phosphate acyltransferase  2 - - - - 
Rv1561  hypothetical protein  2 - - - - 
Rv1933c fadE18 acyl-CoA dehydrogenase  2 - - - - 
Rv2067c  hypothetical protein  2 - - - - 
Rv2089c pepE dipeptidase PepE  2 - X - - 
Rv2356c PPE40 PPE family protein  2 - - - - 
Rv2361c 
 
long (C50) chain Z-isoprenyl diphosphate synthase 
(Z-decaprenyl diphosphate synthase)  2 - - - - 
Rv2386c mbtI salicylate synthase  2 - - - - 
Rv2391 nirA ferredoxin-dependent nitrite reductase  2 - - - - 
Rv2650c  phiRv2 prophage protein  2 - - - - 
Rv2733c  hypothetical protein  2 - - - - 
Rv2832c 
ugpC 
sn-glycerol-3-phosphate transport ATP-binding 
ABC transporter 2 - - - - 
Rv2978c  transposase  2 - - - - 
Rv3175  amidase  2 - - - - 
Rv3201c  ATP-dependent DNA helicase  2 - - - - 
Rv3255c manA mannose-6-phosphate isomerase  2 - - - - 
Rv3286c sigF RNA polymerase sigma factor 2 - - - - 
Rv3300c  hypothetical protein  2 - - - - 
Rv3647c  hypothetical protein  2 - - - - 
Rv3665c dppB peptide ABC transporter transmembrane protein  2 - - X - 
Rv3730c  hypothetical protein 2 - - - - 
Rv3737  transmembrane protein  2 - - X - 
Rv3754 tyrA prephenate dehydrogenase  2 - - - - 
Rv3797 fadE35 acyl-CoA dehydrogenase FADE35  2 - - - - 
Rv3817  phosphotransferase  2 - - - - 
Rv3863  hypothetical protein  2 - - - - 
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a – An “X” indicates the presence of an N-terminal signal peptide predicted using SignalP v. 4.0 (90) 
b – An “X” indicates the presence of an N-terminal Tat signal peptides as predicted using TatP and TatFind 
c –  An “X” indicates one or more putative transmembrane domains predicted using using TMHMM  v. 2.0 (116)  
d – An “X” indicates a potential lipoprotein containing a putative lipobox-type signal peptide as predicted by the LipoP v. 1.0 
program (51) or using a lipoprotein pattern search against the M. tuberculosis H37Rv genome (121) 
 
Table 3.3 Proteins identified only in the M. tuberculosis mc
2
3112 (secA2) cell wall 
by at least 2 peptides. 
Locus 
Gene 
Name 
Description/Function 
Total 
Peptides 
Sec
a
 Tat
b
 TM
c
 Lipo
d
 
Rv1527c pks5 polyketide synthase pks5  8 - - - - 
Rv3127   hypothetical protein 6 - - - - 
Rv3414c sigD RNA polymerase sigma factor  6 - - - - 
Rv1997 ctpF metal cation transporter P-type ATPase A  5 - - X - 
Rv2905 lppW alanine rich lipoprotein  5 X - - X 
Rv3267   hypothetical protein 5 X - X - 
Rv0572c   hypothetical protein 4 - - - - 
Rv1477   invasion protein  4 X - - - 
Rv1710   hypothetical protein  4 - - - - 
Rv2486 echA14 enoyl-CoA hydratase  4 - - - - 
Rv2590 fadD9 fatty-acid-CoA ligase  4 - - - - 
Rv3822   hypothetical protein  4 - - - - 
Rv0063   oxidoreductase  3 X - - - 
Rv0711 atsA arylsulfatase AtsA  3 - - - - 
Rv0807   hypothetical protein 3 - - - - 
Rv0865 mog molybdopterin biosynthesis  3 - - - - 
Rv1094 desA2 acyl-[acyl-carrier protein] desaturase  3 - - - - 
Rv1467c fadE15 acyl-CoA dehydrogenase  3 - - - - 
Rv1813c   hypothetical protein 3 X X X - 
Rv1816   transcriptional regulatory protein  3 - - - - 
Rv1889c   hypothetical protein 3 - - - - 
Rv2308   hypothetical protein  3 - - - - 
Rv2417c   hypothetical protein 3 - - - - 
Rv2925c rnc ribonuclease III  3 - - - - 
Rv3203 lipV lipase LipV  3 - - - - 
Rv3263   DNA methylase (modification methylase)  3 - - - - 
Rv3396c guaA GMP synthase  3 - - - - 
Rv3562 fadE31 acyl-CoA dehydrogenase 3 - - - - 
Rv3913 trxB2 thioredoxin reductase TRXB2  3 - - - - 
Rv0040c mtc28 secreted proline rich antigen  2 X - X - 
Rv0101 nrp peptide synthetase  2 - - - - 
Rv0244c fadE5 acyl-CoA dehydrogenase  2 - - - - 
Rv0263c   hypothetical protein  2 - - - - 
Rv0264c   hypothetical protein 2 - - - - 
Rv0266c oplA 5-oxoprolinase  2 - - - - 
Rv0302   TetR/ACRR family transcriptional regulator  2 - - - - 
Rv0309   hypothetical protein  2 X - X - 
Rv0803 purL phosphoribosylformylglycinamidine synthase II  2 - - - - 
Rv0839   hypothetical protein 2 - - - - 
Rv0840c pip proline iminopeptidase  2 - - - - 
Rv0844c narL 
nitrate/nitrite response transcriptional 
regulatory protein NarL  2 - - - - 
Rv0853c pdc pyruvate or indole-3-pyruvate decarboxylase pd 2 - - - - 
Rv0868c moaD2 molybdenum cofactor biosynthesis protein D  2 - - - - 
Rv1074c fadA3 acetyl-CoA acetyltransferase  2 - - - - 
Rv1076 lipU lipase LipU  2 - - - - 
Rv1117   hypothetical protein 2 - - - - 
Rv1219c   transcriptional regulatory protein  2 - - - - 
Rv1224 tatB sec-independent translocase  2 - - X - 
Rv1315 murA UDP-N-acetylglucosamine 1- 2 - - - - 
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carboxyvinyltransferase  
Rv1358   transcriptional regulatory protein  2 - - - - 
Rv1466   hypothetical protein 2 - - - - 
Rv1529 fadD24 acyl-CoA synthetase  2 - - - - 
Rv1559 ilvA threonine dehydratase  2 - - - - 
Rv1566c   inv protein  2 X - X - 
Rv1724c   hypothetical protein 2 - - - - 
Rv1856c   short chain dehydrogenase  2 - - - - 
Rv1887   hypothetical protein  2 - - - - 
Rv1969 mce3D MCE-family protein MCE3D  2 X - X - 
Rv2003c   hypothetical protein  2 - - - - 
Rv2004c   hypothetical protein 2 - - - - 
Rv2032 acg hypothetical protein 2 - - - - 
Rv2109c prcA proteasome (alpha subunit) 2 - - - - 
Rv2166c   cell division protein MraZ  2 - - - - 
Rv2178c aroG 
3-deoxy-D-arabino-heptulosonate 7-phosphate 
synthase 2 - - - - 
Rv2211c gcvT glycine cleavage/aminomethyltransferase T  2 - - - - 
Rv2362c recO DNA repair protein RecO  2 - - - - 
Rv2454c   
2-oxoglutarate ferredoxin oxidoreductase 
subunit beta  2 - - - - 
Rv2501c accA1 
acetyl-/propionyl-coenzyme A carboxylase 
subunit alpha  2 - - - - 
Rv2917   hypothetical protein 2 - - - - 
Rv2923c   hypothetical protein  2 - - - - 
Rv3210c   hypothetical protein  2 - - - - 
Rv3370c dnaE2 error-prone DNA polymerase  2 - - - - 
Rv3432c gadB glutamate decarboxylase 2 - - - - 
Rv3463   hypothetical protein  2 - - - - 
Rv3524   hypothetical protein 2 - - X - 
Rv3550 echA20 enoyl-CoA hydratase  2 - - - - 
Rv3583c   transcription factor  2 - - - - 
Rv3628 ppa inorganic pyrophosphatase  2 - - - - 
Rv3651   hypothetical protein 2 - - - - 
Rv3710 leuA 2-isopropylmalate synthase  2 - - - - 
Rv3711c dnaQ DNA polymerase III subunit epsilon  2 - - - - 
Rv3717   hypothetical protein  2 X - - - 
Rv3823c mmpL8 integral membrane transport protein  2 - - X - 
Rv3837c   phosphoglycerate mutase  2 - - - - 
Rv3858c gltD glutamate synthase subunit beta  2 - - - - 
a – An “X” indicates the presence of an N-terminal signal peptide predicted using SignalP v. 4.0 (90) 
b – An “X” indicates the presence of an N-terminal Tat signal peptides as predicted using TatP and TatFind 
c –  An “X” indicates one or more putative transmembrane domains predicted using using TMHMM  v. 2.0 (116)  
d – An “X” indicates a potential lipoprotein containing a putative lipobox-type signal peptide as predicted by the LipoP v. 1.0 
program (51) or using a lipoprotein pattern search against the M. tuberculosis H37Rv genome (121) 
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Table 3.4 Solute-binding lipoproteins of M. tuberculosis. The M. tuberculosis H37Rv 
genome contains 18 predicted periplasmic solute-binding proteins (SPBs), which are the 
lipoprotein components of ABC-type transporters. Mass spectrometry analysis resulted in 
the identification of 15 SBPs. A log2 (secA2/WT) ratio of 1 corresponds to a 2-fold 
change. Protein changes of at least 2-fold are highlighted red, and p values of 0.05 or less 
are highlighted yellow. Also shown is the average spectral count (Avg SpC) obtained for 
each protein and the presence of either a Sec or Tat signal peptides (SP). 
Name Locus 
log2 
(secA2/
WT) 
p 
Avg 
SpC 
SPa 
Putative 
Substrateb 
SubI Rv2400c -2.25 0.048 2.6 Sec sulfate 
DppA Rv3666c -1.79 0.045 5.7 Sec peptide 
Rv2041c Rv2041c -1.69 0.084 5.3 Tat sugar 
GlnH Rv0411c -1.64 0.05 6.5 Tat glutamine 
PhoS1 Rv0934 -1.36 0.081 137 Sec phosphate 
OppA Rv1280c -1.06 0.001 22.5 Tat peptide 
FecB2 Rv0265c -1.03 0.014 13.0 Tat iron (III) dicitrate 
Rv2585c Rv2585c -0.86 0.148 13.5 Sec peptide 
FecB Rv3044 -0.84 0.136 22.2 Sec iron (III) dicitrate 
PstS/PstS2 Rv0932c -0.74 0.224 26.8 Sec phosphate 
ProX Rv3759c -0.42 0.407 7.4 Sec glycine-betaine/L-proline 
LpqZ Rv1244 -0.32 0.69 5.2 Sec glycine/betaine 
LpqY Rv1235 -0.23 0.27 25.7 Sec sugar 
LpqW Rv1166 0.06 0.884 21.7 Sec peptide 
PstS3/PhoS2 Rv0928 0.44 0.008 9.7 Sec phosphate 
UspC Rv2318 - - - Sec sugar 
ModA Rv1857 - - - Sec molydenum 
UgpB Rv2833c - - - Tat glycerol-3-phosphate 
a – Signal peptide predictions for Sec using SignalP v. 4.0 (90) and Tat using TatP (3)and TatFind (102) 
b – Predicted substrate specificity (6) 
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Table 3.5 DosR-regulated proteins of M. tuberculosis. The M. tuberculosis H37Rv 
genome contains at least 49 genes within the Dos regulon. Our proteomic analysis 
resulted in the identification of 26 of the corresponding proteins. Proteins identified are 
shown here with the relative abundance obtained between wild type and secA2 mutant. 
A log2 (secA2/WT) ratio of 1 corresponds to a 2-fold change. Protein changes of at least 
2-fold are highlighted green, and p values of 0.05 or less are highlighted yellow. Some 
proteins were either identified in only wild type (WT-only, red) or the secA2 mutant 
strain (SecA2-only, dark green). 
Name Locus 
log2 
(secA2/WT) 
p 
Avg 
SpC 
Peptides Description 
 Rv0079 2.113 0.022 12.3 - hypothetical protein  
 Rv0080 1.4222 0.002 7.4 - hypothetical protein  
 Rv0082 WT-only - - 2 oxidoreductase  
nrdZ Rv0570 3.1218 
0.001 6.6 
- 
ribonucleoside-diphosphate reductase large 
subunit 
 Rv0572c SecA2-only - - 4 hypothetical protein 
 Rv1738 1.704 0.018 6.2 - hypothetical protein  
 Rv1812c 0.1784 0.425 9.2 - dehydrogenase  
 Rv1813c SecA2-only - - 3 hypothetical protein 
 Rv1996 1.1724 0 10.4 - hypothetical protein  
ctpF Rv1997 SecA2-only - - 5 metal cation transporter P-type ATPase A  
 Rv2003c SecA2-only - - 2 hypothetical protein  
 Rv2004c SecA2-only - - 2 hypothetical protein 
 Rv2005c 0.9686 0.015 21.7 - hypothetical protein  
 Rv2030c 2.6715 0.013 12.4 - hypothetical protein  
hspX Rv2031c 2.4246 0.036 36.2 - heat shock protein 
acg Rv2032 SecA2-only - - 2 hypothetical protein 
TB31.7 Rv2623 3.7 0 7.6 - hypothetical protein  
 Rv2625c 3.202 0.019 9.8 - hypothetical protein  
 Rv2626c 1.6694 0.04 1.9 - hypothetical protein  
 Rv2627c 4.0448 0.001 12.0 - hypothetical protein  
 Rv3127 SecA2-only - - 6 hypothetical protein 
tgs1 Rv3130c 1.2116 0.033 19.9 - triacylglycerol synthase  
devS Rv3132c 0.7346 0.274 27.8 - two component sensor histidine kinase 
dosR/d
evR Rv3133c 1.692 
0.001 4.6 
- 
two component transcriptional regulatory 
protein 
 Rv3134c 1.8568 0.032 7.5 - hypothetical protein  
bfrB Rv3841 0.5666 0.038 21.7 - bacterioferritin 
 Rv0081 - - - - probable transcriptional regulatory protein 
 Rv0083 - - - - probable oxidoreductase 
 Rv0569 - - - - hypothetical protein 
 Rv0571c - - - - hypothetical protein 
 Rv0574c - - - - hypothetical protein 
 Rv1733c - - - - probable conserved transmembrane protein 
 Rv1734c - - - - hypothetical protein 
narX Rv1736c - - - - probable nitrate reductase 
narK2 Rv1737c - - - - possible nitrate/nitrite transporter 
otsB1 Rv2006 - - - - probable trehalose-6-phosphate phosphatase 
fdxA Rv2007 - - - - ferredoxin 
 Rv2028c - - - - Universal stress protein family protein 
pfkB Rv2029c - - - - 6-phosphofructokinase 
 Rv2624c - - - - Universal stress protein family protein 
 Rv2628 - - - - hypothetical protein 
 Rv2629 - - - - hypothetical protein 
 Rv2630 - - - - hypothetical protein 
 Rv2631 - - - - hypothetical protein 
vapB22 Rv2830c - - - - possible antitoxin 
 Rv3126c - - - - hypothetical protein 
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 Rv3128c - - - - hypothetical protein 
 Rv3129 - - - - hypothetical protein 
 Rv3131 - - - - hypothetical protein 
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CHAPTER 4 
Export of a Mycobacterial SecA2 Substrate is Influenced by the  
Twin-arginine Translocation Pathway
1
 
 
The majority of bacterial protein export occurs via the conserved Sec export 
pathway, which is powered by the essential SecA ATPase. SecA recognizes preproteins 
with signal peptides and powers their translocation through the SecYEG membrane 
channel. Mycobacteria and some Gram positive bacteria have two non-redundant SecA 
homologs. While SecA1 is the essential ATPase required for housekeeping Sec export, 
SecA2 is required for export of a smaller set of proteins. Some SecA2 proteins utilize an 
accessory membrane channel called SecY2. SecA2-only systems, which include those in 
mycobacteria, lack SecY2 and are thought to function in concert with the SecA1/SecYEG 
machinery. Previous studies in M. smegmatis demonstrate that features of the mature 
domain of a preprotein determine if SecA2 is required for export. In addition, prior work 
shows the mature domain of the SecA2-dependent Ms1704 protein is compatible with 
export by the Tat pathway. Here, we show that export of Ms1704 containing its native 
signal peptide is not only SecA2-dependent, as we observed before, but it is also 
influenced by the Tat pathway. Because the Tat system only exports folded 
________________________ 
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proteins across the cytoplasmic membrane, these results support our hypothesis that the 
defining feature of the mature domains of SecA2-dependent preproteins of mycobacteria 
is a tendency to fold in the cytoplasm. Our data also suggest that some Ms1704 export 
occurs via SecA2/SecYEG, while additional Ms1704 export occurs in a Sec-independent 
manner using the Tat machinery. Thus, SecA2 may serve an important role in exporting 
some preproteins with cytoplasmic folding tendencies through SecYEG. 
 
Introduction  
Protein export is a fundamental aspect of bacterial physiology, allowing proteins 
to be transported past the cytoplasmic membrane so they can fulfill necessary roles in cell 
envelope maintenance, nutrient acquisition, or other vital functions (8, 11, 48). Bacterial 
pathogens, including Mycobacterium tuberculosis, also rely on extra-cytoplasmic 
proteins for modulating the host environment to promote bacterial survival and growth 
(71). Mycobacterial species possess two conserved pathways for powering protein 
export: the general secretion (Sec) and twin-arginine translocation (Tat) systems (39).  
General Sec export is universal and responsible for the majority of housekeeping 
protein export, making Sec systems essential in all bacteria including mycobacteria (9). 
Proteins destined for Sec export, which are known as preproteins, are synthesized with N-
terminal signal peptides, which contain a positively charged N-terminus, hydrophobic 
core, and C-terminal cleavage region (28). Upon recognition by the cytoplasmic SecA 
protein, preproteins are delivered to the membrane-embedded SecYEG protein complex 
(9). In addition to SecA-targeting, the Sec signal peptide also has an important role in 
interacting with SecY to stabilize an open SecY channel conformation (24, 31, 38, 64). 
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SecA is an ATPase that undergoes cycles of ATP hydrolysis to drive translocation of the 
unfolded preprotein through the SecYEG channel (15). Following or during export, 
periplasmic signal peptidases cleave the signal peptide and the exported protein then 
folds to assume a mature confirmation (50).  
Unlike Sec export systems, the Tat pathway is not universal, but widespread 
among bacteria (13, 46, 49). Tat export is essential in M. tuberculosis and tat mutants are 
not viable. The Mycobacterium smegmatis Tat pathway, however, is not essential and tat 
mutants exist in the non-pathogenic model species (43, 53, 61). In contrast to the Sec 
system that only exports unfolded preproteins, the Tat pathway is built to accommodate 
proteins that fold in the cytoplasm, and will even reject unfolded substrates (12, 20). Tat 
preproteins contain N-terminal signal peptides with tripartite structures similar to those of 
Sec preproteins, but Tat signal peptides are characterized by the presence of the 
conserved twin-arginine motif: S/T-R-R-X-F-L-K, or more generically as R-R-X-Φ-Φ, 
where ɸ represents a hydrophobic residue (3). The Tat signal peptide first targets a folded 
preprotein to the TatBC protein complex in the cytoplasmic membrane (37, 42, 56, 70). 
TatA monomers are then recruited to the TatBC-preprotein complex with energy supplied 
by the proton motive force (23, 45, 79, 81). The preprotein is translocated across the 
membrane through the membrane-spanning TatA pore and the signal peptide is removed 
by periplasmic signal peptidases (22, 40).   
In addition to the conserved Sec and Tat protein export pathways, M. tuberculosis 
also has specialized protein export pathways that have important roles during infection.  
The SecA2-dependent protein export system is one such specialized pathway (39). SecA2 
systems are found in all mycobacteria and some Gram positive species and are 
186 
 
characterized by the presence of a second non-redundant SecA homolog, which is called 
SecA2 to distinguish it from the canonical SecA described above (57). While the 
canonical SecA, which is called SecA1 in these systems, has an essential role in powering 
general Sec export, SecA2 is dispensable for in vitro growth but necessary for export of a 
subset of proteins (6, 27, 58). The SecA2 proteins are functionally conserved between 
pathogenic M. tuberculosis and the non-pathogenic M. smegmatis; consequently,  
M. smegmatis is often used as a model to study mycobacterial SecA2 export (58).  
There are two types of SecA2 systems: SecA2–SecY2 systems include an 
accessory SecY2 membrane channel, while SecA2-only systems lack an obvious 
alternative protein-conducting channel (18). It is well established that SecA2–SecY2 
systems are dedicated to exporting proteins that are first glycosylated in the cytoplasm, a 
post-translational modification that interferes with export by the canonical 
SecA1/SecYEG machinery (2, 10). SecA2-only systems, like those in mycobacteria, are 
thought to utilize one or more components of the canonical pathway to promote protein 
export (including SecA1 and SecYEG), but this relationship is not well understood (17, 
58). In contrast to SecA2–SecY2 systems, the characteristics that direct preproteins to 
SecA2 in SecA2-only systems is only beginning to be explored, but it is clear that the 
same targeting rules of SecA2–SecY2 preproteins do not apply to substrates of SecA2-
only systems. 
In M. smegmatis there are two known SecA2 substrates: Ms1704 and Ms1712 
(21). Both are lipoproteins and predicted to function as the solute-binding components of 
two ABC transporters (48). It has been demonstrated that although Ms1704 and Ms1712 
contain Sec signal peptides required for export to the cell wall, these signal peptides are 
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not specific for targeting to SecA2 (19). Instead, there are one or more features of the 
mature domains of these mycobacterial SecA2 preproteins that necessitate the 
requirement for SecA2 for export. The feature(s) of the mature domain of mycobacterial 
substrates that defines SecA2-dependency is unlikely to include glycosylation as seen 
with substrates of the SecA2–SecY2 systems (19). Interestingly, the Ms1704 mature 
domain can be efficiently exported by the Tat system (19). Because the Tat pathway only 
exports folded proteins, it has been used in the past as a reporter for cytoplasmic folding 
(12, 20, 56). The Tat compatibility of the mature domain of Ms1704 suggests that SecA2 
substrates can fold in the cytoplasm and this folding propensity may be the feature that 
distinguishes SecA2 substrates from SecA2-independent Sec preproteins. 
In our proteomic study described in Chapter 3 we discovered that a number of 
predicted M. tuberculosis Tat substrates (presumably preproteins that fold in the 
cytoplasm) depend on SecA2 for maximum export. These results raised the possibility of 
there being a subset of preproteins that are compatible with either the SecA2 or Tat 
pathways for transport across the cytoplasmic membrane. Many of the predicted Tat 
substrates that were influenced by SecA2 in M. tuberculosis are members of the solute-
binding protein (SBP) family (4, 69). This was a striking discovery because the two 
known M. smegmatis SecA2 substrates, Ms1704 and Ms1712, are also SBP proteins (21, 
48). Moreover, a genomic survey of predicted Tat substrates identifies numerous SBPs, 
across a diverse set of organisms, suggesting that it is common for SBPs to fold in the 
cytoplasm to be Tat exported (63).  
Here, we test the influence of the Tat machinery on export of a SecA2 substrate in 
M. smegmatis. Surprisingly, inactivation of the tatC component of the Tat pathway 
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negatively impacted export of the SecA2-dependent Ms1704 substrate. Our results 
suggest there may be a common subset of preproteins that are compatible for export by 
either the SecA2 or Tat systems. Our data also reaffirms our developing model where 
SecA2 fulfills a role in facilitating export of certain folded preproteins via the 
SecA1/SecYEG pathway. 
 
Materials and Methods 
Bacterial strains and growth conditions: Escherichia coli DH5α was used for all DNA 
cloning and grown at 37º C in Luria-Bertani medium (Fisher) supplemented with 40 
µg/ml kanamycin or 150 µg/mL hygromycin when appropriate. M. smegmatis mc
2
155 
(wild type) (65), NR116 (∆secA2) (58), JM567 (∆tatC) (43), or LL154 (∆tatC ΔsecA2) 
were grown at 30º C in Mueller-Hinton medium (BD Diagnostic Systems) with 0.1% 
(v/v) Tween 80 and supplemented with 20 µg/mL kanamycin and 50 µg/mL hygromycin 
when appropriate.  
Construction of M. smegmatis ∆tatC ∆secA2 mutant: Strain LL154, the M. smegmatis 
∆tatC ∆secA2 mutant, was constructed by two-step allelic exchange, as described 
previously (58), using the ∆tatC mutant JM567 strain and the ∆secA2 suicide plasmid 
pNR6. Successful deletion of secA2 was confirmed by Southern blot analysis (data not 
shown).  
Plasmid construction and M. smegmatis electroporation: All plasmids and 
oligonucleotides used in this study are listed in Tables 4.1 and 4.2, respectively. All 
cloned plasmid inserts were confirmed error-free by DNA sequencing (Eton Biosciences, 
NC). Plasmids were electroporated into M. smegmatis as previously described (5).  
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Creation of TatC expression plasmid. To create a plasmid expressing M. tuberculosis 
TatC under control of the hsp60 promoter, tatC (Rv2093c) was amplified from M. 
tuberculosis H37Rv genomic DNA with primers ForwMtbTacCwXm and 
RevMtbTatCwPst and cloned into pCR2.1 to yield pEY3.The TatC piece was then 
excised by digestion with PstI and XmnI and ligated into similarly cut pMV261 to yield 
plasmid pEY04. The Phsp60-tatCMtb piece was then moved from EY04 into the integrating 
plasmid pMV361 to yield pMF253. 
Subcellular fractionation: Subcellular fractions of M. smegmatis cells were generated as 
previously described (21, 59). Briefly, whole cell lysates of M. smegmatis were generated 
by passing cells 4 times through a French pressure cell at 20,000 psi. Unlysed cells were 
removed by centrifugation at 3,000 x g to generate clarified whole cell lysates (WCL). 
Protein concentrations of WCLs were determined by BCA assay using a BSA standard 
(Pierce) and equalized between all strains. One milliliter of each equalized lysate was 
centrifuged at 27,000 x g for 30 minutes to pellet cell wall material (CW), then 100,000 x 
g for 2 hours to separate membrane (M) and soluble (SOL) fractions. The soluble fraction 
contains the cytosolic components.  
Immunoblotting: Whole cell lysate (WCL) and subcellular fraction proteins (CW, 
MEM, and SOL) derived from the same amount of starting cells between strains for each 
experiment were analyzed by immunoblotting. Protein samples were combined with 1X 
SDS-PAGE buffer, boiled, and separated on a 12% SDS acrylamide gel. Proteins were 
transferred to a nitrocellulose membrane and detected using either anti-HA (Covance) 
used at 1:10,000, anti-PhoA (Research Diagnostics International) used at 1:20,000, anti-
19kD (provided by Douglas Young, MRC National Institute for Medical Research) used 
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at 1:20,000, or anti-MspA (provided by Michael Niederweis, University of Alabama at 
Birmingham) used at 1:20,000. Proteins were detected using either anti-rabbit or anti-
mouse secondary antibodies conjugated to alkaline phosphatase as appropriate (GE 
Healthcare). Signal was detected using ECF reagent (GE Healthcare). 
 
Results 
Export of the SecA2-dependent Ms1704 is influenced by the Tat pathway 
The fact that multiple predicted Tat substrates of M. tuberculosis are affected by 
deletion of secA2 suggested that there might be a common set of preproteins compatible 
with both SecA2 and Tat export pathways (Chapter 3). In support of this idea, the mature 
domain of the Ms1704 SecA2 substrate is compatible with Tat export if engineered to 
possess a Tat signal peptide (Chapter 2) (19). Therefore, we wanted to determine if a 
functional Tat pathway influenced export of a SecA2-dependent protein containing its 
native signal peptide. For this purpose, we used a previously characterized M. smegmatis 
tatC deletion mutant, which is deficient for Tat-dependent export (43). We first 
expressed a C-terminal HA-tagged version of the SecA2 substrate Ms1704 in wild type 
M. smegmatis, the secA2 deletion mutant, or the tatC deletion mutant. Cultures were 
grown to an approximate OD600 of 0.5-1.0 at 30° C and then cells harvested by 
centrifugation. Because the tatC mutant grows slower, starting tatC mutant cultures 
were inoculated with approximately twice the number of cells as the wild type and 
secA2 mutant strains, and harvested at the same time as the other two strains. Export of 
Ms1704-HA to the cell wall was analyzed as follows. For each strain equalized whole 
cells lysates (WCLs) were generated and subjected to differential ultracentrifugation to 
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isolate cell wall (CW), cytoplasmic membrane (M) and the cytosol-containing soluble 
fractions. Whole cell lysates and all corresponding subcellular factions were separated by 
SDS-PAGE, then proteins were transferred to a membrane for immunoblotting using an 
anti-HA antibody. 
As previously published, Ms1704-HA was readily exported to the cell wall in 
wild type M. smegmatis, but this export was compromised upon deletion of secA2 (Figure 
4.1A) (19, 21, 58). Surprisingly, when we expressed Ms1704-HA in the tatC mutant, 
export to the cell wall was completely abolished. However, the total amount of Ms1704 
was also reduced in the whole cell lysate. The reduced level of Ms1704 in the whole cell 
lysate was reminiscent of the protein instability that is observed with certain Tat 
substrates in the absence of export (12, 62, 75). Therefore, the reduction of Ms1704-HA 
in the tatC cell wall is likely a reflection of an export defect. Export of the control cell 
wall porin, MspA, was unaffected by deletion of either secA2 or tatC as expected, and 
indicated that comparable levels of total protein were present in the cell wall samples of 
all three strains. 
 
Export of the SecA2-independent Ms6020 is influenced by the Tat pathway 
Previously, we showed that export of another solute-binding protein, Ms6020, 
occurred independently of SecA2, despite relatively high amino acid similarity to M. 
smegmatis SecA2 substrates (48% similar to the Ms1704 mature domain and 41% similar 
to the Ms1712 mature domain) (19). In light of our observation that Ms1704 was 
influenced by the Tat pathway we set out to test if the SecA2-independent Ms6020 was 
similarly affected by deletion of tatC. As previously demonstrated, export of Ms6020-HA 
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to the cell wall occurred in wild type M. smegmatis but was unaffected by deletion of 
secA2 (Figure 4.1B) (19). Similar to Ms1704-HA, the level of Ms6020-HA was also 
severely compromised in the tatC mutant cell wall, consistent with there being an 
export defect in this strain. Also like Ms1704-HA, total Ms6020-HA levels were reduced 
in the tatC whole cell lysate. Again, endogenous MspA levels were equivalent in all 
three strains expressing Ms6020-HA, indicating that total cell wall protein levels 
remained similar. 
 
The Tat pathway effect is specific to export of Ms1704 and Ms6020 
For our cell wall localization experiments, both Ms1704-HA and Ms6020-HA 
were expressed under control of a constitutive promoter on a multi-copy plasmid. We 
were concerned that the subcellular fractionation phenotypes observed for Ms1704 and 
Ms6020 in the tatC mutant might be artifacts from over-expressing these proteins in this 
mutant strain background. Therefore, we also tested the impact of tatC deletion on two 
other exported SecA2-independent substrates expressed from the same promoter and 
multi-copy plasmid. The 19kDa lipoprotein is an M. tuberculosis protein previously 
shown to be exported to the cell wall independent of SecA2 when expressed in M. 
smegmatis (21). As shown in Figure 4.1C, export of the 19kDa lipoprotein to the cell wall 
occurred equally well in wild type and the secA2 mutant as expected. Furthermore, 
19kD was expressed well in the tatC mutant and 19kD export to the cell wall was 
unchanged in this strain compared to wild type and the secA2 mutant. We also tested the 
effect of tatC deletion on export of the PhoAMsmeg alkaline phosphatase, which is another 
mycobacterial lipoprotein exported independently of SecA2 (21). PhoAMsmeg export to the 
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cell wall was unaffected by deletion of secA2 as expected. Additionally PhoAMsmeg export 
readily occurred in the M. smegmatis tatC mutant.  
Taken together, these results demonstrate that export of two M. smegmatis solute-
binding proteins (SBPs), one that requires SecA2 for export (Ms1704) and one that is 
SecA2-independent (Ms6020), is compromised in a tatC mutant. Total protein levels of 
both these SBPs were also reduced in the tatC whole cell lysate, which is likely 
reflective of protein instability in the absence of export. Furthermore, these tatC-
dependent phenotypes are not an artifact of over-expression. 
 
Export of Ms1704 is completely abolished by simultaneous deletion of secA2 and tatC 
 The Ms1704-HA export defect associated with deletion of secA2 is not always 
complete. It is common to see some residual Ms1704-HA exported to the M. smegmatis 
cell wall in the secA2 mutant (Figure 4.2A and unpublished observations). Given the 
results above, we considered the possibility that the Tat export system accounts for the 
residual Ms1704-HA export seen in the secA2 mutant. Conversely, tatC deletion does 
not always result in 100% abrogation of Ms1704-HA localization to the cell wall (Figure 
4.2A, long exposure). If export of Ms1704 is shared between the SecA2 and Tat export 
pathways, then absolutely no Ms1704-HA export should occur in a secA2 tatC double 
mutant. 
 To test this, we generated a M. smegmatis secA2 tatC double mutant by 
deleting secA2 in the tatC mutant background using allelic exchange as previously 
described (58). This secA2 tatC double mutant retained previously published 
phenotypes of the tatC mutant strain used, including both a slow in vitro growth 
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phenotype and sensitivity to beta-lactam antibiotics (data not shown) (43). Additionally, 
deletion of secA2 resulted in acquisition of the previously published increased azide 
sensitivity of the M. smegmatis secA2 deletion mutant (58).  
 We next expressed Ms1704-HA and compared its export in the following four M. 
smegmatis strains: wild type, the secA2 mutant, the tatC mutant, and the newly 
constructed secA2 tatC double mutant (Figure 4.2A). As expected Ms1704-HA was 
exported to the cell wall in wild type M. smegmatis, and this export was reduced in the 
secA2 mutant. Again, we also observed an Ms1704-HA cell wall localization defect and 
reduced levels of Ms1704-HA in the whole cell lysate of the tatC mutant. The 
phenotype of the secA2 tatC double mutant was particularly interesting for two 
reasons.  First, deletion of secA2 rescued the reduced level of Ms1704-HA protein in the 
whole cell lysate associated with absence of tatC. Second, the secA2 tatC double 
mutant did, in fact, exhibit a complete export defect of Ms1704-HA to the cell wall. 
 These results suggest that Ms1704-HA export is influenced by both SecA2 and 
TatC in M. smegmatis, and a strain lacking both export machinery components cannot 
export any Ms1704-HA to the cell wall. A striking observation is that the presumed 
instability of Ms1704-HA in the tatC mutant is rescued by deletion of secA2.  
 
Expression of SecA2 partially complements the Ms1704 export defect of secA2 tatC 
double mutant 
 The Ms1704-HA export defect in the M. smegmatis secA2 mutant is a phenotype 
that has previously been complemented by introduction of a secA2 expressing plasmid 
(21, 58). However, we wanted to determine if the Ms1704-HA export defect in the newly 
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created secA2 tatC double mutant strain could also be complemented by exogenous 
expression of SecA2. In addition, we wanted to test the possibility that over-expression of 
SecA2 might suppress the Ms1704-HA export defect of the tatC mutant. 
 To test this, we transformed an integrating plasmid expressing the secA2 gene 
from M. tuberculosis, pWRJA2, into either the secA2 mutant, tatC mutant, or the 
secA2 tatC double mutant. We then expressed Ms1704-HA in all of these strains and 
performed an immunoblot on subcellular fractions to look for Ms1704-HA export to the 
cell wall. As expected, exogenous expression of SecA2Mtb restored Ms1704-HA export to 
the cell wall of the secA2 mutant (Figure 4.2B). In the tatC deletion mutant, the 
endogenous secA2 gene is still present, but very little Ms1704-HA export is seen. When 
SecA2 was over-expressed in this strain (by providing the secA2Mtb gene on pWRJA2), 
the Ms1704-HA export defect remains the same; we were unable to detect any restoration 
of Ms1704-HA export. Finally, expression of SecA2Mtb in the secA2 tatC double 
mutant resulted in partial, but not complete, restoration of Ms1704-HA export (Figure 
4.2B). This observation holds true over two independent biological replicates (data not 
shown).  
 Taken together, these results show that increased levels of SecA2 protein 
achieved with pWRJA2, cannot suppress the export defect of Ms1704-HA observed in 
the tatC mutant.  In addition, introduction of a secA2Mtb expression plasmid alone into 
the secA2 tatC double mutant can partially, but not fully, complement the Ms1704-HA 
export defect of the double mutant. These results are in line with the observation that 
some portion of Ms1704-HA export is reliant on the Tat pathway. 
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Expression of TatC complements the Ms1704 export defect of the secA2, tatC, and 
the secA2 tatC mutants. 
 Next, we wanted to complement the export phenotypes of Ms1704-HA observed 
in the M. smegmatis tatC mutant to determine if they are due to inactivation of the tatC 
gene. To test this, we constructed a TatC complementing plasmid. The tatC gene from M. 
tuberculosis H37Rv (rv2093c) was cloned under the hsp60 promoter and expressed from 
an integrating plasmid. This plasmid, pMF253, was shown to produce functional TatC 
protein by first confirming its ability to complement the tatC mutant phenotypes of slow 
growth and beta-lactam sensitivity (data not shown) (43).  
 We then transformed pMF253 into either the secA2 mutant, tatC mutant, or 
secA2 tatC double mutant. We then expressed Ms1704-HA in all of these strains and 
performed an immunoblot on subcellular fractions to look for Ms1704-HA export to the 
cell wall. As expected, exogenous expression of the tatCMtb gene restored Ms1704-HA 
export in the tatC single deletion strain (Figure 4.2C), indicating that the observed 
Ms1704-HA export defect of this strain was due to deletion of tatC. Furthermore, the 
plasmid expressing tatCMtb also restored to wild type levels the amount of Ms1704-HA 
protein in the whole cell lysate. Thus, both the protein stability and export defect of 
Ms1704-HA in the tatC mutant are attributable to the deletion of tatC. 
The secA2 deletion mutant still has the endogenous tatC gene present in the M. 
smegmatis genome. In the experiment shown in Figure 4.2A, an Ms1704-HA export 
defect was observed in the secA2 mutant although residual export of Ms1704-HA to the 
cell wall was seen. This result is not surprising to us and it is consistent with there being 
functional TatC that can also promote export of Ms1704 in the secA2 mutant. A striking 
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observation was that over-expression of tatC achieved by providing the M. tuberculosis 
tatC gene on pMF253 restored export of Ms1704-HA in the secA2 mutant (Figure 
4.2C). This restoration of Ms1704-HA export in the secA2 mutant strain by over-
expression of tatC was comparable to the secA2 complemented with SecA2Mtb (Figure 
4.2C). Finally, expression of tatC from pMF253 restored Ms1704-HA export in the 
secA2 tatC double mutant to a level comparable to that seen in the wild type strain. 
Taken together, our results show that Ms1704-HA export is affected by both 
deletion of secA2 and tatC. Furthermore, the Ms1704-HA export defect of the tatC 
mutant can be complemented by exogenous expression of tatC and over-expression of 
tatC can restore Ms1704-HA export in the secA2 mutant. 
 
Discussion 
In contrast to the better characterized SecA2–SecY2 systems, the mechanisms of 
SecA2-only export are just beginning to be explored. The current model of export by 
SecA2-only systems, including those of mycobacteria, is that SecA2 functions with 
machinery from the canonical Sec pathway including SecA1 and SecYEG (17, 58). A 
defining feature of mycobacterial SecA2 substrates is their mature domain (19). In 
Chapter 2, we showed that the mature domain of a SecA2 substrate is compatible for 
export by the Tat pathway (19). This was demonstrated by fusing a Tat signal peptide to 
the mature domain of the Ms1704 SecA2 substrate (19). Export of this signal peptide 
chimera occurred in a Tat-dependent manner. We therefore hypothesized that a tendency 
to fold in the cytoplasm is the defining feature of the mature domains of SecA2-
dependent preproteins in mycobacteria.   
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In the past, we attributed any residual export of Ms1704 observed in the secA2 
mutant to be a result of export via the canonical SecA1/SecYEG pathway. Here, we 
provide evidence that the residual export of Ms1704 is instead occurring via the Tat 
machinery, not the Sec pathway. First, we demonstrated that export of Ms1704 
containing its native signal peptide was reduced in a tatC mutant. The tatC export 
defect was similar to that of the secA2 mutant, meaning that export was reduced 
compared to a wild type strain, but a small amount of residual Ms1704-HA export could 
sometimes be detected in the cell wall (Figure 4.2A, long exposure). However, in a 
secA2 tatC double mutant Ms1704-HA export was completely abolished. 
Furthermore, we showed that expression of tatC from a plasmid was able to restore 
Ms1704-HA export to wild type levels in the secA2 mutant. Taken together, these 
results suggest that a portion of Ms1704 can be exported in a SecA2-dependent manner, 
while additional Ms1704 export can occur via the Tat pathway. These results are 
significant in suggesting that in mycobacteria, there is a relationship between the SecA2 
and Tat export systems at the level of a shared subset of preproteins, which includes 
Ms1704. Because the Tat pathway only accommodates folded proteins, this reinforces a 
predicted role of SecA2 in exporting preproteins that are prone to cytoplasmic folding.  
 
Ms1704 can be exported by either the SecA2 or Tat export pathways 
Our results suggest there may be a common subset of preproteins, including 
Ms1704, that are compatible with export by either the SecA2 or Tat systems. This 
reaffirms a developing model where SecA2 fulfills a role in adapting some preproteins 
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containing mature domains with folding characteristics of Tat substrates for export by the 
canonical Sec system (Figure 4.4).  
Protein export by the conserved Sec and Tat pathways are generally thought of as 
independent processes, as Sec export is limited to unfolded proteins and the Tat system 
only accommodates folded proteins (47). This leads to a simplistic idea that within the 
cytoplasm there are either unfolded preproteins that are strictly routed to the Sec 
machinery for export, or folded preproteins that are strictly routed to Tat for export. 
However, there are examples of preproteins in multiple bacterial species that appear 
compatible for export by either the Sec or Tat systems. For example, in Streptomyces 
lividans export of multiple proteins with presumed Sec signal peptides, including some 
solute-binding proteins like Ms1704, are reduced in a tat mutant (26). In Bacillus subtilis, 
there are numerous exported proteins containing predicted Tat signal peptides that are 
secreted in a tat mutant, presumably by the Sec system (34). Shared export by the Sec 
and Tat systems has also been noted in plant chloroplasts, which contain eukaryotic 
homologs of the Sec and Tat machinery (29). Therefore, the idea that Ms1704 can be 
exported by both the Sec and Tat pathways in mycobacteria is plausible.  
Several lines of evidence suggest that the export of Ms1704 by the SecA2 and Tat 
systems are independent processes. In other words, SecA2 likely does not function in 
conjunction with the Tat machinery to promote export in mycobacteria. First, it has been 
demonstrated that depletion of SecA1 affects export of Ms1704, which is consistent with 
SecA2 functioning in conjunction with the SecA1/SecYEG machinery (58). Second, the 
Ms1704 export defects seen in the secA2 and tatC single mutants are not 100%, while 
Ms1704 export in the secA2 tatC double mutant is completely abolished. The additive 
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negative effects of deleting secA2 and tatC on Ms1704 export suggests that SecA2 and 
TatC function independently. Third, Ms6020 export was reduced in the tatC mutant, but 
unaffected by deletion of secA2. Additionally, results from our M. tuberculosis proteomic 
study in Chapter 3 showed that export of several predicted Tat substrates was reduced in 
the secA2 mutant, but these export defects were incomplete. Similar to the incomplete 
Ms1704-HA export defect in the M. smegmatis secA2 mutant, the partial export defects 
of the M. tuberculosis secA2 mutant suggests that SecA2 functions independent from 
TatC. Thus, while both SecA2 and Tat contribute to Ms1704 export, current data supports 
a model where these are independent export processes.  
 
Targeting of SecA2 substrates to the Tat machinery 
An important piece of data from this study is that it appears signal peptides 
compatible with both SecA2 and Tat pathways exist in mycobacteria. In E. coli, there are 
examples of strict Tat signal peptides that function exclusively with the Tat machinery, 
and also examples of “promiscuous” signal peptides that appear to function with both Sec 
and Tat (74). For promiscuous signal peptides, the deciding factor for whether a protein is 
exported by the Sec or Tat systems is the nature of the mature domain. Therefore, in 
addition to the signal peptide, the mature domain is important for determining whether a 
preprotein can be exported unfolded via Sec or folded via Tat (12). In this Chapter, we 
show that Ms1704 containing its native signal peptide is exported by both SecA2 and Tat 
pathways. This suggests that Ms1704 also has a promiscuous signal peptide that allows 
targeting to both Sec and Tat machinery. Importantly, our results suggest that in addition 
to a promiscuous signal peptide, the Ms1704 mature domain is also promiscuous in 
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nature, as it is able to adopt an unfolded conformation for SecA2-dependent export via 
SecYEG or maintain a folded conformation for Tat export.   
The twin-arginine residues in Tat signal peptides are nearly invariant, and 
substitution of one or both arginine residues usually prevents Tat-dependent export (66). 
However, there are some examples of Tat signal peptides (both naturally occurring and 
engineered) that only have one arginine residue yet are compatible for Tat-dependent 
export (30, 32, 41, 44, 66). These unusual Tat signal peptides usually contain a lysine 
residue in place of one of the arginine residues. Therefore instead of an arginine pair in 
the signal peptide there is a “KR” or “RK” pair present. Both Ms1704 and Ms6020 are 
predicted to contain Sec signal peptides, and no current Tat peptide prediction program 
picks up either as a potential Tat signal peptide (1, 52, 60). However, Ms1704 contains an 
“RK” in the N-terminus of its native signal peptide while Ms6020 has a “KR” (Figure 
4.3A). In addition, both Ms1704 and Ms6020 have hydrophobic amino acid residues 
following the “KR” or “RK” pair, which is another signature of the consensus Tat motif, 
R-R-X-Φ-Φ, where ɸ represents a hydrophobic residue (3, 51). Thus, it is certainly 
possible that Ms1704 and Ms6020 have signal peptides that are compatible with the Tat 
system that are overlooked by the current prediction programs. 
One approach that has successfully been used in mycobacteria to test if signal 
peptides are compatible with export by the Tat pathway is to use a beta-lactamase 
reporter (43, 44). The M. tuberculosis BlaC beta-lactamase requires export by the Tat 
system in order to confer resistance to beta-lactam antibiotics. When the signal peptide 
from a Tat substrate is fused to ‘BlaC (lacking its native Tat signal peptide), the resulting 
BlaC fusion protein can be exported and confer beta-lactam resistance, reporting on Tat 
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export. Importantly, the ‘BlaC reporter only works when exported by the Tat pathway 
and not by the Sec pathway. Efforts are currently underway to use the BlaC reporter 
system to test the signal peptides of Ms1704 and Ms6020 for Tat compatibility. 
As an alternative strategy, we attempted to change the distribution of Ms1704 and 
Ms6020 preproteins away from the Tat machinery and towards the Sec machinery by 
switching their signal peptides with a stronger Sec signal peptide, one that is SecA2-
independent. We created two signal peptide fusion chimeras where the endogenous signal 
peptides of Ms1704 and Ms6020 were exchanged with the predicted Sec signal peptide 
from M. smegmatis PhoA. Unlike the signal peptides of Ms1704 and Ms6020, there is no 
“KR” or “RK” pair in the PhoA signal peptide (Figure 4.3A). Previously, we showed 
such a fusion of the signal peptide of the M. smegmatis PhoA to Ms1704-HA (ssPhoA-
Ms1704-HA) is exported in M. smegmatis in a SecA2-dependent manner  (Chapter 2) 
(19). We predicted that export of ssPhoA-Ms1704 and ssPhoA-Ms6020 would occur 
independently of the Tat pathway because the PhoA signal peptide would only target the 
preproteins to the SecA2/SecYEG machinery. However, we were surprised to find that 
that these chimeric constructs resulted in slow growth of all M. smegmatis strains tested: 
wild type, the secA2 mutant, and the tatC mutant (data not shown). We suspect that 
the toxicity issues associated with these signal peptide chimeras are due to blockage of 
canonical Sec export, which is an essential process (78). If a substrate is folded tightly 
upon engagement with the SecY channel, this is toxic to the cell, as it blocks essential 
housekeeping export functions (78). The ability of Ms1704 and Ms6020 to be exported 
by the Tat system suggests that they fold in the cytoplasm. Therefore, routing these Tat-
compatible substrates to the Sec machinery could be detrimental to cell viability. While 
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these toxicity observations are in line with our current model, the Tat-dependency of the 
ssPhoA-Ms1704 and ssPhoA-Ms6020 chimeras is still currently being tested.  
Another discrepancy that needs to be resolved is why Ms1704 and Ms6020 both 
have possible Tat-compatible signal peptides, are both Tat-dependent for export, yet only 
Ms1704 is influenced by SecA2. There are two possibilities to consider that would 
explain these results. First, the Ms6020 signal peptide might be better at directing a 
protein to the Tat pathway in comparison to Ms1704, which explains why despite the 
homology between the Ms1704 and Ms6020 mature domains, Ms6020 export is SecA2-
independent. There is a naturally occurring Tat signal peptide in the B. subtilis TtrB 
protein that contains a “KR” motif, similar to Ms6020, and is compatible for Tat export 
(30). However, changing the “KR” pair of TtrB to “RK” (more similar to that of Ms1704) 
results in Tat-dependent export that is significantly slowed, but not completely blocked 
(30). Alternatively, it is possible that the mature domain of Ms6020 folds too rapidly for 
export by the Sec pathway, even with the aid of SecA2, while the mature domain of 
Ms1704 tends to remain partially folded and is more amendable to export assistance by 
SecA2. 
 
A Model for shared export between SecA2 and Tat systems 
The two SecA2 substrates of M. smegmatis, Ms1704 and Ms1712 are examples of 
putative sugar-binding proteins, which are part of the larger solute-binding protein (SBP) 
family (21, 72). Based on Tat signal peptide prediction, SBPs represent a common class 
of Tat substrates across a diverse set of organisms. There is also experimental evidence 
that SBP export is reduced by deletion of tat components in E. coli, Agrobacterium 
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tumefaciens, and Bacillus subtilis (14, 34, 54, 63). Thus, it appears that SBPs are a family 
of proteins whose mature domains tend to fold in the cytoplasm making them compatible 
for Tat export. Our results add some Tat exported mycobacterial SBPs to the list and, 
interestingly, show that a Tat compatible mycobacterial SBP (Ms1704) can also be 
exported in a SecA2-dependent fashion. In addition to Ms1704 and Ms1712, our 
proteomic study identified 13 putative SBPs underrepresented in the secA2 M. 
tuberculosis cell wall (Chapter 3). Therefore, we find that export of many mycobacterial 
SBPs also tend to be influenced by SecA2. Many of these M. tuberculosis SBPs contain 
predicted Tat signal peptides with twin-arginine residues (Figure 4.3B). These 
observations suggest proteins that fold in the cytoplasm, like SBPs, are likely to demand 
SecA2 for Sec-dependent export and also have the option of export by the Tat pathway. 
Our developing model could also extend to the SecA2-only system of  Listeria 
monocytogenes, where three SBPs also exhibit SecA2-dependent export defects and 
contain signal peptides with “KK” or “KR” motifs (55). 
In our proposed model, there exists a population of preproteins (including 
Ms1704) that are compatible for export via SecYEG, with assistance of SecA2, or Sec-
independent export via the Tat machinery. The purpose of routing preproteins to both 
export pathways is unknown at this time, but we can speculate on the advantage afforded 
to the bacterial cell through shared export between the Sec and Tat systems. There might 
be a benefit to exporting proteins such as Ms1704 in an unfolded conformation through 
SecYEG with the help of SecA2. Ms1704 is a predicted sugar-binding lipoprotein, and it 
might benefit the bacterial cell to not allow folding of Ms1704 in the cytoplasm where it 
might bind a sugar molecule that the bacterial cell could use as an energy source. 
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Somewhat analogous to this possibility, it has been suggested that it is advantageous for 
some Tat substrates to fold in the cytoplasm prior to export in order to prevent 
competitive binding with cofactors in the periplasm (51, 73). Therefore, the location 
where folding occurs can impact binding to cofactors or substrates. 
An equally plausible explanation is that there is a selective pressure to maintain 
preproteins that utilize both Sec and Tat pathways for export in order to maximize and 
allow fine-tuning of protein export. This would prevent overwhelming of either export 
system during times of stress. There is evidence that the balance of Sec versus Tat-
dependent export of shared substrates can be altered due to environmental changes. In 
Bacillus subtilis, increases in the salinity of the extra-cellular environment can drive 
export of some Tat preproteins to the Sec pathway (76, 77). The Sec-Tat balance of 
export can also be perturbed upon over-expression of proteins (35). In M. smegmatis, 
there might be environmental changes, perhaps changes in salinity or temperature, that 
perturb the kinetics of protein folding in the cytoplasm and demand adjustment of Sec 
and Tat usage for protein export. This might help explain why the severity of the SecA2-
dependent phenotype of substrates, like Ms1704, varies across experiments. It would be 
interesting to determine if changes in the demand on the SecA2 system versus the Tat 
pathway extends to M. tuberculosis when inside the stressful environment of the 
macrophage, as SecA2 export is required for bacterial survival and growth during 
infection (7, 36). There is a cytoplasmic chaperone of E. coli that is activated under 
conditions of redox stress to specifically deal with increased protein mis-folding (25, 33). 
While unknown at this time, it is interesting to speculate that redox, pH, temperature, or 
other environmental changes associated with the phagosomal environment encountered 
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by M. tuberculosis could influence cytoplasmic folding and the demand on SecA2 for 
export.  
As for the exact role of SecA2 in export, it is possible that SecA2 functions in 
providing the additional energy required for translocation through SecYEG of proteins 
with a propensity to fold. Alternatively, SecA2 could have a role in maintaining 
preproteins in an unfolded translocation competent state, prior to export by SecA1 and 
SecYEG. An interesting observation of these studies is that overall Ms1704 protein levels 
were reduced in the tatC mutant, suggesting that Ms1704 was undergoing degradation 
in this strain in the absence of Tat export. The reduced levels of Ms1704 in the tatC 
mutant were reversed upon simultaneously deletion of secA2. It has been demonstrated 
that SecA of E. coli exhibits a proofreading function, and can assist in the folding of 
cytoplasmic proteins that are not meant to be exported (16). Somewhat analogous to that 
type of proofreading function of E. coli SecA, the mycobacterial SecA2 protein might 
lead to degradation of Ms1704-HA when all the protein is exclusively routed to the Sec 
pathway. The accumulation of folded Ms1704-HA would be especially taxing to the Sec 
translocase in the tatC mutant, which is where we see the most Ms1704 degradation 
occurring. However, the molecular basis for the SecA2-dependent degradation we 
observed is unknown at this point. 
 
Conclusion 
While the exact function of the mycobacterial SecA2 protein is unknown, our data 
supports a model where SecA2 is required for allowing preproteins that fold in the 
cytoplasm to be competently exported by the Sec translocase. Our results also suggest 
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that there may be a pool of mycobacterial Tat substrates with unconventional Tat signal 
peptides that are currently not appreciated. Furthermore, these proteins with 
unappreciated Tat signal peptides could also represent novel SecA2 substrates. Thus, the 
acquisition of SecA2 appears to be an important adaptation of mycobacteria, possibly to 
prevent blockage of the essential SecYEG channel by preprotein folding. In addition to 
the Tat systems, the SecA2 system represents a parallel pathway for getting proteins that 
fold in the cytoplasm past the membrane. 
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Table 4.1 Plasmids used in this study 
 
Plasmid Genotype Description Source 
pCR2.1 bla aph ColE1 TA cloning vector Invitrogen 
pMV261 aph oriM Phsp60 ColE1 
Episomal mycobacterial shuttle 
vector  
(67) 
pMV361 hyg int attP ColE1 
Integrating mycobacterial shuttle 
vector 
(67) 
pML440 
PAL5000 origin, ColE1 origin, hyg, 
pimyc-phoA 
M. smegmatis PhoA expression 
plasmid, episomal 
(80) 
pHSG58 aph Phsp60-Ms1704-HA oriM ColE1 
Ms1704-HA expression vector, 
episomal 
(21) 
pMF170 aph Phsp60-Ms6020-HA oriM ColE1 
Ms6020-HA expression vector, 
episomal 
(19) 
pHSG67 aph Phsp60-19kD oriM ColE1 
M. tuberculosis 19Kd expression 
vector, episomal 
(21) 
pEY03 bla aph ColE1 M. tuberculosis TatC in pCR2.1 This work 
pEY04 aph Phsp60-tatC oriM ColE1 
M. tuberculosis TatC expression 
vector, episomal 
This work 
pMF253 aph Phsp60-tatC int attP ColE1 
M. tuberculosis TatC expression 
vector, integrating 
This work 
pWRJA2 aph Phsp60-Ms1712-HA oriM ColE1 
M. tuberculosis SecA2 
expression vector, integrating 
(68) 
 
 
 
Table 4.2 Oligonucleotides used in this study 
 
Primer Name Sequence (5’-3’) 
ForwMtb TacCwXm GAATACGTTCGTGCGCGCCGCCGGTCTTC 
RevMtbTatCwPst CTGAGCTGGCTAGCGGGCCTACG 
 
 
 
 
 
 
 
 
209 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Export of Ms1704 and Ms6020 is dependent on TatC 
Equalized whole cell lysates (WCL) generated from wild type, ΔsecA2, and ΔtatC M. 
smegmatis cells expressing either (A) Ms1704-HA (B) Ms6020-HA (C) 19kDa or PhoA 
were subjected to ultracentrifugation to generate subcellular fractions. Fractions were 
separated by SDS-PAGE, and proteins detected with either anti-HA antibody, anti-PhoA, 
or anti-19kDa antibodies as appropriate. The total amount of cell wall (CW), membrane 
(M), and soluble (SOL) fractions shown is equivalent to the amount of WCL loaded. 
Native MspA was detected as a cell wall quality control. Parts A and B are representative 
blots from three biological replicates. Part C represents one biological replicate. 
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Figure 4.2 Export of Ms1704-HA requires both SecA2 and TatC, and deletion of 
secA2 rescues reduced Ms1704 protein levels of tatC mutant. 
Equalized whole cell lysates (WCL) generated from wild type, ΔsecA2, ΔtatC, or ΔsecA2 
ΔtatC M. smegmatis cells expressing  Ms1704-HA and either (A) empty vector 
(pMV361) (B) M. tuberculosis SecA2 (pWRJA2) or (C) M. tuberculosis TatC (pMF253) 
were subjected to ultracentrifugation to generate subcellular fractions. Fractions were 
separated by SDS-PAGE, and the localization of Ms1704-HA determined using an anti-
HA antibody. The total amount of cell wall (CW) and membrane (M) fractions shown is 
twice the corresponding amounts WCL and SOL samples loaded. The immunoblot shown 
is representative of two independent replicates. For part (A): an additional longer 
exposure of the immunoblots is also included. 
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Figure 4.3 Signal peptides of SecA2-dependent SBPs 
(A) Shown here are the signal peptides of SecA2-independent M. smegmatis PhoA and 
Ms6020 compared to the signal peptides of SecA2-dependent SBPs Ms1704 and 
Ms1712. A Tat signal peptide from the M. tuberculosis PlcB protein and the Tat 
consensus motif is also shown for comparison. (B) The Tat consensus in all 15 SBPs 
identified in a proteomic study of the M. tuberculosis cell wall (Chapter 3). Proteins that 
followed a trend of being reduced in the M. tuberculosis secA2 mutant are boxed in 
grey. M. tuberculosis proteins with predicted Tat signal peptides as determined by TatP 
and/or TatFind are underlined (1, 44, 60). All signal peptides are shown up to the amino 
acid adjacent to the cleavage site, except OppA where a portion of the signal peptide C-
terminus was omitted. All positively charged residues are shown in red, while 
hydrophobic residues are shown in bold.  
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Figure 4.4 Model for shared export of Ms1704 by SecA2 and Tat pathways. 
(A) In wild type M. smegmatis, Ms1704 has a signal peptide that allows interaction with 
both the Sec and Tat pathway. Ms1704 must be unfolded for export by the Sec pathway, 
which requires the assistance of SecA2. Export via Tat occurs with Ms1704 proteins that 
are fully folded. (B) In a secA2 mutant, all Ms1704 export occurs by the Tat pathway. 
(C) In a tatC mutant, all Tat export is abolished (indicated by crossed out Tat 
translocase). All Ms1704 export occurs through the Sec pathway with assistance from 
SecA2. We propose that this situation is taxing to the essential Sec translocase leading to 
degradation of nonexported Ms1704. (D) In a secA2 tatC double mutant Ms1704 is 
not exported at all. Ms1704 preprotein does not encounter machinery from either export 
system and can accumulate in the cytoplasmic (the instability of Ms1704 that occurs in 
the tatC mutant is avoided).  
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CHAPTER 5 
DISCUSSION 
 
Tuberculosis disease is a major global health crisis. Nearly a third of the world’s 
population is infected with Mycobacterium tuberculosis and this epidemic results in 1.4 
million deaths annually (77). Several factors contribute to the large burden of M. 
tuberculosis infection and mortality including lack of an effective vaccine, co-infection 
with HIV, and the ability of this bacterium to establish latent infections (77). Despite the 
existence of anti-mycobacterial therapies, the incidence of multi-drug resistant M. 
tuberculosis strains continues to increase (65). A better understanding of M. tuberculosis 
physiology would aid in the development of new drugs (27). 
Protein export systems are one particularly interesting aspect of M. tuberculosis 
biology to explore because exported proteins are ideally positioned to interact with the 
host during infection (55). Exported proteins also contribute to synthesizing and 
maintaining the unique architecture of the mycobacterial cell envelope and they are 
essential for acquiring nutrients from the extra-cellular environment (17, 51). Along with 
conserved protein export systems of M. tuberculosis, there exists the specialized SecA2-
dependent protein export system. The SecA2 pathway contributes to the ability of M. 
tuberculosis to survive and grow inside the phagosomal compartments of host 
macrophages (13, 67). However, we are only beginning to understand the mechanisms 
behind SecA2 export and how SecA2-dependent exported proteins 
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contribute to M. tuberculosis virulence. The work presented in this dissertation helps to 
better define the relationship of the specialized SecA2 system to other conserved protein 
export machinery and it moves us toward a better understanding of the mechanism of 
SecA2-dependent export. Importantly, the proteomic analysis of the M. tuberculosis cell 
wall fractions that is part of this dissertation generated a list of putative SecA2-dependent 
exported effectors that not only help refine a mechanistic model of SecA2-mediated 
export, but could help explain the vital role of SecA2 export during M. tuberculosis 
infection. 
The general Sec export pathway is the most widely conserved system for 
exporting proteins in bacteria, and is essential in all species including mycobacteria (22, 
34, 63). The Sec system is comprised of the membrane-spanning SecYEG protein 
channel and a cytoplasmic SecA motor protein (15). Proteins are synthesized with N-
terminal signal peptides for recognition by SecA. SecA then delivers these signal peptide 
containing preproteins to the cytoplasmic membrane for export. SecA is an ATPase that 
promotes translocation of the unfolded preprotein through SecYEG using cycles of ATP 
hydrolysis (23, 50). It is essential that the preprotein maintain an unfolded conformation 
during passage through the SecYEG channel and this is often achieved by assistance of 
cytoplasmic chaperones (3, 28). In addition to unfolded Sec exported preproteins there is 
also a category of preproteins that fold in the cytoplasm prior to their export. Such folded 
preproteins are translocated across the cytoplasmic membrane by the twin-arginine 
translocation (Tat) pathway (53). The Tat system only works with folded substrates and 
will even reject unfolded proteins (19). While the Tat pathway is not universally found in 
all bacteria, the mechanisms of Tat export appear to be conserved among a large group of 
224 
 
bacteria, including mycobacteria (20, 44, 48). Preproteins destined for Tat export are 
synthesized with N-terminal signal peptides that are distinguished from Sec signal 
peptides, specifically in that they contain two nearly invariant arginine residues (9). Tat 
preproteins first associate with the TatBC integral membrane proteins before TatA 
monomers are then recruited (30, 43, 47, 59, 69). The resulting TatA homomultimers 
form membrane-spanning channels of varying sizes in order to accommodate various 
folded proteins and protein complexes (32, 76).  
 The specialized SecA2 export systems are characterized by the presence of a 
second non-redundant SecA ATPase, called SecA2 (25). In bacteria with two SecA 
proteins, SecA1 fulfills a vital role in canonical Sec export, while SecA2 export is more 
specialized and limited to a smaller subset of proteins (12, 14, 24, 34, 61). SecA2 systems 
exist in all mycobacteria and a diverse set of Gram positive species (60). Two general 
types of SecA2 systems have been described. The SecA2–SecY2 systems appear to 
function independent of canonical Sec export and are dedicated to exporting a single 
glycosylated protein substrate (7, 16). The SecA2-only system, which lacks a SecY2 or 
obvious accessory protein-conducting channel, is the type of SecA2 system found in 
mycobacteria (12). The developing model of SecA2-only export is that SecA2 functions 
in concert with machinery from the canonical Sec system, including SecYEG and SecA1 
(24, 61). General Sec export has been extensively studied for a long time, resulting in a 
relatively sophisticated understanding of the Sec export process (22). The idea that some 
SecA2 proteins evolved as an adaptation to the general Sec machinery is exciting as it 
suggests that there are capabilities and/or limitations to Sec export that have not been 
previously appreciated.  
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The work presented in this thesis focused on investigating the proteins exported 
by the mycobacterial SecA2 export system. We hypothesized that there exist specific 
features of SecA2-dependent preproteins that necessitate the involvement of SecA2 in 
their export. By studying two proteins exported by SecA2 in Mycobacterium smegmatis, 
we demonstrated a distinction between the SecA2-defining elements of substrates 
exported by SecA2–SecY2 systems and those exported by SecA2-only systems such as in 
mycobacteria. Our work also revealed a potential relationship between preproteins 
exported by the mycobacterial SecA2 and Tat pathways. Finally, our efforts to identify 
SecA2-dependent exported proteins in M. tuberculosis revealed new examples of proteins 
that appear to depend on SecA2 for localization to the cell wall including multiple solute-
binding lipoproteins, components of two Mce transporters, and other exported proteins 
with putative roles in M. tuberculosis virulence. Many of these potential SecA2 substrates 
may account for the important role of the M. tuberculosis SecA2 pathway in virulence. 
 
Defining features of mycobacterial SecA2 substrates reside in the mature domain of 
the protein and are distinct from SecA2-SecY2 systems. 
 SecA2–SecY2 systems, such as those in Streptococcus gordonii and 
Streptococcus parasanguinis, are dedicated to exporting substrates that are first heavily 
glycosylated in the cytoplasm. Studies in these organisms show that glycosylation of the 
preprotein blocks their export by the canonical Sec pathway (7, 16). In addition, at least 
two targeting elements have been described that route these modified substrates to the 
accessory SecA2–SecY2 machinery. These features include conserved amino acid 
residues in the signal peptide and the AST domain (for accessory sec transport) contained 
226 
 
in the N-terminus of the mature domain of the protein, the latter of which is required for 
binding SecA2 (5, 6, 8). Prior to the studies described in this dissertation, nothing was 
known about the feature(s) that impose SecA2-dependency on substrates of SecA2-only 
systems.  
In M. smegmatis, SecA2 is required for export of Ms1704 and Ms1712 to the cell 
wall (31). These proteins are predicted solute-binding (SBP) components of two ABC 
transporters with putative roles in sugar uptake (70). Additionally, both are lipoproteins 
with seemingly typical N-terminal Sec signal peptides (54, 68, 72). By studying export of 
several signal peptide chimeric proteins, we demonstrated that although a signal peptide 
is required for Ms1704 and Ms1712 export, SecA2-specific signal peptides do not appear 
to exist in mycobacteria (Chapter 2) (26, 31). Hence, one or more features of the mature 
domains of Ms1704 and Ms1712 impart SecA2-dependency. Unlike the glycoprotein 
substrates of SecA2-SecY2 systems, neither Ms1704 nor Ms1712 appear to be 
glycosylated. In Chapter 2, we also determined that the extreme N-terminus of the 
Ms1704 mature domain is not required for export by the SecA2-dependent pathway, 
suggesting that mycobacterial SecA2 substrates do not contain a similar AST domain 
required for SecA2-targeting (26).  
 
A mycobacterial SecA2 substrate can be exported by the Tat pathway 
 A remarkable finding described in Chapter 2, is that the mature domain of 
Ms1704 can be efficiently exported by the Tat pathway when fused to a Tat signal 
peptide (26). With the resulting ssPlcB-Ms1704 chimera, export of the Ms1704 protein 
occurred in a strictly SecA2-independent but Tat-dependent manner (26). Because the Tat 
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system only accommodates folded preproteins, this result implied that at least some 
cytoplasmic Ms1704 preprotein is folded (19). This result led to our hypothesis that a 
tendency to fold in the cytoplasm is the defining feature of the mature domains of SecA2-
dependent preproteins in mycobacteria.   
Inspection of the native signal peptide of Ms1704 does not reveal a twin arginine 
motif characteristic of Tat signal peptides, and the signal peptide is not predicted to be a 
Tat signal peptide by any of the current Tat signal peptide prediction programs (4, 62). 
Therefore, we were surprised to discover that Ms1704 containing its native signal peptide 
is reduced in the cell wall of an M. smegmatis tatC mutant (Chapter 4). This suggested 
that some amount of Ms1704 is exported by the Tat system. In the tatC mutant the 
export defect of native Ms1704 is not 100%. Similarly, a partial export defect for native 
Ms1704 is seen in the secA2 mutant. However, Ms1704 export is completely absent in a 
secA2 tatC double mutant. Furthermore, export of Ms1704 could be restored in a 
strain lacking secA2 by over-expressing tatC. The simplest interpretation of these data is 
that the Ms1704 preprotein is compatible with two separate export pathways. Ms1704 
can either be exported in a SecA2-dependent fashion, presumably being translocated 
across the membrane via SecYEG in an unfolded state, or it can be exported in a folded 
conformation by the Tat machinery. 
The idea that the signal peptide of Ms1704 can functionally target this preprotein 
to either the SecA2/Sec or Tat machinery is not out of the realm of possibility. This is 
because Tat and Sec signal peptides do share the same basic tripartite structure, including 
a positively charged N-terminus and hydrophobic stretch. Furthermore, there are 
examples of promiscuous signal peptides that can successfully route certain proteins to 
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either the Sec or Tat pathway depending on the folded state of the fused mature domain 
(10, 39, 73). Further, there are examples of functional Tat signal peptides that lack one of 
the twin arginine residues (35, 36, 46, 49, 66). Some of these Tat motif variants contain a 
“KR” pair similar to the native signal peptide of Ms1704. Efforts are currently underway 
to test the ability of the Ms1704 signal peptide to promote Tat-dependent export. If our 
model holds true, where some proteins like Ms1704 can be exported by two parallel 
systems (SecA2/Sec or Tat), this would significantly improve our understanding of both 
the SecA2-dependent and Tat export pathways of mycobacteria. Further, investigation of 
the signal peptides on such proteins  may help to reveal other proteins that are exported 
by the SecA2 and/or Tat systems of mycobacteria that are not currently recognizable. 
When considered, this last possibility could aid efforts to identify novel virulence factors 
exported by the M. tuberculosis SecA2 system.  
 
Similar substrates are exported by SecA2 and Tat pathways 
 The only two known SecA2-dependent exported proteins of M. smegmatis are 
solute-binding proteins (SBPs). SBPs are a diverse family of periplasmic proteins with 
roles in binding molecules for uptake via ABC-type membrane importers (11, 45). For 
reasons unknown at this point, SBPs are also a common class of Tat exported protein 
across a diverse set of organisms, as SBPs with predicted Tat signal peptides are 
widespread (64). Experimentally demonstrated Tat-dependent SBPs have also been 
described in E. coli, Agrobacterium tumefaciens, and Bacillus subtilis (21, 38, 57). In 
Chapter 3, we discovered that almost all the SBPs of M. tuberculosis are reduced in the 
cell wall of the secA2 mutant, notably four of these SBPs contain predicted Tat signal 
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peptides. Thus, it appears SBPs have features that frequently demand export by the Tat 
system and/or SecA2-dependency in M. smegmatis and M. tuberculosis. These 
observations are consistent with our model that folded preproteins are likely to demand 
export by SecA2, and provide further support that the defining feature of mycobacterial 
SecA2 substrates are cytoplasmic folding tendencies. The relationship of SecA2 to Tat 
export could also extend to other SecA2-only systems outside mycobacteria. In support 
of this idea, there are also three SBPs exported by the SecA2-only system of Listeria 
monocytogenes (58). Interestingly, a SBP of E. coli (the ribose-binding protein) is 
exported by the Sec system, but a subset of this SBP is also exported by the Tat system, 
particularly when Sec export is chemically inhibited (56). While E. coli does not possess 
a SecA2 protein, this report reaffirms a model where SBPs are a family of proteins that 
can exist in the cytoplasm in folded conformations competent for Tat export.  
 
A model for SecA2 in protein export   
 The experiments described in this dissertation support the following model for 
SecA2-only export (Figure 5.1). The majority of Sec exported proteins are unfolded 
preproteins that are recognized by the canonical SecA1 protein and translocated in an 
unfolded conformation through SecYEG through cycles of SecA1 ATP hydrolysis. A 
subset of preproteins can fold in the cytoplasm, a property of the mature domain that 
demands specialized machinery for translocation across the cytoplasmic membrane. 
Folded preproteins containing strict Tat-targeting signal peptides are exported in a folded 
conformation through the Tat machinery. However, the folded state of a cytoplasmic 
preprotein can range from partially folded to a stable fully folded conformation (28, 41), 
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the latter of which is only compatible with the Tat system for export. If a partially folded 
preprotein has a promiscuous signal peptide (that can function in both Sec- and Tat-
targeting) then this preprotein can follow one of two independent pathways. The 
preprotein can adopt a fully folded conformation for export by the Tat system. 
Alternatively, the partially folded preprotein can be translocated through SecYEG, but 
this requires the assistance of SecA2. Some SecA2 substrates might be preproteins 
containing strict Sec signal peptides. Other SecA2 substrates (like Ms1704) may have 
promiscuous signal peptides and mature domains capable of either Tat-mediated export 
or Sec-mediated export with SecA2.  
The exact function of SecA2 during export of such select substrates (and how that 
function differs from SecA1) remains elusive. The first possibility is that SecA2 performs 
an “unfoldase” function, which has been described for other proteins like the bacterial 
AAA+ proteases (71). In this model, SecA2 would actively unfold the mature domains of 
preproteins in order to maintain competence for SecYEG-mediated export. However, this 
possibility seems unlikely because SecA2 does not have any predicted structural 
similarities to unfoldase proteins. The M. tuberculosis SecA1 and SecA2 proteins exhibit 
50% similarity at the amino acid level, and most of the functional domains are conserved 
between these proteins. SecA2 is an ATPase and this enzymatic activity is required for its 
function, just like the canonical SecA1 protein (61). Given the high similarity to the 
canonical SecA1 proteins, it is more plausible that SecA2 performs a similar function to 
SecA1 in export.  
Another possible function for SecA2 is to interact with preproteins in the 
cytoplasm that are overlooked by SecA1 and target these proteins to SecYEG for export. 
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In mycobacteria, SecA2 exhibits a primarily cytoplasmic localization, while SecA1 is 
evenly distributed between the cytoplasm and cytoplasmic membrane (61). Because it 
appears SecA2 is specifically needed for export of proteins more prone to cytoplasmic 
folding, it is possible there are chaperones that first interact with the preprotein before 
recognition by SecA2. These chaperones might include those with known roles in Sec 
export including GroEL or DnaK, which interact with nascent preproteins in order to 
maintain a conformation suitable for export and prevent inappropriate interactions 
leading to protein aggregation. (28). SecA2 could then deliver these proteins from the 
cytoplasmic chaperones to the SecA1/SecYEG machinery. Alternatively, SecA2 alone 
may be sufficient for recognizing preproteins, maintaining them in an unfolded state, then 
targeting them to the Sec translocase.  This targeting function is analogous to the activity 
of the SecB chaperone described in E. coli canonical Sec export. 
Another possibility is that SecA2 is required for energizing transport of certain 
preproteins through SecYEG. Proteins need to be unfolded for transport through 
SecYEG, and sometimes cytosolic chaperones aid in this process. However, it has also 
been shown that the force applied to a preprotein from translocation itself (powered by 
SecA) can unfold proteins (1, 52). It is possible that SecA2 is able to provide more 
energy for protein translocation of partially folded proteins while SecA1 cannot. In this 
case, the forward movement of the preproteins with the assistance of SecA2 ATP 
hydrolysis could unfold some regions of the preprotein. In fact, it has been demonstrated 
that loss of a particular structural loop in the motor portion of E. coli SecA results in 
hyperactive ATPase activity and an accelerated rate of ADP release (18). In 
mycobacteria, this variable subdomain (VAR) is present in SecA1 but absent in SecA2. If 
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SecA2 had this accelerated ATPase activity, it could power partially folded preproteins 
through SecYEG more efficiently than SecA1, quickly resulting in SecYEG channel 
access for translocation of the next preprotein. This proposed role for SecA2 in 
energizing export is not mutually exclusive from a possible function in Sec translocase-
targeting.  
Future investigating of the mycobacterial SecA2 system will undoubtedly benefit 
from a more reductionist approach afforded by in vitro translocation systems, which have 
been so valuable in generating the large body of literature on canonical Sec export. In 
vitro translocation is also starting to be applied to studying mechanisms of Tat export 
(78). In vitro translocation techniques could help elucidate potential energetic advantages 
of routing preproteins to either the Sec or Tat export pathways. This technique could also 
help determine if SecA2 has a SecA1/SecYEG-targeting function and exactly what level 
of preprotein folding SecA2 is capable of handling. 
 
Proposed advantage of SecA2-mediated export in mycobacteria 
If our model is correct that SecA2-mediated export is a strategy used by 
mycobacteria to export folded proteins, then an important question remains: why is 
SecA2 necessary and Tat export not sufficient for handling export of folded proteins? 
One plausible explanation for the existence of SecA2 in mycobacteria is that utilization 
of both Sec and Tat pathways allows a fine-tuning of protein export to prevent 
overwhelming of either system during times of stress on protein export. SecA2 could play 
an integral role in connecting Sec- and Tat-mediated export, by adapting over-flow from 
the Tat machinery for export via SecYEG. For preproteins containing promiscuous signal 
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peptides, the state of the mature domain will dictate whether preprotein export will occur 
via Sec or Tat. The proportion of unfolded, partially folded and fully folded preprotein in 
the cytoplasm could be influenced by environmental stress. Stresses that can contribute to 
preprotein unfolding are changes in temperature or oxidative stress (2, 29). Other 
environmental conditions that influence the Sec-Tat balance (presumably because they 
affect cytoplasmic folding) are salinity and protein over-expression (40, 74, 75). Thus 
perhaps, SecA2 has a vital role in allowing mycobacterial species to adapt protein export 
to changing environmental conditions. Certain environmental stresses could lead to an 
increase in the partially folded preprotein pool that SecA2 assists in exporting. In M. 
smegmatis these stresses might be changes in salinity or temperature that perturb the 
kinetics of protein folding in the cytoplasm and demand adjustment of SecA2 and Tat 
usage for protein export. This might explain why the severity of the SecA2-dependent 
phenotype of substrates, like Ms1704, varies across experiments. For M. tuberculosis, the 
stressful environment inside the macrophage could promote cytoplasmic preprotein 
unfolding of some Tat substrates, demanding that SecA2 assist in exporting these 
partially folded substrates through SecYEG. In support of this possibility it is known that 
oxidative stress, which is experienced by M. tuberculosis in the phagosome, can induce 
protein unfolding and aggregation in the cytoplasm in other bacteria (33, 37). While the 
effects of the phagosome environment on cytoplasmic protein folding have not been 
studied in M. tuberculosis, if bacterial preprotein unfolding increases inside the 
macrophage this could help explain why SecA2 is required for bacterial survival and 
growth during infection (13, 42).  
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Contribution of SecA2 exported proteins to M. tuberculosis virulence 
 Finally, the contribution of SecA2 to M. tuberculosis virulence remains to be 
reconciled. Our proteomic study of SecA2 export in M. tuberculosis revealed many 
changes in cell wall protein abundance upon deletion of secA2, but these changes were 
seen over a large set of proteins (Chapter 3). Because many of the export defects in the 
secA2 mutant were incomplete, it is likely that the attenuation of the M. tuberculosis 
secA2 mutant during infection is not due to reduced export of a single protein. Of 
particular interest for validation of SecA2-dependency and future work are the large array 
of solute-binding proteins and Mce transporters. Collectively, the impact of secA2 
deletion on the export of many SBPs with putative roles in nutrient acquisition could 
severely reduce the fitness of M. tuberculosis. Additionally, the M. tuberculosis secA2 
mutant also exhibited reduced levels of some exported proteins with proposed roles in 
virulence, such as arresting phagosomal maturation. Together, the reduction in export of 
many proteins with contributions to M. tuberculosis survival and growth in the 
macrophage could explain the attenuation of the secA2 mutant. Finally, if there is 
overlap between the substrates exported by SecA2 and Tat pathways, and environmental 
stress leads to greater reliance on SecA2, then the full impact of SecA2 on protein export 
may not be apparent until M. tuberculosis is exposed to the stresses associated with 
infection. In line with this last idea, work in other bacterial species demonstrates that 
whether some exported proteins utilize Sec or Tat can change under certain conditions 
(40, 74, 75).  
235 
 
Taken together, the results described in this dissertation have advanced our 
understanding of the mechanisms of SecA2-only export. Importantly, our studies lead to 
a model where a defining feature of proteins exported by the SecA2 pathway of 
mycobacteria is a tendency to fold prior to export. In addition, we demonstrated a 
relationship between the types of preproteins exported by the SecA2 and Tat export 
systems. The idea that some proteins can use both the canonical Sec and Tat systems for 
export with the help of promiscuous signal peptides is not new. However, this is the first 
time that a function for SecA2 in adapting preproteins with Tat-compatible folding 
properties for export through the Sec machinery has been proposed. Our work suggests 
that SecA2 is an important addition to the canonical Sec and Tat translocation systems of 
mycobacteria, allowing efficient protein translocation of folded preproteins across the 
cytoplasmic membrane. 
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Figure 5.1 Model for mycobacterial SecA2 export 
Substrates destined for Sec export are synthesized with Sec signal peptides (white oval). 
The essential SecA1 protein recognizes these preproteins and using cycles of ATP 
hydrolysis, drives the unfolded preproteins through the SecYEG membrane channel. 
Conversely, substrates destined for Tat export are synthesized with Tat signal peptides 
(black ovals). Tat preproteins fold in the cytoplasm, and are translocated across the 
cytoplasmic membrane by the TatABC machinery. SecA2 functions with the canonical 
SecA1/SecYEG machinery to assist in Sec export of some partially folded preproteins. 
We propose that there are shared substrates, like SBPs, that are partially or fully folded in 
the cytoplasm. If these shared substrates possess promiscuous signal peptides, they can be 
exported by Tat in a folded conformation or exported through SecYEG in an unfolded 
conformation with assistance from SecA2. 
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Appendix  
 
Label-free quantitation of M. tuberculosis cell wall proteins using a spectral 
counting comparison between wild type (H37Rv) and a secA2 mutant 
 
 
Locus 
Gene  
Name 
Description/Function 
log2 
A2/WT 
p 
Avg 
SpC 
Seca Tatb TMc Lipod 
Rv0001 dnaA chromosomal replication initiation protein  -1.482 0.002 47.4 - - - - 
Rv0003 recF recombination protein F  -0.4678 0.278 11.6 - - - - 
Rv0005 gyrB DNA gyrase subunit B  0.633 0.005 15.5 - - - - 
Rv0006 gyrA DNA gyrase subunit A  0.5363 0.131 48.2 - - - - 
Rv0007  hypothetical protein  -0.5502 0.132 17.7 - - X - 
Rv0008c  hypothetical protein  0.1811 0.573 6.6 - - X - 
Rv0009 ppiA 
iron-regulated peptidyl-prolyl cis-trans 
isomerase 
1.107 0.153 18.8 
- - - - 
Rv0010c  hypothetical protein  -0.667 0.149 3.5 - - X - 
Rv0011c  putative septation inhibitor protein  0.5996 0.086 11.7 - - X - 
Rv0012  hypothetical protein  0.723 0.034 7.6 - - X - 
Rv0013 trpG para-aminobenzoate synthase component II  1.5612 0.159 4.6 - - - - 
Rv0014c pknB 
transmembrane serine/threonine-protein 
kinase B   
-0.7508 0.042 55.7 
- - X - 
Rv0015c pknA 
transmembrane serine/threonine-protein 
kinase A  
-0.8217 0.126 23.3 
- - X - 
Rv0016c pbpA penicillin-binding protein -0.9748 0.005 31.5 X - X - 
Rv0017c rodA cell division protein -0.1698 0.241 12.5 - - X - 
Rv0018c ppp serine/threonine phosphatase  -0.3504 0.411 31.2 - - X - 
Rv0019c  hypothetical protein  -0.7787 0.057 28.0 - - X - 
Rv0020c TB39.8 hypothetical protein  0.0978 0.743 50.7 - - - - 
Rv0021c  hypothetical protein  -0.1757 0.607 4.9 - - - - 
Rv0025  hypothetical protein  -0.1354 0.66 2.0 - - - - 
Rv0029  hypothetical protein  -0.0684 0.831 9.2 - - - - 
Rv0030  hypothetical protein  0.8605 0.076 1.2 - - - - 
Rv0034  hypothetical protein  1.8005 0.002 1.7 - - - - 
Rv0037c  integral membrane protein  1.1548 0.141 0.9 - - X - 
Rv0038  hypothetical protein  -0.0178 0.923 7.0 - - - - 
Rv0042c  MarR family transcriptional regulator  -0.2968 0.625 18.5 - - - - 
Rv0043c  GntR family transcriptional regulator  1.4092 0.167 3.3 - - - - 
Rv0045c  hydrolase  -1.9126 0.061 5.5 - - - - 
Rv0046c ino1 myo-inositol-1-phosphate synthase  -1.884 0.124 4.5 - - - - 
Rv0047c  hypothetical protein  -0.654 0.529 6.6 - - - - 
Rv0048c  hypothetical protein  0.2827 0.403 21.3 - - X - 
Rv0049  hypothetical protein  0.4228 0.42 5.0 - - - - 
Rv0050 ponA1 bifunctional penicillin-binding protein 1A/1B  -0.2526 0.456 51.9 - - - - 
Rv0051  transmembrane protein  -0.8364 0.017 6.7 - - X - 
Rv0052  hypothetical protein  -0.4078 0.628 6.8 - - - - 
Rv0053 rpsF 30S ribosomal protein S6  0.186 0.798 9.9 - - - - 
Rv0054 ssb single-stranded DNA-binding protein  1.3518 0.113 4.7 - - - - 
Rv0055 rpsR 30S ribosomal protein S18  0.0227 0.898 18.7 - - - - 
Rv0056 rplI 50S ribosomal protein L9  0.487 0.33 7.1 - - - - 
Rv0060  hypothetical protein  1.1137 0.019 1.1 - - - - 
Rv0062 celA1 endo-1,4-beta-glucanase  0.3526 0.09 3.7 - - X - 
Rv0066c icd2 isocitrate dehydrogenase  0.8478 0.133 9.0 - - - - 
Rv0068  short chain dehydrogenase  -0.3862 0.179 23.4 - - - - 
Rv0070c glyA serine hydroxymethyltransferase  -0.848 0.311 15.3 - - - - 
Rv0072  glutamine-transport transmembrane protein  -0.4502 0.083 57.8 - - X - 
Rv0073  glutamine-transport ATP-binding protein  0.8449 0.086 12.1 - - - - 
Rv0077c  oxidoreductase  0.5782 0.092 28.3 - - - - 
Rv0078  transcriptional regulator 1.1452 0.017 8.6 - - - - 
Rv0079  hypothetical protein  2.113 0.022 12.3 - - - - 
Rv0080  hypothetical protein  1.4222 0.002 7.4 - - - - 
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Rv0088  hypothetical protein  0.0004 0.999 86.5 - - - - 
Rv0090  hypothetical protein  -0.3842 0.1 8.6 - - X - 
Rv0091 mtn 5'-methylthioadenosine nucleosidase  -0.1379 0.414 1.6 - - - - 
Rv0092 ctpA cation transporter P-type ATPase A  0.0846 0.48 13.6 - - X - 
Rv0093c  hypothetical protein  0.1136 0.541 1.4 - - X - 
Rv0102  integral membrane protein  1.0688 0.004 1.3 - - X - 
Rv0103c ctpB cation-transporter P-type ATPase B  0.5272 0.605 2.2 - - X - 
Rv0107c ctpI cation-transporter ATPase I  0.7322 0.083 25.6 - - - - 
Rv0108c  hypothetical protein  0.9965 0.249 3.7 - - - - 
Rv0110  integral membrane protein  1.1137 0.019 1.1 - - X - 
Rv0112 gca GDP-mannose 4,6-dehydratase  -0.02 0.943 5.4 - - - - 
Rv0113 gmhA phosphoheptose isomerase  0.912 0.137 3.3 - - - - 
Rv0117 oxyS oxidative stress response regulatory protein -0.4362 0.129 19.0 - - - - 
Rv0118c oxcA putative oxalyl-CoA decarboxylase  -0.3648 0.432 15.6 - - - - 
Rv0119 fadD7 acyl-CoA synthetase  0.198 0.79 1.8 - - - - 
Rv0120c fusA2 elongation factor G  0.1534 0.355 25.4 - - - - 
Rv0123  hypothetical protein  0.512 0.471 1.3 - - - - 
Rv0125 pepA serine protease 0.686 0.332 7.6 X - X - 
Rv0127  hypothetical protein  -0.207 0.488 11.5 - - - - 
Rv0129c fbpC secreted antigen 85-C 0.9697 0.135 26.2 - X X - 
Rv0131c fadE1 acyl-CoA dehydrogenase  -0.3572 0.627 10.9 - - - - 
Rv0133  acetyltransferase  0.5786 0.007 11.1 - - - - 
Rv0134 ephF epoxide hydrolase 0.302 0.252 19.9 - - - - 
Rv0136 cyp138 cytochrome P450 138  -0.2028 0.719 21.3 - - - - 
Rv0139  oxidoreductase  -0.1426 0.685 11.8 - - - - 
Rv0144  TetR family transcriptional regulator  1.0018 0.069 9.2 - - X - 
Rv0145  hypothetical protein  1.0252 0.104 2.2 - - - - 
Rv0146  hypothetical protein  1.6103 0.066 3.6 - - - - 
Rv0147  aldehyde dehydrogenase  -0.9752 0.067 99.6 - - - - 
Rv0148  short-chain type dehydrogenase/reductase  1.7242 0.067 7.9 - - - - 
Rv0149  quinone oxidoreductase  -1.0261 0.622 1.7 - - - - 
Rv0153c ptbB 
phosphotyrosine protein phosphatase) 
(PTPase)  
0.336 0.672 3.5 
- - - - 
Rv0155 pntAa NAD(P) transhydrogenase subunit alpha  0.5328 0.085 12.7 - - - - 
Rv0156 pntAb NAD(P) transhydrogenase subunit alpha  -2.0296 0.017 8.8 - - X - 
Rv0157 pntB 
NAD(P) transhydrogenase subunit beta  -0.3026 0.006 
119.
0 - - X - 
Rv0164 TB18.5 hypothetical protein  0.881 0.232 3.0 - - - - 
Rv0165c  GntR family transcriptional regulator  -0.0751 0.86 18.1 - - - - 
Rv0166 fadD5 acyl-CoA synthetase  0.802 0.01 29.0 - - - - 
Rv0167 yrbE1A MCE1-associated -0.59 0.179 14.9 - - X - 
Rv0168 yrbE1B MCE1-associated -1.1818 0.018 4.4 - - X - 
Rv0169 mce1A MCE1-associated -1.1012 0.018 80.5 - - X - 
Rv0170 mce1B 
MCE1-associated -0.7972 0.012 
125.
1 - - X - 
Rv0171 mce1C 
MCE1-associated -0.9534 0.003 
144.
6 - - X - 
Rv0172 mce1D 
MCE1-associated -0.932 0.001 
119.
8 - - X - 
Rv0173 lprK 
MCE1-associated lipoprotein -0.8102 0.006 
113.
7 - - X X 
Rv0174 mce1F 
MCE1-associated -1.1782 0.009 
155.
4 - - X - 
Rv0175  MCE1-associated 0.941 0.028 19.6 - - X - 
Rv0176  MCE1-associated -0.8535 0.005 30.9 - - X - 
Rv0177  MCE1-associated -0.1526 0.608 26.5 - - X - 
Rv0178  MCE1-associated 0.0686 0.87 56.4 - - X - 
Rv0179c lprO lipoprotein -0.1354 0.718 2.0 X - X X 
Rv0180c  transmembrane protein  -0.8432 0.066 24.3 - - X - 
Rv0182c sigG RNA polymerase factor sigma-70  -0.5794 0.255 8.6 - - - - 
Rv0183  lysophospholipase  0.1954 0.201 40.2 - - - - 
Rv0184  hypothetical protein  -0.5503 0.092 3.6 - - - - 
Rv0185  hypothetical protein  0.2548 0.281 15.8 - - - - 
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Rv0187  O-methyltransferase  1.3045 0.014 1.3 - - - - 
Rv0189c ilvD dihydroxy-acid dehydratase  1.7486 0.023 7.8 - - - - 
Rv0190  hypothetical protein  -0.3648 0.575 2.6 - - - - 
Rv0194  ATP-binding protein ABC transporter  -0.6233 0.057 2.8 - - X - 
Rv0196  transcriptional regulator 0.356 0.364 1.0 - - - - 
Rv0199  hypothetical protein  0.0042 0.976 14.3 - - X - 
Rv0200  transmembrane protein  -0.4634 0.156 12.7 - - X - 
Rv0201c  hypothetical protein  -0.5597 0.405 5.5 - - - - 
Rv0202c 
mmpL1
1 
transmembrane transport protein MmpL11 -0.6872 0.033 21.9 
X - X - 
Rv0204c  transmembrane protein  -0.3647 0.178 3.8 - - X - 
Rv0206c mmpL3 
transmembrane transport protein MmpL3  -0.152 0.198 
153.
6 - - X - 
Rv0207c  hypothetical protein  1.5364 0.107 1.3 - - - - 
Rv0215c fadE3 acyl-CoA dehydrogenase  1.393 0.234 2.6 - - - - 
Rv0217c lipW esterase 0.0994 0.841 11.2 - - - - 
Rv0220 lipC esterase -0.1892 0.412 15.1 - - - - 
Rv0221  hypothetical protein  -0.0705 0.806 22.9 - - - - 
Rv0224c  methyltransferase (methylase)  -0.6335 0.248 1.3 - - - - 
Rv0227c  hypothetical protein  -1.2276 0.003 66.9 - - X - 
Rv0229c  hypothetical protein  -0.4214 0.464 2.1 - - X - 
Rv0233 nrdB ribonucleotide-diphosphate reductase subunit  -0.6164 0.448 4.4 - - - - 
Rv0236c  transmembrane protein  -0.1788 0.849 1.2 X - X - 
Rv0237 lpqI lipoprotein -0.3204 0.352 22.5 X - - X 
Rv0241c  hypothetical protein  0.652 0.102 22.1 - - - - 
Rv0242c fabG 3-ketoacyl-(acyl-carrier-protein) reductase  0.3664 0.03 44.7 - - - - 
Rv0243 fadA2 acetyl-CoA acetyltransferase  0.265 0.288 27.2 - - - - 
Rv0245  oxidoreductase  0.4127 0.364 2.1 - - - - 
Rv0247c  fumarate reductase iron-sulfur subunit  0.144 0.682 60.1 - - - - 
Rv0248c sdhA 
succinate dehydrogenase flavoprotein subunit  -0.8976 0.002 
152.
4 - - - - 
Rv0249c  succinate dehydrogenase membrane anchor  0.0596 0.689 0.9 - - X - 
Rv0255c cobQ1 cobyric acid synthase  -0.4952 0.298 12.1 - - - - 
Rv0262c aac 
aminoglycoside 2'-N-acetyltransferase  
(AAC(2')-IC)  
-0.308 0.413 5.0 
- - - - 
Rv0265c  periplasmic IRON-transport lipoprotein  -1.0434 0.014 13.0 - X - X 
Rv0270 fadD2 acyl-CoA synthetase  -0.0387 0.818 19.6 - - - - 
Rv0271c fadE6 acyl-CoA dehydrogenase  -0.2178 0.68 11.8 - - - - 
Rv0273c  transcriptional regulator -0.4214 0.261 3.2 - - - - 
Rv0274  hypothetical protein  0.2547 0.323 2.5 - - - - 
Rv0275c  TetR family transcriptional regulator  0.6602 0.248 6.0 - - - - 
Rv0276  hypothetical protein  0.8892 0.031 13.3 - - - - 
Rv0281  hypothetical protein  0.9686 0.066 2.1 - - - - 
Rv0282  hypothetical protein  1.2378 0.022 4.6 - - - - 
Rv0283  hypothetical protein  -0.5958 0.006 42.5 - - X - 
Rv0284  
hypothetical protein  -0.2322 0.321 
317.
0 - - X - 
Rv0289  hypothetical protein  1.4734 0.102 6.7 - - - - 
Rv0290  transmembrane protein  -0.0584 0.763 99.4 - - X - 
Rv0291 mycP3 membrane-anchored mycosin  -0.9572 0.035 7.8 X - X - 
Rv0292  transmembrane protein  -0.4428 0.037 68.5 - - X - 
Rv0293c  hypothetical protein  -0.252 0.883 2.2 - - - - 
Rv0299  hypothetical protein  -0.0903 0.524 1.4 - - - - 
Rv0303  dehydrogenase/reductase  0.7608 0.22 11.7 - - - - 
Rv0307c  hypothetical protein  0.2601 0.467 15.3 - - - - 
Rv0308  integral membrane protein  -0.2633 0.207 19.4 - - X - 
Rv0312  hypothetical protein  -0.0314 0.929 5.7 - - X - 
Rv0313  hypothetical protein  -0.2362 0.236 6.6 - - - - 
Rv0314c  hypothetical protein  -0.8364 0.358 8.1 - - X - 
Rv0315  beta-1,3-glucanase precursor  0.0665 0.773 12.4 X X - - 
Rv0317c glpQ2 glycerophosphoryl diester phosphodiesterase  1.2016 0.011 29.9 - - - - 
Rv0328  TetR/AcrR family transcriptional regulator  1.1355 0.028 3.2 - - - - 
Rv0329c  hypothetical protein  1.655 0.056 3.4 - - - - 
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Rv0333  hypothetical protein  0.5476 0.159 7.1 - - - - 
Rv0337c aspC aminotransferase 0.8553 0.152 3.1 - - - - 
Rv0338c  iron-sulfur-binding reductase  -0.318 0.078 99.7 - - X - 
Rv0339c  transcriptional regulator -2.1756 0.024 8.1 - - - - 
Rv0343 iniC isoniazid inductible gene protein 1.9708 0.063 8.9 - - - - 
Rv0344c lpqJ lipoprotein -0.58  0.8 X - - X 
Rv0346c ansP2 L-asparagine ABC transporter permease  0.0248 0.891 25.2 - - X - 
Rv0350 dnaK 
molecular chaperone DnaK  0.2112 0.069 
102.
1 - - - - 
Rv0352 dnaJ1 chaperone protein -0.201 0.613 40.0 - - - - 
Rv0353 hspR HEAT shock protein transcriptional repressor -0.9585 0.319 8.9 - - - - 
Rv0356c  hypothetical protein  0.4981 0.117 2.1 - - - - 
Rv0358  hypothetical protein  -0.0789 0.919 1.9 - - - - 
Rv0360c  hypothetical protein  0.862 0.077 0.7 - - - - 
Rv0361  hypothetical protein  -0.1054 0.748 21.8 - - X - 
Rv0364  transmembrane protein  -0.0004 0.999 8.3 - - X - 
Rv0365c  hypothetical protein  -0.3126 0.691 7.1 - - - - 
Rv0369c  membrane oxidoreductase  0.5898  0.8 - - X - 
Rv0377  LysR family transcriptional regulator  -1.3956 0.015 9.7 - - - - 
Rv0379 secE2 protein transport protein  -1.2116 0.011 69.5 - - - - 
Rv0381c  hypothetical protein  -0.952 0.128 2.3 - - - X 
Rv0382c pyrE orotate phosphoribosyltransferase  1.0048 - 0.5 - - - - 
Rv0383c  hypothetical protein  -0.3904 0.225 48.7 - - X - 
Rv0384c clpB endopeptidase ATP binding protein  1.1132 0.279 8.5 - - - - 
Rv0385  hypothetical protein  -0.1697 0.705 6.7 - - - - 
Rv0386  LuxR/UHPA family transcriptional regulator  -1.2058 0.126 8.3 - - - - 
Rv0392c ndhA membrane NADH dehydrogenase  -0.6528 0.024 33.2 - - X - 
Rv0394c  hypothetical protein  0.6548 0.476 1.4 - - X - 
Rv0399c lpqK lipoprotein -2.4903 0.112 3.2 X - - X 
Rv0400c fadE7 acyl-CoA dehydrogenase  1.0048 - 0.5 - - - - 
Rv0402c mmpL1 transmembrane transport protein MmpL1  0.2858 0.827 0.9 - - X - 
Rv0406c  beta lactamase like protein  0.3387 0.366 5.8 - - - - 
Rv0408 pta phosphate acetyltransferase  0.918 0.188 4.5 - - - - 
Rv0409 ackA acetate kinase  1.0596 0.004 1.3 - - - - 
Rv0410c pknG serine/threonine-protein kinase -0.1895 0.103 39.4 - - - - 
Rv0411c glnH glutamine-binding lipoprotein  -1.6566 0.05 6.5 X - - X 
Rv0412c  hypothetical protein  -0.257 0.156 26.9 - - X - 
Rv0413 mutT3 7,8-dihydro-8-oxoguanine-triphosphatase  0.723 0.255 9.0 - - - - 
Rv0415 thiO thiamine biosynthesis oxidoreductase ThiO  0.1733 0.487 7.6 - - - - 
Rv0417 thiG thiazole synthase  -0.1379 0.414 0.5 - - - - 
Rv0418 lpqL lipoprotein aminopeptidase -0.0234 0.9 33.9 X - X X 
Rv0419 lpqM lipoprotein peptidase -2.0968 0.019 11.5 X - X X 
Rv0421c  hypothetical protein  1.1548 0.141 0.9 - - - - 
Rv0423c thiC thiamine biosynthesis protein ThiC  1.8295 0.097 2.3 - - - - 
Rv0424c  hypothetical protein  -0.6032 0.17 1.7 - - - - 
Rv0425c ctpH metal cation transporting P-type ATPase  2.3846 0.005 9.3 X - X - 
Rv0426c  hypothetical protein  0.3278 0.024 36.3 X - X - 
Rv0431  putative tuberculin related peptide  0.0584 0.869 26.9 - - X - 
Rv0432 sodC periplasmic superoxide dismutase [Cu-Zn] -0.2983 0.774 26.3 X - - X 
Rv0433  carboxylate-amine ligase  0.5188 0.559 2.9 - - - - 
Rv0434  hypothetical protein  1.017 0.02 5.4 - - - - 
Rv0436c pssA 
CDP-diacylglycerol--serine O-
phosphatidyltransferase  
1.1698 0.33 4.6 
- - X - 
Rv0437c psd phosphatidylserine decarboxylase  -0.09 0.941 9.7 - - - - 
Rv0438c moeA2 molybdopterin biosynthesis protein -0.0095 0.942 3.2 - - - - 
Rv0439c  short chain dehydrogenase  0.105 0.768 24.9 - - - - 
Rv0440 groEL2 
chaperonin GroEL  0.6047 0.15 
228.
2 - - - - 
Rv0441c  hypothetical protein  -0.0178 0.965 7.8 - - - - 
Rv0444c  hypothetical protein  0.7058 0.102 36.0 - - - - 
Rv0445c sigK RNA polymerase sigma factor 0.6898 0.031 23.1 - - - - 
Rv0450c mmpL4 transmembrane transport protein MmpL4  0.1022 0.518 49.6 - - X - 
Rv0452  transcriptional regulator 0.4493 0.134 2.3 - - - - 
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Rv0455c  hypothetical protein  0.2278 0.574 9.6 X - X - 
Rv0461  hypothetical protein  0.0428 0.939 7.6 - - X - 
Rv0462 lpd dihydrolipoamide dehydrogenase  -0.4934 0.178 21.9 - - - - 
Rv0464c  hypothetical protein  0.139 0.828 12.6 - - - - 
Rv0465c  transcriptional regulator 0.4168 0.365 5.2 - - - - 
Rv0467 icl isocitrate lyase  0.0652 0.933 5.2 - - - - 
Rv0468 fadB2 3-hydroxybutyryl-CoA dehydrogenase  0.3548 0.05 9.4 - - - - 
Rv0469 umaA mycolic acid synthase  0.5474 0.287 11.5 - - - - 
Rv0470c pcaA mycolic acid synthase  0.9359 0.208 3.5 - - - - 
Rv0472c  TetR family transcriptional regulator  0.1568 0.676 2.5 - - - - 
Rv0473  transmembrane protein  0.255 0.047 8.9 - - X - 
Rv0474  transcriptional regulator 0.3836 0.051 11.1 - - - - 
Rv0475 hbhA iron-regulated heparin binding hemagglutinin 1.1105 0.101 6.1 - - - - 
Rv0476  transmembrane protein  -0.977 0.277 6.3 X - X - 
Rv0479c  hypothetical protein  -0.5838 0.092 28.8 - - X - 
Rv0484c  short-chain type oxidoreductase  1.9622 0.084 2.9 - - - - 
Rv0487  hypothetical protein  0.497 0.048 2.6 - - - - 
Rv0490 senX3 
putative two component sensor histidine 
kinase 
-0.5793 0.099 12.9 
- - X - 
Rv0492c  oxidoreductase GMC-type  0.1548 0.651 9.5 - - - - 
Rv0493c  hypothetical protein  -0.3436 0.243 7.6 - - - - 
Rv0495c  hypothetical protein  -0.4955 0.493 4.4 - - - - 
Rv0496  hypothetical protein  -0.18 0.297 43.3 - - - - 
Rv0497  transmembrane protein  -0.3686 0.162 27.7 - - X - 
Rv0498  hypothetical protein  -0.7245 0.543 1.8 - - - - 
Rv0500 proC pyrroline-5-carboxylate reductase  -0.8091 0.186 3.9 - - - - 
Rv0500A  hypothetical protein  -1.0903 0.012 1.2 - - - - 
Rv0501 galE2 UDP-glucose 4-epimerase  -0.4332 0.208 29.9 - - - - 
Rv0502  hypothetical protein  -0.4432 0.07 13.9 - - - - 
Rv0503c 
cmaA2 
cyclopropane-fatty-acyl-phospholipid 
synthase 2 ( 
0.8614 0.03 8.1 
- - - - 
Rv0505c serB1 phosphoserine phosphatase  -0.8673 0.021 16.5 - - X - 
Rv0506 mmpS2 membrane protein  0.107 0.78 2.6 - - X - 
Rv0507 mmpL2 transmembrane transport protein MmpL2  -0.1704  0.7 - - X - 
Rv0509 hemA glutamyl-tRNA reductase  0.1848 0.53 14.5 - - - - 
Rv0511 hemD uroporphyrin-III C-methyltransferase 1.265 0.25 7.7 - - - - 
Rv0513  transmembrane protein  -0.1076 0.756 18.7 - - X - 
Rv0516c  hypothetical protein  1.9686 0.037 6.3 - - - - 
Rv0517  membrane acyltransferase  0.1766 0.884 3.1 - - X - 
Rv0523c  hypothetical protein  -0.291 0.338 29.0 - - - - 
Rv0524 hemL glutamate-1-semialdehyde aminotransferase  -0.6829 0.191 17.9 - - - - 
Rv0525  hypothetical protein  0.4678 0.239 16.7 - - - - 
Rv0526  thioredoxin protein  -0.643 0.126 26.2 X X - X 
Rv0528  transmembrane protein  -1.0916 0.103 12.1 - - X - 
Rv0529 ccsA cytochrome C-type biogenesis protein -0.5908 0.373 5.2 - - X - 
Rv0530  hypothetical protein  0.0868 0.555 46.1 - - - - 
Rv0531  hypothetical protein  0.2513 0.711 5.1 - - X - 
Rv0533c fabH 3-oxoacyl-(acyl carrier protein) synthase III  -1.9896 0.048 6.3 - - - - 
Rv0534c menA 
1,4-dihydroxy-2-naphthoate 
octaprenyltransferase  
-0.698 0.085 2.8 
- - X - 
Rv0537c  integral membrane protein  -0.6042 0.159 15.3 - - X - 
Rv0538  hypothetical protein  -1.5286 0.093 9.4 - - X - 
Rv0539  dolichyl-phosphate sugar synthase  -0.1379 0.414 1.6 - - - - 
Rv0540  hypothetical protein  2.352 0 2.4 - - - - 
Rv0543c  hypothetical protein  0.9097 0.016 1.7 - - - - 
Rv0544c  transmembrane protein  -0.3647 0.178 3.8 - - X - 
Rv0545c pitA inorganic phosphate transporter  -0.283 0.344 3.0 X - X - 
Rv0547c  short chain dehydrogenase  -0.2094 0.355 26.6 - - - - 
Rv0548c menB naphthoate synthase  -1.034 0.018 3.6 - - - - 
Rv0556  transmembrane protein  0.4589 0.073 12.7 - - X - 
Rv0558 ubiE 
ubiquinone/menaquinone biosynthesis 
methyltransferase  
0.5589 0.107 15.7 
- - - - 
Rv0559c  hypothetical protein  -0.3185 0.56 2.7 X - - - 
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Rv0561c  oxidoreductase  0.302 0.572 3.3 - - - - 
Rv0563 htpX heat shock protein -0.2586 0.704 10.0 - - X - 
Rv0565c  monooxygenase  -0.2526 0.517 7.4 - - X - 
Rv0566c  putative nucleotide-binding protein  -0.1698 0.746 4.3 - - - - 
Rv0567  methyltransferase/methylase  0.0328 0.913 21.2 - - - - 
Rv0568 
cyp135B
1 
cytochrome P450 135B1  0.3232 0.382 17.1 
- - - - 
Rv0570 nrdZ ribonucleoside-diphosphate reductase 3.1218 0.001 6.6 - - - - 
Rv0580c  
hypothetical protein  -0.6192 0.134 
102.
5 - - - - 
Rv0583c lpqN lipoprotein -0.4422 0.071 27.5 X - - X 
Rv0598c  hypothetical protein  0.3482 0.376 2.0 X - - - 
Rv0604 lpqO lipoprotein -0.9362 0.005 14.0 X - - X 
Rv0605  resolvase  0.1136 0.541 2.1 - - - - 
Rv0606  hypothetical protein  -1.1984 - 0.6 - - - - 
Rv0610c  hypothetical protein  -0.7948 0.456 2.8 - - - - 
Rv0613c  hypothetical protein  -0.0548 0.779 49.3 - - - - 
Rv0617  hypothetical protein  0.0048  0.3 - - - - 
Rv0618 galTa 
galactose-1-phosphate uridylyltransferase 
galTa  
0.1138 0.919 1.4 
- - - - 
Rv0625c  transmembrane protein  -1.2215 0.103 6.8 - - X - 
Rv0629c recD exonuclease V alpha chain  -0.4213 0.478 11.6 - - - - 
Rv0630c recB exonuclease V beta chain  0.8558 0.218 21.9 - - - - 
Rv0631c recC exonuclease V gamma chain  1.5026 0.102 11.1 - - - - 
Rv0632c echA3 enoyl-CoA hydratase  0.7328 0.065 38.1 - - - - 
Rv0633c  hypothetical protein  -0.6976 0.046 28.1 - - X - 
Rv0634c  glyoxalase II  0.0532 0.797 1.5 - - - - 
Rv0635 HadA  (3R)-hydroxyacyl-ACP dehydratase subunit  -1.098 0.116 12.6 - - - - 
Rv0636 HadB  (3R)-hydroxyacyl-ACP dehydratase subunit  0.3427 0.373 9.5 - - - - 
Rv0637  HadC  (3R)-hydroxyacyl-ACP dehydratase subunit -0.4446 0.482 19.5 - - - - 
Rv0638 secE preprotein translocase subunit SecE  -0.2768 0.234 26.8 - - X - 
Rv0639 nusG transcription antitermination protein NusG  0.2742 0.333 4.2 - - - - 
Rv0640 rplK 50S ribosomal protein L11  -0.1131 0.731 6.7 - - - - 
Rv0641 rplA 50S ribosomal protein L1  0.048 0.962 1.4 - - - - 
Rv0642c mmaA4 methoxy mycolic acid synthase  0.6825 0.199 11.2 - - - - 
Rv0643c mmaA3 methoxy mycolic acid synthase  -0.31 0.751 3.6 - - - - 
Rv0644c mmaA2 methoxy mycolic acid synthase  0.3143 0.365 10.7 - - - - 
Rv0646c lipG lipase/esterase -0.3372 0.265 14.0 - - - - 
Rv0647c  hypothetical protein  0.2773 0.263 20.6 - - - - 
Rv0651 rplJ 50S ribosomal protein L10  0.2278 0.468 14.1 - - - - 
Rv0652 rplL 50S ribosomal protein L7/L12  0.0328 0.934 11.2 - - - - 
Rv0654  dioxygenase  0.2584 0.845 1.2 - - - - 
Rv0655 mkl 
ribonucleotide ABC transporter ATP-binding  -0.8418 0.02 
108.
0 - - - - 
Rv0663 atsD arylsulfatase -0.1522 0.858 3.1 - - - - 
Rv0667 rpoB DNA-directed RNA polymerase subunit beta  -0.0008 0.994 59.7 - - - - 
Rv0668 rpoC 
DNA-directed RNA polymerase subunit beta'  -0.1108 0.508 
316.
1 - - - - 
Rv0669c  hydrolase  -0.5417 0.146 15.9 - - - - 
Rv0671 lpqP lipoprotein 1.4621 0.182 2.9 X - X X 
Rv0676c mmpL5 transmembrane transport protein MmpL5  0.3824 0.021 58.4 - - X - 
Rv0677c mmpS5 hypothetical protein  0.3756 0.201 22.1 - - X - 
Rv0678  hypothetical protein  -0.1024 0.77 17.9 - - - - 
Rv0679c  putative threonine rich protein  -0.667 0.224 4.1 X - - X 
Rv0681  TetR family transcriptional regulator  0.8045 0.339 1.1 - - - - 
Rv0682 rpsL 30S ribosomal protein S12  0.3562 0.309 37.6 - - - - 
Rv0683 rpsG 30S ribosomal protein S7  0.0546 0.726 26.2 - - - - 
Rv0684 fusA1 elongation factor G  0.279 0.301 22.2 - - - - 
Rv0685 tuf 
elongation factor Tu  -0.2138 0.386 
224.
8 - - - - 
Rv0686  hypothetical protein  -0.0946 0.526 99.6 - - X - 
Rv0687 fabG 3-ketoacyl-(acyl-carrier-protein) reductase  -0.1395 0.911 1.6 - - - - 
Rv0688  putative ferredoxin reductase  1.1712 0.433 1.5 - - - - 
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Rv0690c  hypothetical protein  0.2884 0.407 6.9 - - - - 
Rv0691c  transcriptional regulator 1.1137 0.019 1.1 - - - - 
Rv0694 lldD1 L-lactate dehydrogenase (cytochrome) -0.5048 0.336 15.2 - - - - 
Rv0695  hypothetical protein  1.8843 0.006 2.3 - - - - 
Rv0696  membrane sugar transferase  -0.2662 0.487 20.7 - - X - 
Rv0700 rpsJ 30S ribosomal protein S10  0.7416 0.048 58.2 - - - - 
Rv0701 rplC 50S ribosomal protein L3  1.07 0.042 10.7 - - - - 
Rv0702 rplD 50S ribosomal protein L4  0.7682 0.07 6.0 - - - - 
Rv0703 rplW 50S ribosomal protein L23  0.5907 0.17 7.9 - - - - 
Rv0704 rplB 50S ribosomal protein L2  0.5464 0.025 52.9 - - - - 
Rv0705 rpsS 30S ribosomal protein S19  0.9102 0 13.3 - - - - 
Rv0706 rplV 50S ribosomal protein L22  0.5564 0.252 5.3 - - - - 
Rv0707 rpsC 
30S ribosomal protein S3  -0.1758 0.206 
110.
8 - - - - 
Rv0708 rplP 50S ribosomal protein L16  1.1266 0.02 12.7 - - - - 
Rv0709 rpmC 50S ribosomal protein L29  -0.4214 0.532 2.1 - - - - 
Rv0710 rpsQ 30S ribosomal protein S17  -0.2414 0.411 11.6 X - - - 
Rv0713  transmembrane protein  -0.5918 0.015 29.4 - - X - 
Rv0714 rplN 50S ribosomal protein L14  0.991 0.028 9.7 - - - - 
Rv0715 rplX 50S ribosomal protein L24  1.4092 0.049 7.1 - - - - 
Rv0716 rplE 50S ribosomal protein L5  0.026 0.919 17.1 - - - - 
Rv0717 rpsN 30S ribosomal protein S14  0.2513 0.661 4.3 - - - - 
Rv0718 rpsH 30S ribosomal protein S8  0.5934 0.25 10.0 - - - - 
Rv0719 rplF 50S ribosomal protein L6  0.6411 0.142 30.8 - - - - 
Rv0720 rplR 50S ribosomal protein L18  0.0227 0.946 12.4 - - - - 
Rv0721 rpsE 30S ribosomal protein S5  -1.5274 0.214 33.3 - - - - 
Rv0722 rpmD 50S ribosomal protein L30  -0.088 0.862 4.1 - - - - 
Rv0723 rplO 50S ribosomal protein L15  -0.3006 0.409 5.5 - - - - 
Rv0724 sppA protease IV 0.2174 0.664 26.2 - - - - 
Rv0728c serA2 D-3-phosphoglycerate dehydrogenase  -1.997 0.002 5.2 - - - - 
Rv0729 xylB D-xylulose kinase 0.302 0.317 2.4 - - - - 
Rv0730  hypothetical protein  0.7263 0.252 2.9 - - - - 
Rv0732 secY preprotein translocase subunit SecY  -0.0571 0.76 40.9 - - X - 
Rv0733 adk adenylate kinase  1.1163 0.239 2.0 - - - - 
Rv0734 mapA methionine aminopeptidase  -0.4624 0.572 5.5 - - - - 
Rv0735 sigL RNA polymerase sigma factor -0.7722 0.289 6.3 - - - - 
Rv0737  transcriptional regulator 0.0738 0.861 6.4 - - - - 
Rv0744c  transcriptional regulator 0.0328 0.95 9.1 - - - - 
Rv0751c mmsB 3-hydroxyisobutyrate dehydrogenase 0.1136 0.541 1.4 - - - - 
Rv0756c  hypothetical protein  0.0204 0.961 13.0 - - - - 
Rv0757 phoP 
two component system response 
transcriptional positive regulator 
1.0316 0.058 13.4 
- - - - 
Rv0758 phoR 
two component system response sensor 
kinase membrane associated 
-0.3492 0.044 25.8 
- - X - 
Rv0759c  hypothetical protein  -0.2574 0.394 13.3 - - - - 
Rv0760c  hypothetical protein  0.1636 0.594 3.7 - - - - 
Rv0761c adhB zinc-containing alcohol dehydrogenase -0.4388 0.582 6.2 - - - - 
Rv0769  short chain dehydrogenase  0.438 0.741 1.8 - - - - 
Rv0771  4-carboxymuconolactone decarboxylase  -0.4214 0.453 4.1 - - - - 
Rv0774c  hypothetical protein  1.5764 0.112 1.4 X X X - 
Rv0775  hypothetical protein  -0.0745 0.929 1.3 - - - - 
Rv0777 purB adenylosuccinate lyase  0.113 0.835 4.0 - - - - 
Rv0778 cyp126 cytochrome P450 126  -1.802 0.001 11.6 - - - - 
Rv0779c  transmembrane protein  0.302 0.122 12.0 - - X - 
Rv0781 ptrBa oligopeptidase B  -0.3844 0.285 4.1 - - - - 
Rv0785  putative FAD-binding dehydrogenase  -0.2226 0.34 10.0 - - - - 
Rv0788 purQ phosphoribosylformylglycinamidine synthase I  2.0994 0.054 5.3 - - - - 
Rv0790c  hypothetical protein  0.2544 0.503 1.0 - - - - 
Rv0792c  GntR family transcriptional regulator  0.0232 0.959 8.6 - - - - 
Rv0794c  oxidoreductase  1.5313 0.138 2.4 - - - - 
Rv0798c cfp29 29 kDa antigen 0.6982 0.057 27.4 - - - - 
Rv0799c  hypothetical protein  -0.6773 0.015 3.8 - - - - 
Rv0801  hypothetical protein  0.7626 0.037 4.2 - - - - 
252 
 
Rv0802c  hypothetical protein  1.862 0.036 1.0 - - - - 
Rv0808 purF amidophosphoribosyltransferase  -0.9404 0.006 1.4 - - - - 
Rv0809 purM phosphoribosylaminoimidazole synthetase  0.039 0.89 6.6 - - - - 
Rv0817c  hypothetical protein  0.836 0.187 10.6 X - X - 
Rv0818  transcriptional regulator -0.1054 0.638 38.2 - - - - 
Rv0820 phoT 
phosphate ABC transporter ATP-binding 
protein  
0.1068 0.837 30.6 
- - - - 
Rv0821c phoY2 phosphate transport regulator  0.5935 0.182 6.4 - - - - 
Rv0822c  hypothetical protein  0.8646 0.085 2.8 - - - - 
Rv0824c desA1 acyl-[acyl-carrier protein] desaturase  0.5886 0.215 10.1 - - - - 
Rv0825c  hypothetical protein  0.1782 0.132 28.8 - - - - 
Rv0831c  hypothetical protein  -0.1622 0.83 12.7 - - - - 
Rv0835 lpqQ lipoprotein -0.607 0.207 1.3 X - - X 
Rv0845  two component sensor kinase  -1.8484 0.004 6.2 - - X - 
Rv0846c  oxidase  -0.4214 0.014 8.1 - X - X 
Rv0851c  short chain dehydrogenase  -0.1698 0.803 2.2 - - - - 
Rv0852 fadD16 fatty-acid-CoA ligase  0.0562 0.937 3.3 - - - - 
Rv0854  hypothetical protein  -0.4955 0.054 5.5 - - - - 
Rv0855 far fatty-acid-CoA racemase  -0.3345 0.632 2.0 - - - - 
Rv0859 fadA acetyl-CoA acetyltransferase  0.0524 0.869 8.8 - - - - 
Rv0860 fadB fatty oxidation protein 3.0943 0.004 17.6 - - - - 
Rv0861c ercC3 DNA helicase   1.0775 0.026 10.9 - - - - 
Rv0862c  hypothetical protein  0.514 0.179 47.0 - - - - 
Rv0864 moaC molybdenum cofactor biosynthesis protein C  -0.4123 0.731 1.9 - - - - 
Rv0866 moaE2 molybdenum cofactor biosynthesis protein E2  0.302 0.317 2.4 - - - - 
Rv0869c moaA molybdenum cofactor biosynthesis protein A  0.302 0.317 1.2 - - - - 
Rv0870c  hypothetical protein  0.4404 0.365 6.2 - - X - 
Rv0871 cspB cold shock-like protein B 1.4533 0.202 1.3 - - - - 
Rv0873 fadE10 acyl-CoA dehydrogenase  -0.3248 0.101 57.4 - - - - 
Rv0874c  hypothetical protein  0.5364 0.287 1.5 - - - - 
Rv0875c  hypothetical protein  -0.8598 0.174 4.8 - - X - 
Rv0879c  transmembrane protein  -0.4214 0.091 2.5 - - X - 
Rv0880  MarR family transcriptional regulator  1.012 0.025 1.1 - - - - 
Rv0881  rRNA methyltransferase  -0.4478 0.264 1.2 - - - - 
Rv0885  hypothetical protein  -0.3648 0.538 9.3 - - - - 
Rv0886 fprB NADPH:adrenodoxin oxidoreductase FprB  0.0738 0.74 7.5 - - - - 
Rv0888  hypothetical protein  -0.4018 0.324 9.9 X - X - 
Rv0890c  LuxR family transcriptional regulator  0.5126 0.176 15.1 - X - - 
Rv0892  monooxygenase  0.0048  0.7 X - X - 
Rv0896 gltA type II citrate synthase  0.2454 0.719 7.8 - - - - 
Rv0899 ompA outer membrane protein A -0.2746 0.203 23.1 - - X - 
Rv0900  hypothetical protein  -0.4236 0.538 1.7 - - X - 
Rv0901  hypothetical protein  -0.661 0.104 5.2 - - X - 
Rv0902c prrB two component sensor histidine kinase PRRB  -0.678 0.021 30.2 - - X - 
Rv0903c prrA 
two component response transcriptional 
regulatory protein PRRA  
1.7033 0.219 1.7 
- - - - 
Rv0904c accD3 acetyl-coenzyme A carboxylase  0.9097 0.016 0.9 - - - - 
Rv0905 echA6 enoyl-CoA hydratase  0.1898 0.703 6.1 - - - - 
Rv0906  hypothetical protein  -0.7756 0.064 15.1 X - - - 
Rv0907  hypothetical protein  0.3471 0.777 4.0 - - - - 
Rv0908 ctpE metal cation transporter ATPase P-type -0.6292 0.318 11.2 - - X - 
Rv0910  hypothetical protein  1.6445 0.001 3.3 - - - - 
Rv0911  hypothetical protein  -0.076 0.911 2.9 - - - - 
Rv0914c  acetyl-CoA acetyltransferase  -0.0498 0.832 19.3 - - - - 
Rv0921  resolvase  -0.667 0.265 4.6 - - - - 
Rv0923c  hypothetical protein  -0.1182 0.786 13.7 - - - - 
Rv0925c  hypothetical protein  0.7827 0.203 1.4 - - - - 
Rv0927c  short chain dehydrogenase  -1.073 0.094 3.3 - - - - 
Rv0928 pstS3 periplasmic phosphate-binding lipoprotein  0.4424 0.008 9.7 X - - X 
Rv0931c pknD 
transmembrane serine/threonine-protein 
kinase  
-0.6422 0.045 
105.
8 - - X - 
Rv0932c pstS2 periplasmic phosphate-binding lipoprotein  -0.7332 0.224 26.8 X - - X 
Rv0933 pstB phosphate ABC transporter ATP-binding 0.1436 0.521 52.3 - - - X 
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protein  
Rv0934 pstS1 
periplasmic phosphate-binding lipoprotein  #NUM! 0.081 
137.
4 X - - X 
Rv0935 pstC1 phosphate ABC transporter transmembrane  -0.6573 0.027 5.9 - - X - 
Rv0936 pstA2 phosphate ABC transporter transmembrane  0.4538 0.115 8.0 - - X - 
Rv0938  ATP-dependent DNA ligase  -0.2226 0.758 5.4 - - - - 
Rv0939  
2-hydroxyhepta-2,4-diene-1,7-dioate 
isomerase  
-0.1656 0.78 12.2 
- - - - 
Rv0949 uvrD1 ATP-dependent DNA helicase II 0.5646 0.186 13.7 - - - - 
Rv0951 sucC succinyl-CoA synthetase subunit beta  1.4092 0.062 3.7 - - - - 
Rv0952 sucD succinyl-CoA synthetase subunit alpha  0.5636 0.376 13.1 - - - - 
Rv0954  transmembrane protein  -0.0543 0.558 27.6 - - X - 
Rv0955  integral membrane protein  -0.0534 0.977 1.1 - - X - 
Rv0957 purH 
phosphoribosylaminoimidazolecarboxamide 
formyltransferase/IMP cyclohydrolase 
-0.412 0.592 3.7 
- - - - 
Rv0958  magnesium chelatase  -0.4372 0.068 29.0 - - - - 
Rv0959  hypothetical protein  0.8958 0.003 31.2 - - - - 
Rv0966c  hypothetical protein  -0.088 0.715 32.0 - - - - 
Rv0968  hypothetical protein  -0.4094 0.396 3.2 - - - - 
Rv0969 CtpV  metal cation transporter P-type ATPase  -0.472 0.055 16.6 - - X - 
Rv0972c fadE12 acyl-CoA dehydrogenase  1.497 0.001 2.1 - - - - 
Rv0979A rpmF 50S ribosomal protein L32  0.5562 0.225 12.7 - - - - 
Rv0981 mprA 
two component response transcriptional 
regulatory protein 
-0.1838 0.506 13.9 
- - - - 
Rv0982 mprB two component sensor kinase -0.945 0.034 15.9 - - X - 
Rv0983 pepD serine protease -0.2987 0.431 16.3 - - X - 
Rv0984 moaB2 pterin-4-alpha-carbinolamine dehydratase  0.0428 0.913 8.5 - - - - 
Rv0985c mscL large-conductance mechanosensitive channel  0.2464 0.099 30.5 - - X - 
Rv0986  adhesion component transport ATP-binding  -0.6646 0.199 9.5 - - - - 
Rv0987  
adhesion component transport 
transmembrane  
-1.667 0.085 3.9 
- - X - 
Rv0988  hypothetical protein  -0.2067 0.47 10.6 - - X - 
Rv0992c  hypothetical protein  0.8407 0.054 1.3 - - - - 
Rv0993 galU UTP--glucose-1-phosphate uridylyltransferase -0.5994 0.004 18.2 - - - - 
Rv0994 moeA1 molybdopterin biosynthesis protein 0.1232 0.542 19.5 - - - - 
Rv0995 rimJ ribosomal-protein-alanine acetyltransferase  0.9044 0.068 4.1 - - - - 
Rv0999  hypothetical protein  1.2238 0.004 14.9 - - - - 
Rv1001 arcA arginine deiminase  -0.58  0.8 - - - - 
Rv1002c  hypothetical protein  0.3697 0.135 5.6 - - X - 
Rv1003  hypothetical protein  0.4505 0.266 0.9 - - - - 
Rv1006  hypothetical protein  -0.4498 0.084 81.9 X - - - 
Rv1007c metG methionyl-tRNA synthetase  -0.9404 0.006 2.9 - - - - 
Rv1013 pks16 acyl-CoA synthetase  -0.563 0.106 23.1 - - - - 
Rv1015c rplY 
50S ribosomal protein L25/general stress 
protein  
0.8531 0.537 1.9 
- - - - 
Rv1016c lpqT lipoprotein -0.875 0.126 6.5 X - - X 
Rv1017c prsA ribose-phosphate pyrophosphokinase  0.5428 0.062 35.6 - - - - 
Rv1019  TetR family transcriptional regulator  2.0367 0.021 2.9 - - - - 
Rv1020 mfd 
transcription-repair coupling factor Mfd 
(TRCF)  
-0.2224 0.756 18.3 
- - - - 
Rv1021  
nucleoside triphosphate 
pyrophosphohydrolase  
1.3586 0.056 5.4 
- - - - 
Rv1022 lpqU lipoprotein -0.4954 0.464 5.8 X - X X 
Rv1023 eno phosphopyruvate hydratase  -0.311 0.4 24.4 - - - - 
Rv1024  hypothetical protein  0.7736 0.148 6.6 - X - - 
Rv1028c kdpD sensor protein KDPD  0.0992 0.794 23.9 - - X - 
Rv1030 kdpB potassium-transporting ATPase subunit B  -0.7689 0.027 6.6 - - X - 
Rv1031 kdpC potassium-transporting ATPase subunit C  -0.2521 0.402 3.8 - - X - 
Rv1033c trcR two component transcriptional regulator 1.9494 0.052 3.7 - - - - 
Rv1045  hypothetical protein  0.6354 0.24 2.3 - - - - 
Rv1050  oxidoreductase  0.1832 0.514 13.8 - - - - 
Rv1056  hypothetical protein  0.4092 0.625 3.5 - - - - 
Rv1060  hypothetical protein  0.6784 0.043 15.5 - - - - 
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Rv1063c  hypothetical protein  -0.698 0.057 1.8 - - - - 
Rv1069c  hypothetical protein  -0.7932 0.487 8.8 - - X - 
Rv1070c echA8 enoyl-CoA hydratase  -1.1847 0.287 2.0 - - - - 
Rv1072  transmembrane protein  -0.5104 0.078 22.4 - - X - 
Rv1077 cbs cystathionine beta-synthase  -1.1379 0.059 0.9 - - - - 
Rv1078 pra proline-rich antigen  0.0964 0.502 66.4 - - X - 
Rv1081c  hypothetical protein  -0.9404 0.006 1.4 - - X - 
Rv1085c  hemolysin-like protein  0.6136 0.609 1.9 - - X - 
Rv1086  
short (C15) chain Z-isoprenyl diphosphate 
synthase  
0.6406 0.091 15.8 
- - - - 
Rv1092c coaA pantothenate kinase  -1.0337 0.342 3.8 - - - - 
Rv1093 glyA serine hydroxymethyltransferase  -0.5924 0.053 26.9 - - - - 
Rv1095 phoH2 PhoH-like protein -0.2142 0.652 8.1 - - - - 
Rv1096  glycosyl hydrolase  0.338 0.35 25.2 - - X - 
Rv1097c  hypothetical protein  -0.7366 0.1 12.4 - - X - 
Rv1098c fumC fumarate hydratase  -0.472 0.689 4.3 - - - - 
Rv1100  hypothetical protein  -0.1314 0.394 14.7 - - X - 
Rv1101c  hypothetical protein  -0.6984 0.035 29.5 - - X - 
Rv1106c  cholesterol dehydrogenase  -0.5408 0.365 14.8 - - - - 
Rv1109c  hypothetical protein  -0.2032 0.223 20.7 - - - - 
Rv1111c  hypothetical protein  -0.7722 0.051 4.2 - - X - 
Rv1118c  hypothetical protein  0.8307 0.158 6.3 - - - - 
Rv1121 zwf1 glucose-6-phosphate 1-dehydrogenase  -0.0314 0.939 1.4 - - - - 
Rv1124 ephC epoxide hydrolase 0.5832 0.457 11.9 - - - - 
Rv1125  hypothetical protein  0.862 0.077 0.7 - - - - 
Rv1129c  transcriptional regulator 0.1924 0.487 10.8 - - - - 
Rv1130  hypothetical protein  -0.3626 0.22 59.8 - - - - 
Rv1131 gltA1 citrate synthase  1.0252 0.104 6.5 - - - - 
Rv1132  hypothetical protein  -1.4204 0.14 20.4 - - X - 
Rv1133c metE 
5-methyltetrahydropteroyltriglutamate--
homocysteine S-methyltransferase  
1.3008 0 51.3 
- - - - 
Rv1138c  oxidoreductase  -0.088 0.861 4.1 - - - - 
Rv1140  integral membrane protein  1.1096 0.078 12.1 - - X - 
Rv1141c echA11 enoyl-CoA hydratase  0.386 0.704 9.5 - - - - 
Rv1144  short-chain type dehydrogenase/reductase  -0.7976 0.496 11.8 - - - - 
Rv1152  transcriptional regulator 0.2628 0.342 9.4 - - - - 
Rv1153c omt O-methyltransferase  -0.6465 0.074 6.5 - - - - 
Rv1154c  hypothetical protein  0.8519 0.28 2.5 - - - - 
Rv1160 mutT2 7,8-dihydro-8-oxoguanine-triphosphatase  1.0781 0.163 4.6 - - - - 
Rv1161 narG 
respiratory nitrate reductase subunit alpha 0.3273 0.413 
121.
8 - - - - 
Rv1162 narH respiratory nitrate reductase subunit beta -0.0199 0.944 25.5 - - - - 
Rv1163 narJ respiratory nitrate reductase subunit delta 0.9427 0.008 11.0 - - - - 
Rv1164 narI respiratory nitrate reductase subunit gamma 0.828 0.028 18.8 - - X - 
Rv1165 typA GTP-binding translation elongation factor -1.5832 0.058 4.7 - - - - 
Rv1166 lpqW lipoprotein 0.051 0.884 21.7 X - - X 
Rv1167c  transcriptional regulator 1.148 0.001 8.6 - - - - 
Rv1168c PPE17 PPE family protein  -0.6104 0.323 2.6 - - - - 
Rv1169c PE11 PE family protein  1.0048 - 0.5 - - - - 
Rv1172c PE12 PE family protein  0.088 0.88 2.4 - - - - 
Rv1173 fbiC FO synthase  -0.163 0.625 9.6 - - - - 
Rv1175c fadH NADPH dependent 2,4-dienoyl-CoA reductase  -0.0464 0.721 69.5 - - - - 
Rv1176c  hypothetical protein  0.8634 0.132 8.7 - - - - 
Rv1177 fdxC ferredoxin FdxC  1.3011 0.269 1.7 - - - - 
Rv1178  N-succinyldiaminopimelate aminotransferase  -0.7553 0.207 4.1 - - - - 
Rv1179c  hypothetical protein  0.3184 0.253 47.0 - - - - 
Rv1180 pks3 
polyketide beta-ketoacyl synthase 0.5753 0.001 
100.
1 - - - - 
Rv1181 pks4 
polyketide beta-ketoacyl synthase 0.3144 0.014 
409.
4 - - - - 
Rv1182 papA3 polyketide synthase associated protein  0.139 0.186 16.8 - - - - 
Rv1183 
mmpL1
0 
transmembrane transport protein MmpL10  0.1072 0.818 37.2 
X - X - 
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Rv1184c  hypothetical protein  -0.3102 0.662 11.1 X - X - 
Rv1185c fadD21 acyl-CoA synthetase  0.706 0.142 9.4 - - - - 
Rv1186c  hypothetical protein  -0.148 0.782 14.5 - - - - 
Rv1188  proline dehydrogenase  -1.1354 0.027 3.2 - - - - 
Rv1190  hypothetical protein  -0.4252 0.519 10.1 - - - - 
Rv1191  hypothetical protein  -0.0404 0.921 31.2 - - - - 
Rv1192  hypothetical protein  -0.2126 0.474 17.4 - - - - 
Rv1193 fadD36 acyl-CoA synthetase  0.5536 0.225 3.4 - - - - 
Rv1194c  hypothetical protein  -0.4054 0.285 13.2 - - - - 
Rv1196 PPE18 PPE family protein  -0.9946 0.125 7.6 - - - - 
Rv1201c  transferase  -0.2036 0.497 15.9 - - - - 
Rv1204c  hypothetical protein  -0.4814 0.446 20.2 - - - - 
Rv1206 fadD6 acyl-CoA synthetase  -0.0358 0.893 40.1 - - - - 
Rv1207 folP2 dihydropteroate synthase 2 -0.449 0.275 5.8 - - - - 
Rv1209  hypothetical protein  0.692 0.144 11.0 - - X - 
Rv1211  hypothetical protein  1.5898 - 0.7 - - - - 
Rv1215c  hypothetical protein  0.5906 0.465 11.1 - - - - 
Rv1216c  integral membrane protein  0.3396 0.14 26.8 - - X - 
Rv1217c  
tetronasin-transport integral membrane 
protein  
0.738 0.053 33.7 
- - X - 
Rv1218c  tetronasin-transport ATP-binding protein ABC  0.7154 0.014 57.6 - - - - 
Rv1223 htrA 
serine protease -0.2098 0.218 
153.
4 - - X - 
Rv1226c  hypothetical protein  0.0048  0.7 - - X - 
Rv1227c  hypothetical protein  -0.1104 0.737 11.5 - - X - 
Rv1228 lpqX lipoprotein -1.2752 0.241 3.1 - - - X 
Rv1229c mrp MRP family ATP-binding protein  0.4613 0.332 14.5 - - - - 
Rv1231c  hypothetical protein  -0.479 0.166 26.7 - - X - 
Rv1232c  hypothetical protein  -1.445 0.047 8.1 - - - - 
Rv1234  hypothetical protein  0.6238 0.165 25.1 - - X - 
Rv1235 lpqY sugar-binding lipoprotein -0.2372 0.27 25.7 X - - X 
Rv1237 sugB 
sugar-transport integral membrane protein 
ABC  
-0.0214 0.94 7.1 
- - X - 
Rv1238 sugC sugar-transport ATP-binding protein ABC  -0.116 0.726 22.0 - - - - 
Rv1239c corA magnesium/cobalt transporter 0.0142 0.96 24.9 - - X - 
Rv1244 lpqZ lipoprotein -0.314 0.69 5.2 X - - X 
Rv1245c  short-chain type dehydrogenase/reductase  -0.5614 0.145 43.3 - - - - 
Rv1247c  hypothetical protein  0.0366 0.916 5.6 - - - - 
Rv1248c kgd alpha-ketoglutarate decarboxylase  0.3582 0.355 27.8 - - - - 
Rv1249c  hypothetical protein  1.1986 0.131 3.3 - - X - 
Rv1252c lprE lipoprotein -0.503 0.566 2.7 X - - X 
Rv1253 deaD cold-shock DEAD-box protein A  0.2622 0.611 32.9 - - - - 
Rv1254  acyltransferase -0.1762 0.669 2.5 - - X - 
Rv1255c  transcriptional regulator -0.1698 0.675 4.2 - - - - 
Rv1259  hypothetical protein  -1.0362 0.044 0.9 - - - - 
Rv1261c  hypothetical protein  0.6536 0.074 34.9 - - - - 
Rv1262c  HIT-like protein  1.107 0.202 5.4 - - - - 
Rv1263 amiB2 amidase  -0.2635 0.597 13.3 - - - - 
Rv1264  adenylyl cyclase  -0.5794 0.163 3.9 - - - - 
Rv1265  hypothetical protein  0.4168 0.255 10.2 - - - - 
Rv1266c pknH 
transmembrane serine/threonine-protein 
kinase H  
-0.4281 0.079 41.2 
- - X - 
Rv1269c  hypothetical protein  -1.0238 0.115 6.6 X X - - 
Rv1270c lprA 
lipoprotein -0.309 0.148 
121.
3 X - X X 
Rv1272c  
drugs-transport transmembrane ATP-binding 
protein ABC transporter  
-0.667 0.164 8.1 
- - X - 
Rv1274 lprB lipoprotein 1.1946 0.024 6.4 X - - X 
Rv1275 lprC lipoprotein 0.2462 0.197 21.1 X - - X 
Rv1278  hypothetical protein  1.0868 0.03 14.6 - - - - 
Rv1279  dehydrogenase FAD flavoprotein  -0.2874 0.327 25.2 - - - - 
Rv1280c oppA periplasmic oligopeptide-binding lipoprotein -1.0478 0.001 22.5 - X X X 
Rv1281c oppD oligopeptide-transport ATP-binding protein -0.0404 0.892 52.5 - - - - 
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ABC  
Rv1283c oppB 
oligopeptide-transport integral membrane 
protein  
-0.0645 0.934 5.2 
- - X - 
Rv1284  hypothetical protein  1.4947 0.006 1.0 - - - - 
Rv1285 cysD sulfate adenylyltransferase subunit 2  0.1811 0.859 3.0 - - - - 
Rv1286 cysN 
bifunctional sulfate adenylyltransferase 
subunit 1  
-0.4376 0.13 15.8 
- - - - 
Rv1288  hypothetical protein  -0.5469 0.045 28.5 - - - - 
Rv1290c  hypothetical protein  1.0531 0.028 1.1 - X X - 
Rv1294 thrA homoserine dehydrogenase  0.2318 0.554 17.7 - - - - 
Rv1297 rho transcription termination factor Rho  -0.0612 0.851 49.9 - - - - 
Rv1304 atpB F0F1 ATP synthase subunit A  0.1508 0.538 26.8 - - X - 
Rv1306 atpF F0F1 ATP synthase subunit B  0.0746 0.643 60.1 - - X - 
Rv1307 atpH 
F0F1 ATP synthase subunit delta  -0.5629 0.368 
131.
7 - - X - 
Rv1308 atpA 
F0F1 ATP synthase subunit alpha  -0.2608 0.471 
333.
1 - - - - 
Rv1309 atpG 
F0F1 ATP synthase subunit gamma  0.123 0.578 
150.
0 - - - - 
Rv1310 atpD 
F0F1 ATP synthase subunit beta  -0.556 0.113 
204.
3 - - - - 
Rv1311 atpC F0F1 ATP synthase subunit epsilon  0.7152 0.036 22.9 - - - - 
Rv1312  hypothetical protein  0.1226 0.4 15.7 - - X - 
Rv1314c  hypothetical protein  0.9515 0.17 0.9 - - - - 
Rv1316c ogt -cysteine methyltransferase  0.6354 0.478 5.0 - - - - 
Rv1319c  adenylate cyclase  -0.607 0.207 2.5 - - X - 
Rv1320c  adenylate cyclase  -1.5118 0.004 3.9 - - X - 
Rv1321  hypothetical protein  -0.0413 0.917 8.0 - - - - 
Rv1327c glgE glucanase -0.698 0.105 14.3 - - - - 
Rv1328 glgP glycogen phosphorylase GlgP  0.7288 0.345 15.0 - - - - 
Rv1331 clpS ATP-dependent Clp protease adaptor protein 0.0742 0.877 3.2 - - - - 
Rv1332  transcriptional regulator 0.107 0.738 2.6 - - - - 
Rv1333  hydrolase  -0.0543 0.879 2.0 - - - - 
Rv1335 CFP10A  9.5 kDa culture filtrate antigen 0.0048  0.7 - - - - 
Rv1337  integral membrane protein  0.1136 0.541 1.4 - - X - 
Rv1338 murI glutamate racemase  1.5825 0.013 5.0 - - - - 
Rv1348  
drugs-transport transmembrane ATP-binding 
protein ABC transporter  
-0.7045 0.131 1.4 
- - X - 
Rv1362c  hypothetical protein  -0.0978 0.735 14.5 - - X - 
Rv1363c  hypothetical protein  -0.9352 0.001 19.5 - - X - 
Rv1368 lprF lipoprotein 0.5293 0.037 55.3 X - X X 
Rv1373  glycolipid sulfotransferase  0.7736 0.399 3.8 - - - - 
Rv1376  hypothetical protein  -0.0486 0.882 1.1 - - - - 
Rv1379 pyrR uracil phosphoribosyltransferase  0.7116 0.027 5.7 - - - - 
Rv1380 pyrB 
aspartate carbamoyltransferase catalytic 
subunit  
-1.1472 0.006 15.6 
- - - - 
Rv1382  export or membrane protein  -0.2244 0.099 11.3 - - X - 
Rv1383 carA carbamoyl phosphate synthase small subunit  1.1832 0.011 4.0 - - - - 
Rv1384 carB carbamoyl phosphate synthase large subunit  1.1218 0.065 14.9 - - - - 
Rv1386 PE15 PE family protein  -0.8136 0.053 2.1 - - - - 
Rv1387 PPE20 PPE family protein  -0.5368 0.024 21.7 - - - - 
Rv1388 mihF putative integration host factor -0.1307 0.817 15.3 - - - - 
Rv1391 dfp phosphopantothenoylcysteine decarboxylase -1.497 0.011 5.5 - - - - 
Rv1392 metK S-adenosylmethionine synthetase  0.3613 0.419 11.7 - - - - 
Rv1393c  monoxygenase  -0.2614 0.221 14.4 - - - - 
Rv1394c cyp132 cytochrome P450 132  -0.64 0.118 4.8 - - - - 
Rv1397c  hypothetical protein  1.107 0.285 3.0 - - - - 
Rv1398c  hypothetical protein  0.1326 0.51 4.5 - - - - 
Rv1399c lipH lipase 0.2544 0.503 2.1 - - - - 
Rv1400c lipI lipase 0.1045 0.727 14.1 - - - - 
Rv1401  hypothetical protein  1.1137 0.019 1.1 - - X - 
Rv1404  transcriptional regulator 0.1036 0.694 12.9 - - - - 
Rv1407 fmu Fmu protein (SUN protein)  -1.147 0.351 2.8 - - - - 
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Rv1409 ribG Probable bifunctional riboflavin biosynthesis  -0.277 0.647 7.1 - - - - 
Rv1410c  
aminoglycosides/tetracycline-transport 
integral  
-0.6584 0.602 14.4 
- - X - 
Rv1411c lprG lipoprotein -0.0143 0.91 60.3 X - - X 
Rv1412 ribC riboflavin synthase subunit alpha  1.0662 0.058 6.2 - - - - 
Rv1417  hypothetical protein  0.144 0.661 5.3 - - X - 
Rv1418 lprH lipoprotein -0.7945 0.087 5.5 X - X X 
Rv1421  hypothetical protein  0.3736 0.318 15.4 - - - - 
Rv1422  hypothetical protein  1.0596 0.004 1.3 - - - - 
Rv1423 whiA transcriptional regulator 1.1254 0.061 15.4 - - - - 
Rv1424c  hypothetical protein  0.1636 0.584 7.6 - - - - 
Rv1425  hypothetical protein  -0.1127 0.587 21.4 - - - - 
Rv1426c lipO esterase -1.1127 0.006 2.5 X - X - 
Rv1427c fadD12 acyl-CoA synthetase  -0.2941 0.425 27.0 - - - - 
Rv1428c  hypothetical protein  -0.7018 0.156 9.0 - - - - 
Rv1429  hypothetical protein  -0.1584 0.829 5.7 - - - - 
Rv1431  hypothetical protein  -0.9437 0.176 3.0 - - X - 
Rv1436 gap glyceraldehyde-3-phosphate dehydrogenase  -0.1016 0.178 8.9 - - - - 
Rv1442 bisC biotin sulfoxide reductase  0.6656 0.022 16.6 - - - - 
Rv1443c  hypothetical protein  -0.2274 0.134 21.8 - - - - 
Rv1444c  hypothetical protein  0.3896 0.395 7.5 - - - - 
Rv1446c opcA putative OXPP cycle protein -0.0952 0.806 25.2 - - - - 
Rv1447c zwf2 glucose-6-phosphate 1-dehydrogenase  0.5152 0.465 12.2 - - - - 
Rv1449c tkt transketolase  0.6488 0.123 3.8 - - - - 
Rv1454c qor quinone reductase  0.107 0.849 1.7 - - - - 
Rv1455  hypothetical protein  0.0231 0.965 8.4 - - - - 
Rv1457c  unidentified antibiotic-transport integral  0.1136 0.541 0.7 - - X - 
Rv1458c  unidentified antibiotic-transport ATP-binding  -0.3761 0.218 25.4 - - - - 
Rv1459c  integral membrane protein  -0.698 0.461 4.5 - - X - 
Rv1461  hypothetical protein  0.588 0.456 4.8 - - - - 
Rv1462  hypothetical protein  -1.802 0.001 2.3 - - - - 
Rv1463  ABC transporter ATP-binding protein  1.9777 0.003 2.6 - - - - 
Rv1464 csd cysteine desulfurase  -1.5526 0.178 5.3 - - - - 
Rv1470 trxA thioredoxin TRXA  1.2431 0.246 1.6 - - - - 
Rv1472 echA12 enoyl-CoA hydratase  0.5395 0.382 16.9 - - - - 
Rv1473  
macrolide ABC transporter ATP-binding 
protein  
0.3928 0.189 3.3 
- - - - 
Rv1474c  transcriptional regulator -0.1076 0.676 12.7 - - - - 
Rv1476  hypothetical protein  0.1913 0.068 24.7 - - X - 
Rv1479 moxR1 transcriptional regulator -0.2554 0.467 77.8 - - - - 
Rv1480  hypothetical protein  0.9896 0.104 10.8 - - - - 
Rv1481  hypothetical protein  -0.7714 0.069 23.1 - - X - 
Rv1483 fabG1 3-oxoacyl-[acyl-carrier protein] reductase 0.4404 0.522 4.2 - - - - 
Rv1484 inhA enoyl-(acyl carrier protein) reductase  0.3246 0.694 3.8 - - - - 
Rv1486c  hypothetical protein  -0.2824 0.271 11.2 - - - - 
Rv1487  hypothetical protein  -0.034 0.957 2.7 - - X - 
Rv1488  
hypothetical protein  -0.3374 0.228 
180.
8 - - X - 
Rv1489  hypothetical protein  1.93 0 10.3 - - X - 
Rv1498A  hypothetical protein  1.1357 0.517 1.9 - - - - 
Rv1500  glycosyltransferase  -0.7782 0.264 6.6 - - X - 
Rv1501  hypothetical protein  1.8408 0.025 1.9 - - - - 
Rv1502  hypothetical protein  0.4403 0.647 3.5 - - - - 
Rv1508c  hypothetical protein  0.243 0.426 50.4 - - X - 
Rv1509  hypothetical protein  -0.6436 0.247 5.4 - - - - 
Rv1513  hypothetical protein  1.1124 0.344 7.2 - - - - 
Rv1514c  hypothetical protein  1.3586 0.102 5.7 - - - - 
Rv1515c  hypothetical protein  0.3128 0.487 12.1 - - - - 
Rv1516c  sugar transferase  0.0906 0.798 17.5 - - - - 
Rv1521 fadD25 acyl-CoA synthetase  0.2142 0.782 4.4 - - X - 
Rv1523  methyltransferase  -0.4008 0.258 17.9 - - - - 
Rv1524  glycosyltransferase  2.5467 0.268 2.3 - - - - 
Rv1526c  glycosyltransferase  -0.2737 0.755 2.3 - - - - 
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Rv1531  hypothetical protein  -0.9126 0.155 3.6 - - - - 
Rv1532c  hypothetical protein  0.5898  0.8 - - - - 
Rv1534  transcriptional regulator  1.302 0.193 3.4 - - - - 
Rv1535  hypothetical protein  0.0759 0.87 8.0 - - - - 
Rv1538c ansA L-aparaginase ansA  -1.7834 - 0.7 - - - - 
Rv1539 lspA lipoprotein signal peptidase  0.3646 0.664 2.5 - - X - 
Rv1543  fatty acyl-CoA reductase  -0.443 0.139 80.6 - - - - 
Rv1544  ketoacyl reductase  0.8782 0 34.9 - - - - 
Rv1546  hypothetical protein  1.2343 0.032 3.6 - - - - 
Rv1547 dnaE DNA polymerase III subunit alpha  2.3813 0.132 2.2 - - - - 
Rv1549 
fadD11.
1 
fatty-acid-CoA ligase  -0.0003 0.999 8.2 
- - - - 
Rv1552 frdA fumarate reductase flavoprotein subunit  0.5764 0.422 1.0 - - - - 
Rv1553 frdB fumarate reductase iron-sulfur subunit -0.5876 0.17 3.7 - - - - 
Rv1556  regulatory protein  -0.8864 0.029 1.1 - - - - 
Rv1563c treY maltooligosyltrehalose synthase 0.5933 0.446 0.7 - - - - 
Rv1569 bioF1 8-amino-7-oxononanoate synthase  0.302 0.381 1.9 - - - - 
Rv1578c  phiRv1 phage protein  0.0169 0.898 3.3 - - - - 
Rv1586c  phiRv1 integrase  1.333 0.147 5.0 - - - - 
Rv1589 bioB biotin synthase  1.3586 0.047 3.2 - - - - 
Rv1591  hypothetical protein  -0.3784 0.3 10.3 - - X - 
Rv1592c  hypothetical protein  0.9686 0.066 2.1 - - - - 
Rv1593c  hypothetical protein  1.012 0.025 3.3 - - - - 
Rv1594 nadA quinolinate synthetase  -0.1572 0.731 13.0 - - - - 
Rv1595 nadB L-aspartate oxidase  0.6353 0.339 1.5 - - - - 
Rv1596 nadC nicotinate-nucleotide pyrophosphorylase  -1.5556 0.028 12.1 - - - - 
Rv1598c  hypothetical protein  0.9708 0.003 29.6 - - - - 
Rv1602 hisH 
imidazole glycerol phosphate synthase 
subunit 
-0.8364 0.08 3.9 
- - - - 
Rv1605 hisF 
imidazole glycerol phosphate synthase 
subunit 
0.5768 0.288 13.7 
- - - - 
Rv1608c bcpB peroxidoxin -0.3844 0.353 10.3 - - - - 
Rv1610  hypothetical protein  -0.1078 0.944 1.9 - - X - 
Rv1611 trpC indole-3-glycerol-phosphate synthase  1.5326 0.057 16.9 - - - - 
Rv1612 trpB tryptophan synthase subunit beta  0.2453 0.803 4.5 - - - - 
Rv1613 trpA tryptophan synthase subunit alpha  0.012 0.948 1.5 - - - - 
Rv1614 lgt prolipoprotein diacylglyceryl transferase  -0.3585 0.02 45.9 - - X - 
Rv1615  hypothetical protein  0.6137 0.506 1.6 - - X - 
Rv1617 pykA pyruvate kinase  0.3586 0.242 7.2 - - - - 
Rv1618 tesB1 acyl-CoA thioesterase II 0.7955 0.172 1.9 - - - - 
Rv1620c cydC cytochrome' transport ABC transporter  0.2454 0.719 7.8 - - X - 
Rv1621c cydD cytochrome' transport t ABC transporter 0.1203 0.797 2.3 - - X - 
Rv1622c cydB cytochrome D ubiquinol oxidase (subunit II)  1.1946 0.111 5.9 - - X - 
Rv1623c cydA 
cytochrome D ubiquinol bd-I oxidase subunit 
I)  
-0.4472 0.024 28.4 
- - X - 
Rv1625c cya adenylyl cyclase  0.2504 0.341 15.9 - - X - 
Rv1627c  lipid-transfer protein  0.3075 0.102 4.0 - - - - 
Rv1628c  hypothetical protein  0.1136 0.541 1.4 - - - - 
Rv1629 polA DNA polymerase I  0.5526 0.175 18.7 - - - - 
Rv1630 rpsA 30S ribosomal protein S1  1.3664 0.025 18.1 - - - - 
Rv1633 urvB excinuclease ABC subunit B  0.0981 0.69 11.9 - - - - 
Rv1636 TB15.3 hypothetical protein  0.4164 0.274 20.7 - - - - 
Rv1638 uvrA excinuclease ABC subunit A  -0.1486 0.487 57.5 - - - - 
Rv1640c lysS lysyl-tRNA synthetase  0.4374 0.031 59.3 - - X - 
Rv1641 infC translation initiation factor IF-3  -1.988 0.007 1.8 - - - - 
Rv1643 rplT 50S ribosomal protein L20  0.3813 0.731 2.4 - - - - 
Rv1647  hypothetical protein  0.0464 0.842 8.7 - - - - 
Rv1649 pheS phenylalanyl-tRNA synthetase subunit alpha  0.5917 0.359 1.9 - - - - 
Rv1650 pheT phenylalanyl-tRNA synthetase subunit beta  -0.997 0.277 1.6 - - - - 
Rv1652 argC 
N-acetyl-gamma-glutamyl-phosphate 
reductase  
-1.2029 0.157 8.1 
- - - - 
Rv1658 argG argininosuccinate synthase  -1.324 0.23 5.8 - - - - 
Rv1660 pks10 chalcone synthase  -0.377 0.04 4.9 - - - - 
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Rv1661 pks7 polyketide synthase -0.7654 0.349 6.1 - - - - 
Rv1662 pks8 polyketide synthase -0.3324 0.377 9.3 - - - - 
Rv1664 pks9 polyketide synthase -0.0828 0.682 0.5 - - - - 
Rv1665 pks11 chalcone synthase  -0.3648 0.333 6.4 - - - - 
Rv1666c cyp139 cytochrome P450 139 0.302 0.381 3.9 - - - - 
Rv1667c  macrolide-transport ATP-binding protein ABC  1.3888 0.233 1.8 - - - - 
Rv1674c  transcriptional regulator 1.012 0.025 1.1 - - - - 
Rv1676  hypothetical protein  -0.1698 0.675 2.1 - - - - 
Rv1678  integral membrane protein  0.302 0.444 3.8 - - X - 
Rv1679 fadE16 acyl-CoA dehydrogenase  -0.6144 0.012 8.8 - - - - 
Rv1680  hypothetical protein  0.6588 0.474 9.0 - - - - 
Rv1683  acyl-CoA synthetase  0.132 0.556 52.1 - - - - 
Rv1684  hypothetical protein  -0.0903 0.524 2.1 - - - - 
Rv1685c  hypothetical protein  0.2544 0.503 1.0 - - - - 
Rv1687c  ABC transporter ATP-binding protein  0.8921 0.098 4.6 - - - - 
Rv1689 tyrS tyrosyl-tRNA synthetase  1.0252 0.069 2.1 - - - - 
Rv1697  hypothetical protein  1.076 0.22 6.7 - - X - 
Rv1698  hypothetical protein  0.0717 0.885 20.9 - - X - 
Rv1699 pyrG CTP synthetase  0.7736 0.079 12.8 - - - - 
Rv1701 xerD site-specific tyrosine recombinase 0.396 0.21 25.5 - - - - 
Rv1703c  catechol-o-methyltransferase  -0.3472 0.174 18.6 - - - - 
Rv1707  transmembrane protein  -0.1774 0.401 36.8 - - X - 
Rv1708  putative initiation inhibitor protein  0.192 0.584 41.6 - - - - 
Rv1711  hypothetical protein  0.2364 0.696 17.7 - - - - 
Rv1731 gabD2 succinic semialdehyde dehydrogenase  -0.2186 0.169 40.8 - - - - 
Rv1738  hypothetical protein  1.704 0.018 6.2 - - - - 
Rv1742  hypothetical protein  -0.186 0.888 3.8 - - - - 
Rv1743 pknE 
transmembrane serine/threonine-protein 
kinase E  
0.0498 0.917 24.1 
- - X - 
Rv1746 pknF membrane serine/threonine-protein kinase -0.0206 0.928 26.3 - - X - 
Rv1747  ATP-binding protein ABC transporter  -0.0584 0.53 78.3 - - X - 
Rv1748  hypothetical protein  0.7884 0.058 10.9 - - X - 
Rv1749c  integral membrane protein  0.886 0.186 16.8 - - X - 
Rv1751  hypothetical protein  -0.0767 0.841 28.1 - - - - 
Rv1754c  hypothetical protein  -2.0167 0.005 2.7 - - X - 
Rv1760  hypothetical protein  0.5336 0.375 5.5 - - - - 
Rv1762c  hypothetical protein  0.4736 0.359 11.7 - - - - 
Rv1766  hypothetical protein  0.862 0.077 0.7 - - - - 
Rv1767  hypothetical protein  1.356 0.027 1.7 - - - - 
Rv1769  hypothetical protein  1.0504 0.242 8.8 - - - - 
Rv1770  hypothetical protein  0.0926 0.859 26.1 - - - - 
Rv1771  oxidoreductase  -0.211 0.097 66.4 - - - - 
Rv1772  hypothetical protein  -0.1955 0.791 1.4 - - - - 
Rv1775  hypothetical protein  0.0874 0.929 3.9 - - - - 
Rv1778c  hypothetical protein  -0.802 0.015 2.7 - - - - 
Rv1780  hypothetical protein  0.393 0.376 1.6 - - - - 
Rv1782  hypothetical protein  -0.2788 0.469 25.9 - - X - 
Rv1783  hypothetical protein  0.1368 0.553 60.1 - - X - 
Rv1784  
hypothetical protein  -0.0566 0.707 
156.
9 - - - - 
Rv1794  hypothetical protein  -0.4 0.027 25.8 - - - - 
Rv1795  hypothetical protein  0.1228 0.191 80.7 - - X - 
Rv1796 mycP5 proline rich membrane-anchored mycosin  -0.8455 0.135 14.4 X - X - 
Rv1797  hypothetical protein  -0.324 0.305 24.3 - - X - 
Rv1798  hypothetical protein  -0.0486 0.882 0.6 - - - - 
Rv1808 PPE32 PPE family protein  0.6588 0.03 6.4 - - - - 
Rv1812c  dehydrogenase  0.1784 0.425 9.2 - - - - 
Rv1819c  drugs-transport ABC transporter  -0.0061 0.983 50.5 - - X - 
Rv1820 ilvG hypothetical protein  -0.1411 0.449 14.4 - - - - 
Rv1822 pgsA2 
CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase  
-0.4848 0.017 20.0 
- - X - 
Rv1823  hypothetical protein  -0.2029 0.665 31.4 - - - - 
Rv1824  hypothetical protein  0.7867 0.022 1.7 - - X - 
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Rv1825  hypothetical protein  -0.7684 0.126 22.4 - - X - 
Rv1827 cfp17 hypothetical protein  0.8304 0.16 4.9 - - - - 
Rv1828  hypothetical protein  0.1043 0.47 17.7 - - - - 
Rv1829  hypothetical protein  0.4627 0.269 11.3 - - - - 
Rv1830  hypothetical protein  1.0048 - 1.0 - - - - 
Rv1833c  haloalkane dehalogenase  -0.2483 0.415 44.9 - - - - 
Rv1834  hydrolase  -1.277 0.182 7.3 - - - - 
Rv1835c  hypothetical protein  0.2137 0.839 4.4 - - - - 
Rv1836c  hypothetical protein  0.1826 0.076 93.9 - - X - 
Rv1837c glcB malate synthase G  1.935 0.005 7.0 - - - - 
Rv1841c  hypothetical protein  -0.9672 0.06 15.6 - - X - 
Rv1842c  hypothetical protein  -0.2008 0.581 8.2 - - X - 
Rv1843c guaB1 inosine 5-monophosphate dehydrogenase  -0.2127 0.396 9.1 - - - - 
Rv1844c gnd1 6-phosphogluconate dehydrogenase  -1.8696 0.006 10.9 - - - - 
Rv1847  hypothetical protein  0.1121 0.897 3.4 - - - - 
Rv1852 ureG urease accessory protein -0.1576 0.589 9.3 - - - - 
Rv1853 ureD urease accessory protein -0.0486 0.882 1.1 - - - - 
Rv1854c ndh NADH dehydrogenase  0.096 0.51 11.9 - - X - 
Rv1855c  oxidoreductase  0.9686 0.027 3.7 - - - - 
Rv1860 apa hypothetical protein  0.619 0.411 3.1 X - X - 
Rv1865c  short chain dehydrogenase  0.3451 0.344 18.6 - - - - 
Rv1866  hypothetical protein  1.0048 - 0.5 - - - - 
Rv1868  hypothetical protein  0.1857 0.583 12.6 - - - - 
Rv1870c  hypothetical protein  0.1712 0.917 1.0 - - - - 
Rv1871c  hypothetical protein  0.1066 0.595 64.0 - - - - 
Rv1872c lldD2 
L-lactate dehydrogenase (cytochrome) -0.3222 0.21 
641.
4 - - - - 
Rv1874  hypothetical protein  0.0072 0.985 2.0 - - - - 
Rv1875  hypothetical protein  0.302 0.533 4.6 - - - - 
Rv1876 bfrA bacterioferritin  -0.7856 0.159 4.0 - - - - 
Rv1880c cyp140 cytochrome p450 140 -0.5624 0.028 40.2 - - - - 
Rv1882c  short chain dehydrogenase  -0.0388 0.888 16.9 - - - - 
Rv1883c  hypothetical protein  0.2142 0.764 4.7 - - - - 
Rv1885c  chorismate mutase  -0.6305 0.161 9.1 X - X - 
Rv1886c fbpB secreted antigen 85-B fbpB  0.005 0.985 73.7 - X X - 
Rv1890c  hypothetical protein  0.4403 0.597 2.1 - - - - 
Rv1893  hypothetical protein  -1.1252 0.272 5.0 - - - - 
Rv1899c lppD lipoprotein 0.0602 0.871 7.7 X - - X 
Rv1900c lipJ lignin peroxidase 0.0252 0.899 4.7 - - - - 
Rv1901 cinA competence damage-inducible protein A  -0.4803 0.43 1.8 - - - - 
Rv1904  hypothetical protein  1.3782 0.041 5.1 - - - - 
Rv1907c  hypothetical protein  0.393 0.376 1.6 - - - - 
Rv1908c katG catalase-peroxidase-peroxynitritase T 1.2972 0 8.6 - - - - 
Rv1912c fadB5 oxidoreductase 0.0364 0.866 30.2 - - - - 
Rv1914c  hypothetical protein  0.862 0.077 1.4 - - - - 
Rv1915 aceAa isocitrate lyase  0.0206 0.909 25.8 - - - - 
Rv1916 aceAb isocitrate lyase  0.0596 0.689 0.9 - - - - 
Rv1919c  hypothetical protein  -0.5452 0.071 45.2 - - - - 
Rv1920  hypothetical protein  0.3529 0.137 31.3 - - - - 
Rv1922  lipoprotein  -1.441 0.001 3.9 X - - X 
Rv1923 lipD lipase -0.3646 0.473 1.6 - - - - 
Rv1924c  hypothetical protein  -0.5449 0.044 13.3 - - X - 
Rv1925 fadD31 acyl-CoA synthetase  -0.3254 0.173 78.0 - - - - 
Rv1926c mpt63 immunogenic protein  -0.8622 0 72.2 X - X - 
Rv1927  hypothetical protein  -0.088 0.921 6.5 - - - - 
Rv1929c  hypothetical protein  1.3896 0.103 5.8 - - - - 
Rv1930c  hypothetical protein  0.686 0.032 4.7 - - - - 
Rv1937  oxygenase  0.1163 0.777 2.7 - - - - 
Rv1940 ribA1 riboflavin biosynthesis protein -0.0903 0.524 0.7 - - - - 
Rv1942c  hypothetical protein  1.6893 0.057 2.1 - - - - 
Rv1956  transcriptional regulator 0.754 0.006 6.7 - - - - 
Rv1957  hypothetical protein  1.2544 0.033 3.5 - - - - 
Rv1976c  hypothetical protein  -0.0486 0.882 1.1 - - - - 
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Rv1977  hypothetical protein  0.3526 0.642 3.7 - - X - 
Rv1978  hypothetical protein  0.3174 0.365 58.1 - - - - 
Rv1980c mpt64 
immunogenic protein (antigen 
MPT64/MPB64)  
0.5872 0.025 18.6 
X - X - 
Rv1984c cfp21 cutinase precursor CFP21  -0.1976 0.606 3.0 X - - - 
Rv1992c ctpG metal cation transporter P-type ATPase G  0.5144 0.141 6.3 - - X - 
Rv1993c  hypothetical protein  -0.3612 0.435 10.2 - - - - 
Rv1996  hypothetical protein  1.1724 0 10.4 - - - - 
Rv1998c  hypothetical protein  0.223 0.4 12.8 - - - - 
Rv2000  hypothetical protein  -1.1469 0.425 1.4 - - - - 
Rv2002 fabG3 20-beta-hydroxysteroid dehydrogenase  1.9686 0.001 8.0 - - - - 
Rv2005c  hypothetical protein  0.9686 0.015 21.7 - - - - 
Rv2010  hypothetical protein  -0.4214 0.2 3.1 - - - - 
Rv2011c  hypothetical protein  0.012 0.948 1.5 - - - - 
Rv2012  hypothetical protein  -0.0903 0.524 1.4 - - - - 
Rv2016  hypothetical protein  0.9994 0.11 9.7 - - - - 
Rv2017  transcriptional regulator 1.3927 0.009 5.5 - - - - 
Rv2018  hypothetical protein  1.4471 0.046 0.9 - - - - 
Rv2021c  transcriptional regulator 0.302 0.317 2.4 - - - - 
Rv2026c  hypothetical protein  1.377 0.007 12.8 - - - - 
Rv2027c  histidine kinase response regulator  0.6792 0.174 24.7 - - - - 
Rv2030c  hypothetical protein  2.6715 0.013 12.4 - - - - 
Rv2031c hspX heat shock protein 2.4246 0.036 36.2 - - - - 
Rv2033c  hypothetical protein  0.7932 0.264 6.6 - - - - 
Rv2035  hypothetical protein  -0.3647 0.178 1.9 - - - - 
Rv2036  hypothetical protein  0.4947 0.053 1.6 - - - - 
Rv2037c  transmembrane protein  -1.7546 0.083 6.7 - - - - 
Rv2041c  sugar-binding lipoprotein  -1.704 0.084 5.3 X X - X 
Rv2042c  hypothetical protein  1.7263 0.12 6.9 - - - - 
Rv2045c lipT carboxylesterase -0.0248 0.928 17.6 - - - - 
Rv2047c  hypothetical protein  0.1262 0.759 18.6 - - - - 
Rv2048c pks12 polyketide synthase 0.1356 0.025 80.3 - - - - 
Rv2051c ppm1 
polyprenol-monophosphomannose synthase 
Ppm1  
-0.4334 0.345 36.8 
- - X - 
Rv2054  hypothetical protein  0.1084 0.577 40.4 - - - - 
Rv2061c  hypothetical protein  0.2498 0.364 20.3 - - - - 
Rv2062c cobN cobaltochelatase subunit CobN  0.4878 0.066 35.7 - - - - 
Rv2066 cobI 
S-adenosyl-L-methionine-precorrin-2 methyl 
transferase/precorrin-3 methylase 
0.4228 0.665 4.6 
- - - - 
Rv2068c blaC class A BETA-lactamase 0.0746 0.811 35.0 X X - X 
Rv2070c cobK cobalt-precorrin-6x reductase  2.3339 0.005 2.2 - - - - 
Rv2071c cobM precorrin-4 C11-methyltransferase 1.302 0.022 2.4 - - - - 
Rv2072c cobL precorrin-6y methyltransferase -1.2264 0.168 4.4 - - - - 
Rv2073c  shortchain dehydrogenase  -0.7055 0.57 12.9 - - - - 
Rv2074  hypothetical protein  0.4551 0.017 10.6 - - - - 
Rv2080 lppJ lipoprotein -1.044 0.122 2.2 X - X X 
Rv2082  hypothetical protein  -0.2737 0.531 9.7 - - - - 
Rv2084  hypothetical protein  0.0048  0.7 - - - - 
Rv2088 pknJ 
transmembrane serine/threonine-protein 
kinase J  
0.6042 0.299 14.3 
- - - - 
Rv2091c  hypothetical protein  -0.6344 0.026 69.6 - - X - 
Rv2093c tatC Sec-independent protein translocase  0.1136 0.541 1.4 - - X - 
Rv2094c tatA twin arginine translocase protein A  0.3761 0.443 7.7 - - X - 
Rv2097c  hypothetical protein  -0.4078 0.19 13.9 - - - - 
Rv2101 helZ helicase 0.2432 0.525 36.4 - - - - 
Rv2102  hypothetical protein  0.0594 0.921 6.0 - - - - 
Rv2110c prcB proteasome (beta subunit) 0.0522 0.932 1.0 - - - - 
Rv2112c  hypothetical protein  -0.513 0.187 6.8 - - - - 
Rv2113  integral membrane protein  -0.7273 0.101 23.1 - - X - 
Rv2114  hypothetical protein  -0.0314 0.946 1.8 - - - - 
Rv2115c  ATPase  1.302 0.085 3.2 - - - - 
Rv2116 lppK lipoprotein 0.034 0.877 10.9 - - - X 
Rv2118c  RNA methyltransferase  1.3526 0.024 5.2 - - - - 
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Rv2120c  integral membrane protein  0.5148 0.562 1.5 - - X - 
Rv2124c metH 
5-methyltetrahydrofolate-homocystein 
methyltransferase  
0.5996 0.236 18.8 
- - - - 
Rv2127 ansP1 L-asparagine permease -0.006 0.991 10.7 - - X - 
Rv2129c  short chain dehydrogenase  0.5487 0.016 70.9 - - - - 
Rv2131c cysQ monophosphatase 0.7772 0.565 9.0 - - - - 
Rv2137c  hypothetical protein  0.476 0.382 15.2 - - - - 
Rv2138 lppL lipoprotein -0.3479 0.202 6.5 X - X X 
Rv2139 pyrD dihydroorotate dehydrogenase 2  -0.1678 0.226 12.5 - - - - 
Rv2145c wag31 
hypothetical protein  -0.0072 0.956 
205.
3 - - - - 
Rv2146c  transmembrane protein  1.0252 0.105 5.5 - - X - 
Rv2151c ftsQ cell division protein -0.2456 0.547 25.0 - - X - 
Rv2153c murG 
undecaprenyldiphospho-
muramoylpentapeptide beta-N- 
acetylglucosaminyltransferase  
0.038 0.924 15.8 
- - - - 
Rv2155c murD 
UDP-N-acetylmuramoyl-L-alanyl-D-glutamate 
synthetase  
-0.1386 0.88 6.9 
- - - - 
Rv2156c mraY 
phospho-N-acetylmuramoyl-pentapeptide-
transferase  
0.8407 0.054 0.7 
- - X - 
Rv2159c  
hypothetical protein  -0.5178 0.221 
351.
7 - - - - 
Rv2161c  hypothetical protein  0.264 0.376 27.4 - - - - 
Rv2171 lppM lipoprotein -0.9928 0.329 9.1 X - X X 
Rv2176 pknL 
transmembrane serine/threonine-protein 
kinase L  
-0.3958 0.511 5.8 
- - X - 
Rv2179c  hypothetical protein  -0.1697 0.804 3.5 - - - - 
Rv2182c  1-acylglycerol-3-phosphate O-acyltransferase  0.1576 0.587 11.7 - - - - 
Rv2183c  hypothetical protein  -0.802 0.015 2.7 - - - - 
Rv2184c  hypothetical protein  0.571 0.256 8.7 - - - - 
Rv2185c TB16.3 hypothetical protein  -0.2403 0.72 17.8 - - - - 
Rv2186c  hypothetical protein  -0.0004 0.999 4.2 - - - - 
Rv2187 fadD15 
long-chain-fatty-acid-CoA ligase  0.0846 0.694 
173.
9 - - - - 
Rv2188c  hypothetical protein  0.0428 0.933 4.2 - - - - 
Rv2190c  hypothetical protein  0.7872 0.008 9.2 X - X - 
Rv2192c trpD anthranilate phosphoribosyltransferase  0.7 0.386 3.3 - - - - 
Rv2193 ctaE cytochrome C oxidase subunit III  0.107 0.765 3.3 - - X - 
Rv2194 qcrC 
ubiquinol-cytochrome C reductase 
QcrC(cytochrome C subunit)  
0.4444 0.018 47.7 
X - X - 
Rv2195 qcrA 
Rieske iron-sulfur protein -0.4236 0.116 
166.
9 - - X - 
Rv2196 qcrB 
ubiquinol-cytochrome C reductase QcrB 
(cytochrome B subunit)  
0.0176 0.871 
133.
3 - - X - 
Rv2197c  transmembrane protein  -0.7501 0.128 7.5 - - X - 
Rv2198c mmpS3 membrane protein  -0.3684 0.067 22.5 - - X - 
Rv2200c ctaC 
transmembrane cytochrome C oxidase 
subunit II 
-0.6208 0.009 
123.
6 - - X - 
Rv2201 asnB asparagine synthetase -0.6016 0.057 21.1 - - - - 
Rv2202c cbhK carbohydrate kinase 0.959 0.252 8.3 - - - - 
Rv2203  hypothetical protein  0.0444 0.925 28.4 - - X - 
Rv2204c  hypothetical protein  0.4156 0.029 19.0 - - - - 
Rv2206  transmembrane protein  -0.6378 0.339 16.7 - - X - 
Rv2210c ilvE branched-chain amino acid aminotransferase  0.302 0.381 1.9 - - - - 
Rv2212  hypothetical protein  1.4533 0.202 1.3 - - - - 
Rv2213 pepB 
leucyl aminopeptidase  -0.364 0.321 
244.
8 - - - - 
Rv2214c ephD short chain dehydrogenase  -0.3788 0.074 36.9 - - X - 
Rv2215 dlaT dihydrolipoamide acetyltransferase  0.8504 0.003 76.3 - - - - 
Rv2216  hypothetical protein  0.0337 0.883 22.1 - - - - 
Rv2219  transmembrane protein  -0.6598 0.502 26.6 - - X - 
Rv2219A  hypothetical protein  0.2378 0.385 6.2 - - X - 
Rv2220 glnA1 glutamine synthetase -0.0314 0.913 17.4 - - - - 
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Rv2221c glnE 
glutamate-ammonia-ligase 
adenylyltransferase 
-0.6164 0.537 3.2 
- - - - 
Rv2222c glnA2 glutamine synthetase  0.1636 0.649 2.9 - - - - 
Rv2224c caeA exported protease  0.0632 0.804 36.1 - - X X 
Rv2226  hypothetical protein  0.4635 0.078 11.6 - - - - 
Rv2232  hypothetical protein  -0.0221 0.968 2.9 - - - - 
Rv2234 ptpA 
phosphotyrosine protein phosphatase  
(protein-tyrosine-phosphatase) (PTPase) 
(LMW phosphatase)  
0.6353 0.309 2.6 
- - - - 
Rv2235  transmembrane protein  -0.1474 0.774 8.8 - - X - 
Rv2237  hypothetical protein  0.4328 0.697 11.5 - - - - 
Rv2240c  hypothetical protein  -0.9955 0.015 6.8 - - - - 
Rv2241 aceE pyruvate dehydrogenase subunit E1  1.0948 0.189 10.3 - - - - 
Rv2242  hypothetical protein  -0.006 0.989 23.6 - - - - 
Rv2243 fabD acyl-carrier-protein S-malonyltransferase  -1.8061 0.072 1.4 - - - - 
Rv2244 acpP 
acyl carrier protein  -0.2532 0.37 
172.
8 - - - - 
Rv2245 kasA 3-oxoacyl-(acyl carrier protein) synthase II  -0.3158 0.65 21.6 - - - - 
Rv2246 kasB 3-oxoacyl-(acyl carrier protein) synthase II  -0.1726 0.729 21.3 - - - - 
Rv2247 accD6 
acetyl/propionyl-CoA carboxylase beta 
subunit 
-0.8242 0.126 34.1 
- - - - 
Rv2249c glpD1 glycerol-3-phosphate dehydrogenase  -1.5188 0.102 9.9 - - - - 
Rv2250c  transcriptional regulator  0.5786 0.004 7.5 - - - - 
Rv2251  flavoprotein  1.5877 0.011 2.1 - - - X 
Rv2252  
diacylglycerol kinase, Involved in synthesis of 
phosphatidylinositol mannosides 
0.2914 0.567 19.5 
- - - - 
Rv2258c  transcriptional regulator  -0.3186 0.266 17.0 - - - - 
Rv2259 adhE2 zinc-dependent alcohol dehydrogenase 0.2278 0.617 4.8 - - - - 
Rv2263  short chain dehydrogenase  -1.0726 0.139 17.1 - - - - 
Rv2272  transmembrane protein  1.0662 0.058 6.2 - - X - 
Rv2280  dehydrogenase  -1.0548 0.07 5.1 - - - - 
Rv2282c  LysR family transcriptional regulator  0.0836 0.88 11.8 - - - - 
Rv2284 lipM esterase -0.3014 0.549 10.7 - - X - 
Rv2285  hypothetical protein  -0.8544 0.03 24.2 - - - - 
Rv2286c  hypothetical protein  1.9097 0.004 1.2 - - - - 
Rv2287 yjcE integral membrane transport protein -0.7743 0.074 3.7 - - X - 
Rv2289 cdh CDP-diacylglycerol pyrophosphatase  -0.567 0.035 55.7 X - X - 
Rv2290 lppO lipoprotein -0.8726 0.138 9.4 X - - X 
Rv2291 sseB thiosulfate sulfurtransferase SseB  -0.8023 0.195 2.1 - - - - 
Rv2294  aminotransferase  -1.1163 0.108 10.2 - - - - 
Rv2296  
haloalkane dehalogenase  0.5966 0.094 
103.
4 - - - - 
Rv2297  hypothetical protein  0.1313 0.51 14.6 - - - - 
Rv2298  hypothetical protein  -0.1716 0.384 55.1 - - - - 
Rv2299c htpG heat shock protein 90  0.8264 0.035 10.5 - - - - 
Rv2301 cut2 cutinase CUT2  0.0874 0.73 4.7 X X X - 
Rv2302  hypothetical protein  0.4434 0.728 1.3 - - - - 
Rv2303c  antibiotic-resistance protein  -0.1357 0.829 2.8 - - - - 
Rv2305  hypothetical protein  -0.1435 0.67 13.6 - - - - 
Rv2307c  hypothetical protein  0.8983 0.259 2.2 - - X - 
Rv2324  AsnC family transcriptional regulator  0.7486 0.436 5.4 - - - - 
Rv2325c  hypothetical protein  0.0148 0.982 2.4 - - X - 
Rv2326c  
transmembrane ATP-binding protein ABC 
transorter  
0.2938 0.454 44.6 
- - X - 
Rv2328 PE23 PE family protein  -1.1644 0.006 3.9 - - - - 
Rv2330c lppP lipoprotein 0.4009 0.424 2.8 X - X X 
Rv2332 mez malate dehydrogenase  0.5046 0.152 10.0 - - - - 
Rv2334 cysK1 cysteine synthase A -0.8864 0.029 1.1 - - - - 
Rv2336  hypothetical protein  -0.8693 0.23 7.9 - - - - 
Rv2337c  hypothetical protein  1.107 0.001 5.1 - - - - 
Rv2338c moeW hypothetical protein  -0.2856 0.303 17.6 - - - - 
Rv2339 mmpL9 transmembrane transport protein MmpL9  0.6054 0.08 8.1 - - X - 
Rv2342  hypothetical protein  1.302 0.101 4.1 - - - - 
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Rv2343c dnaG DNA primase  -0.1076 0.665 4.4 - - - - 
Rv2345  
transmembrane protein  -0.2659 0.136 
130.
7 X - X - 
Rv2346c esxO putative ESAT-6 like protein  -0.9952 - 0.5 - - - - 
Rv2350c plcB membrane-associated phospholipase C  0.3586 0.568 7.9 X X - - 
Rv2351c plcA membrane-associated phospholipase C  -2.1356 0.008 3.2 - X - - 
Rv2357c glyS glycyl-tRNA synthetase  -0.4664 0.084 17.6 - - - - 
Rv2360c  hypothetical protein  -0.526 0.417 2.6 - - - - 
Rv2363 amiA2 amidase  -0.8004 0.01 24.7 - - - - 
Rv2364c era GTP-binding protein -0.0495 0.945 1.1 - - - - 
Rv2366c  transmembrane protein  -0.1387 0.781 7.3 - - X - 
Rv2370c  hypothetical protein  -0.283 0.579 7.0 - - - - 
Rv2373c dnaJ2 chaperone protein 0.1089 0.578 20.4 - - - - 
Rv2374c hrcA heat-inducible transcription repressor  -0.0609 0.458 74.0 - - - - 
Rv2375  hypothetical protein  0.887 0.028 3.1 - - - - 
Rv2376c cfp2 low molecular weight antigen 2 0.274 0.786 2.5 X - X - 
Rv2383c mbtB 
phenyloxazoline synthase MBTB 
(phenyloxazoline synthetase)  
1.0184 0.157 11.5 
- - - - 
Rv2385 mbtJ putative acetyl hydrolase 0.0633 0.885 2.4 - - - - 
Rv2387  hypothetical protein  -0.4672 0.205 7.9 - - X - 
Rv2388c hemN coproporphyrinogen III oxidase  -0.1379 0.414 0.5 - - - - 
Rv2392 cysH phosphoadenosine phosphosulfate reductase  0.6884 0.23 2.4 - - - - 
Rv2394 ggtB gamma-glutamyltranspeptidase precursor -0.4633 0.074 25.0 X X - X 
Rv2397c cysA1 
sulfate-transport ATP-binding protein ABC 
transporter 
1.0596 0.004 3.8 
- - - - 
Rv2399c cysT 
sulfate-transport integral membrane protein 
ABC transporter 
0.2996 0.427 1.7 
- - X - 
Rv2400c subI sulfate-binding lipoprotein  -2.2542 0.048 2.6 - - - X 
Rv2402  hypothetical protein  0.6329 0.532 1.6 - - - - 
Rv2403c lppR lipoprotein 0.5377 0.681 2.1 X - X X 
Rv2404c lepA GTP-binding protein 1.218 0.084 3.5 - - - - 
Rv2405  hypothetical protein  0.8242 0.085 15.2 - - - - 
Rv2406c  hypothetical protein  1.0252 0.123 5.8 - - - - 
Rv2409c  hypothetical protein  0.8674 0.036 9.3 - - - - 
Rv2410c  hypothetical protein  1.6886 0.119 7.3 - - - - 
Rv2411c  hypothetical protein  1.9436 0.055 6.8 - - - - 
Rv2412 rpsT 30S ribosomal protein S20  0.3526 0.521 5.4 - - - - 
Rv2413c  hypothetical protein  -1.2806 0.027 15.1 - - - - 
Rv2418c  hypothetical protein  -0.7056 0.063 7.0 - - - - 
Rv2420c  hypothetical protein  -0.1379 0.414 0.5 - - - - 
Rv2425c  hypothetical protein  -1.1622 0.315 5.9 - - - - 
Rv2426c  hypothetical protein  -0.1634 0.597 15.8 - - - - 
Rv2427c proA gamma-glutamyl phosphate reductase  -0.9436 0.39 4.9 - - - - 
Rv2429 ahpD alkyl hydroperoxide reductase subunit D  -0.8054 0.146 8.1 - - - - 
Rv2441c rpmA 50S ribosomal protein L27  1.0252 0.058 9.8 - - - - 
Rv2442c rplU 50S ribosomal protein L21  0.5388 0.382 8.5 - - - - 
Rv2444c rne ribonuclease E  1.2378 0.018 6.1 - - - - 
Rv2445c ndk nucleoside diphosphate kinase  1.8303 0.049 4.1 - - - - 
Rv2447c folC folylpolyglutamate synthase protein -1.0903 0.012 1.2 - - - - 
Rv2449c  hypothetical protein  -0.3092 0.28 34.2 - - - - 
Rv2453c mobA 
molybdopterin-guanine dinucleotide 
biosynthesis protein A  
0.7618 0.054 10.8 
- - - - 
Rv2456c  integral membrane transport protein  -0.4045 0.244 4.5 - - X - 
Rv2457c clpX ATP-dependent protease ATP-binding subunit -0.0946 0.901 16.2 - - - - 
Rv2460c clpP2 
ATP-dependent Clp protease proteolytic 
subunit  
0.4684 0.05 28.7 
- - - - 
Rv2461c clpP 
ATP-dependent Clp protease proteolytic 
subunit  
0.692 0.009 7.9 
- - - - 
Rv2462c tig trigger factor  1.0596 0.004 1.3 - - - - 
Rv2463 lipP esterase/lipase 0.097 0.607 8.2 - - - - 
Rv2464c  DNA glycosylase  1.012 0.025 1.1 - - - - 
Rv2467 pepN aminopeptidase N  -1.0868 0.018 4.2 - - - - 
Rv2468c  hypothetical protein  -0.7128 0.117 21.4 - - - - 
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Rv2470 glbO globin 0.862 0.077 2.1 - - - - 
Rv2473  alanine and proline rich membrane protein  -0.9497 0.039 8.2 X - X - 
Rv2475c  hypothetical protein  0.3212 0.716 1.4 - - - - 
Rv2476c gdh NAD-dependent glutamate dehydrogenase  0.806 0.021 80.4 - - - - 
Rv2477c  putative ABC transporter ATP-binding protein  0.0814 0.827 32.1 - - - - 
Rv2482c plsB2 glycerol-3-phosphate acyltransferase  -0.3362 0.353 33.6 - - - - 
Rv2483c plsC 
bifunctionnal putative L-3-phosphoserine 
phosphatase/1-acyl-SN-glycerol-3-phosphate 
acyltransferase  
0.7386 0.026 42.2 
- - - - 
Rv2484c  hypothetical protein  0.2688 0.383 10.3 - - - - 
Rv2485c lipQ carboxylesterase -0.6806 0.39 5.8 - - - - 
Rv2488c  LuxR family transcriptional regulator  0.571 0.591 5.4 - - - - 
Rv2495c pdhC 
branched-chain alpha-keto acid 
dehydrogenase subunit E2  
1.8238 0.033 2.4 
- - - - 
Rv2496c pdhB 
pyruvate dehydrogenase E1 component beta 
subunit 
-0.0486 0.882 1.7 
- - - - 
Rv2497c pdhA 
pyruvate dehydrogenase E1 component alpha 
subunit 
0.6786  0.5 
- - - - 
Rv2498c citE citrate (Pro-3S)-lyase beta subunit  0.0964 0.299 4.8 - - - - 
Rv2500c fadE19 acyl-CoA dehydrogenase  -0.6335 0.248 1.3 - - - - 
Rv2509  short-chain type dehydrogenase/reductase  0.4886 0.053 61.1 - - - - 
Rv2516c  hypothetical protein  -1.0658 0.009 11.6 - - - - 
Rv2518c lppS lipoprotein -1.5564 0.094 8.6 - - X X 
Rv2520c  hypothetical protein  -0.2326 0.403 24.0 - - X - 
Rv2521 bcp bacterioferritin comigratory protein 1.1234 - 1.2 - - - - 
Rv2524c fas 
fatty acid synthase  0.3092 0.013 
384.
6 - - - - 
Rv2526  hypothetical protein  -1.9952 - 0.8 - - - - 
Rv2527  hypothetical protein  0.5302 0.432 6.7 - - - - 
Rv2529  hypothetical protein  0.5272 0.695 1.2 X - - - 
Rv2531c  amino acid decarboxylase  1.1306 0.042 10.5 - - - - 
Rv2532c  hypothetical protein  -1.1932 0.161 6.4 X - X - 
Rv2533c nusB transcription antitermination protein NusB  0.393 0.376 1.6 - - - - 
Rv2534c efp elongation factor P  2.2588 0.014 2.6 - - - - 
Rv2536  
transmembrane protein  -0.4196 0.182 
135.
9 - - X - 
Rv2553c  hypothetical protein  -0.5794 0.105 12.3 - - X - 
Rv2554c  Holliday junction resolvase-like protein  0.862 0.077 0.7 - - - - 
Rv2555c alaS alanyl-tRNA synthetase  0.6818 0.039 18.5 - - - - 
Rv2556c  hypothetical protein  -0.3647 0.567 2.1 - - - - 
Rv2559c rarA  recombination factor protein  -0.6953 0.03 12.8 - - - - 
Rv2560  hypothetical protein  -0.2835 0.658 2.7 - - X - 
Rv2563  
glutamine-transport transmembrane protein 
ABC transporter  
-0.3675 0.009 92.0 
- - X - 
Rv2564 glnQ 
glutamine-transport ATP-binding protein ABC 
transporter 
0.0617 0.724 22.3 
- - - - 
Rv2565  hypothetical protein  -0.4116 0.069 40.7 - - - - 
Rv2566  hypothetical protein  0.4162 0.266 30.5 - - - - 
Rv2567  hypothetical protein  0.6068 0.513 5.0 - - - - 
Rv2571c  
transmembrane alanine and valine and 
leucine rich protein  
-0.1718 0.73 7.1 
- - X - 
Rv2574  hypothetical protein  -0.7068 0.152 8.5 - - - - 
Rv2575  hypothetical protein  1.302 0.071 3.5 - X X - 
Rv2581c  glyoxalase II  -0.5656 0.444 11.9 - - - - 
Rv2582 ppiB peptidyl-prolyl cis-trans isomerase B  -1.5034 0.041 26.1 - - X - 
Rv2583c relA GTP pyrophosphokinase  -0.232 0.552 15.1 - - - - 
Rv2584c apt adenine phosphoribosyltransferase  0.2931 0.064 69.5 - - - - 
Rv2585c  lipoprotein  -0.8512 0.148 13.5 X - - X 
Rv2586c secF preprotein translocase subunit SecF  -0.602 0.002 55.6 - - X - 
Rv2587c secD preprotein translocase subunit SecD  0.0349 0.857 31.1 - - X - 
Rv2588c yajC preprotein translocase subunit YajC  0.1811 0.677 21.4 - - X - 
Rv2594c ruvC Holliday junction resolvase  0.7661 0.145 5.4 - - - - 
Rv2597  hypothetical protein  1.04 0.294 8.4 - - X - 
266 
 
Rv2599  hypothetical protein  -2.3303 0.002 3.2 X - X - 
Rv2604c  glutamine amidotransferase subunit PdxT  1.0252 0.005 3.3 - - - - 
Rv2606c  pyridoxal biosynthesis lyase PdxS  -0.0102 0.975 6.8 - - - - 
Rv2609c  hypothetical protein  -0.56 0.091 21.0 - - X - 
Rv2610c pimA alpha-mannosyltransferase 0.5898  0.8 - - - - 
Rv2611c  lipid A biosynthesis lauroyl acyltransferase  -1.3215 0.127 8.0 - - - - 
Rv2612c pgsA1 
CDP-diacylglycerol--inositol 3-
phosphatidyltransferase  
0.2696 0.493 10.3 
- - X - 
Rv2616  hypothetical protein  0.2378 0.49 8.7 - - - - 
Rv2617c  hypothetical protein  -1.6763 0.059 3.9 - - X - 
Rv2619c  hypothetical protein  0.5272 0.695 1.2 - - - - 
Rv2620c  transmembrane protein  0.5919 0.474 3.0 - - X - 
Rv2622  methyltransferase (methylase)  0.8686 0.024 27.9 - - - - 
Rv2623 TB31.7 hypothetical protein  3.7 0 7.6 - - - - 
Rv2625c  hypothetical protein  3.202 0.019 9.8 - - X - 
Rv2626c  hypothetical protein  1.6694 0.04 1.9 - - - - 
Rv2627c  hypothetical protein  4.0448 0.001 12.0 - - - - 
Rv2632c  hypothetical protein  0.3112 0.587 2.6 - - - - 
Rv2633c  hypothetical protein  0.148 0.337 28.2 - - - - 
Rv2637 dedA transmembrane protein DedA  -0.43 0.329 9.7 - - X - 
Rv2638  hypothetical protein  0.198 0.746 1.8 - - - - 
Rv2643 arsC arsenic-transport integral membrane protein 1.3238 0.124 2.2 - - X - 
Rv2652c  phiRv2 prophage protein  0.9638 0.047 0.7 - - - - 
Rv2658c  prophage protein  0.2709 0.664 3.2 - - - - 
Rv2672  secreted protease  -0.2942 0.406 25.2 X - X X 
Rv2673  integral membrane protein  -0.4608 0.035 18.5 - - X - 
Rv2676c  hypothetical protein  1.1266 0.004 5.7 - - - - 
Rv2682c dxs1 1-deoxy-D-xylulose-5-phosphate synthase  -0.0254 0.947 25.6 - - - - 
Rv2683  hypothetical protein  1.978 0.044 3.2 - - - - 
Rv2688c  
antibiotic ABC transporter ATP-binding 
protein  
-2.6338 0.001 4.8 
- - - - 
Rv2690c  hypothetical protein  -0.2414 0.579 12.3 - - X - 
Rv2691 ceoB TRK system potassium uptake protein -0.1696 0.782 5.0 - - - - 
Rv2692 ceoC TRK system potassium uptake protein -1.7229 0.039 1.3 - - - - 
Rv2693c  
integral membrane alanine and leucine rich 
protein  
1.1137 0.019 1.1 
- - X - 
Rv2694c  hypothetical protein  0.6353 0.012 7.7 - - - - 
Rv2696c  hypothetical protein  0.0252 0.899 4.7 - - - - 
Rv2697c dut 
deoxyuridine 5'-triphosphate 
nucleotidohydrolase  
-0.8587 0.114 2.9 
- - - - 
Rv2698  alanine rich transmembrane protein  -0.1152 0.748 4.9 - - X - 
Rv2700  secreted alanine rich protein  -1.3106 0.032 10.6 - - X - 
Rv2702 ppgK 
polyphosphate glucokinase PPGK 
(polyphosphate-glucose phosphotransferase)  
0.2544 0.503 4.2 
- - - - 
Rv2703 sigA RNA polymerase sigma factor  1.4092 0.123 6.9 - - - - 
Rv2713 sthA soluble pyridine nucleotide transhydrogenase  0.1914 0.483 30.9 - - - - 
Rv2715  hydrolase  -0.2794 0.086 29.8 - - - - 
Rv2718c nrdR transcriptional regulator 0.6588 0.115 21.3 - - - - 
Rv2721c  
hypothetical protein  -1.2432 0.009 
106.
7 X - X - 
Rv2724c fadE20 acyl-CoA dehydrogenase  -0.6414 0.506 4.2 - - - - 
Rv2725c hflX GTP-binding protein 0.1285 0.902 1.9 - - - - 
Rv2726c dapF diaminopimelate epimerase  -0.5507 0.087 3.0 - - - - 
Rv2728c  hypothetical protein  0.2453 0.494 3.1 X - - - 
Rv2732c  transmembrane protein  0.0002 1 13.7 - - X - 
Rv2734  hypothetical protein  0.6352 0.148 1.8 - - - - 
Rv2736c recX recombination regulator 1.0596 0.004 1.3 - - - - 
Rv2737c recA DNA recombination protein 0.5886 0.334 5.4 - - - - 
Rv2739c  alanine rich transferase  -0.8152 0.261 5.6 - - - - 
Rv2740  hypothetical protein  0.6461 0 44.8 - - - - 
Rv2743c  hypothetical protein  -0.2412 0.756 8.1 - - X - 
Rv2744c 35kd_ag 
hypothetical protein  0.4848 0.162 
117.
3 - - - - 
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Rv2745c  transcriptional regulator 0.1136 0.541 0.7 - - - - 
Rv2746c pgsA3 
CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase  
-0.613 0.019 11.5 
- - X - 
Rv2748c ftsK cell division transmembrane protein 3.08 0.007 7.5 - - X - 
Rv2749  hypothetical protein  0.2431 0.781 1.2 - - - - 
Rv2751  hypothetical protein  0.2326 0.451 27.5 - - - - 
Rv2756c hsdM 
type I restriction/modification system DNA 
methylase 
-0.1152 0.923 7.6 
- - - - 
Rv2766c fabG 3-ketoacyl-(acyl-carrier-protein) reductase  1.5313 0.039 4.6 - - - - 
Rv2772c  transmembrane protein  0.1345 0.46 17.6 - - X - 
Rv2773c dapB dihydrodipicolinate reductase  1.1548 0.141 1.8 - - - - 
Rv2777c  hypothetical protein  1.7263 0.03 2.2 - - - - 
Rv2778c  hypothetical protein  0.5432 0.158 26.9 - - - - 
Rv2782c pepR zinc protease -0.217 0.711 3.2 - - - - 
Rv2783c gpsI polynucleotide phosphorylase/polyadenylase  0.016 0.904 25.5 - - - - 
Rv2784c lppU lipoprotein -1.0253 0.033 4.3 X - - X 
Rv2785c rpsO 30S ribosomal protein S15  0.6114 0.117 23.1 - - - - 
Rv2794c  hypothetical protein  -1.1379 0.059 0.9 - - - - 
Rv2795c  hypothetical protein  0.2039 0.774 2.8 - - - - 
Rv2796c lppV lipoprotein 1.0252 0.06 5.3 - - - X 
Rv2799  hypothetical protein  -1.232 0.019 14.1 - - X - 
Rv2800  hydrolase  -0.607 0.207 2.5 - - - - 
Rv2803  hypothetical protein  -0.1379 0.414 0.5 - - - - 
Rv2809  hypothetical protein  0.4848 0.574 3.3 - - - - 
Rv2821c  hypothetical protein  1.3387 0.177 4.4 - - - - 
Rv2822c  hypothetical protein  -1.0646 0.034 9.2 - - - - 
Rv2823c  hypothetical protein  2.5487 0.018 1.3 - - - - 
Rv2824c  hypothetical protein  0.5412 0.358 5.5 - - - - 
Rv2837c  hypothetical protein  -0.9693 0.455 6.5 - - - - 
Rv2839c infB translation initiation factor IF-2  0.4748 0.296 19.1 - - - - 
Rv2842c  hypothetical protein  0.3216 0.178 7.3 - - - - 
Rv2843  hypothetical protein  -0.4572 0.05 17.3 X - X X 
Rv2844  hypothetical protein  -0.711 0.194 15.4 - - - - 
Rv2846c efpA integral membrane efflux protein EfpA  0.1136 0.541 0.7 - - X - 
Rv2848c cobB cobyrinic acid a,c-diamide synthase  0.4496 0.28 2.4 - - - - 
Rv2849c cobO 
cob(I)yrinic acid a,c-diamide 
adenosyltransferase  
-0.5794 0.163 3.9 
- - - - 
Rv2850c  magnesium chelatase  -0.0042 0.995 12.2 - - - - 
Rv2852c mqo malate:quinone oxidoreductase  -0.2526 0.517 7.4 - - - - 
Rv2854  hypothetical protein  0.3287 0.354 5.8 - - - - 
Rv2855 mtr mycothione reductase  0.054 0.952 2.1 - - - - 
Rv2860c glnA4 glutamine synthetase  -0.4236 0.538 0.9 - - - - 
Rv2861c mapB methionine aminopeptidase  -0.1354 0.718 2.0 - - - - 
Rv2862c  hypothetical protein  -1.4634 0.152 5.4 - - - - 
Rv2868c ispG 
4-hydroxy-3-methylbut-2-en-1-yl diphosphate 
synthase  
0.9969 0.193 8.1 
- - - - 
Rv2869c  transmembrane protein  -0.5489 0.121 8.2 - - X - 
Rv2873 mpt83 cell surface lipoprotein (lipoprotein P23)  -0.1796 0.556 8.1 X - - X 
Rv2883c pyrH uridylate kinase  1.6382 0.012 3.0 - - - - 
Rv2884  transcriptional regulator 0.6994 0.481 10.5 - - - - 
Rv2886c  resolvase  0.6352 0.431 3.7 - - - - 
Rv2888c amiC amidase  -0.2714 0.235 38.0 - - - - 
Rv2889c tsf elongation factor Ts  0.512 0.471 1.3 - - - - 
Rv2890c rpsB 30S ribosomal protein S2  -0.3647 0.356 41.6 - - - - 
Rv2894c xerC site-specific tyrosine recombinase 1.0563 0.125 4.9 - - - - 
Rv2900c fdhF formate dehydrogenase H  0.2082 0.773 7.3 - - - - 
Rv2901c  hypothetical protein  0.4812 0.027 13.2 - - - - 
Rv2902c rnhB ribonuclease HII  0.862 0.077 0.7 - - - - 
Rv2903c lepB signal peptidase I -0.499 0.554 11.2 - - X - 
Rv2904c rplS 50S ribosomal protein L19  0.91 0.016 17.0 - - - - 
Rv2907c rimM 16S rRNA-processing protein 0.6353 0.047 1.4 - - - - 
Rv2909c rpsP 30S ribosomal protein S16  0.6042 0.045 12.6 - - - - 
Rv2910c  hypothetical protein  0.302 0.609 3.2 - - - - 
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Rv2911 dacB2 D-alanyl-D-alanine carboxypeptidase  1.6452 0.01 6.6 X - - - 
Rv2913c  D-amino acid aminohydrolase  0.7244 0.168 12.9 - - - - 
Rv2914c pknI 
transmembrane serine/threonine-protein 
kinase I  
0.6408 0.13 21.3 
- - X - 
Rv2915c  hypothetical protein  1.4504 0.039 1.4 - - - - 
Rv2918c glnD PII uridylyl-transferase  0.3526 0.411 3.3 - - - - 
Rv2919c glnB nitrogen regulatory protein P-II 1.1168 0.006 5.6 - - - - 
Rv2921c ftsY cell division protein -0.3002 0.152 41.9 - - X - 
Rv2922c smc chromosome partition protein Smc  0.0607 0.724 54.8 - - - - 
Rv2924c fpg formamidopyrimidine-DNA glycosylase  -1.1955 0.205 2.2 - - - - 
Rv2927c  hypothetical protein  2.7992 0.001 4.4 - - - - 
Rv2928 tesA thioesterase TESA  1.1163 0.039 3.8 - - - - 
Rv2931 ppsA 
phenolpthiocerol synthesis type-I polyketide 
synthase 
0.683  0.7 
- - - - 
Rv2932 ppsB 
phenolpthiocerol synthesis type-I polyketide 
synthase PPSB  
-2.0039 0.006 2.6 
- - - - 
Rv2933 ppsC 
phenolpthiocerol synthesis type-I polyketide 
synthase PPSC  
-0.472 0.426 2.8 
- - - - 
Rv2934 ppsD 
phenolpthiocerol synthesis type-I polyketide 
synthase PPSD  
0.3204 0.317 15.4 
- - - - 
Rv2935 ppsE 
phenolpthiocerol synthesis type-I polyketide 
synthase PPSE  
-0.4842 0.021 14.8 
- - - - 
Rv2936 drrA 
daunorubicin-DIM-transport ATP-binding 
protein ABC transporter 
-0.971 0.003 15.5 
- - - - 
Rv2937 drrB 
daunorubicin-DIM-transport integral 
membrane protein ABC transporter 
-0.1379 0.414 1.1 
- - X - 
Rv2938 drrC 
daunorubicin-DIM-transport integral 
membrane protein ABC transporter 
-0.4687 0.581 1.3 
- - X - 
Rv2940c mas 
multifunctional mycocerosic acid synthase 
membrane-associated MAS  
1.0815 0.011 70.4 
- - - - 
Rv2941 fadD28 acyl-CoA synthetase  -0.32 0.752 22.1 - - - - 
Rv2942 mmpL7 transmembrane transport protein MmpL7  -0.7492 0.014 28.8 - - X - 
Rv2945c lppX lipoprotein 0.0556 0.648 38.9 X - X X 
Rv2946c pks1 polyketide synthase 0.0684 0.871 11.6 - - - - 
Rv2947c pks15 polyketide synthase -0.7941 0.272 17.5 - - - - 
Rv2949c  hypothetical protein  0.7326 0.209 7.8 - - - - 
Rv2950c fadD29 acyl-CoA synthetase  -0.4713 0.094 1.8 - - - - 
Rv2951c  oxidoreductase  0.1736 0.236 46.2 - - - - 
Rv2952  methyltransferase (methylase)  0.6225 0.048 34.4 - - - - 
Rv2953  hypothetical protein  -0.1027 0.779 37.8 - - - - 
Rv2954c  hypothetical protein  0.2006 0.745 9.6 - - - - 
Rv2955c  hypothetical protein  -0.1244 0.785 15.8 - - - - 
Rv2959c  methyltransferase (methylase)  0.727 0.026 13.3 - - - - 
Rv2962c  glycosyl transferase  -0.2452 0.213 12.2 - - - - 
Rv2967c pca pyruvate carboxylase  0.585 0.006 65.5 - - - - 
Rv2969c  hypothetical protein  -1.246 0.436 28.0 - - X - 
Rv2970c lipN lipase/esterase -0.3442 0.463 23.3 - - - - 
Rv2971  oxidoreductase  1.271 0 3.7 - - - - 
Rv2975c  hypothetical protein  -1.0903 0.012 1.2 - - - - 
Rv2976c ung uracil-DNA glycosylase  1.302 0.107 3.3 - - - - 
Rv2977c thiL thiamine monophosphate kinase  0.0048  0.7 - - - - 
Rv2980  hypothetical protein  0.302 0.573 3.4 - - X - 
Rv2984 ppk polyphosphate kinase  0.8605 0.076 1.2 - - - - 
Rv2986c hupB 
DNA-binding protein HU  0.626 0.056 
335.
2 - - - - 
Rv2987c leuD isopropylmalate isomerase small subunit  -0.088 0.812 14.8 - - - - 
Rv2988c leuC isopropylmalate isomerase large subunit  1.5764 0.112 1.4 - - - - 
Rv2989  transcriptional regulator 1.3268 0.002 9.5 - - - - 
Rv2994  integral membrane protein  -0.045 0.927 9.2 - - X - 
Rv2995c leuB 3-isopropylmalate dehydrogenase  1.9376 0.029 2.9 - - - - 
Rv2996c serA1 D-3-phosphoglycerate dehydrogenase  -0.246 0.614 6.3 - - - - 
Rv2997  alanine rich dehydrogenase  -0.5309 0.57 1.9 - - - - 
Rv2999 lppY lipoprotein -0.3189 0.154 12.7 X - - X 
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Rv3001c ilvC ketol-acid reductoisomerase  -0.476 0.219 22.3 - - - - 
Rv3002c ilvH acetolactate synthase 3 regulatory subunit  -0.0144 0.96 11.7 - - - - 
Rv3003c ilvB1 acetolactate synthase 1 catalytic subunit  0.8128 0.066 15.1 - - - - 
Rv3004 cfp6 low molecular weight protein antigen 6 0.2607 0.78 4.4 - - X - 
Rv3005c  hypothetical protein  -0.1814 0.595 15.2 - - X - 
Rv3006 lppZ lipoprotein -0.4463 0.395 34.0 X - - X 
Rv3007c  oxidoreductase  0.42  1.2 - - - - 
Rv3011c gatA 
aspartyl/glutamyl-tRNA amidotransferase 
subunit  
-0.4999 0.042 3.5 
- - - - 
Rv3016 lpqA lipoprotein 0.4404 0.309 4.7 X - - X 
Rv3028c fixB electron transfer flavoprotein subunit alpha  0.9548 0.024 20.5 - - - - 
Rv3029c fixA electron transfer flavoprotein subunit beta  1.1501 0.121 7.5 - - - - 
Rv3033  hypothetical protein  0.1723 0.214 11.4 X - - - 
Rv3034c  transferase  0.2857 0.622 3.4 X - - - 
Rv3035  hypothetical protein  -1.1469 0.31 2.8 - - - - 
Rv3036c TB22.2 hypothetical protein  1.0596 0.004 1.3 X - - - 
Rv3038c  hypothetical protein  -0.6704 0.184 17.0 - - - - 
Rv3040c  hypothetical protein  -0.1294 0.801 3.1 - - - - 
Rv3041c  ABC transporter ATP-binding protein  -0.9004 0.075 17.5 - - - - 
Rv3043c ctaD cytochrome C oxidase polypeptide I  0.061 0.754 33.6 - - X - 
Rv3044 fecB FEIII-dicitrate-binding periplasmic lipoprotein -0.8278 0.136 22.2 X - - X 
Rv3046c  hypothetical protein  -0.7569 0.427 1.1 - - - - 
Rv3049c  monooxygenase  -0.0026 0.991 27.3 - - - - 
Rv3050c  AsnC family transcriptional regulator  0.0532 0.797 0.7 - - X - 
Rv3051c nrdE ribonucleotide-diphosphate reductase subunit  1.4303 0.008 19.4 - - - - 
Rv3052c nrdI ribonucleotide reductase stimulatory protein  1.3316 0.002 18.2 - - - - 
Rv3053c nrdH glutaredoxin electron transport protein NrdH  -0.1379 0.414 0.5 - - - - 
Rv3057c  short chain dehydrogenase  -0.0914 0.865 17.2 - - - - 
Rv3058c  TetR family transcriptional regulator  0.3072 0.145 15.6 - - - - 
Rv3059 cyp136 cytochrome P450 136  -1.4278 0.018 26.0 - - - - 
Rv3062 ligB ATP-dependent DNA ligase  -1.0887 0.003 4.7 - - - - 
Rv3066  DeoR family transcriptional regulator  -0.277 0.551 4.6 - - - - 
Rv3069 ccrB camphor resistance protein CrcB  0.302 0.513 4.1 - X X - 
Rv3071  hypothetical protein  -0.0994 0.773 7.0 - - - - 
Rv3075c  hypothetical protein  0.9255 0.339 1.2 - - - - 
Rv3076  hypothetical protein  -0.2082 0.187 13.2 - - - - 
Rv3077  hydrolase  -1.6661 0.045 9.5 - - - - 
Rv3080c pknK 
serine/threonine- kinase transcriptional 
regulator  
0.5997 0.685 4.2 
- - - - 
Rv3081  hypothetical protein  0.2589 0.591 8.4 - - - - 
Rv3083  monooxygenase  -1.4806 0.001 12.1 - - - - 
Rv3084 lipR acetyl-hydrolase/esterase -0.9057 0.019 11.7 - - - - 
Rv3085  short-chain type dehydrogenase/reductase  0.6372 0.031 21.4 - - - - 
Rv3087  hypothetical protein  0.4924 0.153 14.2 - - - - 
Rv3088  hypothetical protein  -0.4674 0.052 34.7 - - - - 
Rv3090  hypothetical protein  -0.3662 0.363 49.5 - - X - 
Rv3091  hypothetical protein  0.0474 0.736 37.0 - - - - 
Rv3092c  integral membrane protein  0.0596 0.931 1.9 - - X - 
Rv3093c  oxidoreductase  -0.9952 - 0.5 - - - - 
Rv3099c  hypothetical protein  2.7391 0.024 1.6 - - - - 
Rv3101c ftsX 
putative cell division (septation  integral 
membrane protein ABC transporter)  
-0.5414 0.017 37.1 
- - X - 
Rv3102c ftsE 
putative cell division septation component-
transport ATP-binding protein ABC 
transporter)  
-0.3242 0.698 33.2 
- - - - 
Rv3104c  transmembrane protein  -0.1472 0.653 14.4 - - X - 
Rv3116 moeB2 molybdenum cofactor biosynthesis protein -0.3922 0.658 7.4 - - - - 
Rv3119 moaE1 molybdenum cofactor biosynthesis protein E  1.4228 0.076 7.2 - - - - 
Rv3120  hypothetical protein  0.0192 0.938 11.5 - - - - 
Rv3130c tgs1 triacylglycerol synthase  1.2116 0.033 19.9 - - - - 
Rv3132c devS two component sensor histidine kinase 0.7346 0.274 27.8 - - - - 
Rv3133c devR 
two component transcriptional regulatory 
protein 
1.692 0.001 4.6 
- - - - 
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Rv3134c  hypothetical protein  1.8568 0.032 7.5 - - - - 
Rv3136 PPE51 PPE family protein  0.0564 0.926 8.3 - - - - 
Rv3139 fadE24 acyl-CoA dehydrogenase  0.1516 0.77 6.7 - - - - 
Rv3140 fadE23 acyl-CoA dehydrogenase  0.0058 0.981 14.9 - - - - 
Rv3141 fadB4 NADPH quinone oxidoreductase  0.9213 0.444 4.5 - - - - 
Rv3143  response regulator  0.2823 0.553 5.2 - - - - 
Rv3144c PPE52 PPE family protein  -0.5309 0.57 1.9 - - - - 
Rv3145 nuoA NADH dehydrogenase subunit A  0.4282 0.273 13.6 X - X - 
Rv3146 nuoB NADH dehydrogenase subunit B  -0.0777 0.622 18.8 - - - - 
Rv3147 nuoC NADH dehydrogenase subunit C  1.2836 0.031 15.3 - - - - 
Rv3148 nuoD NADH dehydrogenase subunit D  0.3928 0.053 20.7 - - - - 
Rv3149 nuoE NADH dehydrogenase subunit E  0.0564 0.859 14.1 - - - - 
Rv3150 nuoF NADH dehydrogenase I chain F  -0.4154 0.304 13.7 - - - - 
Rv3151 nuoG NADH dehydrogenase subunit G  0.0504 0.79 53.0 - - - - 
Rv3152 nuoH NADH dehydrogenase subunit H  -0.5226 0.249 11.3 - - X - 
Rv3153 nuoI NADH dehydrogenase subunit I  0.4202 0.442 9.2 - - - - 
Rv3154 nuoJ NADH dehydrogenase subunit J  0.466 0.006 5.8 - - X - 
Rv3155 nuoK NADH dehydrogenase subunit K  -0.547 0.079 12.5 - - X - 
Rv3156 nuoL NADH dehydrogenase subunit L  -0.3279 0.368 27.2 - - X - 
Rv3157 nuoM NADH dehydrogenase subunit M  0.245 0.314 49.9 - - X - 
Rv3158 nuoN NADH dehydrogenase subunit N  -0.3958 0.072 40.3 - - X - 
Rv3161c  dioxygenase  1.7992 0.034 4.1 - - - - 
Rv3165c  hypothetical protein  0.302 0.456 7.4 - - X - 
Rv3166c  hypothetical protein  -0.3648 0.422 2.5 - - X - 
Rv3168  hypothetical protein  0.8303 0.229 6.6 - - - - 
Rv3170 aofH flavin-containing monoamine oxidase  -0.0314 0.939 2.8 - - - - 
Rv3173c  TetR/ACRR family transcriptional regulator  0.1412 0.731 8.2 - - - - 
Rv3188  hypothetical protein  1.1137 0.019 1.1 - - - - 
Rv3190c  hypothetical protein  -1.082 0.257 9.7 - - - - 
Rv3193c  
hypothetical protein  -0.3314 0.013 
158.
5 - - X - 
Rv3194c  hypothetical protein  -1.009 0.018 28.0 X - X - 
Rv3196A  hypothetical protein  -0.0903 0.524 1.4 - - - - 
Rv3197  ABC transporter ATP-binding protein  -0.2111 0.069 13.0 - - - - 
Rv3198A  glutaredoxin protein  -0.503 0.345 2.4 - - - - 
Rv3198c uvrD2 ATP-dependent DNA helicase II 0.2998 0.226 11.6 - - - - 
Rv3199c nudC NADH pyrophosphatase  0.302 0.764 3.0 - - - - 
Rv3200c  transmembrane cation transporter  0.3548 0.007 38.5 - - X - 
Rv3202c  ATP-dependent DNA helicase  -0.58  0.8 - - - - 
Rv3204  
DNA-methyltransferase (modification 
methylase)  
0.4471 0.147 1.2 
- - - - 
Rv3205c  hypothetical protein  0.7827 0.001 5.3 - - - - 
Rv3206c moeB1 molybdopterin biosynthesis-like protein -0.7085 0.468 3.5 - - X - 
Rv3207c  hypothetical protein  -0.3036 0.475 12.9 X - X - 
Rv3208A TB9.4 hypothetical protein  -1.4236 0.132 1.6 - - - - 
Rv3211 rhlE ATP-dependent RNA helicase RhlE  0.1266 0.804 8.1 - - - - 
Rv3212  hypothetical protein  -0.0894 0.721 11.5 X - X - 
Rv3213c  SOJ/PARA-like protein  -0.7544 0.392 22.5 - - - - 
Rv3215 entC isochorismate synthase  0.0638 0.864 10.3 - - - - 
Rv3218  hypothetical protein  -0.2646 0.35 14.4 - - - - 
Rv3220c  two component sensor kinase  0.7116 0.293 7.2 - - - - 
Rv3224  short chain dehydrogenase  2.1636 0.022 4.4 - - - - 
Rv3225c  transferase  -0.1777 0.729 7.6 - - - - 
Rv3229c  linoleoyl-CoA desaturase  -0.186 0.676 3.1 - - - - 
Rv3230c  oxidoreductase  -0.3277 0.568 6.9 - - - - 
Rv3232c pvdS transcriptional regulator 0.0946 0.582 49.2 - - - - 
Rv3233c  hypothetical protein  -0.1697 0.603 5.4 - - - - 
Rv3234c  hypothetical protein  0.0192 0.958 7.9 - - - - 
Rv3236c  integral membrane transport protein  1.2164 0.005 3.6 - - X - 
Rv3237c  hypothetical protein  0.302 0.4 22.0 - - - - 
Rv3238c  integral membrane protein  0.7426 0.064 9.5 - - X - 
Rv3240c secA1 preprotein translocase subunit SecA  -0.0558 0.709 56.3 - - - - 
Rv3241c  hypothetical protein  -0.5072 0.114 45.9 - - - - 
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Rv3243c  hypothetical protein  -0.3539 0.023 11.1 - - - - 
Rv3244c lpqB lipoprotein -0.3566 0.218 32.3 X - - X 
Rv3245c mtrB two component sensory histidine kinase  -0.4842 0.203 31.6 - - X - 
Rv3246c mtrA 
two component sensory transduction 
transcriptional regulatory protein 
1.6682 0.2 10.0 
- - - - 
Rv3248c sahH S-adenosyl-L-homocysteine hydrolase  0.2557 0.381 47.1 - - - - 
Rv3249c  TetR family transcriptional regulator  2.3168 0.016 6.1 - - - - 
Rv3253c  cationic amino acid transport protein  0.239 0.846 0.9 - - X - 
Rv3254  hypothetical protein  -0.5187 0.089 12.8 - - - - 
Rv3256c  hypothetical protein  0.8354 0.297 5.0 - - - - 
Rv3259  hypothetical protein  -0.3646 0.445 3.1 - - - - 
Rv3264c manB 
D-alpha-D-mannose-1-phosphate 
guanylyltransferase  
0.2502 0.286 14.1 
- - - - 
Rv3265c wbbL1 
dTDP-RHA:A-D-GlcNAc-diphosphoryl 
polyprenol  
-0.0488 0.824 14.8 
- - - - 
Rv3266c rmlD dTDP-6-deoxy-L-lyxo-4-hexulose reductase -1.223 0.053 10.2 - - - - 
Rv3268  hypothetical protein  -0.7412 0.417 3.3 - - - - 
Rv3269  hypothetical protein  0.8702 0.028 42.3 - - - - 
Rv3270 ctpC 
metal cation-transporting P-type ATPase C  0.3544 0.016 
118.
2 - - - - 
Rv3271c  integral membrane protein  1.6276 0.01 5.7 - - X - 
Rv3272  hypothetical protein  -0.1672 0.759 13.5 - - - - 
Rv3273  
transmembrane carbonic anhydrase  -0.1814 0.01 
101.
0 - - X - 
Rv3274c fadE25 acyl-CoA dehydrogenase  -0.123 0.819 7.9 - - - - 
Rv3275c purE 
phosphoribosylaminoimidazole carboxylase 
catalytic subunit  
0.3112 0.587 2.6 
- - - - 
Rv3276c purK 
phosphoribosylaminoimidazole carboxylase 
ATPase subunit  
0.0048  0.7 
X - - - 
Rv3277  transmembrane protein  -0.5794 0.316 4.0 - - X - 
Rv3278c  transmembrane protein  0.3008 0.049 20.2 - - X - 
Rv3280 accD5 propionyl-CoA carboxylase beta chain  2.0638 0.175 2.5 - - - - 
Rv3282 maf Maf-like protein  0.0252 0.963 3.6 - - - - 
Rv3285 accA3 
bifunctional acetyl-/propionyl-coenzyme A 
carboxylase subunit alpha  
0.8874 0.225 18.0 
- - - - 
Rv3288c usfY hypothetical protein  0.9515 0.17 0.9 - - X - 
Rv3289c  transmembrane protein  0.1136 0.541 0.7 - - X - 
Rv3291c  AsnC family transcriptional regulator  -0.7484 0.429 3.2 - - - - 
Rv3295  TetR family transcriptional regulator  2.571 0 3.8 - - - - 
Rv3296 lhr ATP-dependent helicase  0.3618 0.48 13.3 - - - - 
Rv3297 nei endonuclease VIII  1.302 0.008 1.9 - - - - 
Rv3298c lpqC esterase -1.4236 0.132 3.1 - - - X 
Rv3299c atsB arylsulfatase 0.7129 0.045 18.9 - - - - 
Rv3301c phoY1 phosphate transporter PhoU  -0.0949 0.816 25.6 - - - - 
Rv3302c glpD2 glycerol-3-phosphate dehydrogenase  0.0514 0.844 33.9 - - - - 
Rv3303c lpdA flavoprotein disulfide reductase  -0.9174 0.023 29.4 - - - - 
Rv3311  hypothetical protein  0.7786 0.089 27.6 - - - - 
Rv3316 sdhC 
succinate dehydrogenase cytochrome B-556 
subunit  
-1.044 0.168 2.3 
- - X - 
Rv3317 sdhD 
succinate dehydrogenase hydrophobic 
membrane anchor subunit 
0.1231 0.496 13.4 
- - X - 
Rv3318 sdhA succinate dehydrogenase flavoprotein subunit  -0.224 0.266 47.2 - - - - 
Rv3319 sdhB succinate dehydrogenase iron-sulfur subunit  -0.096 0.803 26.1 - - - - 
Rv3329  hypothetical protein  -0.1016 0.541 9.0 - - - - 
Rv3330 dacB1 penicillin-binding protein -0.4404 0.204 1.6 X - X - 
Rv3331 sugI sugar-transport integral membrane protein 0.3896 0.347 4.3 - - X - 
Rv3334  MerR family transcriptional regulator  -0.1338 0.574 8.7 - - - - 
Rv3335c  integral membrane protein  0.2453 0.348 3.9 - - X - 
Rv3338  hypothetical protein  0.85 0.058 4.9 - - - - 
Rv3359  oxidoreductase  -0.0534 0.977 2.5 - - - - 
Rv3362c  ATP/GTP-binding protein  -0.2178 0.191 17.4 - - - - 
Rv3363c  hypothetical protein  0.107 0.797 3.3 - - - - 
Rv3365c  hypothetical protein  -0.2214 0.047 127. - - X - 
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1 
Rv3373 echA18 enoyl-CoA hydratase  -0.103 0.795 11.2 - - - - 
Rv3376  hypothetical protein  -0.429 0.201 8.7 - - - - 
Rv3377c  cyclase  0.2431 0.781 2.5 - - - - 
Rv3378c  hypothetical protein  0.8538 0.357 4.9 - - - - 
Rv3384c  hypothetical protein  -0.3648 0.561 2.6 - - - - 
Rv3389c htdY dehydrogenase  -0.0486 0.882 1.1 - - - - 
Rv3390 lpqD lipoprotein 0.0188 0.913 82.4 X - X X 
Rv3391 acrA1 short chain dehydrogenase  0.31 0.637 10.2 - - - - 
Rv3392c cmaA1 
cyclopropane-fatty-acyl-phospholipid 
synthase 1  
0  0.0 
- - - - 
Rv3398c idsA1 
multifunctional 
dimethylallyltransferase/farnesyl diphosphate 
synthetase 
-0.5053 0.051 2.6 
- - - - 
Rv3401  hypothetical protein  1.6537 0.008 15.2 - - - - 
Rv3404c  hypothetical protein  1.477 0.242 4.4 - - - - 
Rv3405c  transcriptional regulator -0.6164 0.242 6.4 - - - - 
Rv3406  dioxygenase  -1.261 0.053 1.8 - - - - 
Rv3407  hypothetical protein  0.4402 0.136 4.2 - - - - 
Rv3408  hypothetical protein  0.2181 0.78 8.9 - - - - 
Rv3409c choD cholesterol oxidase precursor  0.063 0.784 23.8 - - - - 
Rv3410c guaB3 inosine 5-monophosphate dehydrogenase  0.1136 0.541 0.7 - - - - 
Rv3411c guaB2 inosine 5'-monophosphate dehydrogenase  1.5698 0.099 13.9 - - - - 
Rv3417c groEL1 
chaperonin GroEL  -0.0179 0.939 
115.
8 - - - - 
Rv3418c groES co-chaperonin GroES  0.9476 0.002 25.1 - - - - 
Rv3419c gcp 
DNA-binding/iron metalloprotein/AP 
endonuclease  
0.0252 0.98 6.8 
- - - - 
Rv3422c  hypothetical protein  0.3586 0.438 4.0 - X - - 
Rv3423c alr alanine racemase  -0.172 0.843 2.3 - - - - 
Rv3435c  transmembrane protein  0.698 0.388 2.2 - - X - 
Rv3436c glmS 
glucosamine-fructose-6-phosphate 
aminotransferase  
-0.2594 0.069 43.7 
- - - - 
Rv3437  transmembrane protein  0.6353 0.339 1.5 - - X - 
Rv3438  hypothetical protein  0.4586 0.157 22.8 - - - - 
Rv3441c glmM phospho-sugar mutase / MRSA protein  0.3662 0.563 7.4 - X - - 
Rv3442c rpsI 30S ribosomal protein S9  0.9984 0.116 11.7 - - - - 
Rv3443c rplM 50S ribosomal protein L13  -0.2102 0.411 16.0 - - - - 
Rv3455c truA tRNA pseudouridine synthase A  -0.1379 0.414 1.1 - - - - 
Rv3456c rplQ 50S ribosomal protein L17  -0.3646 0.715 8.8 - - - - 
Rv3457c rpoA DNA-directed RNA polymerase subunit alpha  -0.4164 0.594 6.1 - - - - 
Rv3458c rpsD 30S ribosomal protein S4  0.8707 0.034 81.3 - - - - 
Rv3459c rpsK 30S ribosomal protein S11  -0.1174 0.761 42.8 - - - - 
Rv3460c rpsM 30S ribosomal protein S13  0.1398 0.581 18.2 - - - - 
Rv3462c infA translation initiation factor IF-1  -0.3844 0.381 8.2 - - - - 
Rv3464 rmlB dTDP-glucose 4,6-dehydratase 0.1939 0.743 1.7 - - - - 
Rv3477 PE31 PE family protein  -0.0238 0.973 4.7 X - - - 
Rv3478 PPE60 PE family protein  -0.9364 0.003 32.3 - - - - 
Rv3479  hypothetical protein  0.1012 0.511 93.7 - - X - 
Rv3480c  hypothetical protein  -0.4562 0.097 26.1 - - - - 
Rv3481c  integral membrane protein  0.0522 0.932 1.0 - - X - 
Rv3482c  hypothetical protein  0.4152 0.411 9.5 - - X - 
Rv3483c  hypothetical protein  0.2054 0.496 10.7 - - X - 
Rv3485c  short chain dehydrogenase  0.048 0.979 1.7 - - - - 
Rv3486  hypothetical protein  0.6352 0.367 1.9 - - - - 
Rv3487c lipF esterase/lipase -0.1527 0.667 14.2 - - - - 
Rv3490 otsA alpha,alpha-trehalose-phosphate synthase  -0.2456 0.208 20.6 - - - - 
Rv3491  hypothetical protein  -0.051 0.819 4.9 X - X - 
Rv3492c  MCE4-associated -0.6102 0.007 18.9 - - X - 
Rv3493c  MCE4-associated -0.0276 0.941 21.9 - - X - 
Rv3494c mce4F MCE4-associated -1.685 0.026 16.5 - - X - 
Rv3495c lprN MCE4-associated lipoprotein -1.43440 0.002 28.3 X - - X 
Rv3496c mce4D MCE4-associated -1.9556 0.023 19.3 - - X - 
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Rv3497c mce4C MCE4-associated -1.4807 0.002 43.5 - - X - 
Rv3498c mce4B MCE4-associated -1.237 0.006 23.0 - - X - 
Rv3499c mce4A MCE4-associated -1.0598 0.001 19.8 X - X - 
Rv3501c yrbE4A MCE4-associated -1.3764 0.003 11.5 - - X - 
Rv3504 fadE26 acyl-CoA dehydrogenase  1.8532 0.093 2.8 - - - - 
Rv3509c ilvX hypothetical protein  -0.4154 0.462 8.8 - - - - 
Rv3516 echA19 enoyl-CoA hydratase  -0.1379 0.414 0.5 - - - - 
Rv3519  hypothetical protein  0.4348 0.479 24.2 - - - - 
Rv3523 ltp3 acetyl-CoA acetyltransferase  -0.7177 0.471 3.0 - - - - 
Rv3525c  siderophore-binding protein  -0.3646 0.659 1.8 - - - - 
Rv3528c  hypothetical protein  -0.3535 0.44 54.9 - - - - 
Rv3537  3-ketosteroid-delta-1-dehydrogenase  -0.0684 0.836 8.4 - - - - 
Rv3545c cyp125 cytochrome P450 125  0.6445 0.018 2.2 - - - - 
Rv3547  hypothetical protein  -0.1242 0.638 43.5 - - - - 
Rv3553  oxidoreductase  -0.8919 0.102 2.0 - - - - 
Rv3554 fdxB electron transfer protein FdxB  -0.5258 0.19 14.4 - - X - 
Rv3568c bphC biphenyl-2,3-diol 1,2-dioxygenase  -0.698 0.057 1.8 - - - - 
Rv3572  hypothetical protein  -1.6637 0.002 2.1 X - - - 
Rv3574  transcriptional regulatory protein TetR-family  -0.9672 0.196 5.1 - - - - 
Rv3575c  transcriptional regulatory protein LacI-family  1.2831 0.379 5.9 - - - - 
Rv3576 lppH lipoprotein 0.0532 0.797 1.5 X - - X 
Rv3581c ispF 
2-C-methyl-D-erythritol 2,4-cyclodiphosphate 
synthase  
-0.2048 0.849 1.7 
- - - - 
Rv3582c ispD 
2-C-methyl-D-erythritol 4-phosphate 
cytidylyltransferase  
-0.2304 0.852 11.4 
- - - - 
Rv3584 lpqE lipoprotein 0.4314 0.13 80.1 X - X X 
Rv3586 disA  DNA integrity scanning protein  0.1636 0.811 2.5 - - - - 
Rv3587c  hypothetical protein  0.3586 0.673 5.6 - - X - 
Rv3588c canB carbonic anhydrase, -0.5598 0.427 2.2 - - - - 
Rv3589 mutY adenine glycosylase -0.503 0.024 12.7 - - - - 
Rv3592 TB11.2 hypothetical protein  1.8302 0.006 2.5 - - - - 
Rv3594  hypothetical protein  -0.5596 0.404 4.1 - - - - 
Rv3596c clpC1 ATP-dependent protease ATP-binding subunit 0.2184 0.486 73.0 - - - - 
Rv3597c lsr2 iron-regulated LSR2 protein precursor  -0.1848 0.716 10.7 - - - - 
Rv3598c lysS lysyl-tRNA synthetase  1.3864 - 1.4 - - - - 
Rv3600c  pantothenate kinase  1.0596 0.004 1.3 - - - - 
Rv3601c panD aspartate alpha-decarboxylase  0.7263 0.252 1.5 - - - - 
Rv3602c panC pantoate--beta-alanine ligase  1.7828 0.034 2.4 - - - - 
Rv3604c  transmembrane protein  -0.1854 0.309 38.9 - - X - 
Rv3606c folK 
2-amino-4-hydroxy-6-
hydroxymethyldihydropteridi ne 
pyrophosphokinase 
-1.0579 0.459 1.6 
- - - - 
Rv3607c folB dihydroneopterin aldolase 0.6353 0.047 2.8 - - - - 
Rv3609c folE GTP cyclohydrolase I  -1.7412 0.036 4.8 - - - - 
Rv3610c ftsH 
membrane-bound protease  (cell division 
protein)  
0.6192 0.01 63.5 
- - X - 
Rv3614c  hypothetical protein  0.0795 0.871 32.4 - - - - 
Rv3615c  hypothetical protein  0.6645 0.04 15.0 - - - - 
Rv3616c  hypothetical protein  -0.406 0.484 13.5 - - - - 
Rv3617 ephA epoxide hydrolase 2.4916 0.015 2.4 - - - - 
Rv3623 lpqG lipoprotein -1.3507 0.216 25.0 X - - X 
Rv3626c  hypothetical protein  -0.3686 0.35 10.3 - - - - 
Rv3627c  hypothetical protein  -1.1495 0.072 20.3 X - X - 
Rv3631  transferase  1.0053 0.156 4.7 - - - - 
Rv3632  hypothetical protein  0.0596 0.689 1.8 - - X - 
Rv3633  hypothetical protein  0.3713 0.09 11.4 - - - - 
Rv3644c  DNA polymerase III subunit delta'  0.0266 0.943 11.4 - - - - 
Rv3645  transmembrane protein  -0.2994 0.359 11.4 - - X - 
Rv3646c topA DNA topoisomerase I  -0.2202 0.623 50.6 - X - - 
Rv3661  hypothetical protein  0.738 0.017 13.1 - - X - 
Rv3662c  hypothetical protein  -0.698 0.104 3.5 - - - - 
Rv3663c dppD peptide ABC transporter ATP-binding protein  -1.387 0.052 7.7 - - - - 
Rv3666c dppA periplasmic dipeptide-binding lipoprotein -1.7659 0.045 5.7 X - X X 
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Rv3667 acs acetyl-CoA synthetase  -0.398 0.41 6.9 - - - - 
Rv3669  transmembrane protein  -0.1136 0.654 56.4 - - X - 
Rv3670 ephE epoxide hydrolase 0.0759 0.883 6.1 - - - - 
Rv3671c  membrane-associated serine protease  -0.783 0.123 19.1 - - X - 
Rv3672c  hypothetical protein  0.3586 0.359 3.2 - - - - 
Rv3673c  membrane-anchored thioredoxin-like protein  -0.1054 0.415 7.2 - - X - 
Rv3674c nth endonuclease III  -0.1354 0.66 2.0 - - - - 
Rv3675  hypothetical protein  0.6353 0.339 3.0 - - X - 
Rv3676 crp CRP/FNR family transcriptional regulator  2.2418 0.001 15.3 - - - - 
Rv3678c  hypothetical protein  -0.893 0.081 2.8 - - - - 
Rv3679  anion transporter ATPase  -0.0596 0.829 10.0 - - - - 
Rv3680  anion transporter ATPase  -0.3952 0.257 45.7 - - - - 
Rv3682 ponA2 penicillin-binding protein 1A/1B  -0.1182 0.633 56.7 X - X - 
Rv3683  hypothetical protein  0.5526 0.2 18.2 - - X - 
Rv3684  lyase  0.0104 0.976 17.9 - - - - 
Rv3685c cyp137 cytochrome P450 137  -0.7612 0.065 20.9 - - - - 
Rv3688c  hypothetical protein  0.961 0.13 5.3 - - - - 
Rv3689  transmembrane protein  -0.0418 0.928 2.4 - - X - 
Rv3690  hypothetical protein  0.7304 0.079 11.7 - - X - 
Rv3691  hypothetical protein  -0.8094 0.014 8.7 - - - - 
Rv3692 moxR2 
methanol dehydrogenase transcriptional 
regulator 
1.1832 0.111 8.8 
- - - - 
Rv3693  hypothetical protein  -0.6176 0.037 26.1 - - X - 
Rv3694c  transmembrane protein  -0.5802 0.283 22.8 - - X - 
Rv3695  hypothetical protein  -0.5462 0.212 7.3 - - X - 
Rv3701c  hypothetical protein  -0.019 0.958 7.6 - - - - 
Rv3703c  hypothetical protein  0.0596 0.689 1.8 - - - - 
Rv3704c gshA glutamate--cysteine ligase  -1.0903 0.012 1.2 - - - - 
Rv3705c  hypothetical protein  -0.4214 0.201 2.5 X - - - 
Rv3708c asd aspartate-semialdehyde dehydrogenase  0.1164 0.504 17.5 - - - - 
Rv3709c ask aspartate kinase  -0.3052 0.4 29.5 - - - - 
Rv3712  ligase  -0.5696 0.461 4.6 - X - - 
Rv3713 cobQ2 cobyric acid synthase -0.8724 0.034 11.1 - - - - 
Rv3714c  hypothetical protein  0.9797 0.029 4.3 - - - - 
Rv3715c recR recombination protein 1.7992 0.006 6.2 - - - - 
Rv3716c  hypothetical protein  -0.1697 0.81 4.1 - - - - 
Rv3718c  hypothetical protein  1.0138 0.075 21.4 - - - - 
Rv3719  hypothetical protein  0.285 0.079 29.9 - - - - 
Rv3720  fatty acid synthase  0.463 0.199 35.9 - - - - 
Rv3721c dnaZX DNA polymerase III subunits gamma and tau  0.0628 0.75 24.7 - - - - 
Rv3723  transmembrane protein  0.1058 0.47 22.2 - - X - 
Rv3726  dehydrogenase  0.3592 0.199 23.9 - - - - 
Rv3729  transferase  0.8644 0.006 31.3 - - - - 
Rv3731 ligC ATP-dependent DNA ligase  0.3112 0.587 2.6 - - - - 
Rv3732  hypothetical protein  -0.0851 0.758 26.6 X - X - 
Rv3734c  hypothetical protein  -0.0652 0.852 56.1 - - - - 
Rv3747  hypothetical protein  0.277 0.23 1.8 - - - - 
Rv3753c  hypothetical protein  -0.1379 0.414 0.5 - - - - 
Rv3758c proV 
(glycine betaine/carnitine/choline/L-proline)  
ATP-binding protein ABC transporter 
-0.1698 0.503 6.8 
- - - - 
Rv3759c proX 
(glycine betaine/carnitine/choline/L-proline) 
binding lipoprotein 
-0.4214 0.407 7.4 
X - - X 
Rv3760  hypothetical protein  0.0252 0.964 6.2 - - X - 
Rv3761c fadE36 acyl-CoA dehydrogenase  0.113 0.803 8.3 - - - - 
Rv3762c  hydrolase  -0.3796 0.453 15.3 - - - - 
Rv3763 lpqH 19 kDa lipoprotein antigen precursor -0.0884 0.364 72.2 X - - X 
Rv3764c  two component sensor kinase  -1.0903 0.012 1.2 - - X - 
Rv3765c  
two component transcriptional regulatory 
protein  
0.2648 0.838 7.4 
- - - - 
Rv3766  hypothetical protein  1.2316 0.009 1.9 - - - - 
Rv3767c  hypothetical protein  0.6354 0.453 2.5 - - - - 
Rv3774 echA21 enoyl-CoA hydratase  0.8392 0.045 8.0 - - - - 
Rv3775 lipE lipase -0.4557 0.184 30.5 - - - - 
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Rv3778c  aminotransferase  -1.8567 0.098 3.3 - - - - 
Rv3779  
transmembrane protein alanine and leucine 
rich  
-0.6338 0.64 3.8 
- - X - 
Rv3780  hypothetical protein  1.9032 0.059 1.0 - - - - 
Rv3781 rfbE O-antigen/lipopolysaccharide ABC transporter 0.4018 0.241 19.7 - - - - 
Rv3782  L-rhamnosyltransferase  0.1796 0.542 17.5 - - - - 
Rv3783 rfbD O-antigen/lipopolysaccharide ABC transporter -1.0733 0.33 2.3 - - X - 
Rv3789  integral membrane protein  0.393 0.376 1.6 - - X - 
Rv3790  oxidoreductase  -1.3336 0.127 4.5 - - - - 
Rv3791  short chain dehydrogenase  -0.4329 0.036 18.0 - - - - 
Rv3792  transmembrane protein  -0.0744 0.831 5.0 - - X - 
Rv3793 embC 
 indolylacetylinositol arabinosyltransferase 
(arabinosylindolylacetylinositol synthase)  
-0.421 0.016 52.2 
- - X - 
Rv3794 embA 
 indolylacetylinositol arabinosyltransferase/ 
arabinosylindolylacetylinositol synthase  
-0.3445 0.054 74.8 
- - X - 
Rv3795 embB 
indolylacetylinositol arabinosyltransferase 
(arabinosylindolylacetylinositol synthase)  
-0.2764 0.068 58.2 
- - X - 
Rv3796  hypothetical protein  -0.2244 0.748 8.5 - X - - 
Rv3799c accD4 propionyl-CoA carboxylase beta chain  1.2202 0.008 6.6 - - - - 
Rv3800c pks13 
polyketide synthase 0.6632 0.002 
221.
7 - - - - 
Rv3801c fadD32 
acyl-CoA synthetase  -0.365 0.152 
163.
1 - - - - 
Rv3802c  hypothetical protein  -0.698 0.12 13.6 - - X - 
Rv3803c fbpD 
secreted MPT51/MPB51 antigen protein FBPD 
( 
-0.52 0.428 12.4 
X - X - 
Rv3804c fbpA secreted antigen 85-A ( 1.1412 0.017 50.0 - X X - 
Rv3805c  transmembrane protein  -0.4632 0.352 17.2 - - X - 
Rv3806c  
phosphoribose diphosphate:decaprenyl-
phosphate phosphoribosyltransferase  
-0.0646 0.963 11.9 
- - X - 
Rv3807c  transmembrane protein  -1.2853 0.124 1.4 - - X - 
Rv3808c glfT UDP-galactofuranosyl transferase GLFT  -0.3156 0.204 24.3 - - - - 
Rv3813c  hypothetical protein  1.9376 0.008 4.2 - - - - 
Rv3814c  acyltransferase  1.1851 0.168 20.6 - - - - 
Rv3815c  acyltransferase  1.0363 0.083 4.6 - - - - 
Rv3816c  acyltransferase  0.7852 0.07 27.6 - - - - 
Rv3818  hypothetical protein  0.5364 0.287 1.5 - - - - 
Rv3819  hypothetical protein  1.2606 0.015 17.3 - - - - 
Rv3824c papA1 polyketide synthase associated protein  -0.0498 0.807 9.8 - - - - 
Rv3825c pks2 
polyketide synthase 0.2949 0.012 
300.
0 - - - - 
Rv3826 fadD23 acyl-CoA synthetase  0.4595 0.694 2.4 - - X - 
Rv3834c serS seryl-tRNA synthetase  -0.6753 0.029 1.9 - - - - 
Rv3835  hypothetical protein  0.9963 0.022 10.5 - - X - 
Rv3841 bfrB bacterioferritin BfrB  0.5666 0.038 21.7 - - - - 
Rv3842c glpQ1 glycerophosphoryl diester phosphodiesterase  -0.4524 0.099 11.2 - - - - 
Rv3843c  transmembrane protein  0.179 0.17 22.2 - - X - 
Rv3846 sodA superoxide dismutase [Fe] SODA  0.1136 0.541 0.7 - - - - 
Rv3849  hypothetical protein  0.5447 0.288 7.7 - - - - 
Rv3850  hypothetical protein  0.7854 0.036 42.0 - X - - 
Rv3852 hns histone-like protein -0.0552 0.751 16.5 - - X - 
Rv3854c ethA monooxygenase 0.5332 0.072 20.4 - - - - 
Rv3864  hypothetical protein  0.0609 0.756 11.5 - - X - 
Rv3865  hypothetical protein  1.1636 0.031 4.1 - - - - 
Rv3866  hypothetical protein  -0.2498 0.624 6.6 - - - - 
Rv3867  hypothetical protein  -0.3746 0.629 5.6 - - - - 
Rv3868  hypothetical protein  2.0177 0.012 8.9 - - - - 
Rv3869  hypothetical protein  0.0702 0.81 21.9 - - X - 
Rv3870  transmembrane protein  0.0664 0.792 58.8 - - X - 
Rv3871  hypothetical protein  0.2591 0.503 55.1 - - - - 
Rv3874 esxB 10 kDa culture filtrate antigen -0.836 0.387 3.3 - - - - 
Rv3876  hypothetical protein  0.5104 0.176 35.0 - - - - 
Rv3877  transmembrane protein  0.1586 0.745 15.0 - - X - 
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Rv3879c  hypothetical protein  0.6919 0.372 2.5 - - - - 
Rv3880c  hypothetical protein  1.1092 0.002 11.3 - - - - 
Rv3882c  hypothetical protein  -0.3346 0.155 39.2 - - X - 
Rv3883c mycP1 membrane-anchored mycosin  -0.2362 0.595 6.0 X - X - 
Rv3884c eccA2 ESX-2 type VII secretion system  1.0068 0.105 5.4 - - - - 
Rv3885c  hypothetical protein  -0.028 0.898 31.6 - - X - 
Rv3886c mycP2 alanine and proline rich mycosin  -0.802 0.019 11.0 X - X - 
Rv3887c  transmembrane protein  -0.7782 0.213 10.2 - - X - 
Rv3888c  hypothetical protein  -0.1161 0.476 47.4 - - - - 
Rv3894c  hypothetical protein  0.001 0.995 68.9 - - X - 
Rv3895c  hypothetical protein  -0.3499 0.185 20.3 - - X - 
Rv3902c  hypothetical protein  1.0048 - 0.5 - - - - 
Rv3908  hypothetical protein  -0.6252 0.018 11.7 - - - - 
Rv3909  hypothetical protein  1.0258 0.003 52.5 X - - - 
Rv3910  
transmembrane protein  -0.3912 0.008 
116.
5 - - X - 
Rv3914 trxC thioredoxin trxC (TRX) (MPT46)  -0.959 0.538 5.1 - - - - 
Rv3915  hydrolase  0.0428 0.864 9.5 - - - - 
Rv3917c parB chromosome partitioning protein 0.3125 0.032 22.0 - - - - 
Rv3918c parA chromosome partitioning protein -1.1878 0.016 12.4 - - - - 
Rv3921c yidC  
putative inner membrane protein translocase 
component  
-0.7448 0.471 19.5 
- - X - 
Rv3923c rnpA ribonuclease P  -0.7412 0.196 5.8 - - - - 
a – An “X” indicates the presence of an N-terminal signal peptide predicted using SignalP v. 4.0 (2) 
b – An “X” indicates the presence of an N-terminal Tat signal peptides as predicted using TatP and TatFind 
c –  An “X” indicates one or more putative transmembrane domains predicted using using TMHMM  v. 2.0 (3)  
d – An “X” indicates a potential lipoprotein containing a putative lipobox-type signal peptide as predicted by the LipoP v. 1.0 
program (1) or using a lipoprotein pattern search against the M. tuberculosis H37Rv genome (4) 
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